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ABSTRACT
ESTABLISHING THE ROLES OF THE DNA BINDING DOMAINS OF
REPLICATION PROTEIN A (RPA)
Nilisha Pokhrel
Marquette University, 2020
During DNA metabolic processes such as replication and repair, double-stranded
DNA is transiently unwound to expose single-stranded DNA (ssDNA). Such ssDNA
intermediates are immediately coated by Replication Protein A (RPA), an essential
single-stranded DNA binding protein present in all eukaryotes. RPA binding to ssDNA
fulfills four goals: 1. The ssDNA is protected from degradation by endo- and exonucleases. 2. A cell-cycle checkpoint signaling cascade is triggered to indicate the
presence of ssDNA. 3. RPA recruits other DNA metabolic enzymes on to the ssDNA. 4.
Finally, RPA promotes the catalytic activity of the recruited enzyme. The overall
objective of my thesis work focuses on deciphering how a single enzyme can coordinate
multiple DNA metabolic processes in the cell to protect genomic integrity.
RPA is a multi-subunit complex composed of four DNA binding domains (DBDsA, B, C and D) and two protein interaction domains (PIDs). The DBDs promote high
affinity binding to ssDNA and the PIDs interact with more than two dozen proteins to
control and coordinate various DNA metabolic processes. The DBDs and PIDs are
tethered by flexible disordered linkers that enable RPA to adopt a variety of
conformations. A long-standing hypothesis posits that specific RPA-conformations drive
a corresponding cellular activity. My thesis work has developed experimental
methodologies to visualize and capture the conformational states of RPA. Furthermore,
we show how RPA-conformations are modulated by RPA-interacting proteins and posttranslational modifications.
The major findings of my thesis research are: i) Establishment of DBDs A, B as
the flexible unit of RPA, and DBDs C, D with RPA14 as the stable unit of RPA. ii)
Existence of four distinct microscopic binding/ dissociation states of DBD-A and DBD-D
in context of full-length RPA iii) DNA structures encountered by RPA affect the
conformational states and arrangement of RPA-DBDs iv) RPA interacting proteins, such
as Rad52, can selectively modify the DNA binding dynamics of a particular DBD. v)
Cooperative binding in Rad52 selectively modulates the DNA binding states of DBD-D
but not DBA-A and vi) Post-translational modification alters microscopic binding states
and conformational arrangement of DBDs on DNA. This alteration can affect both
assembly and stability of the RPA-DNA complex alone, or in the presence of proteins
seeking to displace RPA from DNA.
In summary, this research provides a comprehensive mechanistic insight into
conformational dynamicity attained by individual modules of RPA.
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CHAPTER 1: INTRODUCTION

1.1

Introduction to Replication Protein A (RPA)

“It has not escaped our notice that the specific pairing we have postulated
immediately suggests a possible copying mechanism for the genetic material” – Watson
and Crick, Nature, 1953.
The structure of double-stranded DNA (dsDNA), as noted by Watson and Crick,
is an elegant structural solution to protect genomic integrity. To copy the genetic
information, or to repair it, the dsDNA is unwound and single-stranded DNA (ssDNA) is
transiently exposed. However, ssDNA is prone to chemical and nucleolytic attacks and
can be easily damaged in the cell. In eukaryotes, the ssDNA binding protein Replication
Protein A (RPA), binds to and protects the exposed ssDNA from enzymatic degradation
(R. Chen & Wold, 2014b; Hass, Lam, & Wold, 2012; Zou, Liu, Wu, & Shell, 2006a).
RPA performs four essential functions in the cell: i) It binds to ssDNA with high
affinity (KD >10-10M) and protects it from degradation by exo- and endonucleases. ii)
Formation of RPA-ssDNA complexes triggers the ATM/ATR cellular DNA damage
checkpoint response. iii) RPA physically interacts with over two dozen DNA processing
enzymes and recruits them to the site of DNA damage. iv) Finally, it hands-off the DNA
to these enzymes and correctly positions them on complex DNA structures to facilitate
their respective catalytic activity (Arunkumar, Stauffer, Bochkareva, Bochkarev, &
Chazin, 2003b; Maréchal & Zou, 2015; Oakley & Patrick, 2010; Prakash & Borgstahl,
2012; Stauffer & Chazin, 2004a).

2

Figure 1-1: Multifaceted role of RPA in DNA metabolic processes. Schematic
showing RPA as the central regulatory protein required in most DNA metabolic
process with a single-stranded DNA intermediate. RPA acts a scaffold for assembly
of various factors involved in DNA related transactions, such as, replication,
recombination, transcription, and repair (HR, BIR, alt-EJ, MMR and NHEJ). Posttranslational modification of RPA by appropriate kinases triggers DDR during
replication fork stalling. In addition, RPA acts as cell-cycle checkpoint and is
hyper-phosphorylated by specific kinases during DNA damage eliciting DDR in a
cell-cycle dependent manner. Original diagram generated by Nilisha Pokhrel that
shows the crystal structure of U. maydis RPA (PDB: 4GNX) solved by (Fan &
Pavletich, 2012b).
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The multifaceted roles of RPA and its significance is underscored by the absolute
requirement of RPA in every DNA metabolic pathway that has a ssDNA intermediate:
DNA replication, recombination, transcription, telomere maintenance, replication restart,
and all types of DNA repair (Fig. 1-1) (Cobb et. al., 2005; Hass et. al., 2012; Maréchal &
Zou, 2015; H. D. Nguyen et. al., 2017; Subramanyam, Ismail, Bhattacharya, & Spies,
2016). Such a broad cellular significance has positioned RPA as an attractive target for
chemotherapeutic drug development.
The roles of RPA in vivo and its in vitro biochemical properties have been
extensively studied and reported. However, one long-standing puzzle with respect to
RPA has yet to be solved: RPA binds to ssDNA with very high affinity (KD >10-10M)
(Arunkumar, Stauffer, Bochkareva, Bochkarev, & Chazin, 2003a; Gnügge & Symington,
2017; Lao, Lee, & Wold, 1999), and the ssDNA buried under has to be handed over to
incoming DNA metabolic enzyme that have DNA binding affinities that are orders of
magnitude lower (Gibb et. al., 2014; Iwona M. Wyka, Kajari Dhar, Sara K. Binz, &
Wold, 2003). How is this ‘hand-off’ mechanism orchestrated in the cell? Probing this
fundamental puzzle raises other related questions:
1. Are these hand-off mechanisms unique to different RPA interacting proteins?
2. How does RPA dictate which RPA-interacting enzyme to recruit onto the
ssDNA?
3. How do the cellular signaling processes communicate with and control RPA
activity through post-translational modifications? How do such modifications
work to alter the functional specificity of RPA?
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4. How does RPA respond to the various DNA contexts it encounters, such as 3′
and 5′ ssDNA overhangs?
Answers to some of these puzzles lie in the structural and conformational complexity of
RPA.

1.1.1

Structural Organization of RPA

RPA was originally discovered as a eukaryotic single strand DNA binding protein
(SSBs) through in vitro cell-free SV40 DNA replication reactions in the presence of
SV40 T antigens (Wold, 1997). RPA is a 116 kDa heterotrimeric complex made up of
RPA70, RPA32 and RPA14 subunits, where the number denotes the approximate
molecular weight of the respective polypeptide (Fig. 1-2 a,b). The subunits are also
termed as Rfa1, Rfa2, Rfa3 in Saccharomyces cerevisiae; or RPA1, RPA2 and RPA3 in
other organisms. A finer structural description of RPA can also be made in terms of
individual sub-domains within each subunit. There are six oligonucleotideoligosaccharide (OB) structural folds labeled A, B, C, D, E, and F. Four OB-folds (A, B,
C and D) coordinate high-affinity RPA-ssDNA interactions and we term these as DNA
binding domains (DBDs) (Fig. 1-2 a, b) (E Bochkareva, Belegu, Korolev, & Bochkarev,
2001; Fan & Pavletich, 2012a). The largest subunit, RPA70, harbors DBD-A, DBD-B
and DBD-C. DBD-D resides within RPA32 (Fig. 1-2 a, b). RPA14, which in itself is an
OB-fold (OB-E), interacts with RPA32 and DBD-C of RPA70 to form the trimerization
core and is critical for the stability of RPA heterotrimer (Fan & Pavletich, 2012a).
Flexible linkers tether DBDs A, B (AB-linker) and DBDs B, C (BC-linker). Apart
from the DBDs, there are two structurally well-defined protein-interaction domains
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(PIDs) that mediate RPA binding to RPA-interacting proteins (RIPs) (Binz & Wold,
2008; Haring, Mason, Binz, & Wold, 2008; Oakley & Patrick, 2010; Xu et. al., 2008).
PID70N is located at the N-terminus of RPA70 and is connected by a long (80 aa) flexible
linker (N-linker) to DBD-A. PID32C is located at the C-terminus of RPA32 and is
connected by a shorter (34 aa) disordered linker (C-linker) to DBD-D. In the existing
literature, PID70N is known as OB-F and PID32C is termed the winged helix (Wh) domain.
The final structural feature of RPA is the phosphorylation motif that resides at the Nterminus of RPA32 (Fig. 1-2). This 40-aa long region has multiple serine/threonine
residues and is extensively phosphorylated by specific kinases in a cell-cycle dependent
manner and in response to DNA damage (Binz, Sheehan, & Wold, 2004a; Elena
Bochkareva et. al., 2002a; Dubois et. al., 2017; Maréchal & Zou, 2015; Oakley & Patrick,
2010). The heterotrimeric structure of RPA is stabilized by a three-helix bundle, where
each subunit of RPA contributes a C-terminal -helix towards the bundle formation to
form a constitutive heterotrimer (Elena Bochkareva, Korolev, Lees-Miller, & Bochkarev,
2002b; Fan & Pavletich, 2012a).

6

a)

b)

Figure 1-2: Structural organization of RPA. a) Schematics of the three subunits of
RPA depicting functional domains with their residue numbers for Sc. RPA. The three
DBDs in RPA 70 (DBD-A, DBD-B and DBD-C) are connected by flexible amino acid
(aa) linkers (dashed navy-blue lines) and the fourth DBD (DBD-D) is present in RPA32.
Of the two protein interaction domains, PID70N and PID32C, OB-F, also known as PID70N
is located at the N-terminus of RPA70 and connected by a long N-linker (dashed navyblue line) to DBD-A. Winged helix domain (Wh), also known as PID32C is located
towards the C-terminus of RPA32 and connected by C-linker (dashed navy-blue line) to
DBD-D. The N-terminus of RPA32 consist of a 34aa long phosphorylation domain, also
called the phospho-tail (red line) that is phosphorylated by various kinases in a cell-cycle
dependent manner to induce DDR. RPA14 itself is an OB-fold (OB-E) that does not bind
to ssDNA but is required for stability of the RPA heterotrimer. b) Crystal structure of
U.maydis RPA (PDB: 4GNX) shown as surface representation with DBDs and PIDs. The
color scheme is same as in a), except, the aa linkers are shown as dashed lines (grey). For
representation purposes, PID70N and PID32C were incorporated into 4GNX.
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1.1.2 DNA binding properties of individual DBDs drive the conformational states
of RPA

The flexible linkers allow the DBDs and PIDs to adopt a multiplex of structural
configurations (Brosey et. al., 2009; J. Chen, Le, Basu, Chazin, & Yan, 2015; R. Chen,
Subramanyam, Elcock, Spies, & Wold, 2016b; Chu Jian Ma, Gibb, Kwon, Sung, &
Greene, 2017a; B. Nguyen et. al., 2014a). One can envision RPA as a series of
interconnected Lego blocks that can be arranged and rearranged in many conformations
on its own, and even more when bound on DNA. Adding to this complexity, multiple
RPA molecules form cooperative nucleoprotein filaments on ssDNA (Gibb, Ye, Kwon,
et. al., 2014a; Lavrik et. al., 1999). Thus, both intra-RPA and inter-RPA conformational
assemblies and states can be formed. When one RPA molecule binds to ssDNA, all four
DBDs or a selected subset of DBDs can engage the DNA. Specific binding modes for
RPA have been defined on ssDNA (RPA does not interact with dsDNA). NaCl
concentration and DNA length dependent 8-nucleotide and 30-nucleotide binding modes
have been established. The models posit preferential binding of DBD-A and DBD-B on
to ssDNA in the 8-nt mode and binding of all four DBDs in the 30-nt mode (Fig. 1-3 a, b)
(Arunkumar et. al., 2003a; Elena Bochkareva et. al., 2002b; Iwona M. Wyka et. al.,
2003; Kumaran, Kozlov, & Lohman, 2006). These findings are in line with 4-nt bound to
DBD-A and DBD-B each and 32-nt bound to the entire RPA molecule (Fan & Pavletich,
2012a). These models also stem from early biochemical studies that measured the ssDNA

8
binding affinities of isolated DBDs. In these studies, DBDs A and B were purified
separately, or together, and their ssDNA

a)

b)

Figure 1-3: Nucleotide dependent modes of RPA-DNA binding. Surface diagram of
RPA showing a) Independent motions of DBDs A, B (shown as reflections of two DBDs
with dashed blue arrow) are coordinated (solid blue arrow) upon binding to 8-nt long
DNA. OB-F adopts conformations independent of DBDs A, B (curved pink dashed
arrows) with or without DNA. b) 30-nt mode with all the DBDs bound on ssDNA. Nlinker and C-linker connecting OB-F and Wh domains, respectively, enable movement of
these two PIDs independent of the DBDs. Traditionally, DBDs A, B were assigned as the
high-affinty domains and DBDs C, D with RPA14 (trimerization core) were assigned as
the low affinity domains (brown font). In chapter 3, our results show that DBDs A and B
are the flexible half of RPA and the trimerization core makes the non-flexible half (red
font).
binding constants were determined using electrophoretic mobility band shift analysis: Ka
= 5x105 M-1 (DBD-A), 5x104 M-1 (DBD-B), 2x107 M-1 (DBDs A+B). In comparison, full
length RPA binds to ssDNA with Ka ~1010 M-1. The trimerization core made up of DBDC (RPA70), DBD-D (RPA32) and RPA14 is considered to have a weaker ssDNA binding
affinity (Ka<106M-1) (Arunkumar et. al., 2003a; Iwona M. Wyka et. al., 2003). Thus, the

9
identity of DBD-A and DBD-B as ‘high-affinity’ domains and DBD-C and DBD-D as
‘low-affinity’ domains has been widely established and systemically adopted in
subsequent models for RPA function. Strikingly, the recently solved crystal structure of
the RPA-ssDNA complex shows the trimerization core bound to 17-nts compared to 4-nt
a piece by DBD-A and DBD-B (Fan & Pavletich, 2012a). This finding made us wonder if
the DNA binding properties of the DBDs were different when in the context of fulllength RPA. To probe this question, the DNA binding properties of each DBD has to be
measured whilst keeping the heterotrimeric RPA intact. Based on the structure, we
hypothesized RPA to be made of two halves: the ‘flexible half’ consisting of DBD-A, B
and PID70N, connected by long disordered linkers, and the ‘less-flexible half’ with DBDC, D and RPA14 (trimerization core) that have extensive buried interaction interfaces and
hold the RPA complex as a heterotrimer (Fig.1-8 b). It is again important to note that
individual DBDs can have differential DNA binding affinities in isolation, but when
tethered via linkers, as in the context of full-length RPA, they can function with a greater
complexity. Furthermore, the intra- and inter-domain conformations adopted by
individual DBDs could be different in context of full-length RPA and extend beyond
observations made with the truncated variants. An example is the BC-linker, which
appears to be uncoiled in the apo-form but forms a transient helix upon binding to 10nt or
longer ssDNA and is absolutely required for high affinity DNA binding (Elena
Bochkareva et. al., 2002b; Brosey et. al., 2013; Fan & Pavletich, 2012a; Walther, Gomes,
Lao, Lee, & Wold, 1999). RPA-DNA engagement has also been proposed to follow a
‘sequential binding model (SBM)’, where the ‘high-affinity’ DBDs A and B, being the
prime contributors for RPA-DNA interactions, bind first and help binding of the ‘low-
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affinity’ trimerization core. Given the importance of DBDs in establishing RPA-ssDNA
complexes, in my thesis research, I set out to decipher the DNA binding properties of the
individual DBDs in the context of the full-length RPA. The following is a summary of
my findings:
1. We developed Fluorescence Enhancement through Non-Canonical Amino
Acids (FEncAA), a new tool to monitor the DNA binding dynamics of single
domain in a multi-domain protein such as RPA (N. Pokhrel et. al., 2017).
2. Using FEncAA, we showed that the assignment of DBDs A and B as high
affinity DNA binding domains were inaccurate. In fact, DBD-A was highly
dynamic and easily displaced by the trimerization core, which was stably
bound to ssDNA (Nilisha Pokhrel et. al., 2019).
3. We showed how RPA interacting proteins (Rips) can remodel a specific DBD
to modulate RPA conformations on DNA (Nilisha Pokhrel et. al., 2019).
4. We showed how multiple RPA molecules arrange on DNA and how DBD-A
and DBD-B binding were affected on DNA upon binding of the next RPA
molecule to form cooperative complexes (Yates et. al., 2018).
5. We showed how phosphorylation of RPA altered the dynamics of specific
DBDs leading to the formation of alternate RPA conformations on ssDNA
(Yates et. al., 2018; Pokhrel et. al. unpublished)
6. Finally, we have shown how RPA can form distinct conformations on ssDNA
with overhangs and gaps (Pokhrel et. al. unpublished).
Note: Experimental and mechanisitic interpretation of the word remodeling:

11
Throughout this dissertation, the word ‘remodeling’ is extensively used in a
context-dependent manner. Mechanistically, the modular structure of RPA allows it to
adopt a multitue of conformations, however, defining and capturing these conformations
is experimentally challenging. We use the word ‘remodeling’ to describe the changes in
the conformations that can be adopted by a particular RPA-DBD, and can be measured
with our experimental system that uses stopped-flow or single-molecule TIRF
microscope. The changes in conformations can be caused by several factors: other DBDs
affecting the conformation of a DBD within an RPA heterotrimeric complex (intra-DBD)
(chapter-3), change in conformations of DBDs due to interaction between two RPA
molecules (inter-DBD)(chapter-6), in response to the change in the DNA topology that
DBD encounters, for example, in the form of overhangs versus blocked end DNA
(chapter 4), or, changes in conformations of a DBD in presence of RIP (chapter 3). In all
these scenarios, the information gained from our experimental system relies on composite
changes. Except for smTIRF microscopy, we cannot ascertain the information regarding
the type, extent or number of conformations being affected.

1.1.3 Fluorescence Enhancement through Non-Canonical Amino Acids (FEncAA)
reveals the dynamics of individual DBDs within the RPA heterotrimer.

Studying RPA poses a unique experimental challenge as it is composed of
individual DNA binding domains that have distinct DNA binding properties. DBDs A
and B function as a single unit and are shown to bind with high-affinity. Whereas, DBDs
C, D and RPA14 function as a separate unit, and bind to ssDNA with lower affinity
(Arunkumar et. al., 2003b; Brosey et. al., 2009; Iwona M. Wyka et. al., 2003).
Meanwhile, these domains also cooperate with each other to form specific
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conformational DNA-bound states of the RPA trimer. To gain a complete mechanistic
insight into individual DBD-DNA binding in context of full-length RPA, we sitespecifically incorporated non-canonical amino acids into individual DBDs of RPA and
introduced fluorophores through click-chemistry. This approach enabled us to generate a
DNA-binding specific read out from each DBD while maintaining the RPA trimer intact.
RPA with fluorescent label on either DBD-A or DBD-D produced quantifiable changes
in fluorescence signal upon binding to ssDNA. We positioned the fluorophore such that
the observed changes in fluorescence directly reflects the dynamics (binding,
dissociation, and/or remodeling) of a single DBD in context of full-length RPA. We
termed this methodology “Fluorescent Enhancement through Non-Canonical Amino
Acids (FEncAA)”. In contrast to GFP or RFP based labeling, which are restricted
towards the C- or N-terminus and involve addition of a sterically bulky group,
fluorophores incorporated for FEncAA are relatively small in size and are less likely to
cause problems due to steric hindrance. Furthermore, FEncAA allows us to track the
actions of individual DBDs in a multi-protein complex making it an excellent probe to
understand how DBD-DNA binding dynamics is influenced by RIPs without perturbing
RPA’s structure, function, and biochemical properties.
The proof-of-principle study establishing FEncAA as an experimental tool is
described in Chapter 2. In chapter 3, I present the comparative analysis of two specific
DBDs, their kinetics and dynamics on ssDNA. We showed that DBD-A binds faster to
ssDNA than DBD-D, but is remodeled under conditions where there is not enough
binding sites for all four DBDs to stably engage ssDNA. On the other hand, DBD-D
forms a stable complex with DNA and does not display this remodeling phase. The
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conditional remodeling of DBD-A under sub-stoichiometric concentrations of DNA or
shorter lengths of ssDNA (number of nucleotides ≤ 20) is induced by its own
trimerization core: a phenomenon we termed as ‘intra-DBD remodeling’. Our findings
contradict the long-held belief that DBDs A and B are the high affinity stable DNA
binders. Our work demonstrates that DBDs A and B are flexible, more dynamic and are
functionally utilized to search for free segments of ssDNA. The trimerization core,
meanwhile, ensures stable engagement of the RPA complex on ssDNA.
The intra-domain remodeling in RPA highlights two key facts: first, DBD-A (and
possibly DBD-B) acts as a ‘sensor’ for binding to ssDNA; and second, DBD-D (and
possibly the trimerization core) acts as ‘stabilizer’ for RPA-DNA engagement. In a
cellular context, upon encountering short ssDNA segments, intra-domain remodeling
would allow PID70N adjacent to DBD-A to recruit RIPs while the trimerization core
maintains stable engagement to DNA. Alternatively, on long stretches of DNA, when all
four RPA-DBDs are engaged, it would allow for functional versatility as both PID70N and
PID32C can recruit different RIPs on DNA. As an alternative to the SBM that classifies
the FAB and trimerization cores as the high affinity and low affinity domains,
respectively, we propose FAB to be the ‘flexible, more dynamic half’ and the
trimerization core as the ‘less-flexible, stable half’ of RPA. Our findings and the related
unique methodologies are significant as it allows one to mechanistically probe how fulllength RPA is remodeled on the ssDNA by RIPs – a critical step in all DNA repair
processes.
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1.1.4

Individual DBDs of RPA are intrinsically dynamic in DNA binding

The word ‘dynamic’ has often been used to describe the repertoire of structural
and functional versatility of RPA. Although high-affinity, recently, RPA-DNA binding
has been ascribed to be highly dynamic consisting of several microscopic binding and
dissociation events. Several studies monitoring movement of ssDNA binding proteins are
derived from the motion of bacterial SSB, and in-context of RPA, performed with human
RPA. Despite being functionally homologous, both SSB and RPA diffuse on ssDNA by
unique mechanisms (B. Nguyen et. al., 2014a; Roy, Kozlov, Lohman, & Ha, 2009; Zhou
et. al., 2011). Homotetrameric SSB has three DNA binding modes: a 35-nucleotide (35nt) binding mode engaging two subunits, 65-nt mode engaging all four subunits of the
homotetramer, and a less characterized 56-nt intermediate mode (Bujalowski, Overman,
& Lohman, 1988). Movement of SSB involves a sliding mechanism with formation of
transient DNA bulges to facilitate the sliding process (Zhou et. al., 2011). Unlike SSB,
RPA does not wrap the DNA. Rather, it transitions from an 8-nt mode engaging DBDs A,
B to a 30-nt mode engaging all four DBDs, extending DNA structure in the processes to
resolve any secondary structures. RPA also diffuses about ten times faster than SSB (one
dimensional diffusion coefficient of RPA is 5000 nt2 s-1 and SSB is 270 nt2 s-1 for SSB)
(Fanning, Klimovich, & Nager, 2006; K. S. Lee et. al., 2014; B. Nguyen et. al., 2014a).
When the local concentration of RPA is high, RPA bound to ssDNA readily undergoes
self-exchange with the surrounding RPA in a process also known as ‘facilitated
exchange’ (Gibb, Ye, Gergoudis, et. al., 2014; Gibb, Ye, Kwon, et. al., 2014b; Chu Jian
Ma, Gibb, Kwon, Sung, & Greene, 2017b). This phenomenon of facilitated exchange
could be a global output of events driven by RPA diffusion. Yet, when engaged on
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ssDNA, the components of RPA driving diffusion or facilitated exchange has not been
fully dissected.
Movement/ diffusion/ facilitated exchange of RPA has been captured using
fluorescently labeled human RPA, where, one or all three subunits have terminal
fluorophores incorporated (R. Chen et. al., 2016b; Gibb, Ye, Gergoudis, et. al., 2014; B.
Nguyen et. al., 2014a). Thus, information regarding the movement of the heterotrimeric
complex is known but not with the resolution at the DBD-level. How individual DBDs
move, the number of steps in this movement and the overall underlying mechanism at the
microscopic level driving this movement is still a mystery. A major reason for this gap in
understanding of what fuels diffusion or facilitated exchange of RPA is the inability to
monitor each module (individual DBDs or PIDs) as they engage or disengage on DNA.
This is further compounded by the heterotrimeric modular structure of RPA where
individual modules can exist in a multitude of conformations independent of DNA, and
then transition to several DNA dependent structural conformations. Recent studies
combining NMR, SAXS, molecular tweezers and molecular dynamics simulation
techniques to probe RPA-DNA binding dynamics have proposed that RPA-DNA binding
has inherent nuances which could potentially translate towards tailoring its functional
processivity (Brosey et. al., 2013; J. Chen et. al., 2015; R. Chen et. al., 2016b;
Kemmerich et. al., 2016; B. Nguyen et. al., 2014a). These microscopic events are
proposed to consist of independent or coordinated binding, dissociation, and
rearrangement of individual DBDs and PIDs, while RPA as a heterotrimeric complex
remains fully engaged on DNA on the macroscopic level. These microscopic events have
been proposed to be the drivers for conformational changes in RPA, the diffusion of RPA

16
and could potentially be one of several mechanisms by which a RIP can modulate RPADNA binding to gain access to DNA. However, direct experimental evidence
demonstrating quantitative assessment of these microscopic events and how it could be
relevant to RPA’s functions has been lacking.
Using smFRET and DBD specific fluorescently labeled RPA, we monitored the
binding of DBD-A and DBD-D in context of full-length RPA at the resolution of a
single-molecule. In chapter 3, I will present experimental evidence revealing the presence
of four distinct microscopic binding- dissociation events/ states of both DBD-A and
DBD-D in RPA. Furthermore, I will show that microscopic binding- dissociation states of
DBD-A differ between full-length RPA and FAB (truncated RPA). This is the first
known quantitative assessment showing DNA binding dynamics of RPA at the resolution
of individual DBDs. Our studies show that in context of a full-length RPA, DBD-A and
DBD-D can adopt maximum of four distinct binding states on DNA. Whereas, in the
truncated RPA, DBD-A is able to adopt two distinct binding states on DNA. This
difference in DNA binding states of DBD-A in context of full length RPA versus
truncated RPA further bolsters our reasoning that truncated forms of RPAs provide
partial information relating to regulation of RPA-DNA binding and individual DBDs of
RPA have the potential of regulating the binding events of other DBDs.

1.1.5

RIPs can selectively modulate RPA- DBD dynamics

Extension of RPA dynamics to understand functional processing is further
complicated by the array of RIPs interacting via PIDs, or RIPs interacting with DBDs or
occasionally RIPs interactions involving composite of both (Elena Bochkareva et. al.,
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2005; Ikegami et. al., 1998; D. Jackson, Dhar, Wahl, Wold, & Borgstahl, 2002; Matsuda
et. al., 1995; Xu et. al., 2008). Usually, majority of RPA-RIPs interactions result in
displacement of RPA from DNA. Active displacement of RPA by helicases or ATPases
can be explained by the ATP-powered enzymatic activity of the helicase changing the
DNA architecture along with displacing RPA-DBDs, which would eventually lead to
complete displacement of RPA heterotrimer from DNA (Awate & Brosh, 2017;
Nimonkar et. al., 2011). However, how RIPs with comparatively lower DNA binding
affinities than RPA and devoid of any enzymatic activity displaces RPA from DNA
(Stephen C. Kowalczykowski et. al., 1998; Sugiyama & Kowalczykowski, 2002a) is still
an area of active investigation. Microdomain dynamics (binding, dissociation, and
rearrangement) of DBDs, including diffusion of RPA has been proposed to open patches
of DNA which could then be accessed by RIPs. Upon establishing an initial ‘toehold’ on
DNA, RIPs could change the structure of DNA or push RPA-DBDs, eventually leading
to displacement of RPA (Brosey et. al., 2013; R. Chen et. al., 2016b; Gibb, Ye, Kwon, et.
al., 2014b; Kemmerich et. al., 2016; Chu Jian Ma et. al., 2017a). But do incoming RIPs
selectively modify the microdomain dynamics of a particular DBD or do they equally
impact the dynamics of all DBDs? If a RIP has composite interaction, for example,
Rad52 which interacts with all three subunits of RPA, including PID70N and PID32C, how
will the modulation of microdomain dynamics differ from RIPs that have a single
interaction site with RPA?
To obtain answers to these questions, we implemented smFRET and monitored
the DNA binding dynamics of DBD-A and DBD-D of RPA in the presence of Rad52. In
chapter 3, I will present results demonstrating DBD specific modulation of DNA binding
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states by Rad52. Specifically, Rad52 altered both the frequency and residence time of
each DNA binding state of DBD-D but did not affect the DNA binding states of DBD-A.
In chapter 5, I will present biochemical properties of Rad52 that drive selective
modulation of DBD dynamics. This is the first evidence of selective modulation of DBD
dynamics by a RIP that has interaction with all the DBDs of RPA and provides an
explanation of what drives this selective modulation. Our findings provide a new
mechanism for displacement of RPA form DNA, where an incoming RIP can selectively
change the conformational state of a particular DBD, possibly weakening its overall
binding, ultimately leading to displacement.

1.1.6

Flexibility of DBDs drive RPA assembly on DNA

It has been known for more than two decades that RPA binds rapidly to ssDNA
and this binding is critical for controlled progression of major cellular events. But how do
multiple RPAs assemble on DNA? To date, a high-resolution crystal structure of RPA
depicting multiple RPAs bound on DNA with intact DBDs and PIDs has not been
resolved. However, over the years an approximate mechanism underlying RPA assembly
has evolved. Before the release of the U.maydis RPA crystal structure, a general
consensus was that DBDs A, B being the high-affinity domains were absolutely required
for binding to ssDNA and would sequentially bind to DNA first, obeying the 8-nt mode.
This would then shift the local conformation of DNA, lowering the energy barrier and
enabling the low affinity domains i.e DBDs C, D to sequentially bind to DNA attaining a
30-nt mode. Finally, DBD-D -DNA engagement would be the weakest as DBD-D made
the least contacts with ssDNA and contributed least to RPA-DNA binding (Arunkumar
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et. al., 2003a; Elena Bochkareva et. al., 2002b). The role of RPA14 which lacks a DBD,
in RPA-DNA binding was unclear, as RPA14 did not bind to ssDNA but was required for
the stability of RPA heterotrimer independent of DNA binding. By deduction, this raises
a straight-forward question: if RPA14 only provides structural support to keep the RPA
heterotrimer intact for the purpose of binding to DNA, why is it still present after all four
DBDs are on DNA? A possible answer to this question is that, following DBDs
engagement on ssDNA, RPA14 could play role in RIP recruitment. But a counterargument to this would be that RPA14 has the least known RIP recruitment, as the
majority of RIP interaction is performed by PID70N, PID32C or DBD surfaces (Fanning et.
al., 2006). Therefore, it is conceivable that RPA14 has the potential to interact with
DBDs and PIDs of its own heterotrimeric complex and the neighboring heterotrimeric
complex, as well. This RPA14 mediated interaction would play a significant role in
stabilizing binding of multiple RPAs on DNA. For this to occur, it is imperative that
domains in the vicinity of RPA14 have enough flexibility to interact with RPA14, and
this interaction is stable enough to be captured/ monitored.
The crusade of visualizing assembly/assembled multiple RPAs on DNA has
involved the use powerful microscopy, such as, electron microscopy, atomic force, and
cryo-electron microscopy (cryo-EM) along with biophysical and biochemical tools. This
has provided structural cues ranging from beads-on-a-string to amorphous nucleoparticles
forming an extended shape (J. Chen et. al., 2015; Eckerich, Fackelmayer, & Knippers,
2001; Hamon et. al., 2007). Yet, these studies provide minimal insight into domaindomain interactions involved when at least two RPAs are bound to DNA. Recently, Yates
et. al., resolved cryo-EM structure showing assembly of dimeric Sc. RPAs on DNA. The
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cryo-EM structures had a well-defined electron density of the trimerization core of both
RPA molecules bound to DNA, including poorly resolved additional density which
suggested interaction between two RPAs could be occurring via RPA14 (Yates et. al.,
2018). By modeling (docking) the crystal structures of DBDs A, B and RPA14 in the
additional density, together with measuring the binding affinity between isolated DBD-A
and RPA14 core (lacking the C-terminal trimerization - helix), Yates et. al.
demonstrated that DBD-A of Sc. RPA could directly interact with RPA14 (Yates et. al.,
2018). The cryo-EM structure showed a potentially different path for DNA binding
(linear path) than the crystal structure of U. maydis RPA which showed DNA following a
U-shaped path (Fig. 1-1 center structure). Based on the cryo-EM structure and additional
biochemical analysis, Yates et. al. proposed that DNA is linearized upon engagement
with multiple Sc. RPAs, where, the path of DNA within an RPA is guided by the action
of flexible DBDs, and between RPAs is guided by the synergistic coordination of DBD
motions along with RPA14 mediated interactions of two RPAs (Yates et. al., 2018).
Yates et. al, further demonstrated the significance of RPA14 in assembly of
multiple RPAs by using a phosphomimetic RPA where the serine at position 178 of the
N-linker was mutated to aspartate (RPA-S178D). S178 has been shown to be
phosphorylated by Mec1 kinase during mitosis and in response to DNA damage (Biswas,
Goto, Wang, Sung, & Sugimoto, 2019; Brush & Kelly, 2000; Brush, Morrow, Hieter, &
Kelly, 1996; Majka & Burgers, 2007). Strikingly, introducing a single negative charge in
between PID70N and DBD-A, as in RPA-S178D, resulted in a 3-fold increase in affinity
between DBD-A and the RPA14 core, independent of the 8-nt mode (Yates et. al., 2018).
Compared to RPA-wt, RPA-S178D bound cooperatively but with lower affinity to longer
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ssDNA (> 100-nt). In addition, of the two RPA-S178D bound to ssDNA, the cyro-EM
density of the trimerization core of the first RPA was well resolved but the trimerization
core of the second RPA situated closer towards the 3′ end of DNA was poorly resolved
(Yates et. al., 2018). These finding suggests altered conformational assembly of RPAS178D, particularly in longer ssDNA.
How any phosphorylation event is translated into structural and functional
tailoring of RPA has been an open question. Therefore, to answer how a single-site
phosphorylation event mechanistically influences assembly of multiple RPAs on DNA, I
performed bulk FRET experiments and compared the assembly of wild-type RPAs (RPAwt) and RPA-S178D as a function of increasing lengths of ssDNA (Chapter 6). Bulk
FRET results showed a loss of inter-DBD remodeling for RPA-S178D, possibly due to
reduced flexibility of DBD-A as it interacts strongly with RPA14. In addition, RPAS178D complex was resistant to clearing by Srs2 helicase than RPA-wt, suggesting a
direct implication of this phosphorylation event in the pre-synaptic phase of HR.

1.1.7

DNA context affects DBD dynamics

DNA processing requires RPA to bind ssDNA presented in different contexts. For
example, the primer template junction encountered during replication initiation is
different than the chicken-foot-structure during elongation, or the 3′ overhang following
end resection in homologous recombination, which is different than the transient ssDNA
encountered during transcription. When ssDNA is present in long-stretches, a subset of
the RPA population will encounter the ssDNA-dsDNA junction, whereas subsequent
binding by the rest of the RPA will bind to ‘normal’ ssDNA i.e. away from the ssDNA-
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duplex junction. This phenomenon is further compounded when RPA loading is
simultaneous with functioning of another DNA modifying enzyme. For example, during
unwinding of dsDNA by DNA helicases, DNA toplogy encountered by RPA close to the
helicase is different than the RPAs that occupy ssDNA space farther away from the
helicase (Wouter L. de Laat et. al., 1998; Raney, Byrd, & Aarattuthodiyil, 2013). Based
on the cryo-EM structure (and as mentioned in section 1.3.6), it could be hypothesized
that RPA14 could be fulfilling a ‘moonlighting’ role in tailoring passage of DNA
between RPA molecules in specific DNA contexts. But the polarity of DNA ‘sensed’ by
individual DBDs of an incoming RPA is highly affected by the ongoing cellular
processes and the DNA-context in which ssDNA is presented to RPA (for example,
overhangs, junctions, forks etc.). Consequently, there has to be a mechanism in place by
which RPA can coordinate ssDNA binding when ssDNA is presented in different DNAcontexts as it requires DBDs to ‘sense’ the polarity and optimize binding to DNA
accordingly. In addition, DBD, PIDs and linkers have to regulate their intrinsic
flexibility, and potentially adopt a particular conformation to be able to interact with
RIPs.
Therefore, to investigate if the ssDNA encountered by RPA in various DNA
contexts affects the binding of RPA-DBDs, I performed stopped flow experiments with
RPA-DBD-Af, RPA-DBD-Df and three types of DNA structures (5′ overhang, 3′
overhang and ssDNA flanked by DNA duplexes (blocked end DNA)). In chapter 4, I will
present experimental results that show trimerization core induced intra-DBD remodeling
of DBD-A requires a free 5′ end of DNA. This result provides mechanistic insight into
the previous observation showing the trimerization core to be sufficient for stable
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engagement to a 5′ overhang DNA (R. Chen et. al., 2016b; W. L. de Laat et. al., 1998;
Pestryakov, Khlimankov, Bochkareva, Bochkarev, & Lavrik, 2004).
DBD-A is situated towards the 5′ end of DNA and under the conditions of shorter
lengths of DNA or scarcity of binding sites, is remodeled by the trimerization core.
Therefore, any blockage at the 5′ end could exert significant steric clashes or tension in
microdomain dynamics of DBD-A and possibly DBD-B, and both DBDs A, B tethered
via AB-linker as a unit. Arrangement of DBDs on a particular DNA substrate, restricted
conformational freedom, and modulation of existing RPA-protein interactions by an
incoming RIP under these conditions could be a possible way of selectively handing over
DNA to a specific RIP during a specific DNA event.
Recent technological advancements in crystallographic and biophysical tools have
enabled access to structural and functional insights of megadalton complexes. In multidomain proteins like RPA, a combination of these techniques is proving to be invaluable
in understanding how these domains arrange, move, coordinate protein-DNA transactions
and fundamentally behave as a ‘master of all trades’.
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CHAPTER 2: MONITORING REPLICATION PROTEIN A (RPA) DYNAMICS
IN HOMOLOGOUS RECOMBINATION THROUGH SITE-SPECIFIC
INCORPORATION OF NON-CANONICAL AMINO ACIDS

2.1 Introduction

Enzymes that bind and function on DNA are necessary for all DNA metabolic
processes such as replication, recombination, repair, and transcription. Multiple DNA
binding proteins function together to catalyze these processes (Nord, 2009). Measuring
the DNA binding properties of a single enzyme is relatively straightforward. However,
when more than one enzyme is present in the reaction, determining the sequence of
binding, and how the presence of one enzyme influences another is required to determine
the overall mechanism of action. In multi-protein, steady-state experiments, the
contribution of an individual enzyme is often probed by varying the concentration of the
target enzyme relative to all other components (including the DNA substrate). Such
experiments do not yield the microscopic rate constants of the individual steps in the
reaction which are required to decipher the complete mechanism of action. Moreover,
transient-kinetic tools are required to capture rapid conformational changes in proteins,
and this information sheds light on how the various proteins interact with each other and
the DNA template. The use of fluorescently-labeled DNA substrates serve as excellent
tools to monitor overall reaction kinetics or to characterize the DNA binding/dissociation
dynamics of a single protein (Anderson, Larkin, Guja, & Schildbach, 2008; Hwang &
Myong, 2014; Song, Graham, & Loparo, 2016; Valuchova, Fulnecek, Petrov, Tripsianes,
& Riha, 2016). For example, short oligonucleotides have been labeled with fluorophores
to monitor the outcome of DNA recombination (Ragunathan, Joo, & Ha, 2011),
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assembly/disassembly of Rad51 nucleoprotein filaments (Antony et. al., 2009b; Danyal
et. al., 2016), track protein movement on DNA and RNA (Fischer & Lohman, 2004;
Lucius et. al., 2002; Rasnik, Myong, Cheng, Lohman, & Ha, 2004), and to capture DNA
unwinding (Bjornson, Amaratunga, Moore, & Lohman, 1994; Fischer, Tomko, Wu, &
Lohman, 2012). Such an approach is limited by the read out from the DNA substrate and
the contribution of individual enzymes cannot be interpreted when multiple proteins are
present in a reaction.
To capture the sequence of binding and dynamics of each enzyme in a multiprotein reaction, one approach is to obtain a direct, quantifiable signal from a fluorescent
label positioned on the individual protein that can undergo a change in fluorescence upon
binding to DNA (Davenport, Harris, Origanti, & Antony, 2016; Fischer & Lohman,
2004). The changes in fluorescence help ascertain enzyme dynamics on DNA and how
such dynamics are influenced by the presence of other DNA binding proteins in the
reaction. Ensemble and single-molecule based fluorescence spectroscopy serve as
powerful tools to investigate enzyme function on nucleic acid substrates, but are reliant
on the generation of proteins tagged with genetically encoded fluorophores such as eGFP
or mCherry (Collins, Ye, Duzdevich, & Greene, 2014; Gorman et. al., 2012; Redding &
Greene, 2013). These tags are large in size, have positional constraints, are likely to
interfere with activity (Fischer, Wooten, Tomko, & Lohman, 2010), and potentially
inhibit protein-protein interactions (Lisby, Barlow, Burgess, & Rothstein, 2004). The
attachment of large genetically-encoded fluorophores is particularly problematic for
smaller DNA binding proteins such as Rad51, RecA or Dmc1, that function by forming
cooperative nucleoprotein filaments on DNA. Finally, attachment of genetically encoded
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fluorophores is often limited to the N- and C-terminal ends of the candidate proteins. Due
to the positional constraints, and their size, they cannot be site-specifically introduced in
internal regions of a protein, which is often necessary to capture conformational
movements and for Förster Resonance Energy Transfer (FRET) studies (Hillisch, Lorenz,
& Diekmann, 2001). Small, chemical fluorophores circumvent many of these issues, and
can be site-specifically placed anywhere in the primary sequence of a protein.
The most commonly used approach to site-specifically attach fluorescent probes on
proteins relies on maleimide-thiol chemistry to cysteine residues (Fox & Kennedy, 1965).
While robust, this approach suffers from the need to generate a single cysteine bearing
functional version of the target protein. This approach is not feasible in proteins where
multiple cysteines are important for function or folding. In addition, screening and isolating
modifiable cysteines in multi-cysteine proteins is time-intensive. This problem is
circumvented using non-canonical amino acids (ncaa), an attractive strategy to engineer
site-specific fluorescently labeled versions of proteins without the need to generate a
single-cysteine version of a protein (C. C. Liu & Schultz, 2010; Young & Schultz, 2010).
The ncaa methodology uses an amber suppressor stop codon (UAG) to mark the site of
incorporation in the protein of interest. Co-expression of the TAG-construct along with a
cognate pair of tRNAAUG and tRNA synthetase, specific to ncaa recognition and
incorporation, generates the site-specific ncaa carrying protein. This methodology has been
successfully used to directly incorporate fluorescent-ncaas (Chatterjee, Guo, Lee, &
Schultz, 2013; H. S. Lee, Guo, Lemke, Dimla, & Schultz, 2009; Summerer et. al., 2006),
or ncaas carrying functional groups that can subsequently be covalently attached to
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fluorophores using click-chemistry (Blizzard et. al., 2015; Leisle, Valiyaveetil, Mehl, &
Ahern, 2015; Miyake-Stoner et. al., 2009; Peeler & Mehl, 2012).
Using the ncaa approach, we sought to address the function of Replication Protein
A (RPA), a key enzyme in various DNA metabolic processes (R. Chen & Wold, 2014b;
Hass et. al., 2012). RPA is essential for survival and functions as a single-stranded DNA
binding protein during DNA replication, replication restart, repair, recombination,
transcription, and telomere maintenance (Binz et. al., 2004a). In addition, RPA has also
been shown to resolve R-loop and G-quadruplex secondary structures (H. D. Nguyen et.
al., 2017; Salas et. al., 2006). Binding of RPA to ssDNA in the cell also serves as a
signaling cue to initiate DNA repair processes acting as a binding platform for the
recruitment of various DNA processing enzymes (Zou, Liu, Wu, & Shell, 2006b). Recent
evidence also points to RPA facilitating the re-establishment of chromatin structures after
DNA replication and repair (S. Liu et. al., 2017). In each of these biologically important
reactions, RPA functions in the presence of several other proteins capable of binding to
DNA, e.g., polymerases, helicases, histones, etc.
RPA plays an indispensable role in homologous recombination (HR), a critical
DNA repair pathway that corrects double stranded DNA (dsDNA) breaks in the genome
(Binz et. al., 2004a; Roy et. al., 2009; Zou et. al., 2006b). Defective HR leads to genomic
rearrangements and chromosomal defects often resulting in hereditary cancers and
cancer-prone diseases such as Fanconi Anemia and Bloom’s syndrome (Daley, Gaines,
Kwon, & Sung, 2014; Daley, Kwon, Niu, & Sung, 2013). In addition to DNA repair, HR
is fundamental to the maintenance of gametic diversity during meiotic crossover events.
During HR, dsDNA at the site of a break is resected to yield long stretches of single
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stranded DNA (ssDNA), which serve as a template for the nucleation of the Rad51
recombinase and formation of nucleoprotein filaments. Rad51 functions as the central
engine in HR by performing ATP-dependent strand exchange (S C Kowalczykowski,
2000; S C Kowalczykowski, Dixon, Eggleston, Lauder, & Rehrauer, 1994). In the cell,
the resected ssDNA is rapidly coated by RPA to protect it from nucleolytic degradation,
and this step has been shown to activate the DNA damage response through several
checkpoint kinases (Zou et. al., 2006b). To promote HR, RPA must first be displaced
from the ssDNA, thus allowing formation of the Rad51 nucleoprotein filament. Prorecombinogenic mediator proteins such as Rad52 and BRCA2 have been shown to
promote Rad51 binding to ssDNA by displacing RPA (Tomko, Fischer, & Lohman,
2012; C. G. Wu, Bradford, & Lohman, 2010; Xie, Wu, Weiland, & Lohman, 2013). The
Rad51 nucleoprotein filament then catalyzes strand exchange to drive homologous
recombination. Similarly, in other instances where homologous recombination is
inhibited, Rad51 filaments are disassembled by anti-recombinogenic mediators such as
the Srs2 helicase (Antony et. al., 2009b; Krejci et. al., 2003; Seong, Colavito, Kwon,
Sung, & Krejci, 2009). In Rad51 filament clearing reactions, RPA is proposed to
sequester naked ssDNA once the Rad51 molecules are removed by Srs2 (Macris & Sung,
2005). While RPA has been shown to regulate several steps in HR, its precise mode of
action in these events is not clearly understood.
The complexity of RPA function in multi-protein contexts necessitates the need
for a site-specifically labeled fluorescent RPA probe to tease out its mechanism of action
in the presence of other DNA binding proteins. The technical complexity in sitespecifically labeling RPA arises from its heterotrimeric arrangement. RPA is composed
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of three subunits - RPA70, RPA32 and RPA14, and contains six oligosaccharideoligonucleotide folds (OB-folds) and four DNA-binding domains (DBD) (E Bochkareva
et. al., 2001; Fan & Pavletich, 2012a). Three of the DBD’s reside on the large RPA70
subunit and the fourth one lies in the RPA32 subunit (Fig. 2-2 a). The DBD’s are
connected by flexible linkers that enable RPA to exist in multiple conformational states
on DNA (R. Chen et. al., 2016b). The individual DBD’s play disparate roles in ssDNA
binding and have been shown to modulate the strength of RPA-ssDNA interactions
and/or its sliding/diffusion on DNA (B. Nguyen et. al., 2014b). DBD’s A and B in
RPA70 are the dominant contributors that cooperatively bind to ssDNA with high affinity
(Ka > 2x107 M-1) (Arunkumar et. al., 2003a). The order of DBD binding and their
orientation on ssDNA controls the polarity of RPA and associated activities (W. L. de
Laat et. al., 1998; Iftode & Borowiec, 2000; Changsoo Kim, Paulus, & Wold, 1994). Our
understanding of how RPA binds to DNA stems from elegant biophysical
characterization of its kinetic and thermodynamic properties (C Kim, Snyder, & Wold,
1992; Kumaran et. al., 2006; B. Nguyen et. al., 2014b; Patrick & Turchi, 2001;
Yuzhakov, Kelman, Hurwitz, & O’Donnell, 1999). How these properties are affected in
the presence of other proteins such as the Rad51 recombinase or mediator proteins such
as Rad52 or BRCA2 remains poorly resolved. Recent advancements in single-molecule
fluorescence microscopy has enabled the study of RPA dynamics on long DNA
substrates in the presence of multiple DNA binding proteins, (Gibb, Ye, Gergoudis, et.
al., 2014; Gibb, Ye, Kwon, et. al., 2014a; Chu Jian Ma et. al., 2017b) but are limited by
resolution of the imaging technology. Thus far, these experiments have been reliant on
genetically encoded fluorophores with the limitations described above. Our ncaa

30
approach overcomes several of these limitations and enables the study of RPA dynamics
in multi-protein reactions.
In this chapter, we describe A) the development of a Saccharomyces cerevisiae
RPA probe (RPAf), labeled at a single site in the heterotrimeric complex using a
combination of ncaa and bio-orthogonal chemistry. This methodology circumvents the
need for maleimide chemistry to covalently attach fluorophores or create a singlecysteine version of the protein, thereby leaving all Cys residues in RPA intact and
rendering a fully functional protein. B) This approach also enables us to perform single
molecule total internal reflection fluorescence (TIRF) microscopy-based investigation of
protein dynamics without the need for genetically encoded fluorophores.C) We have
identified a unique position in the RPA32 subunit which enables strategic attachment of a
fluorescent reporter that does not affect RPA function, but yields a quantifiable change in
fluorescence upon binding to ssDNA. D) Finally, using RPAf, we describe the kinetics of
RPA binding, dissociation, facilitated self-exchange, and facilitated exchange in the
presence of Rad51 and HR-mediator proteins.

2.2 Materials and Methods

2.2.1 Materials

Standard laboratory chemicals and protease inhibitor cocktail (PIC) were
purchased from Sigma-Aldrich (St. Louis, MO) and Research Products International (Mt.
Prospect, IL). Q-sepharose, Heparin and S200 size exclusion chromatography columns
were from GE Healthcare (Pittsburgh, PA). Ni2+-NTA agarose was from Gold
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Biotechnology (St. Louis, MO). Biogel-P4 resin was from Bio-Rad Laboratories
(Hercules, CA). Enzymes for molecular Biology were from New England Biolabs
(Ipswich, MA). Oligonucleotides were purchased from Integrated DNA Technologies
(Coralville, IA). Fmoc-4-amino-phenylalanine was from Angene International Ltd.
(Nanjing, China), and was used to prepare 4AZP, in collaboration with Dr. Christopher
Dockendorff (Department of Chemistry, Marquette University). Commercial 4azidophenylananine was purchased from Chem-Impex International (Wood Dale, IL).
MB543 DBCO was purchased from Click Chemistry Tools (Scottsdale, AZ). Alexa Fluor
594 DIBO alkyne and BL21Ai cells were purchased from ThermoFisher Scientific
(Waltham, MA).
Note: 4AZP was prepared by Dr. Disha Gandhi, a graduate student in the lab of
Dr. Dockendorff at the time, and the full protocol is not mentioned in this dissertation. It
is available at (N. Pokhrel et. al., 2017)

2.2.2 Plasmids for protein overexpression and ncAA incorporation

The plasmid expressing all three subunits of RPA (p11d-tscRPA) was a kind gift
from Dr. Marc Wold (University of Iowa). The amber suppression stop codon (TAG) in
RPA14 was substituted with an ochre stop codon (TAA), and a C-terminal 6X
polyhistidine tag was incorporated in RPA32 using Q5 site directed mutagenesis (New
England Biolabs, Ipswich, MA). Finally, a single TAG stop codon was introduced at
position W101 in the RPA32 subunit marking the site for incorporation of p-azido-Lphenylalanine (4AZP). Plasmids for 4AZP incorporation are as described (Hammill,
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Miyake-Stoner, Hazen, Jackson, & Mehl, 2007; Miyake-Stoner et. al., 2009; Peeler &
Mehl, 2012).

2.2.3 Expression and purification of proteins

Wild type RPA was overexpressed in BL21Ai cells containing plasmid p11dtscRPA and purified as described (Sibenaller, Sorensen, & Wold, 1998) with the
following modifications. 4 L Luria-broth cultures were grown for each protein
preparation. Cells were induced with 0.4 mM IPTG and 0.05 % (w/v) L-arabinose when
they reached OD600 = 0.6, and grown for an additional 3 hours at 37 ºC. Harvested cells
were resuspended in 120 ml cell resuspension buffer (30 mM Hepes, pH 7.8, 300 mM
KCl, 0.1 mM EDTA, protease inhibitor cocktail, 1 mM PMSF, 10 % v/v glycerol and 10
mM imidazole). Cells were lysed using 400 μg/ml lysozyme followed by sonication.
Clarified lysates were fractionated on a Ni2+-NTA agarose column. Protein was eluted
using cell resuspension buffer containing 400 mM imidazole. Fractions containing RPA
were pooled and diluted three-fold with buffer H0 (30 mM Hepes, pH 7.8, 0.1 mM
EDTA, pH 8.0, 1 mM DTT, and 10 % v/v glycerol). The diluted protein sample was then
fractionated over a Q-sepharose column equilibrated with buffer H100 (buffer H0 with 100
mM KCl). Protein was eluted with a linear gradient H100 – H400 (superscript denotes final
KCl concentration in the buffer). Fractions containing RPA were pooled and diluted with
H0 buffer to match the conductivity of buffer H100, and further fractionated over a 10ml
Heparin column. Protein was eluted using a linear gradient H100-H1000, and fractions
containing RPA were pooled and concentrated using an Amicon spin concentrator (30
kDa molecular weight cut-off). RPA was dialyzed into storage buffer (30 mM Hepes, pH
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7.8, 30 mM KCl, 2 mM DTT, and 10 % v/v glycerol), flash frozen using liquid nitrogen,
and stored at -80 ºC. RPA concentration was measured spectroscopically using 280 =
98,500 M-1cm-1.
To obtain RPA carrying 4AZP, the p11d-tscRPA-TAG32-101 plasmid, which
contains the TAG at position 101 in the RPA32 subunit, was cotransformed into BL21Ai
cells with the plasmid pDule2-pCNF containing the orthogonal tRNAUAG and tRNA
synthetase for 4AZP (Fig 2-2 a) (Miyake-Stoner et. al., 2009; Peeler & Mehl, 2012).
Cotransformants were selected using both ampicillin (100 μg/ml) and spectinomycin (50
μg/ml). An overnight culture (50 ml) from a single colony was grown in LB media
containing ampicillin and spectinomycin. 10 ml of the overnight culture was added to 1 L
of minimal media. The minimal media for ncaa incorporation was prepared as previously
described (Hammill et. al., 2007), but lactose was excluded. Cells were grown at 37 °C
until the OD600 reached 2.0 and then induced with 0.4 mM IPTG and 0.05 % L-arabinose
along with 1 mM 4AZP. The 4AZP solution was prepared by first dissolving 206 mg in
250 μl of 5 M NaOH, vortexed extensively, and then adjusted to 8 ml with H2O, and the
entire mixture was added to 1 L of media to achieve a 1 mM final concentration.
Induction was carried out at 37 ºC for 3 hours. Cells were resuspended in cell
resuspension buffer and purified as described above for wild type RPA. Care should be
taken not to add DTT during purification of RPA4AZP as it interferes with downstream
click chemistry reactions. RPA4AZP was flash frozen and stored at -80 °C. Srs2 and Rad51
were purified as described (Antony et. al., 2009b). Escherichia coli SSB was purified as
described (Lohman, Green, & Beyer, 1986).
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Note: We have made subtle changes to the purification process of both wild-type
RPA and fluorescently labeled RPA, which are described in chapter 3. Except for this
chapter, all the chapters requiring purification of wild-type RPA, RPA with mutations,
and fluorescent RPA variants were conducted by following the protocol described in
chapter 3.

2.2.4 Bio-orthogonal labeling of RPA

~2.5 ml of 20 μM RPA4AZP was incubated with 1.5 molar excess (30 μM) of
DBCO-MB543 (an alkyne derivatized fluorophore) in labeling buffer (30 mM Hepes, pH
7.8, 300 mM KCl, and 10 % v/v glycerol) for 1 hour at 4 ºC temp. Labeled RPA (RPAf)
was separated from excess dye using Biogel-P4 gel filtration (50 cm x 2 cm bed volume),
in storage buffer (30 mM Hepes, pH 7.8, 30 mM KCl, and 10 % v/v glycerol). Labeling
efficiency was calculated using absorption values at 280 nm and 550 nm and 280 =
98,500 and 550 = 105,000 for RPA and MB543 fluorophore, respectively. When
measuring the concentration of RPAf, a correction factor of 0.127 was applied to the
protein absorbance value at 280 nm to correct for the contribution of MB543 dye
absorbance at 280 nm. See appendix II (section 9.1-9.4) for detailed procedure.

2.2.5 Fluorescence measurements

Fluorescence spectra were obtained using a PTI QM40 instrument (Horiba
Scientific, Edison, NJ, USA). 100 nM of ssDNA [(dT)97] or plasmid dsDNA (100 nM
nucleotides) were added to quartz cuvettes containing 2 ml solutions of 100 nM RPAf in
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reaction buffer (30 mM HEPES, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM βmercaptoethanol and 6% (v/v) glycerol). Samples were excited at 535 nm and emission
spectra (555–580 nm) were recorded. All experiments were performed at 25 °C.

2.2.6 DNA binding

The DNA binding activity of RPAf was measured using electromobility band shift
analysis. To generate a 5′ 32P-(dT)35, in vitro Polynucleotide kinase reaction (PNK) with
1M (dT)35 in presence of 32P-ATP was performed. Briefly, to prepare 100l of 1M
32P-

(dT)35, in a 1.5ml microfuge tubes, 10l of 10X PNK buffer (NEB, Ipswich, MA),

10l of 10M (dT)35, 2l of stock PNK enzyme (NEB, Ipswich, MA), 5l of 250Ci
32P-ATP

(commercial stock) and 73 l of MilliQ water were added, vortex gently to

ensure proper mixing, spun down for ~10 sec using a table- top centrifuge and incubated
at 37oC for 2 hours. Excess 32P-ATP was separated from 32P- (dT)35 using MicrospinTM
G-25 columns (GE) as per the manufacturer’s protocol. To ensure complete separation,
25 l of the radiolabeled reaction was loaded per column. Thus, in total, 4 columns were
used for separation of 32P- (dT)35 from residual 32P-ATP and the clarified 32P-(dT)35 was
pooled in a single 1.5ml microfuge tube. For a total reaction volume of 20l, 50 nM of
32

P-(dT)35 oligonucleotide was incubated with increasing concentrations of RPA or RPAf

(0 – 1 μM) in reaction buffer for 10 minutes at 4 ºC. 1 μl of DNA loading dye (50 % v/v
glycerol and 0.2 % w/v bromophenol blue in 1 X TBE) was added to the reaction and
mixed thoroughly, following which 20ul samples were resolved using an 8 % TBEacrylamide gel at 110 volts for 45 minutes (composition per gel: 2ml of 10x TBE, 1ml of
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40% bis- acrylamide, 100l of 10% APS, 20 l of TEMED, 6.9ml of MilliQ H2O,
polymerized at room temperature). Gels were exposed overnight onto a phosphorimaging
screen and scanned using a STORM scanner (GE Healthcare, Pittsburgh, PA). Bound and
unbound DNA signals were quantitated using ImageQuant software and the fraction
ssDNA bound to RPA was calculated using the equation:
((bound 32P signal)/(bound 32P signal + unbound 32P signal))*[ssDNA]

(Eq. 1)

2.2.7 Stopped-Flow assays of RPA binding

All stopped-flow experiments described below to monitor RPAf dynamics were
performed on an Applied Photophysics SX20 instrument (Surrey, UK) in reaction buffer
(30 mM Hepes, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM -mercaptoethanol and 6 %
v/v glycerol) at 25 °C. Samples were excited at 535 nm and emission was monitored
using a 555 nm cut-off filter (Newport corp., Irvine, CA).

2.2.8 RPAf-ssDNA binding kinetics

To quantitate RPAf binding to ssDNA, 100 nM RPAf was rapidly mixed with 30
nm (dT)97 oligonucleotide (post-mixing concentrations). Assuming a binding site size of
18-20 nt for RPA (Kumaran et. al., 2006), we expect 4-5 molecules to occupy each (dT)97
oligonucleotide in our experiment. Data were fit to a single exponential plus linear
equation to obtain observed rate constants:
F = A (1 - e-k1t) + k2t

(Eq. 2)
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Where, F is change in RPAf fluorescence, A and k1 are the amplitude and
observed rate of the exponential phase, k2 is the steady state rate and t is time. To
measure non-specific changes in RPAf fluorescence in the presence of other proteins, 100
nM RPAf was mixed with Rad51 (0.97 μM) or Srs2 (200 nM). No change in fluorescence
was observed. The concentrations of proteins mentioned are post-mixing concentrations
in the stopped flow instrument.

2.2.9 RPAf facilitated exchange kinetics

RPAf-(dT)97 complexes were preformed using 200 nM RPAf and 60 nM (dT)97 in
one syringe and rapidly mixed with increasing concentrations of RPAWT from the second
syringe (100–1000 nM) and the change in RPAf fluorescence was monitored. Facilitated
exchange experiments with Escherichia coli SSB were assayed similarly, where
preformed RPAf-(dT)97 complexes were challenged with SSB (40–200 nM). Both data
were analysed using Eq. 2 to obtain observed rate constants. kobs,1 was plotted against
[RPA] and a linear fit was used to generate a rate for the facilitated exchange processes.

2.2.10 RPAf kinetics during homologous recombination

To quantitate the dynamics of RPAf in the presence of Rad51, RPAf(dT)97 complexes were performed as described above and challenged with Rad51 (0.97
μM; post-mixing concentration) in the absence or presence of ATP (5 mM). Assuming a
binding site size of 3.3 nt/Rad51, there are ∼30 Rad51 binding sites per (dT)97 substrate.
To saturate ∼900 nM Rad51 binding sites we used 970 nM Rad51 in our experiments.
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Rad51 displaces RPAf in the presence of ATP (Fig 2-12 b) and the change in
fluorescence was fit using a double exponential equation:
[F = A1(1 - e-k1t) + A2(1 - e-k2t)]

(Eq. 3)

The analysis yields two observed rate constants. Similarly, displacement of RPAf by Srs2
was measured by challenging RPAf-(dT)97 complexes with increasing concentrations of
Srs2 (100 or 200 nM; post-mixing). Data were well described by Eq. 2 and yielded
observed rate constants for the process. Finally, the ability of RPAf to disrupt Rad51ssDNA nucleoprotein filaments in the presence or absence of Srs2 was investigated by
premixing Rad51 (1.94 μM) with (dT)97 (60 nM) in one syringe and challenging the
complex with RPAf (200 nM) in the absence or presence of Srs2 (200 nM) [all
concentrations pre-mixing]. 5 mM ATP was present in both reactions. The filament
clearing data in the presence of Srs2 is described by Eq. 2.

2.2.11 Tryptophan quenching experiments to obtain RPA–ssDNA binding kinetics

Intrinsic tryptophan fluorescence was used to capture RPA binding to ssDNA in
reaction buffer. 100 nM RPAWT or RPAf was rapidly mixed with 30 nM
(dT)97 oligonucleotide and the change in Trp fluorescence was monitored by exciting the
sample at 290 nm and measuring emission with a 350 nm cut-off filter. To obtain the
association rates for RPAWT and RPAf, similar intrinsic tryptophan quenching stoppedflow experiments were performed with 100 nM RPAWT or RPAf (post-mixing
concentrations) and increasing concentrations of (dT)35. All tryptophan quenching
stopped-flow data were fit using Eq. 2 to obtain the observed rate constants for RPA–
DNA binding.
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2.2.12 Single molecule DNA curtain assays to monitor RPA facilitated exchange

ssDNA curtains were prepared and visualized by total internal reflection
fluorescence microscopy (TIRFM), as previously described, with the exception that GFPRPA was replaced with RPAf (C.J. Ma, Steinfeld, & Greene, 2017; Chu Jian Ma et. al.,
2017b). Briefly, a lipid bilayer is built upon a glass support with nanofabricated
chromium barriers and pedestals inside a microfluidic flowcell that allows for buffer
exchange. Long ssDNA were generated using rolling circle replication with Phi29 DNA
polymerase from a circular ssDNA template (M13mp18) primed with a 5′-biotinylated
oligonucleotide. ssDNA is then tethered to the lipid bilayer through a biotin-streptavidinbiotin linkage and pushed against the nanofabricated barrier with hydrodynamic force.
Flowing HR buffer (30mM Tris-acetate, pH 7.5, 100 mM KCl, 5 mM Mg(OAc)2, 1 mM
DTT, 2 mM ATP and 0.2 mg/ml BSA) containing 100 pM RPAf allows for visualization
of ssDNA and a second attachment point is made through non-specific interaction of the
3′ end of ssDNA to a chromium pedestal to keep the ssDNA in the evanescent TIRF
field. Presynaptic complex assembly was initiated by injecting 2 μM Rad51 in HR buffer
lacking RPAf. Disassembly of the presynaptic complex was initiated by flushing the
sample chamber with HR buffer with 100 pM RPAf lacking ATP as previously described
(C.J. Ma et. al., 2017; Chu Jian Ma et. al., 2017b).
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2.3 Results

2.3.1 Generation of fluorescent RPAf using non-canonical amino acids and bioorthogonal chemistry

A fluorescent version of RPA that produces a change in signal upon binding to
ssDNA would facilitate investigation of its binding dynamics in the presence of multiple
DNA binding proteins. To obtain a fluorescent version of RPA (RPAf) that does not
contain a large protein-based fluorophore, we used a combination of ncaa incorporation
and bio-orthogonal chemistry. RPA is composed of three subunits – RPA70, RPA32 and
RPA14, where the number corresponds to their respective molecular weights. There are
14 total cysteine residues in Saccharomyces cerevisiae RPA and the ncaa methodology
circumvents the need to generate a cysteine-free version of the protein for site-specific
labeling. We used the crystal structure of Ustilago maydis RPA as a guide for the
positioning of the ncaa (Fig 2-1 a) (Fan & Pavletich, 2012a), and selected a position that
resides close to the DNA binding interface in the RPA32 subunit. Both the RPA70 and
RPA32 subunits interact with DNA through conserved DNA binding domains, and a
greater degree of contacts reside in the larger RPA70 subunit (Fig 2-1 a). We chose to
insert the ncaa at position W101 in RPA32 due to its proximity to DNA in the crystal
structure. Strong sequence conservation in this region is also observed (Fig 2-1 b)
suggesting that this region might be responsive to conformational changes upon binding
to ssDNA. In addition, the region is situated away from terminal portions of RPA70 and
RPA32, which are known to mediate protein–protein interactions (R. Chen & Wold,
2014a).
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We used p-azido-L-phenylalanine (4AZP) as the ncaa as it can be readily coupled
to commercially available alkyne-fluorophores using click chemistry. A C-terminal
polyhistidine tag was engineered into RPA32 to separate out 4AZP carrying RPA from
prematurely truncated protein that is formed when the UAG is read as a stop codon
during protein expression. The RPA plasmid was coexpressed with a cognate pair of
amber suppressor tRNA and amino-acyl tRNA synthetase specific for the incorporation
of 4AZP. RPA4AZP purified as a single complex (Fig 2-2 a, b) and similar to the wild type
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RPA protein sedimented as a single species in sedimentation velocity experiments with
apparent molecular weights consistent with a heterotrimer (Fig 2-3).

a)

b)

Figure 2-1: Position of non-canonical amino acid insertion in RPA. a) Crystal
structure of Ustilago maydis RPA bound to ssDNA is shown (PDB ID: 4GNX) with
RPA70, RPA32 and RPA14 colored green, red and yellow, respectively. The zoomed-in
image shows two loops, L-a and L-b, flanking the ssDNA (black sticks) and Trp-101 is
shown as stick representation in blue. b) Conservation of amino acid sequence in the
region where Trp-101 resides in RPA32. W101 is highlighted in bold (red).
Site specific incorporation of 4AZP at position W101 in RPA32 was confirmed
by subjecting the protein to LC-MS analysis after tryptic digestion. Further MS-MS
fragment analysis obtained using a linear ion trap generate spectra confirming the
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presence of peptides corresponding to RPA32 carrying 4AZP at position 101 (Fig 2-4).
The peptide contains amino acids RK right before the site of 4AZP incorporation. Since
trypsin cuts after both R and K, we observe both the shortest peptide, with the K cut off,
and a missed cleavage fragment, starting with K. The data also confirm the presence of
peptides with 4AZP at position 101 and no tryptophan containing peptide (at 101) was
observed. Peptides containing 4-aminophenylalanine at position 101 were also detected.
Laser-induced degradation of azide (–N3) to amine (–NH2) occurs during MS analysis (Y.
Li, Hoskins, Sreerama, & Grayson, 2010) and such chemical conversions do not occur
during cell growth, as established for 4AZP incorporation in other systems (W. Liu,
Brock, Chen, Chen, & Schultz, 2007; Nehring, Budisa, & Wiltschi, 2012; Shao, Singh,
Slade, Jones, & Balasubramanian, 2015).
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a)

b)

Figure 2-2: Insertion of ncAA and bio-orthogonal labeling of RPA. a) Plasmids used
for the overexpression of RPA and ncaa components. The three subunits of RPA are
cloned into a pET vector and the RPA32 subunit is engineered to carry a C-terminal
polyhistidine tag and a TAG inserted for the incorporation of 4AZP. The genes for the
tRNA that recognizes the amber suppressor codon and inserts 4AZP (tRNACUA) and its
corresponding tRNA synthetase are engineered into the pDULE2-pCNF plasmid. b)
SDS-PAGE analysis of RPAWT, RPA4ZAP and the MB543-labeled RPA (RPAf)proteins
are shown after coommassie staining (left) or fluorescence imaging (right). Site-specific
fluorescence labeling of the RPA32 subunit is observed.
Fluorescent RPA (RPAf) was generated by incubating RPA4AZP with
dibenzocyclooctyne (DBCO) functionalized MB543 fluorescent dye, which covalently
tethered the fluorophore onto the protein through strain-promoted azide-alkyne
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cycloaddition. Site-specific fluorescent labeling of RPAf was confirmed by analyzing the
protein on SDS-PAGE, where only the RPA32 subunit is detected upon fluorescence
imaging (Fig 2-2 b). RPA70 and RPA 14 serve as internal negative control and cannot be
detected in fluorescence imaging. RPAf sediments as a stable trimer in sedimentation
velocity experiments suggesting that fluorescence labeling does not alter the overall
structure of the protein complex (Fig 2-3). The copper-free coupling reaction yielded
∼50-65% labeling efficiencies and had no deleterious effects on the integrity of the
protein, as evaluated by SDS-PAGE analysis (Fig 2-2 b).
In reactions where copper-based click chemistry was attempted with 5-FAMalkyne in the presence of 0.1 mM CuSO4, 0.5 mM Tris(3hydroxypropyltriazolylmethyl)amine, 5 mM sodium ascorbate and 5 mM amino
guanidine, no labeling of RPA4AZP was achieved and RPA4AZP showed severe degree of
degradation over time in our reaction conditions (data not shown). For Saccharomyces
cerevisiae RPA4AZP, DBCO functionalized fluorophores appear to be ideally suited under
our reaction conditions because we do not observe non-specific labeling (Fig 2-2 b).
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Figure 2-3: Sedimentation velocity analysis of RPAf. Analytical ultracentrifugation
analysis of RPA, RPA with 4AZP incorporated, and RPA samples bio-orthogonally
labeled with MB543 show the presence of a single heteromeric species with predicted
molecular weights – 114 kDa, 116.4 kDa and 117 kDa, respectively. AUC experiments
were performed with 3 μM RPA at 25 °C.
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a)

b)

Figure 2-4: Mass spectrometric analysis of RPA4AZP. Wild type RPA and RPA4AZP
were separated on a 12 % SDS-PAGE gel and bands corresponding to RPA32 were
excised, extracted, digested with trypsin, and analysed using electrospray orbitrap MS
and MS/MS sequencing. a) Data from the orbitrap analysis shows the presence of the
peptide carrying the 4AZP replacement at position 101. The predicted mass of the peptide
[K(4AZP)SEDANDLAAGNDDSSGK] with the 4AZP modification is 661.28. The
spectra show the presence of the (M+3H)3+ species with mass of 661.28 (denoted by the
arrow). b) A zoomed version of the MS/MS spectra and analysis of the peptide show
excellent coverage and high resolution of the species corresponding to the expected
peptide and position of 4AZP.
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2.3.2 ssDNA binding properties of RPAf

We next examined the spectral properties of RPAf to determine whether a change
in fluorescence is observed upon binding to ssDNA. The excitation–emission spectra of
RPAf show maximal fluorescence excitation and emission at 555 nm (λex) and 566 nm
(λem), respectively (Fig 2-5 a). RPA binds ssDNA selectively, rapidly, and with high
affinity; and RPAf binding to ssDNA produces a ∼5% enhancement in total fluorescence
(Fig 2-5 b). No change in fluorescence is observed in the presence of dsDNA due to the
lack of RPA binding. Next, to assess whether the positioning of the fluorophore
interfered with the ssDNA binding properties of RPA, we compared the DNA binding
affinities of RPAWT and RPAf using electrophoretic mobility shift analysis. Titration of
increasing amounts of RPAWT or RPAf with a 32P-labeled (dT)35 oligonucleotide
generated a RPA–ssDNA complex visible as a slower migrating band in the gel (Fig 2-5
c). Quantitation of the bandshifts show that both proteins bind stoichiometrically to the
(dT)35 ssDNA substrate (Fig 2-5 d). RPA carrying the incorporated 4AZP (RPA4AZP) also
binds to (dT)35 with similar affinity (Fig 2-6). Therefore, positioning of the fluorophore at
position 101 in the RPA32 subunit does not interfere with ssDNA binding affinity.
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a)

b)

c)

d)

Figure 2-5: ssDNA binding properties of RPAf. a) Excitation and emission spectra of
RPAf show maximum values at 555 nm (λex) and 566 nm (λem). b) RPAf was excited at
535 nm and emission spectra were recorded in the absence or presence of ssDNA [(dT)97]
or plasmid dsDNA. A ∼5% increase in fluorescence signal is observed when ssDNA is
present in the reaction. c) Electromobility band shift analysis (EMSA) of RPAWT (top)
and RPAf (bottom) binding to 50 nM 32P-labeled (dT)35 oligonucleotides show bound and
unbound complexes and d) quantitation of the EMSA data show stoichiometric binding
to ssDNA for both RPA and RPAf.
RPA binds rapidly to ssDNA, and on longer ssDNA substrates multiple RPA
molecules bind and form a protein coated filament. Occluded ssDNA binding site sizes of
18–20 nt and 25–26 nt at low (0.02 M) versus high (1.5 M) NaCl concentrations have
been reported for yeast RPA (Kumaran et. al., 2006). Our reactions are performed at 100
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mM KCl, where a 18–20 nt site size is expected. Thus, on a (dT)97 oligonucleotide, ∼4–5
RPA molecules could bind. To observe the kinetics of RPAf binding to ssDNA, we
performed a stopped-flow fluorescence experiment by rapidly mixing RPAf with a
(dT)97 oligonucleotide (Fig 2-7 a). The reaction was excited at 535 nm and emission
monitored using a 555 nm long pass filter. The data displays rapid (kobs,1 = 23 ± 1.2 s−1)
and slow phases (kobs,2 = 0.003 ± 0.0006 s−1) of change in fluorescence signal upon
binding to ssDNA (Fig 2-7 b, c). To compare the ssDNA binding kinetics of RPAf with
the RPAWT protein, we monitored changes in intrinsic tryptophan fluorescence of
RPAWT and RPAf (Fig 2-7 d, e). Both RPA proteins bind rapidly to (dT)97, and two
binding phases are observed. The rapid phase shows kobs,1 = 28 ± 1.8 s−1 and 32 ± 3.8 for
RPAWT and RPAf, respectively (Fig 2-7 d, e). The slower phase shows kobs,2 = 0.014 ±
0.004 s−1 and 0.008 ± 0.003 for RPAWT and RPAf, respectively (Fig 2-7 d, e).
To test if the second phase reflected reorganization of multiple RPA molecules on
the (dT)97 substrate, we performed these experiments on a shorter DNA substrate (dT)35.
Given the occluded site-size of RPA (18–20 nt/RPA), less than two RPA molecules will
bind to a (dT)35 oligonucleotide. If kobs,2 reports on Trp fluorescence changes associated
with rearrangement of multiple RPA molecules on the (dT)97 substrate, then on a
(dT)35 substrate kobs,2 should be significantly slower. We determined the association rate
of RPAWT and RPAf by monitoring the change in Trp fluorescence as a function of
increasing (dT)35 oligonucleotide concentration (Fig 2-8). Under these conditions, kobs,2 is
slower (0.002–0.006 s−1) compared to our observations on (dT)97 (0.014 and 0.008 s−1;
Fig 2-7). More importantly, these rates do not change with increasing DNA
concentration. The data also yield association rates for RPAWT and RPAf, and the values
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are very similar for both proteins: 5.2 ± 0.3 × 10−10 M−1s−1 versus 5.6 ± 0.5 ×
10−10 M−1s−1 for RPAWT and RPAf, respectively ( Fig 2-8). These data suggest that the
ssDNA binding kinetics are similar between RPAWT and RPAf protein. It should be noted
that in the experiments with RPAf where fluorescence changes are monitored at 555 nm
(Fig 2-7 b, c), only conformational changes in RPA32, close to the single fluorophore, are
observed upon binding to ssDNA; whereas, in the Trp-quenching experiments, global
conformational changes in both RPA70 and RPA32 are captured. The smallest RPA14
subunit is not thought to interact with DNA (Fan & Pavletich, 2012a). These
experimental differences might account for the small variations in the two observed rate
constants.
a)

b)

Figure 2-6: Electrophoretic mobility band shift analysis of RPA4AZP DNA
interaction. a) 50 nM 32P-end labeled (dT)35 was incubated with increasing concentration
of RPA4AZP and the band shift was assessed as described in the methods. b) Quantitation
of the band shifts in panel A show stoichiometric binding of RPA4AZP to (dT)35.
To test whether RPAf fluorescence is influenced by other proteins, we mixed it
with Rad51 or Srs2 and monitored the change in fluorescence. We observe no change in
the fluorescence signal when Rad51 or Srs2 is present in the reaction (Fig 2-7 f). Rad51
and RPA have been shown to interact in the absence of DNA (Nehring et. al., 2012),
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whereas no physical interactions have been reported between RPA and Srs2, but are
known to work together in Rad51 clearing reactions (Seong et. al., 2009). Both
RPAWT and RPAf physically interact with Rad51 ( Fig 2-9). These experiments suggest
that RPAf is fully functional, retains the ability to interact with Rad51, and can be used to
investigate RPA–DNA binding dynamics in multi-protein reactions.
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a)

b)

d)

e)

c)

f)

Figure 2-7: Kinetics of RPA binding to ssDNA. a) Schematic of stopped-flow
experiment to capture RPA–ssDNA binding kinetics. b) A rapid change in
RPAf fluorescence is observed upon binding to a (dT)97 ssDNA oligonucleotide (red
trace), whereas no change in fluorescence is observed in the absence of DNA (black
trace). c) Fit of the stopped-flow data (dashed blue line) show the presence of a rapid
(kobs,1 = 23 ± 1.2 s−1) and slow phase (kobs,2 = 0.003 ± 0.0006 s−1) for ssDNA dependent
changes in RPAf fluorescence. Intrinsic tryptophan fluorescence changes in d)
RPAWT and e) RPAf upon binding to ssDNA reveal rapid changes in fluorescence and fit
of the data yield kobs,1 = 28 ± 1.8 s−1, kobs,2 = 0.014 ± 0.004 s−1 for RPAWT, and kobs,1 = 32
± 3.8 s−1, kobs,2 = 0.008 ± 0.003 s−1 for RPAf, respectively. f) Free Rad51 or Srs2 in the
reaction do not affect the basal fluorescence of RPAf.
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a)

b)

c)

d)

Figure 2-8: Intrinsic tryptophan-based measurement of RPA-(dT)35 kinetics.
Increasing concentrations of (dT)35 was rapidly mixed with 100 nM a) RPAWT or b)
RPAf [post-mixing concentrations], and the change in intrinsic tryptophan fluorescence
was measured. Data were fit to a single exponential + linear fit (Eq.2) and two observed
rate constants were obtained. kobs,1 and kobs,2 describe the exponential and linear phases,
respectively. c) Plot of kobs,1 as a function of [(dT)35] yields association constants of
5.2±0.3x10-10M-1s-1 versus 5.6±0.5x10-10M-1s-1 for RPA and RPAf, respectively. d) kobs,2
does not change appreciably for either RPAWT or RPAf.
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Figure 2-9: RPA-Rad51 interactions. 3 μM of His-RPAWT, His-RPAf or a non-specific
protein (L-protein, an unrelated oxidoreductase protein) were bound to Ni2+-NTA beads
in the presence of Rad51 (3 μM), washed and then sequentially eluted with increasing
concentrations of imidazole (100, 200 and 400 mM – elutions 1, 2 and 3). Rad51 forms a
complex with RPAWT and RPAf, and is found in the elution samples. There is no Rad51
binding to the non-specific control protein. Lanes represent: M = protein marker, L =
total Load, 1, 2, 3 = serial imidazole elutions.
2.3.3 Facilitated exchange of RPAf by RPA and SSB

RPA bound on ssDNA has been shown to undergo facilitated exchange with free
RPA in the reaction (Gibb, Ye, Gergoudis, et. al., 2014). To test whether RPAf can be
utilized to capture such dynamics on ssDNA we performed stopped-flow experiments
where preformed RPAf–ssDNA filaments were challenged with increasing concentrations
of RPAWT or Rad51. In the first series of experiments, RPAf -(dT)97 complexes were preformed by incubating RPAf and (dT)97 oligonucleotides and rapidly mixed with
increasing concentrations of RPAWT (unlabeled). The resulting change in fluorescence
shows a rapid drop in fluorescence and both the observed rate constant and amplitude of
the signal change increases with free RPA concentration (Fig 2-10 a, b). A plot of
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the kobs versus free RPA concentration yields an apparent rate for the facilitated exchange
process (0.7 ± 0.1 × 1012 M−1 s−1; Fig 2-10 c). A hypothetical model has been proposed
for facilitated exchange where the four OB-folds of RPA can be remodelled individually,
while allowing the complex to remain on the ssDNA (Gibb, Ye, Gergoudis, et. al., 2014).
The precise mechanism of how this self-propagated facilitated exchange occurs is poorly
understood. Escherichia coli SSB, the functional homolog of RPA in prokaryotes, can
also catalyze facilitated exchange of RPA (Gibb, Ye, Gergoudis, et. al., 2014). In fact, we
observe faster and effective displacement of RPAf by E. coli SSB with an apparent
facilitated exchange rate of 47.3 ± 1.7 × 1012 M−1 s−1 (Fig 2-10 d-f). While both RPA and
SSB are homologs, they are structurally unrelated and bind to DNA using different
mechanisms (Ferrari, Bujalowski, & Lohman, 1994). The differences between SSBinduced versus facilitated self-exchange of RPA remain to be explored.
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a)

b)

d)

e)

c)

f)

Figure 2-10: Facilitated exchange of RPAf on ssDNA by RPA and SSB. a) Schematic
of stopped-flow experiments to capture facilitated exchange of RPAf by unlabeled
RPAWT. b) Pre-formed RPAf-ssDNA complexes formed on (dT)97 ssDNA substrates are
effectively displaced by unlabeled RPAWT. The rate of exchange increases with
concentration of unlabeled RPAWT, and c) yields an apparent observed rate of 0.7 ± 0.1 ×
1012 M−1 s−1 for facilitated exchange. d) Schematic of facilitated exchange experiments
with E. coli SSB, which e) displaces or exchanges with RPAf more effectively than
RPAWT with f) an apparent observed rate of 47.3 ± 1.7 × 1012 M−1 s−1.
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2.3.4 Dynamics of RPAf during homologous recombination events

RPA-coated ssDNA serve as the foundation for the nucleation and growth of
Rad51 presynaptic filaments in homologous recombination. Rad52 is a mediator protein
that functions to promote the exchange of RPA for Rad51 on the DNA (Xie et. al., 2013).
However, in single molecule DNA curtain experiments, Rad51 displaces RPA in the
absence of Rad52 (Gibb, Ye, Kwon, et. al., 2014a). Rad51 binds to ssDNA in the
presence of ATP and forms stable complexes (Antony et. al., 2009b). Rad51 binding to a
Cy3-labeled DNA substrate results in an increase in fluorescence. Using this assay, we
first measured the rate of Rad51 binding to free 5′-Cy3-(dT)79 oligonucleotide (kobs,1 = 1.3
± 0.3 s−1; and kobs,2 = 0.008 ± 0.001 s−1; Fig 2-11). To investigate RPAf dynamics during
Rad51 nucleoprotein filament formation, we preformed RPAf-(dT)97 complexes and
challenged them with Rad51 in the absence or presence of ATP (Fig 2-12 a). In the
absence of ATP, there is no change in the fluorescence signal, as yeast Rad51 does not
form a complex with ssDNA in the absence of ATP and hence no nucleoprotein filament
formation is expected, thus is not able to displace RPAf (Fig 2-12 b). In the presence of
ATP, Rad51 displaces RPAf as it forms a filament on the ssDNA substrate. The change in
fluorescence signal shows RPAf being dissociated in two distinct steps with kobs,1 = 0.26
± 0.08 s−1 and kobs,2 = 0.02 ± 0.004 s−1 (Fig 2-12 b). Whether the two rate constants reflect
Rad51 nucleation and growth, respectively, remains to be established. In the absence of
other mediator proteins such as Rad52, our data show that Rad51 can form a stable
nucleoprotein filament with rapid kinetics on RPA-coated ssDNA.
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Figure 2-11: Kinetics of Rad51 binding to 5′ Cy3-(dT)79 ssDNA. Stopped flow
analysis of Rad51 (1.5 μM) binding to 5′ Cy3-(dT)79 ssDNA oligonucleotide (40 nM) in
reaction buffer (50 mM Tris-HCl, pH 7.6, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5
mM ATP and 6 % v/v glycerol) at 25 °C. Cy3 fluorescence was measured by exciting the
sample at 515 nm and emission was monitored using a 555 nm long-pass filter. Data were
fit to a single-exponential plus linear equation to obtain observed rate constants: F = A(1
- e-k1t) + k2t. k1 and k2 are the two observed rate constants and A is the amplitude of Cy3
fluorescence change. A rapid and slow phase with observed rate constants of 1.3 ± 0.3s-1
and 0.008 ± .001 s-1 were captured.
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The Srs2 helicase/translocase is an anti-HR mediator and functions by
disassembling Rad51 nucleoprotein filaments (Krejci et. al., 2003). Srs2 is a motor
protein in yeast and uses ATP to translocate along ssDNA substrate and capable of
unwinding dsDNA(Antony et. al., 2009b; Davenport et. al., 2016; Lytle et. al., 2014; Qiu
et. al., 2013). Single stranded DNA binding proteins such as SSB and RPA can diffuse
along ssDNA substrates and other DNA binding proteins have been shown to modulate
this sliding behavior to displace SSB/RPA from DNA (B. Nguyen et. al., 2014b; Rasnik
et. al., 2004). We tested if a translocase such as Srs2 would be able to displace RPAf from
ssDNA. When preformed RPAf-(dT)97 complexes are rapidly mixed with Srs2 and ATP,
an initial drop in fluorescence is observed followed by signal stabilization (Fig 2-12 c, d).
When the concentration of Srs2 is doubled in the reaction to 200 nM (post-mixing), the
fluorescence signal does not appreciably change as in experiments with 100 nM Srs2.
The early exponential drop in signal yields kobs = 8.3 ± 1.2 s−1 and 8.5 ± 0.8 s−1 for 100
and 200 nM Srs2 in the reaction, respectively (Fig 2-12 d). These data suggest that there
is displacement of RPAf by Srs2. However, Srs2 is either rapidly outcompeted on ssDNA
by the dissociated RPAf, or RPAf rapidly rebinds the DNA after it’s removed by Srs2.
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a)

b)

c)

d)

Figure 2-12: Dynamics of RPAf during pre- synapsis stages of homologous
recombination. a) Schematic of Rad51 binding to RPAf–ssDNA complexes. b)
Preformed RPAf–ssDNA complexes are not disrupted by Rad51 in the absence of ATP
(gray trace), but effectively displaced in the presence of ATP (orange trace). The data is
well described by a double exponential fit yielding kobs,1 = 0.26 ± 0.08 s−1 and kobs,2 =
0.02 ± 0.004 s−1. c) Schematic of stopped-flow experiments to observe the effect of Srs2
on RPAf–ssDNA complex stability. The brown arrow depicts potential rebinding of
RPAf in the reaction. d) Increasing concentrations of Srs2 show a small change in the
fluorescence signal, but no significant change in overall fluorescence is observed. Insert
shows an exponential phase with an observed rate constant of 8.5 ± 0.8 s−1.
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a)

b)

Figure 2-13: Srs2 regulates Rad51 filament disassembly and RPA exchange. a)
Schematic of events during filament disassembly. The brown arrows denote removal of
RPAf upon Rad51 rebinding. b) In filament clearing experiments, a preformed Rad51
filament prevents RPAf from binding to ssDNA (blue trace), however, when Srs2 is
present in the reaction, a gradual increase in fluorescence is observed (pink trace)
highlighting clearing of Rad51 molecules from ssDNA by Srs2 followed by
RPAf binding to ssDNA. The data displays a single exponential profile (dotted line)
with kobs = 0.005 ± 0.001 s−1.
RPA has been shown to promote Rad51 filament disassembly by Srs2 and is
proposed to sequester the ssDNA substrate following Rad51 dissociation (Krejci et. al.,
2003). To test this model, we preformed Rad51 nucleoprotein filaments on a
(dT)97 substrate and rapidly mixed it with RPAf in the absence or presence of Srs2 (Fig 22 e). In the absence of Srs2, no RPAf binding is observed. However, when Srs2 is present
in the reaction, an increase in fluorescence is observed (kobs = 0.005 ± 0.002 s−1; Fig 2-13
b). These data suggest that Srs2 displaces Rad51 and enables binding of RPAf to the free
ssDNA. However, it should be noted that Rad51 displaces RPA (Fig 2-12 b), hence the
apparent rate for filament clearing would also be severely influenced by RPAf removal by
Rad51. The presence of mediator proteins during homologous recombination might
enable stabilization of RPA on the ssDNA.
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2.3.5 Single molecule DNA curtain analysis of RPAf dynamics in HR

Using ncaa to generate fluorescent DNA binding proteins will be useful in single
molecule analysis of enzyme reactions because it overcomes the need to attach
genetically encoded fluorophores. This approach is vital to studying proteins such as
Rad51 and RecA, which are rendered inactive when GFP is tethered to the termini
(Fischer et. al., 2010). We have previously shown that GFP- or mCherry-tagged RPA can
be used for preparing and visualizing ssDNA curtains for single molecule studies of HR
intermediates (Gibb, Ye, Kwon, et. al., 2014a). As a proof of principle, we next sought to
determine whether RPAf could also be used in double-tethered ssDNA curtain
measurements to visualize the RPAf-ssDNA complexes and monitor assembly of the
Rad51 presynaptic complex (Fig 2-14 a, b). For these experiments, long ssDNA
substrates (∼50 knt) were loaded into a sample chamber and tethered to a lipid bilayer
through a biotin–streptavidin linkage that also serves to prevent non-specific protein
binding to the surface of the flowcell. Flushing the chamber with buffer containing 100
pM RPAf revealed ssDNA-RPAf complexes when visualized by total internal reflection
fluorescence microscopy (TIRFM; Fig 2-14 b). To further establish if these are bonafide
ssDNA–RPAf complexes, we next tested whether Rad51 is able to displace RPAf.
Injection of 2 μM wild type Rad51 (dark/unlabeled) in the presence of 2 mM ATP
resulted in the rapid loss of fluorescence signal as RPAf is displaced from the ssDNA
(Fig 2-14 d). Consistent with previous findings, (Gibb, Ye, Kwon, et. al., 2014a) these
presynaptic Rad51 filaments remained stable on the ssDNA, even after flushing unbound
Rad51 and introducing 100 pM free RPAf into solution for 30 min. Switching to a buffer
that is identical except that it lacks ATP shows rapid return of RPAf signal as the Rad51-
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ADP dissociates and is replaced by RPAf (Fig 2-14 d). These experiments highlight the
utility of RPAf for use in single molecule experiments of recombination intermediates
where large genetically-encoded fluorescent tags could potentially confound
measurements or affect protein function.
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a)

b)

c)

d)

Figure 2-14: ssDNA curtains to visualize RPAf. a) Schematic of a RPA-coated doubletethered ssDNA curtain. b) Representative examples of individual ssDNA molecules
bound by RPAf (shown in magenta). The 5′-biotin tether is oriented at the top of each
window that are all 2.7 × 13.5 μm. c) Schematic showing the ssDNA curtain experiment
time course beginning in the top panel with an RPA-coated ssDNA molecule. Injecting 2
μM Rad51 displaces RPAf from the ssDNA to form the pre-synaptic filament that is
resistant to rebinding of RPAf in the middle panel. Flushing ATP from the system results
in spontaneous Rad51 dissociation and the re-binding of RPAf. d) A representative
kymograph of a ssDNA molecule through time. At the start, ssDNA is already coated by
RPAf and buffer containing 100 pM RPAf is flowing through the chamber at 0.2 ml/min.
Switching to a buffer lacking RPAf shows that bound RPAf remains stable until the
introduction of 2 μM wild type Rad51 when flow is stopped. The loss of RPAf signal is
evidence that Rad51 outcompetes the bound RPAf to form a pre-synaptic filament.
Resuming flow with buffer containing 100 pM RPAf and 2 mM ATP shows the ssDNA
remains dark as RPAf cannot displace Rad51. However, switching to buffer with 100 pM
RPAf and no ATP shows assembly and disassembly of a wild type Rad51 filament on an
RPAf-coated ssDNA molecule.
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2.4 Discussion

Multiple DNA binding proteins function together during all DNA metabolic
process such as replication and repair. To investigate the mechanism of action of a single
enzyme that functions in a multi-protein context, a quantifiable experimental signal from
the enzyme of interest is required. In this study, we generated a fluorescent version of
RPA (RPAf) utilizing the ncaa methodology. 4AZP was used as the ncaa and inserted at
position 101 in the RPA32 subunit. W101 in one of two aromatic residues in RPA32
proposed to interact with DNA. However, mutation of both aromatic residues does not
affect DNA replication as the mutant cells show normal growth rates (Dickson,
Krasikova, Pestryakov, Lavrik, & Wold, 2009). A slight sensitivity to UV damage is
observed in the double mutant (Brill & Bastin-Shanower, 1998; Rosenkranz et. al., 2006).
The MB543 fluorescent dye was covalently attached to RPA4AZP using strain-promoted
azide–alkyne cycloaddition. Upon binding to ssDNA, RPAf generates a robust and
quantifiable change in florescence, and the DNA binding properties of RPAf are similar
to RPAWT including stoichiometric and rapid binding to ssDNA (Fig 2-5, 2-7 and 2-8).
This approach leaves all the cysteine residues intact and generates functional RPA
complexes. This methodology is an attractive alternative to using genetically-encoded
fluorophores which are large, interfere with function, and have positional limitations for
attachment.
RPA is a unique protein that functions as a control hub to recruit various proteins,
thereby coordinating almost all DNA metabolic processes in the cell (Sugitani & Chazin,
2015). By monitoring the change in fluorescence signal in RPAf we can selectively
investigate its dynamics in multi-protein reactions such as HR. Here, we have captured
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the kinetics of RPA binding, dissociation, and facilitated exchange during HR in in the
presence of the Rad51 recombinase and Srs2, an anti-recombination mediator. Multiple
DNA binding proteins are required to orchestrate HR and are present together during
various steps in the reaction. The 5′ ends flanking a dsDNA break are nucleolytically
cleaved during resection to yield ssDNA overhangs that are sequestered by RPA (Mazón
et. al., 2010; Mimitou & Symington, 2009). We show that RPAf binds rapidly to free
ssDNA (kobs = 23 ± 1.2 s−1; Fig 2-7 c) and self-exchanges at a 6–7-fold slower rate (kobs =
3–4 s−1; Fig 2-10 c). These data show that RPA bound to ssDNA are stable, as described
previously (Niedziela-Majka, Chesnik, Tomko, & Lohman, 2007). During pre-synapsis,
RPA bound to ssDNA needs to be displaced for Rad51 to bind and form the
nucleoprotein filament. Pro-recombination mediator proteins such as Rad52 and BRCA2
are known to promote the binding of Rad51 on RPA-coated ssDNA (Tomko et. al., 2012;
C. G. Wu et. al., 2010; Xie et. al., 2013). RPA interacts with both Rad52 and BRCA2 and
assembly of Rad51 on RPA-coated ssDNA is regulated through post-translational
modifications (Kozlov, Cox, & Lohman, 2010; Tomko, Fischer, & Lohman, 2010). The
observed rate of Rad51 binding and filament formation on naked ssDNA is ∼1.3 s−1 ( Fig
2-11), whereas on RPAf coated DNA, Rad51 binds and displaces RPAf at ∼0.26 s−1 (Fig
2-12 b). These data suggest that Rad51 displaces RPA at ∼15-fold slower rate compared
to the RPA facilitated self-exchange process. The difference in rate constants suggest that
the mechanism of Rad51 binding to an RPA-coated ssDNA is different compared to
facilitated self-exchange. The four OB-folds of RPA bind to ssDNA with different
affinities and can be individually remodeled by other proteins to gain access to ssDNA
(R. Chen et. al., 2016b; Gibb, Ye, Gergoudis, et. al., 2014). Such differences in DNA
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binding affinities within the OB-folds allow RPA to be tightly bound on the ssDNA,
while allowing access to other DNA binding proteins that they recruit during various
DNA metabolic processes. However, for complete RPA displacement, all four OB-folds
will have to dissociate from ssDNA.
During facilitated self-exchange, RPAf could dissociate from the ends or internal
regions and the vacant ssDNA binding site can now be occupied by unlabeled RPA. On
the other hand, RPA has also been shown to diffuse on ssDNA (B. Nguyen et. al., 2014b)
and could be pushed off by free RPA or other proteins (Chu Jian Ma et. al., 2017b). Our
data suggests that an active sliding-pushing off mechanism might be more applicable as
we observe different observed rate constants for facilitated-self exchange (∼3.5 s−1; Fig
2-10 c), facilitated exchange with SSB (∼17 s−1: Fig 2-10 f), and displacement by Rad51
(0.26 s−1; Fig 2-12 b). However, a passive mechanism, where the individual DNA
binding domains of RPA dissociates followed by replacement with another DNA binding
protein, cannot be ruled out. In our experiments, a (dT)97 ssDNA substrate is used where
both ends of the DNA are free. Whether RPA can be removed effectively by other
proteins in cases where the ends are blocked, as in a replication fork or dsDNA bound by
histones, remains to be investigated. Sliding and diffusion models of RPA movement on
ssDNA have been suggested and how these models fit into mechanisms of facilitated
self-exchange versus Rad51-mediated displacement remain to be explored (Gibb, Ye,
Gergoudis, et. al., 2014; B. Nguyen et. al., 2014b). While in vitro assays show that
mediators such as Rad52 are not required to displace RPA from ssDNA, (Chu Jian Ma et.
al., 2017b) mediators can enhance the rate of Rad51 nucleation and growth in HR
reactions where other DNA structures and proteins are present.
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Rad51 nucleoprotein filaments promote the search for homology and catalyze
strand-exchange (synapsis) in HR followed by replication and strand resolution. The
dynamics between Rad51 and RPA during pre-synapsis is of immense interest as
mutations in Rad51, RPA, BRCA2 and Rad52 have all been linked to various cancerous
states (P. A. Jeggo & Lobrich, 2015; Penny A. Jeggo, Pearl, & Carr, 2016). To capture
the kinetics of Rad51 nucleation and filament growth in the presence of RPA and
mediator proteins, we are currently developing ncaa-based fluorescent Rad51 to directly
investigate its dynamics in HR. In other scenarios, Rad51 filaments are displaced by antiHR mediator proteins such as the Srs2 helicase. In the presence of ATP, Rad51 forms a
stable nucleoprotein filament on ssDNA substrates that is refractory to RPA rebinding
(Fig 2-14 c, d). Previous studies have shown that Srs2 displaces Rad51 by stimulating
ATP hydrolysis within the nucleoprotein filament and the reaction is enhanced in the
presence of RPA (Antony et. al., 2009b; Qiu et. al., 2013; Van Komen, Reddy, Krejci,
Klein, & Sung, 2003). Based on these studies, current models posit RPA sequestering the
ssDNA behind the Srs2 helicase as it clears Rad51 molecules (Macris & Sung, 2005). We
have measured the binding of RPAf behind the Srs2 helicase during Rad51 filament
clearing (Fig 2-13 a). RPAf binding in this context occurs at kobs = 0.005 s−1, much slower
than the rates of Srs2 filament clearing previously reported (Antony et. al., 2009b;
Davenport et. al., 2016). Since Rad51 can displace RPAf in our experiments (Fig 2-12 b),
RPAf molecules that bind behind the Srs2 helicase will be exchanged by free Rad51 in
the reaction. Thus, how RPA is stabilized during filament clearing remains to be
established. One possibility is the contribution of a mediator protein that might stabilize
RPA binding to DNA or post-translational modifications of Rad51 could prevent its
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rebinding or exchanging RPA. Interestingly, our results suggest that a motor protein such
as Srs2 is capable of displacing RPAf from ssDNA. RPAf–ssDNA complexes challenged
with Srs2 show a small, but rapid initial drop in RPAf fluorescence (kobs = 8.5 ± 0.8 s−1;
Fig 2-12 d) followed by a plateauing of the signal. This suggests that RPAf being
displaced is either rapidly able to compete off Srs2 from ssDNA or binds to the free
ssDNA behind the Srs2 helicase, causing the stabilization in fluorescence signal (Fig 212 c, d). Single molecule fluorescence experiments will be required to better understand
these mechanisms and the ncaa methodology can be applied to generate fluorescently
labeled proteins.
We show the application of RPAf in single molecule DNA curtain assays where
dynamics of RPA on long ∼50 knt substrates are captured (Fig 2-14) Assembly of
RPAf molecules can be visualized and its displacement during facilitated self-exchange
can be quantitated. Flowing in Rad51 with ATP displaces RPAf and formation of the
nucleoprotein filament is observed. When ATP is washed out of the reaction, Rad51
dissociates and binding of RPAf is clearly visualized. The development of fluorescent
Rad51 and mediator proteins will be applicable to monitoring their individual dynamics
during HR and other DNA metabolic processes.
In summary, we have used RPAf to describe its dynamics during HR. Since RPA
coordinates several DNA metabolic processes, this approach now presents a powerful
experimental tool to investigate its dynamics in DNA replication, replication restart,
nucleotide excision repair, dynamics on telomeric ends, and other such processes on
DNA. The use of ncaa to generate fluorescently-labeled proteins should be broadly
applicable to investigating other processes in multi-protein systems. In addition, this
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methodology enables click chemistry based attachment of dyes that will enable us to
investigate conformational changes in this region using EPR and NMR specific probes.
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CHAPTER 3: DYNAMICS AND SELECTIVE REMODELING OF DNA
BINDING DOMAINS OF RPA

3.1 Introduction

In eukaryotic cells, RPA binds to transiently exposed ssDNA and serves as a hub
protein to coordinate DNA replication, recombination, repair, and telomere
maintenance(R. Chen & Wold, 2014a; Wold, 1997). Cellular functions of RPA rely on its
high ssDNA binding affinity, ability to physically interact with over two dozen DNA
processing enzymes, and to correctly position these enzymes on complex DNA
structures. The precise mechanisms by which RPA functions in many contexts and how
RPA differentiates between multiple DNA metabolic events is a long-standing puzzle (R.
Chen & Wold, 2014a; Fanning et. al., 2006; Wold, 1997). RPA is heterotrimeric, flexible,
and modular in structure. It is composed of three subunits: RPA70, RPA32 and RPA14
(Fig. 3-1 a, b), which harbor six oligonucleotide/oligosaccharide binding folds (OB-folds;
labeled A through F). We refer to the DNA binding OB-folds as DNA binding domains
(DBDs; Fig. 3-1 b). RPA binds to ssDNA with sub-nanomolar affinity but can be
displaced by DNA binding proteins with much lower DNA binding affinity. Recent
studies have suggested that the RPA-ssDNA complex is relatively dynamic (R. Chen et.
al., 2016b; Gibb, Ye, Gergoudis, et. al., 2014; B. Nguyen et. al., 2014b) positing a
selective dissociative mechanism where not all DBDs are stably bound to the DNA,
whereas, microscopic dissociation of individual DNA binding domains occurs.
In all existing models for RPA function, DBDs A and B are assigned as high
affinity binding domains. Purified DBD-A, DBD-B and DBD-A/DBD-B constructs bind
ssDNA with Kd values of 2 μM, 20 μM and 50 nM, respectively (Arunkumar, Stauffer,
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Bochkareva, Bochkarev, & Chazin, 2003; Bochkareva, Korolev, Lees-Miller, &
Bochkarev, 2002; Iwona M. Wyka, Kajari Dhar, Sara K. Binz, & Wold, 2003). The
trimerization core made up of DBD-C, DBD-D and DBD-E is considered to have a
weaker ssDNA binding affinity (Kd> 5 μM) (Elena Bochkareva, Frappier, Edwards, &
Bochkarev, 1998). Additionally, mutational analysis of individual aromatic residues that
interact with the ssDNA in either DBD-C or DBD-D show minimal perturbations on
ssDNA binding affinity (R. Chen et. al., 2016b). Paradoxically, in the crystal structure of
the RPA-ssDNA complex (Fig. 3-1 b), the ssDNA interactions of all four DBDs are
similar, with DBD-C having more contacts with ssDNA bases than DBD-A, DBD-B or
DBD-D (Fan & Pavletich, 2012a). Thus, the exact nature of the contributions from each
DBD to RPA function is likely complicated and may be influenced by the dynamics of
DBD-ssDNA interaction.
Both the N-terminus of RPA70 and the C-terminus of RPA32 interact with
distinct sets of RPA-interacting proteins (RIPs). During DNA processing, RIPs must
displace RPA from ssDNA. Displacement may be achieved by modulating the DNA
binding activity of specific DBDs within RPA. In such a model, a protein that exchanges
for RPA does not dissociate all DBDs at once but displaces individual DBDs after
gaining access to DNA that is transiently exposed by dissociation of a DBD. Moreover, if
the RPA-ssDNA complex were to be considered as a sequential, linear assembly of
DBDs as seen in the crystal structure, then depending on the DBD first displaced, a
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downstream DNA binding protein could be positioned at the 5′ or 3′ end of the RPAoccluded ssDNA.
a)

b)

Figure 3-1: Non-canonical amino acid-based fluorescent RPAs report on individual
DBD dynamics. a) The residue numbers for the three RPA subunits and their respective
DNA binding domains (DBDs A-F) are denoted. The winged-helix (wh) domain in
RPA32 and DBD-F in RPA70 mediate interactions with RPA-interacting proteins (RIPs).
The N-terminus of RPA32 that is phosphorylated is shown in red. Crystal structures of
the ordered domains are shown as surface representations with intervening disordered
linkers as dotted lines (black). DBD-C, DBD-D and RPA14 interact to form the
trimerization core. b) Crystal structure of the DNA binding domains of U. maydis RPA
bound to ssDNA (PDB ID:4GNX). Residues T211 in DBD-A and W101 in DBD-D are
sites where 4-azidophenylalanine (4AZP) is incorporated (residue numbering
in Saccharomyces cerevisiae RPA). The bound ssDNA is shown as sticks (black).
The recombination mediator Rad52 is one example of a RIP. It belongs to a group
of proteins that orchestrate homologous recombination (HR) and homology directed
DNA repair. S. cerevisiae Rad52 regulates recombination by facilitating replacement of
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RPA on ssDNA with the Rad51 nucleoprotein filament, an active species in homology
search and DNA strand exchange (Benson, Baumann, & West, 1998; New, Sugiyama,
Zaitseva, & Kowalczykowski, 1998; Akira Shinohara & Ogawa, 1998; Sung, 1997).
Nucleation of the Rad51 filament is a slow and tightly controlled process as Rad51 fails
to compete for binding to ssDNA with RPA (Sugiyama & Kowalczykowski, 2002b).
Thus, Rad52 must physically interact with both RPA and Rad51 to promote Rad51
filament nucleation. The mechanism by which Rad52 loads Rad51 on the ssDNA is
unclear except that Rad51 filament formation is simultaneous with displacement of RPA
from ssDNA and likely proceeds through a Rad52-RPA-ssDNA intermediate (Sugiyama
& Kowalczykowski, 2002b). Within this complex, Rad52 was shown to stabilize the
RPA-ssDNA interaction (Gibb, Ye, Kwon, et. al., 2014a), further mystifying its assigned
mechanism of action as a recombination mediator to displace RPA (Gibb, Ye, Kwon, et.
al., 2014a).
To determine how individual DBDs work in the context of the full-length protein
and investigate how proteins such as Rad52 modulate RPA binding, we generated
fluorescent forms of RPA containing a non-canonical amino acid (ncAA) that is labeled
with the fluorescent dye MB543 in either DBD A or D. When positioned near the DNAbinding site, MB543 produces a change in fluorescence intensity upon binding to ssDNA.
Using direct measurements of full-length RPA carrying a fluorescently-labeled DBD
binding to, and dissociating from ssDNA, we show that both DBD-A and DBD-D are
highly dynamic, frequently binding to and dissociating from ssDNA. We also show that
RPA-ssDNA complexes exist in at least 4 distinct conformational states offering
differential access to the ssDNA within this complex. Rad52 interacts with the RPA-
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ssDNA complex and selectively modulates the dynamics of DBD-D preventing its full
engagement to ssDNA and thereby opening the 3′ end of the RPA-occluded sequence.

3.2 Materials and methods

3.2.1 Chemicals and reagents

Chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA)
and Research Products International (Mt. Prospect, IL, USA). Resins used for protein
purification were from the following vendors: Q-sepharose, Heparin and S200 from GE
Healthcare (Pittsburgh, PA, USA); Ni2+-NTA agarose form Gold Biotechnology (St.
Louis, MO), and Biogel-P4 from Bio-Rad Laboratories (Hercules, CA, USA). Enzymes
used for cloning and the Q5- quick change mutagenesis kit were purchased from New
England Biolabs (Ipswich, MA, USA). 4-Azidophenylalanine (4AZP) was prepared from
Fmoc-4-amino-phenylalanine (Angene Inc., Nanjing, China) as described . All
fluorophores used to generate fluorescently labeled proteins were purchased from Click
Chemistry Tools (Scottsdale, AZ, USA). BL21Ai and BL21 Rosetta pLysS cells were
purchased from Thermo Fisher Scientific (Waltham, MA, USA).

3.2.2 DNA

Cy3-labeled, biotinylated and unmodified oligonucleotides were purchased form
Integrated DNA Technologies (Coralville, IA).
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3.2.3 Plasmids for Protein Expression

Plasmid plld_tscRPA carrying the open reading frames for all three RPA subunits
from S. cerevisiae (Sibenaller et. al., 1998) was the template used to construct the wild
type RPA plasmid (EANP-scRPA-70-32-14) by substituting the two original TAG stop
codons with TAA stop codons using Q5 site-directed mutagenesis. This plasmid was
used as the template to generate all further constructs described in this study. Q5 sitedirected mutagenesis was used to insert the following polyhistidine (his6) affinity tags
and mutations: To generate fluorescent RPA-DBD-A, a his6 tag was first introduced at
the C-terminal end of RPA70 using the following primers – 5′
CACCATCACTAATGGATCTCGATCCCG 3′ and 5′
GTGATGATGAGCTAACAAAGCCTTGGATAAC 3′ to generate plasmid EANPscRPA-70his6-32-14. An amber suppression codon ‘TAG’ was introduced at the position
corresponding to T 211 using the following primers 5′AGAAATTAAATAGTGGCACAATCAAAGAG 3′ and 5′
CCCTTGTAGGAAACTCTTG 3′ (EANP-scRPA-70his6-T211TAG-32-14). Generation of the
plasmid for fluorescent RPA-DBD-D (EANP-scRPA-70-32 his6-W101TAG -14) was
previously described (section 2.2.2) (N. Pokhrel et. al., 2017). To generate RPA-FAB, the
open reading frame encompassing the N-terminus (DBD-F), DBD-A and DBD-B of S.
cerevisiae RPA70 (amino acids 1-422) was amplified from plasmid EANP-scRPA-7032-14 and a his6 tag was inserted at the end of DBD-B using primers
5′GGAGATATACCATGGGCAGTGTTCAACTTTCGAGGGG 3′ and
5′ATAAAATAGGATCCTTAGTGGTGATGATGGTGATGGTTTGCGTTGCGGCCC
3′. This was subsequently sub-cloned into a pRSFDuet-1 vector using NcoI and BamHI
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restriction sites (EANP-scRPA-F-A-Bhis6). A TAG codon was introduced at position
T211 in DBD-A (EANP-scRPA-F-AT211TAG -Bhis6) to incorporate non-canonical amino
acids during protein purification. The plasmid to purify CBD tagged S. cerevisiae Rad52
was a kind gift from Dr. Eric Greene (Columbia University, NY) (Described in detail in
chapter 5, section 5.2.1 and 5.2.2).

3.2.4 Proteins

4AZP (4-azidophenylalanine) incorporated RPA were purified as described
(chapter 2, section 2.2.3- 2.2.4) with the following modifications. Stock 4AZP solutions
for a 1 L culture were prepared by dissolving 206 mg of 4AZP in 2 ml of 100% methanol
and then diluted with 3 ml of ddH2O and added to the culture (1 mM final concentration)
during induction of protein expression with IPTG and arabinose. Wild-type RPA (RPAwt)
was purified as described with the addition of a final ssDNA cellulose separation as
described (chapter 2, section 2.2.3). RPA4AZP was purified as described in methods section
of chapter 2, section 2.2.3), with the following modifications: The protein eluates
containing RPA4AZP from the Ni2+-NTA column was diluted with buffer H0 (30 mM
HEPES, pH 7.8, 0.1 mM EDTA, 10% glycerol (v/v)) to match the conductivity of H100
(superscript denotes concentration of KCl in mM) and fractionated over a 10 ml heparin
column equilibrated with buffer H100. RPA4AZP was eluted with a linear gradient of H100H1000. Fractions containing RPA4AZP were pooled, diluted with buffer H0 to a conductivity
equivalent to H100 and applied on to a 25 ml (bed volume) ssDNA column. The column
was sequentially washed with 200 ml of buffer H300 followed by 150 ml of H500. RPA4AZP
was step eluted with H2000. Fractions containing RPA4AZP were dialyzed in storage buffer
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(30 mM Hepes, pH 7.8, 100 mM KCl, 10% glycerol (v/v)) and subjected to labeling with
fluorophore or flash frozen in liquid nitrogen and stored at -80oC. Site-specific
Incorporation of 4AZP was confirmed using mass spectrometry. We did not see difference
in activity of RPA4AZP with or without the use of ssDNA column in the purification process.
RPA-FAB and RPA-FAB4AZP proteins were generated by co-transforming the respective
plasmids and pDULE2-CNF in Rossetta (DE3)pLysS cells, expressed, and purified as
described above for the full length RPA4ZP versions, with the following modifications.
Eluates containing RPA-FAB from the Ni2+-NTA chromatography step were pooled and
diluted with buffer H0 to match the conductivity of buffer H100 and applied on to a 10 ml
Q-sepharose column equilibrated with buffer H100. FAB4AZP does not bind to the Qsepharose column and comes out in the flow-through. The Q-sepharose column was further
washed with 100 ml of buffer H100. The flow-through and wash fractions from the Qsepharose column were combined and fractioned over a 10 ml Heparin column equilibrated
with H100 buffer. Protein was eluted using a linear gradient of H100-H2000. Fractions
containing FAB4AZP were pooled, concentrated using an Amicon spin concentrator (30 kDa
molecular weight cut-off), and subjected to labeling with fluorophores.
S. cerevisiae Rad52 was purified as described in (Gibb, Ye, Kwon, et. al., 2014a)
with the following modifications. Rad52 was fractionated using a 20 ml chitin sepharose
column and fractions containing Rad52 were pooled and diluted with buffer R (50 mM
Tris-HCl, pH 7.5, 1 mM EDTA, pH 8.0, 1X protease inhibitor cocktail, 10% glycerol (v/v))
to a conductivity equivalent to buffer R200 (subscript denotes concentration of NaCl in mM)
and applied on to a 10 ml heparin column equilibrated with buffer R200. Rad52 was eluted
with a linear gradient of R200-R1000. Fractions containing Rad52 were pooled, diluted with
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buffer R to a conductivity equivalent to R100 and purified further over a 25 ml ssDNA
cellulose column using a linear gradient of R100-R1500. Fractions containing Rad52 were
pooled, concentrated using a Amicon spin concentrator (30 kDa molecular weight cut-off)
and dialyzed in storage buffer (20 mM Tris-HCl, pH 8.0. 200 mM NaCl, 0.2 mM EDTA,
pH 8.0, 10% glycerol (v/v)). Rad52 was flash frozen with liquid nitrogen and stored at 80oC. A detailed procedure is mentioned in section 5.2.2 of chapter 5.

3.2.5 Generation of fluorescently labeled RPA variants

RPA variants carrying 4AZP were labeled with MB543, Cy3 or Cy5 as described
in the section 2.2.4 of chapter 2, with the following modifications. Briefly, ~ 3 ml of
RPA4AZP (10 μM) was incubated on a rocker with 1.5-fold molar excess (15 μM) of either
DBCO-MB543, DBCO-Cy3 or DBCO-Cy5 for 2 hours at 4 oC. Labeled RPA variants
were separated from excess dye using a Biogel- P4 gel filtration column (65 ml bed
volume) using storage buffer (30 mM HEPES, pH 7.8, 100 mM KCl and 10% (v/v)
glycerol). Fractions containing labeled RPA were pooled, concentrated using a 30 kDa
cut-off spin concentrator and flash frozen using liquid nitrogen. Fluorescent RPA were
stored at -80 oC. Labeling efficiency was calculated using absorption values measured at
280 nm and ε280= 98500 M-1cm-1for RPA, at 550 nm with ε550= 105,000 M-1cm-1for
DBCO-MB543, at 555 nm with ε555= 150,000 M-1cm-1for DBCO-Cy3, and at 650 nm
with ε650= 250,000 M-1cm-1 for DBCO-Cy5 fluorophores. A correction factor was
applied to the final concentration of labeled protein (See appendix II (section 9.1-9.4) for
detailed procedure). We obtain 45 ± 17 % and 40 ± 25 % labeling efficiencies for the
RPA-DBD-AMB543 and RPA-DBD-DMB543 versions, respectively.
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3.2.6 Fluorescence measurements

Fluorescence spectra were obtained using a PTI QM40 instrument (Horiba
Scientific, Edison, NJ). For RPA-DBD-AMB543, RPA-DBD-ACy5 and RPA-DBD-ACy3 slit
widths were set at 1.25 nm for excitation and 3 nm for emission. For RPA-DBD-DCy3 and
RPA-DBD-DCy5 slit widths were set at 0.5 nm for excitation and 2 nm for emission. For
RPA-DBD-AMB543, 2 ml of 50 nM RPA-AMB543 in reaction buffer (30 mM Hepes, pH 7.8,
100 mM KCl, 5 mM MgCl2, 1 mM β-mercaptoethanol and 6 % v/v glycerol) was added
to a quartz cuvette, and the spectra were collected in the absence or presence of 50 nM
ssDNA [(dT)45] or ds plasmid DNA (100 nM nucleotides) with constant stirring. Samples
were excited at 535 nm and emission spectra (555 – 600 nm) were recorded. A similar
experimental setup was used to obtain fluorescence spectra for 50 nM RPA-FABMB543
upon addition of 100 nM (dT)45. For RPA-DBD-DCy3 and RPA-DBD-ACy3, 2 ml of 100
nM protein was used and 100nM of (dT)45 was added with constant stirring. The samples
were excited at 559 nm and emission spectra (539 nm- 579 nm) were recorded. Similarly,
for RPA-DBD-ACy5 and RPA-DBD-DCy5, 2 ml of 100 nM proteins were used and 100
nM of (dT)45 were added to the reaction. Samples were excited at 690 nm and emission
spectra (640- 700 nm) were recorded. All experiments were performed at 25 °C.

3.2.7 Site-size measurement

The total number of nucleotides occupied by RPA variants (RPA-wt, RPA-DBDAMB543 and RPA-DBD-DMB543) in reaction buffer was determined as previously described
using poly(dT) ssDNA (Kumaran et. al., 2006). Briefly, 1.95ml of 100nM RPA in
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reaction buffer (30mM HEPES, pH 7.8, 5mM MgCl2, 6% glycerol (v/v), 1 mM βME,
100 mM KCl) was added to a 2ml quartz cuvette. First, to determine the fixed emission
wavelength to be used in the experiment, using a fluorometer, RPA was excited at 290nm
and emission spectra (300-350) collected. The peak emission wavelength (emi (max) ) was
noted, and used for rest of the experimentation.
For rest of the experiment, RPA was excited at exci: 290nm and emission
collected at emi (max), for a total of 10 seconds (time-based setting in the fluorometer).
100nM RPA was titrated with increasing concentrations of Poly(dT) (0.5 M to 12 M),
and decrease in tryptophan fluorescence recorded. (Note: Each titrant (aliquot) consisted
of 2l 495M Poly(dT). In total, 24 aliquots were added and addition of each aliquot
increased the concentration of Poly(dT) in the cuvette by 0.). Following addition of
each aliquot of Poly(dT), samples in the cuvette were mixed thoroughly by stirring for a
minute, and emission collected for 10 seconds. The resulting data was analyzed using the
tabulation worksheet from Timothy Lohman’s Lab, Department of Biochemistry and
Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA,
and plotted to determine the site-size.

3.2.8 DNA Binding

The DNA binding activity of unlabeled and fluorescent RPA was measured using
electromobility band shift analysis. 50 nM of 32P-labeled (dT)30 oligonucleotide was
incubated with increasing concentrations of RPA-wt or RPA-DBD-AMB543 or RPA-DBDDMB543 (0 – 1 µM) in reaction buffer for 10 minutes at 4 ºC. 1 ml of DNA loading dye (50
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% v/v glycerol and 0.2 % w/v bromophenol blue in 1 X TBE) was added to the samples
and resolved using an 8 % TBE-acrylamide gel (110 volts, 25 °C). Gels were exposed
overnight onto a phosphorimaging screen and scanned using a STORM scanner (GE
Healthcare, Pittsburgh, PA). Bound and unbound DNA signals were quantitated using
ImageQuant software and the fraction ssDNA bound to RPA was calculated using the
equation:
((bound 32P signal)/(bound 32P signal + unbound 32P signal))*[ssDNA]

(Eq. 1)

Detailed procedure for radiolabeling nucleotide and preparation of 8% TBE gel is
described in section 2.2.6 of chapter 2.

3.2.9 Stopped flow analysis of RPA-DNA interactions

Stopped-flow experiments described below to monitor RPA – ssDNA dynamics
were performed using an Applied Photophysics SX20 instrument (Surrey, UK) in
reaction buffer (30 mM Hepes, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM βmercaptoethanol and 6 % v/v glycerol) at 25 °C. All the concentrations mentioned in the
methods are ‘pre-mixing’ concentrations which are reduced to half upon mixing the
samples to provide final ‘post- mixing’ concentrations. RPA labeled with MB543 were
excited at 535 nm and emission was monitored using a 555 nm cut-off filter (Newport
corp., Irvine, CA). Changes in tryptophan fluorescence were monitored by exciting the
samples at 290 nm and emission was measured using a 350 nm cut-off filter. For the
FRET experiments, the Cy5-labeled RPA and Cy3-labeled DNA samples were mixed and
excited at 555 nm and changes in Cy5 fluorescence was monitored with a 645 nm cut-off
emission filter.
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3.2.10 RPA-DBD-AMB543, RPA-DBD-DMB543 and RPA-FABMB543 ssDNA binding
kinetics

To quantitate RPA-DBD-AMB543, RPA-DBD-DMB543 or RPA binding to ssDNA,
200 nM of the respective protein was rapidly mixed with 200 nm of (dT)25
oligonucleotide, and the change in MB543 fluorescence was captured. All the data were
fitted using either Kaleidagraph or Kintek Explorer to obtain the appropriate rate
constants. For RPA-DBD-AMB543, the data were fit to a two-step model:
Δf=A1(1−e−k1*t)+A2(1−e−k2*t)+k3*t

(Eq. 2)

Where, Δf is the change in fluorescence signal, A1 and A2 are the amplitude of
fluorescence change, and k1, k2, and k3 are the observed rate constants and t is time. For
RPA-DBD-DMB543 and RPA-FABMB543, the data were well described by a single step
binding model defined phenomenologically by a single exponential plus linear equation.
Δf=A1(1−e−k1*t)+k2*t

(Eq. 3)

3.2.11 RPA-DBD-AMB543, RPA-DBD-DMB543, and RPA- FABMB543 association
kinetics

To obtain the rate of association for DBD-A binding to ssDNA, 200 nM RPAAMB543 in one syringe was rapidly mixed with increasing concentrations (50- 400 nM) of
(dT)35 oligonucleotide from the second syringe and the change in fluorescence of RPADBD-AMB543 was monitored. All the data obtained were analyzed using Eq.2 to obtain
observed rate constants. kobs,1 was plotted against [(dT)35] and a linear fit was used to
generate a rate for DBD-A binding to ssDNA. Similarly, to measure DBD-D binding to
ssDNA, 200nM RPA-DBD-DMB543 in one syringe was rapidly mixed with increasing
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concentrations (50- 400 nM) of (dT)35 oligonucleotide from the second syringe and the
change in fluorescence of RPA-DMB543 was monitored. Finally, to obtain the rate of
association of FAB binding to ssDNA, 300 nM of FABMB543 in one syringe was rapidly
mixed with increasing concentration of (dT)30 oligonucleotide (100-1000 nM) from the
second syringe and the change in fluorescence of FABMB543 was monitored. For RPADBD-DMB543 and RPA-FABMB543, all the data obtained were analyzed using Eq.3 to
obtain observed rate constants. kobs,1 was plotted against [(dT)35] and against [(dT)30] for
RPA-DBD-DMB543 and RPA-FABMB543 respectively. A linear fit was used to generate a
rate for DBD-D and FAB binding to ssDNA.

3.2.12 RPA-AMB543 and RPA-DMB543 length dependent association kinetics

To measure the oligonucleotide length dependent rate of association for DBD-A,
200 nM RPA-DBD-AMB543 was rapidly mixed with 200 nM (dT)8, (dT)10, (dT)15, (dT)20,
(dT)25, (dT)30 or (dT)35 and change in fluorescence was monitored. All the data obtained
were analyzed using Eq.2 to obtain the observed rates. kobs,1 was plotted against (dT)n to
determine the rate for oligonucleotide length dependent association of DBD-A. Using the
same concentration of reactants, similar experiments were performed with RPA-DBDDMB543 and RPA-FABMB543 to measure the oligonucleotide length dependent rate of
association for DBD-D. All the data obtained were analyzed using Eq.3 to obtain the
observed rates. kobs,1 was plotted against (dT)n to determine the rate for oligonucleotide
length dependent association of FAB and DBD-D.
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3.2.13 RPA-DBD-ACy5 and RPA-DBD-DCy5 polarity for DNA binding

For all FRET experiments, samples (Cy3) were excited at 555 nm and Cy5
fluorescence emission was monitored with a 645 nm long-pass emission filter. 5′ or 3′
Cy3-labeled DNA (100 nM) was mixed with the appropriate Cy5-labeled RPA protein
and the change in Cy5 fluorescence was captured. Data were fit to Eq. 3 to obtain
observed rate constants for the resulting change in fluorescence.

3.2.14 RPA-DBD-AMB543 and RPA-DBD-DMB543 facilitated exchange kinetics

200 nM of either RPA-DBD-AMB543 or RPA-DBD-AMB543 was premixed with 200
nM (dT)25 in one syringe to form the RPA-DNA complex and rapidly mixed with
increasing concentrations of RPA-wt from the second syringe (100 – 500 nM). The
change in MB543 fluorescence was monitored, and the data were analyzed using Eq.3 to
obtain observed rate constants. kobs,1 was plotted against [RPA-wt] and a linear fit was
used to generate a rate for the facilitated exchange processes.

3.2.15 RPA-FABMB543 facilitated exchange kinetics

To measure the facilitated exchange kinetics of FABMB543, FABMB543- (dT)30
complexes were pre-formed using 375 nM FABMB543 and 100 nM (dT)30 in one syringe.
FABMB543- (dT)30 complexes were rapidly mixed with increasing concentrations of RPAwt from the second syringe (100 – 500 nM) and the change in fluorescence of FABMB543
was monitored. All the data obtained were analyzed using Eq.3 to obtain observed rate
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constants. kobs,1 was plotted against [RPA-wt] and a linear fit was used to generate a rate
for the facilitated exchange processes.

3.2.16 Tryptophan binding kinetics

Intrinsic tryptophan fluorescence was used to capture the binding of unlabeled
and fluorescently labeled RPA variants to ssDNA in reaction buffer. 200 nM RPA (RPAwt or RPA-DBD-AMB543 or RPA-DBD-DMB543) was rapidly mixed with increasing
concentrations (50- 400 nM) of (dT)35 oligonucleotide and the change in Trp fluorescence
was monitored by exciting the sample at 290 nm and measuring emission with a 350 nm
cut-off filter. Data were fit using Eq.3 and kobs,1 was plotted against [(dT)35]. A linear fit
was used to obtain the observed rate constants for RPA-DNA binding.

3.2.17 Single Molecule Experiments and Data analysis

All the experimental procedures for single-molecule imaging, data collection and
analysis is described in (Nilisha Pokhrel et. al., 2019) and was carried by Colleen
Caldwell in Dr. Maria Spies laboratory, University of Iowa, Iowa.

3.3 Results

3.3.1 Direct read out of DBD dynamics using non-canonical amino acids and
fluorescence

Directly monitoring the dynamics (binding, dissociation, or remodeling) of a
single enzyme in multi-protein reactions remains technically challenging. To decipher
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how the DBDs of RPA function in the context of the heterotrimeric RPA complex, we
labeled DBD-A or DBD-D (in RPA70 and RPA32, respectively; Fig. 3-2 a, b) of S.
cerevisiae RPA (N. Pokhrel et. al., 2017) with MB543, an environmentally sensitive
fluorophore. To confirm that labeling of RPA did not affect function, DNA binding
properties of all fluorescent versions of RPA were extensively characterized and
compared to the activity of wild type RPA. To compare DNA binding, stopped flow
experiments were performed by mixing unlabeled or fluorescent RPA (RPA-AMB543 or
RPA-DMB543) with increasing concentrations of ssDNA [(dT)35], and the change in
intrinsic tryptophan fluorescence was measured (Fig 3-3 a-c). Unlike RPA labeled at
individual DBDs with MB543, tryptophan signal changes reflect ssDNA binding and
conformational changes within all DBDs of RPA. The data were fit as described in the
Methods section and yielded observed rate constants (Fig. 3-3 d-f) for the two phases.
Both rate constants, and their dependence on [DNA] were similar between unlabeled and
fluorescent RPA, suggesting that fluorescent RPA have DNA binding activity similar to
wild type RPA (Fig 3-3 f). We next performed electromobility band shift analysis
(EMSA) to monitor RPA-ssDNA binding using radiolabeled (dT)30. Fluorescent and
wild-type RPA (50 nM) bound stoichiometrically to ssDNA (50 nM (dT)30) (Fig. 3-4 a),
again suggesting similar DNA binding properties. Finally, since each DBD binds to a
distinct number of DNA bases (Fan & Pavletich, 2012a), we measured the occluded sitesize of fluorescent and wild-type RPA using poly(dT) ssDNA and measured the change
in intrinsic tryptophan fluorescence (Fig 3-4 b). Site-sizes for S. cerevisiae have been
shown to vary between 18 – 27 nt (Kumaran et. al., 2006). Under our reaction conditions,
wild type RPA occludes 20 nt/RPA and both RPA-DBD-AMB543 and RPA-DBD-DMB543
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occlude 20 nt/RPA (Fig. 3-4 b). These DNA binding experiments suggest that the activity
of the fluorescent RPAs are similar to wild type RPA. RPA labeled at domain A (RPADBD-AMB543) and domain D (RPA-DBD-DMB543) produce enhanced fluorescence upon
binding to ssDNA (Fig. 3-5 a, b) (N. Pokhrel et. al., 2017).

a)

b)

Figure 3-2: 12% SDS-PAGE gel showing site-specifically labeled DBD-A and DBDD. a), b) left, Coomassie stained gel image showing all three subunits of RPA, while only
a) right, RPA70, harboring DBD-A is visible in fluorescence scan and b) right, RPA32,
harboring DBD-D, is visible in fluorescence scan.
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a)

b)

d)

e)

c)

f)

Figure 3-3: DNA binding properties of fluorescent RPA. Stopped flow experiments
were performed by mixing 100nM a) RPA-wt, b) RPA-DBD-AMB543 or c) RPA-DBDDMB543 with increasing concentrations of ssDNA [(dT)35], and the change in intrinsic
tryptophan fluorescence was recorded. d) -f) Data were fit as described in methods to
obtain koff and kon values, and the apparent Kd values were calculated.
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a)

b)

Figure 3-4: DNA occupancy of fluorescently labeled RPA. a) Stoichiometric binding
of unlabeled or labeled versions of RPA to 32P-labeled [(dT)30] oligonucleotide (50 nM) is
observed in EMSA experiments. b) Occluded site-size measurements were performed by
adding increasing concentrations of poly(dT) ssDNA to RPA (0.2 μM) and monitoring
the change in tryptophan fluorescence. All versions of RPA occlude ~20±2 nt/RPA in our
reaction conditions (30 mM Hepes, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM βmercaptoethanol and 6 % v/v glycerol). These experiments show that the DNA binding
properties of the labeled RPA are similar to the unlabeled wild type RPA complex.
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a)

b)

Figure 3-5: Fluorescently labeled RPA-DBD- A and RPA-DBD-D are responsive to
DNA binding. A robust change in MB543 is observed upon a) RPA-AMB543 b) RPADMB543 binding to DNA. The observed change in fluorescence signal is specific for
engagement of that particular DBD on DNA and directly reports DBD dynamics. Raw
traces for each DBD-DNA engagement were fit according to the kinetic equations
described in the methods section.
RPA binding to ssDNA is a paradigm for reactions where multiple DNA binding
enzymes function together on a single DNA template. Knowledge of where, how, and
when each enzyme gains access to the DNA in this multi-enzyme milieu is fundamental
to deciphering when and how specific DNA repair/recombination processes are
orchestrated. Site-specific labeling with MB543 allows us to monitor the dynamics of
individual DBDs in the context of the full-length RPA heterotrimer and in multi-protein
reactions. We measured the DNA binding kinetics for RPA-DBD-AMB543 and RPA-DBDDMB543 providing direct read outs of each domain’s engagement with ssDNA in the
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context of full-length RPA. RPA-DBD-AMB543or RPA-DBD-DMB543 were rapidly mixed
with ssDNA [(dT)25], and the change in fluorescence was measured (Fig. 3-5 a, b). Upon
binding to ssDNA, both RPA-DBD-AMB543 and RPA-DBD-DMB543 produce a robust change
in fluorescence intensity (Fig 3-5 a-b, 3-6 b, c), which is not seen for binding to doublestranded DNA (Fig 3-6 d) or in case of RPA-ACy5, when excited at 535nm and emission
spectra monitored (Fig 3-6 e). The data for RPA-DBD-AMB543 is best described by a twostep model (kobs,1 =30.6±9.8 s−1 and kobs,2 = 10.3±9.8 s−1), whereas intensity changes
associated with RPA-DBD-DMB543 best fits a single-step DNA binding model (kobs =
36.2±2.3 s−1). The first step in both models is similar and reflects the initial interaction of
RPA with ssDNA. The second step for RPA-DBD-AMB543 possibly reflects a
rearrangement of DBD-A, as has been observed in structural studies (Brosey et. al.,
2015a, 2013). To probe the nature of these differences further, we performed these
binding experiments as a function of increasing DNA concentration using (dT)35, which
provides enough space for engagement of all the DBDs of RPA (Fig. 3-7 a-f). While
measurements of RPA-ssDNA interaction footprints under our buffer conditions yield
occluded site sizes of ~20 nt/RPA (Fig. 3-4 b), the modularity of the DBDs have been
shown to produce occluded site-sizes between 18–28 nt (Kumaran et. al., 2006).
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b)

a)

d)

c)

e)

Figure 3-6: Spectral properties of fluorescent RPA. a) Structure of DBCO-MB543
used to fluorescently label RPA in this study. b) Excitation and emission spectra of RPADBD-AMB543 in solution. c) Percent change in fluorescence enhancement was measured
for RPA-DBD-AMB543 in the absence or presence of ssDNA or d) dsDNA. The change in
fluorescence is specific for ssDNA interactions with RPA. e) No change in fluorescence
is observed for RPA-DBD-ACy5 upon binding to ssDNA. Similar analysis for RPA-DBDDMB543 is shown in Chapter 2, figure 2-5 a, b.
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The observed rate for the first association step for both RPA-DBD-AMB543 and
RPA-DBD-DMB543 increases as a function of DNA concentration yielding bimolecular
kON values (1.1±0.6 ×108M−1s−1 and 2.1±0.4×108M−1s−1, respectively; Fig. 3-7 c, f). The
second step, observed only for RPA-DBD-AMB543, is not linear (Fig. 3-7 c). This is
consistent with a conformational rearrangement of DBD-A after the complex with
ssDNA has been established and depends on the protein to DNA ratio in the reaction.
Under conditions where RPA is present in excess over ssDNA, we clearly observe
biphasic binding and dissociation/rearrangement phases for RPA-DBD-AMB543 (orange
and pink traces in Fig. 3-7 b; 3-8 b), but not for RPA-DBD-DMB543 (Fig. 3-7 e, 3-8 e).
These data suggest that the dynamics of individual DBDs are not identical, possibly
reflecting different functional roles; as shown in our single-molecule studies.
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a)

b)

c)

d)

e)

f)

Figure 3-7: ssDNA concentration dependent binding of RPA-DBD-A and RPADBD-D. a), d) Diagrammatic representation of RPA-DBD-AMB543 or RPA-DBDDMB543 binding to ssDNA and producing a change in fluorescence. Stopped flow
experiments done with b) 100nM RPA-DBD-AMB543 e) 100nM RPA-DBD-DMB543 with
increasing concentrations of [(dT)35] ssDNA shows the observed rates in fluorescence
change for c) RPA-DBD-AMB543 and f) RPA-DBD-DMB543. The data for RPA-DBDAMB543 are best fit using a two-step model whereas the data for RPA-DBD-DMB543 fit to a
one-step process, suggesting distinct DNA context dependent changes in their dynamics.
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a)

b)

c)

d)

e)

f)

Figure 3-8: ssDNA length dependent binding of RPA-DBD-A and RPA-DBD-D. a),
d) Cartoon diagram of RPA-DBD-AMB543 or RPA-DBD-DMB543 binding to increasing
lengths of ssDNA and producing a change in fluorescence. Stopped flow experiments
done with b) 100nM RPA-AMB543 e) 100nM RPA-DMB543 rapidly with increasing lengths
(dT)n (where n= 8,10,15,20,25,30,35) shows the observed rates in fluorescence change
for c) RPA-DBD-AMB543 and f) RPA-DMB543. The data for RPA-DBD-AMB543 are best fit
using a two-step model whereas the data for RPA-DBD-DMB543 fit to a one-step process.
Pink and oranges traces in RPA-AMB543 show remodeling of DBD-A when the ssDNA is
short and not enough for all DBDs to engage. This is absent in RPA-DMB543 suggesting
distinct DBD binding dynamics.
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3.3.2 FRET analysis confirms primary assessments of DBD-ssDNA dynamics

In the experiments described above, the change in fluorescence intensity arises
from local environmental changes of the fluorophore upon binding to the ssDNA. We
suggest that changes in the MB543 fluorescence reflect changes in the electrostatic
environment of the dye (Fig 3-9 a-d). To reaffirm that the accuracy of the dynamics we
measure for each fluorescent DBD reflects ssDNA interactions, we used Förster
Resonance Energy Transfer (FRET) to capture DBD-ssDNA binding kinetics. RPA binds
to ssDNA with specific polarity where DBD-A is positioned closer to the 5′ end of the
ssDNA (Fan & Pavletich, 2012a; Kolpashchikov et. al., 2001). Similar to the MB543labeled proteins, we generated Cy5-labeled RPAs where either DBD-A or DBD-D was
labeled with Cy5. We next performed FRET experiments with either 5′ or 3′ Cy3-endlabeled DNA [(dT)34]. On 5′Cy3 DNA, a high FRET signal is observed for RPA-DBDACy5, and a medium FRET state is captured for RPA-DBD-DCy5 (Fig. 3-10 a, b). In the
corollary experiment with 3′Cy3 DNA, a low FRET state for RPA-DBD-ACy5 and a high
FRET state for RPA-DBD-DCy5 are observed (Fig. 3-10 c, d). These experiments are
consistent with the expected 5′ to 3′ polarity of RPA binding. Strikingly, the observed
rate for the appearance of the RPA-DBD-DCy5 high FRET state (36±2s−1; Fig. 3-10 d)
agrees with the rate for change in fluorescence intensity of RPA-DBD-DMB543 upon
binding to ssDNA (36.2±2s−1; Fig. 3-5 b). Similarly, the observed rate of 21±1s−1 for the
appearance of the RPA-DBD-ACy5 high FRET state (Fig. 3-10 b) is likely a composite of
the two observed phases captured in fluorescence intensity changes of the RPA-DBDAMB543 ssDNA complex (kobs,1 =30s−1 and kobs,2=10s−1; Fig. 3-5 a). The FRET data affirm
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that the ssDNA binding responsive fluorescence intensity enhancements reflect specific
DBD-ssDNA interactions.

a)

b)

c)

d)

Figure 3-9: Changes in MB543 fluorescence reflect conformational changes
associated with electrostatic interactions. The change in MB543 fluorescence was
measured as a function of increasing concentrations of a) dimethyl formamide (DMF) or
c) ethanol, and b) & d) the respective change in fluorescence was plotted. The solvent
dependent changes in emission spectra are suggestive of electrostatic changes around the
fluorophore.
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a)

b)

c)

d)
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Figure 3-10: FRET experiments capture the polarity of RPA binding on ssDNA. a),
c) Models of the expected FRET states and the polarity of the Cy5-DBD with respect to
the Cy3-DNA. Boxes are color coded to match the traces in the data. Stopped flow
experiments were performed by rapidly mixing either RPA-DBD-ACy5 or RPA-DBDDCy5 with ssDNA labeled at the b) 5′ end or d) 3′ end with Cy3. Cy3 was excited and
change in Cy5 emission was measured. The proximity of the Cy3 and Cy5 fluorophores
dictate the observed FRET efficiency and results in the enhancement of Cy5 emission.
Since RPA binds to ssDNA with a 5′ -> 3′ polarity, when RPA-DBD-ACy5 resides close
to the 5′Cy3 on DNA, a high FRET state is observed. Similarly, when RPA-DBD-DCy5
binds close to the 3′Cy3, a high FRET signal is captured. kobs values for change in FRET
were obtained by fitting the data to a single exponential plus linear equation. Black traces
are DNA only (no RPA). Pink and Green traces are experiments with RPA-DBD-ACy5
and RPA-DBD-DCy5, respectively. The measured rates match well to the rates observed
for RPA labeled with MB543 (Fig. 3-5 a, b) suggesting that the ssDNA dependent
changes in RPA-MB543 intensity reflect specific DBD-ssDNA interactions.
3.3.3 Differential effects of ssDNA length on DBD conformations

Since each DBD has varying footprints on ssDNA (Fan & Pavletich, 2012a) we
measured the DBD dynamics as a function of ssDNA length and found that the
kobs,1 increases as a function of ssDNA length for RPA-DBD-AMB543 (Fig. 3-8 a-c),
whereas the same parameter saturated for RPA-DBD-DMB543 at ~20 nt (Fig. 3-8 d-f). On
shorter DNA lengths, both binding and dissociation phases are clearly observed for RPADBD-AMB543 (Fig. 3-8 b: (dT)15 and (dT)20 traces); however, only a single binding phase
for RPA-DBD-DMB543 is observed with all ssDNA lengths (Fig. 3-8 e). Since ssDNA and
RPA are in molar equivalents in these experiments, the dissociation from shorter DNA
probably occurs from intra-subunit competition between the four DBDs of RPA. DBDs
F, A and B are considered the conformationally flexible half (Brosey et. al., 2009). In
contrast, DBDs C, D and E constitutively interact to form the trimerization core and are
more conformationally rigid. We considered the possibility that the trimerization core
might be outcompeting the more dynamic DBD-A (and possibly DBD-B) under
conditions of excess RPA or when the length of the DNA is too short to accommodate all
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the DBDs. To test this scenario, we generated the RPA-FAB fragment containing DBDs
F, A and B and labeled it with MB543 in DBD-A (RPA-FAB-AMB543). RPA-FAB-AMB543
bound to ssDNA [(dT)45] and produced an 89% enhancement in fluorescence (Fig. 3-11
a). Stopped flow measurement of DNA binding kinetics of RPA-FAB-AMB543 yield
kon=1.0±0.1×108M−1s−1 (Fig.3-11 b-d), which is similar to that measured for RPA-DBDAMB543 (1.1±0.6×108 M−1s−1; Fig. 3-7 b, c), suggesting that DBD-A has intrinsically
distinct DNA binding capacity compared to DBD-D, and possibly other DBDs as well.
Interestingly, RPA-FAB-AMB543 binds to ssDNA with monophasic kinetics under both
conditions of excess protein or shorter DNA lengths (Fig.3-11 b, c). We do not observe
the second phase where a decrease in fluorescence signal (Fig. 3-11 b, c) as observed for
RPA-DBD-AMB543 (Fig. 3-7 b, 3-8 b; orange trace). These data show that the second
rearrangement phase observed for RPA-DBD-AMB543 is due to competition from either
DBD-C and/or D) and rearrangements between the DBDs within full length RPA when
the binding sites on ssDNA are limiting. Free RPA in solution can displace ssDNAbound RPA through a mechanism called ‘facilitated exchange’ (Gibb, Ye, Gergoudis, et.
al., 2014). ssDNA-bound RPA-FAB-AMB543 is exchanged at two orders of magnitude
faster than either RPA-DBD-AMB543 or RPA-DBD-DMB543 (Fig. 3-12 a-c, h), suggesting
that the presence of all the DBDs enhance the stability of RPA on ssDNA. Interestingly,
RPA-DBD-AMB543 and RPA-DBD-DMB543 are exchanged at similar rates suggesting that
unlabeled RPA can efficiently compete for either DBD (Fig. 3-12 d-h). We propose that
when only a short segment of ssDNA ((dT)15 or (dT)20) is available, DBD-A rapidly
binds and dissociates, whereas DBD-D (and possibly the trimerization core) forms more
stable, longer-lived complexes with ssDNA, thus outcompeting DBD-A from short
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ssDNA substrates. These data also suggest that the interactions of each DBD and
resulting conformations of the RPA-ssDNA complex are sensitive to the context of DNA
encountered during various DNA metabolic processes in the cell (Discussed in detail in
chapter 4).
a)

c)

b)

d)

Figure 3-11: The RPA fragment comprised of FAB domains displays rapid and
monophasic binding to ssDNA. The FAB region of RPA (DBDs F, A and B) was
purified and labeled with MB543 at DBD-A (RPA-FAB-AMB543), and a) produces a
robust change in fluorescence upon binding to ssDNA. b) Stopped flow analysis shows
rapid binding of RPA-FAB-A MB543 (100 nM) to 100 nM of ssDNA of increasing lengths
(dT)n. A minimum of 15 nt is required to observe binding. c) RPA-FAB-Af binding
dynamics on ssDNA were measured by monitoring the change in fluorescence upon
binding to increasing concentrations of [(dT)30] ssDNA. d) Measurement of DNA
binding kinetics reveal kon (1.1±0.1 x108 M-1s-1). The RPA-FAB-AMB543 binding data
were fit to a single exponential plus linear equation to obtain kobs,1.
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b)

a)

d)

c)

e)

g)

f)

h)

Figure 3-12: RPA-FAB is exchanged more readily on ssDNA compared to the fulllength RPA. a)-c) Preformed RPA-FAB-AMB543:(dT)25 complexes were challenged with
increasing concentrations of unlabeled RPA-wt and the rate of exchange was measured
by monitoring the decrease in fluorescence intensity. RPA-FAB-AMB543 was cleared at an
apparent rate of (1.3±0.3x108 M-1s-1). In comparison, d)-h) the rates of exchange of RPADBD-AMB543 or RPA-DBD-DMB543 by RPA-wt was two orders of magnitude slower.
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3.3.4 Single-molecule analysis reveals the presence of multiple conformational states
involving DBD-D and DBD-A

Ensemble stopped flow experiments described above suggest that the terminal
DBDs of RPA associate with ssDNA with different rates and that, upon binding to
ssDNA, RPA commences a complex and dynamic rearrangement of its DBDs. Singlemolecule total internal reflection microscopy (smTIRFM) was used to directly observe
RPA-DBD-AMB543 and RPA-DBD-DMB543 binding to and dissociation from surfacetethered ssDNA in the context of the RPA heterotrimer. In the smTIRFM experiments,
biotinylated ssDNA (66 nt) was tethered to the surface of the TIRFM flow cell
(see Methods and (Nilisha Pokhrel et. al., 2019) for details). The surface was illuminated
with a 532 nm laser to excite the MB543 dye on fluorescent-RPA molecules entering the
evanescent field (Fig. 3-13 a, b). Binding of a MB543-labeled RPA to surface-tethered
ssDNA molecules generates a fluorescence signal at a particular location of the flow cell
surface. This signal persists until RPA dissociates, transitions to a dark-state and then
dissociates, or until the dye photobleaches.
Several hundred molecules are observed in the field of view, each yielding a
fluorescence trajectory (i.e. change in fluorescence in a particular location on the slide as
a function of time) (Boehm, Subramanyam, Ghoneim, Washington, & Spies, 2016). The
trajectories allow measurement of binding and dissociation of individual RPA molecules.
Moreover, fluorescence changes of the dye in the trajectory can also report on the
presence of conformational states in the dye-decorated protein (Ghoneim & Spies, 2014).
The experiments were carried out in three stages: first, the surface was observed for 30
seconds to confirm the absence of the non-protein derived fluorescence spots; second,
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RPA-DBD-AMB543 or RPA-DBD-DMB543 was injected into the flow cell; finally, at 120
seconds, protein-containing solution was replaced with the buffer (Fig. 3-13 a, b). The
last step ensured that the observed changes in fluorescence can be attributed to single
RPA molecules. Fluorescence trajectories were extracted from the recorded movies and
were normalized (see (Nilisha Pokhrel et. al., 2019) for more details). Resultant
trajectories showed dynamics within the RPA-ssDNA complex (Fig. 3-13 c, d).
Moreover, transitions between different fluorescence states persisted during the last
segment of the experiment suggesting that they truly reflect the conformational dynamics
of individual RPA-ssDNA complexes. Global analysis of normalized trajectories for the
ssDNA-bound RPA-DBD-AMB543 and RPA-DBD-DMB543 was performed with ebFRET
(Subramanyam, Kinz-Thompson, Gonzalez, Spies, & Spies, 2018; van de Meent,
Bronson, Wiggins, Gonzalez, & Jr., 2014). This analysis revealed that the fluorescence
derived from both proteins best fit a 4-state model, with state 1 corresponding to very low
fluorescence and states 2–4 corresponding to increasing fluorescence enhancement (Fig.
3-13 c, d). Segments of the trajectories between 120 and 210 seconds, which can be
attributed to the dynamics of a single bound RPA, were used in the quantification of the
lifetimes and visitation frequencies for all states.
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a)

c)

b)

d)

Data collected by Colleen Caldwell and Maria Spies, University of Iowa
Figure 3-13: Single molecule analysis to capture the conformational dynamics of
DBDs. a), b) Experimental scheme for visualizing conformational dynamics of DBD-A
and DBD-D. Binding of fluorescently labeled RPA to a surface-tethered ssDNA (purple
line) brings the MB543 fluorophore within the evanescent field of TIRFM. NA –
neutravidin, b – biotin. c), d) Representative fluorescence trajectories for individual RPADBD-AMB543 and RPA-DBD-DMB543 molecules, (purple and green lines, respectively).
Black lines are the results of ebFRET fitting.
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We attribute state 4 in each case to the RPA conformation where the labeled
domain is potentially fully engaging the ssDNA; because in bulk experiments, we
observed the ssDNA-dependent fluorescence increase in the full-length RPA carrying the
fluorophore, and RPA-FAB-AMB543 (containing only DBD-A and DBD-B). To rule out
that the lowest fluorescence state (state 1) followed by the reappearance of the
fluorescence during the last 90 seconds of the experiment is due to the RPA dissociation
and rebinding, we substituted the buffer wash with the buffer supplemented with high
concentration of ssDNA. In the absence of additional RPA in the solution, ssDNA
competitor cannot strip the bound RPA from the DNA but can sequester all dissociated
RPA molecules (Gibb, Ye, Gergoudis, et. al., 2014). As expected, the addition of ssDNA
into the reaction chamber had no effect on the RPA fluorescence states (Fig. 3-14 a-d).
The four fluorescence states and their dwell times were consistent between independent
experiments suggesting that the normalization scheme we developed yields reproducible
results (Fig. 3-15 a-d, 3-16 a-d). For both RPA-DBD-AMB543 and RPA-DBD-DMB543,
states 1 and 4 were the most stable with average dwell times around 1 second compared
to states 2 and 3 whose average dwell times were between 300 and 500 ms. As evident
from the representative trajectories (Fig. 3-13 c, d), RPA spends significant periods of
time in states where DBD-A or DBD-D are not fully engaged, providing a window of
binding opportunity for lower affinity proteins.
In addition, we found that the collective DNA binding affinities of all DBDs
produce stable RPA-ssDNA complexes. DBDs A and B have been canonically assigned
as responsible for high affinity DNA binding of the RPA complex. By carrying out
single-molecule experiments with the RPA-FAB-AMB543 we found that it forms a less
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stable complex on ssDNA and readily dissociates (Fig. 3-17 a-d). These findings agree
with the results from bulk stopped flow experiments (Fig. 3-11 a-d, 3-12 h). Fluorescence
trajectories recorded for RPA-FAB-AMB543 were best fit with the three-state model (Fig.
3-17 a, c). State 1 corresponded to free ssDNA and its lifetime displayed a linear
dependence on the RPA-FAB-AMB543 concentration (Fig. 3-17 d). States, 2 and 3 were
present in the bound state of RPA-FAB-AMB543 whose two DBDs had been suggested to
form a dynamic complex on the ssDNA (Pretto et. al., 2010). The presence of only two
fluorescence states in the RPA-FAB-AMB543 further confirms that the four states observed
for the full-length RPA are not photophysical states inherent to the MB543 dye.
In ensemble experiments, where several thousands of molecules are monitored,
the composite fluorescence data obtained for DBD-A is fitted with a double-exponential+
a linear phase model, while, data for DBD-D is fitted with a single-exponential + a linear
phase model (Fig. 3-5, 3-6, 3-7, 3-8). In such cases, the double exponential suggests that
are two likely phases/ steps in DBD-A binding to DNA. Similarly, a single exponential
phase suggests that there is one step in DBD-D binding to DNA, till an equilibrium is
reached. Each of these steps can have number of association- dissociation within but
when observed with stopped flow instrument, they are collected a composite signal from
thousands of molecules. This is different from the smTIRF data that monitors one
molecule of RPA-DBD-A or RPA_DBD-D bound on DNA at a time and shows presence
of four distinct states of binding.
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a)

b)

c)

d)

Data collected by Colleen Caldwell and Maria Spies, University of Iowa
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Figure 3-14: Scavenger ssDNA in the buffer wash step confirms that RPA-DBDAMB543 remains bound to ssDNA in observed dark state events. a) Experimental
scheme for visualization of the effect of excess ssDNA on the RPA-DBD-DMB543
dynamics and association with DNA. Binding of the RPA-DBD-DMB543 (100pM) to the
surface-tethered ssDNA (blue line) brings the MB543 fluorophore within the evanescent
field and its excitation. 1nM ssDNA (42nt) was added at 90s when excess RPA was
washed away. NA – neutravidin, b – biotin. b) Representative fluorescence trajectories
depicting the conformational dynamics of the individual RPA-DBD-DMB543 molecules.
After replacement of RPA in the reaction chamber with 1nM ssDNA, the same four
conformational states are observed in the RPA-DBD-DMB543 trajectories. As seen in
experiments where excess RPA was washed away with Reaction buffer, reappearance of
higher fluorescence states are observed after visitation of the dark state (state 1) in the
presence of excess ssDNA. RPA that dissociated would have been bound by the excess
free DNA, thus indicating that the reappearance of higher fluorescence states (2,3,4) is
due to RPA remaining bound while in the dark state (1). c) Comparison of the stability of
each state available to RPA-DBD-DMB543 when excess RPA is washed away with
reaction buffer (grey) or reaction buffer containing 1nM ssDNA (blue). The data on Y
axis are the lifetimes calculated from the respective dwell time distributions. Data for
each independent experiment is plotted separately. d) Comparison of the fractional
visitation to each state available RPA-DBD-DMB543 when excess RPA is washed away
with reaction buffer (grey) or reaction buffer containing 1nM ssDNA (blue).
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a)

c)

b)

d)

Data collected by Colleen Caldwell and Maria Spies, University of Iowa
Figure 3-15: Quantification ebFRET to confirm DBD-A domain dynamics in RPADBD-AMB543. Dwell time histograms for the four fluorescent states obtained by the
ebFRET fitting of RPA-DBD-AMB543 trajectories from three independent experiments a)
after buffer wash, and b) Rad52 wash. c) Fractional visitation to each state available to
RPA-DBD-AMB543 alone (grey) and in the presence of Rad52 (blue). d) Stability of each
state available to RPA-DBD-AMB543 alone (grey) and in the presence of Rad52 (blue).
The data on Y axis are the lifetimes for the respective dwell time distributions.
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a)

c)

b)

d)

Data collected by Colleen Caldwell and Maria Spies, University of Iowa
Figure 3-16: Quantification ebFRET to confirm DBD-D domain dynamics in RPADBD-DMB543. Dwell time histograms for the four fluorescent states obtained by the
ebFRET fitting of RPA-DBD-DMB543 trajectories from three independent experiments a)
after buffer wash, and b) Rad52 wash. c) Fractional visitation to each state available to
RPA-DBD-AMB543 alone (grey) and in the presence of Rad52 (blue). d) Stability of each
state available to RPA-DBD-DMB543 alone (grey) and in the presence of Rad52 (blue).
The data on Y axis are the lifetimes for the respective dwell time distributions.
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a)

b)

Data collected by Colleen Caldwell and Maria Spies, University of Iowa
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Figure 3-17: Single-molecule analysis of RPA-FAB-AMB543-ssDNA interaction. a)
Experimental scheme for visualization of the binding and conformational dynamics of
FAB. Binding of the fluorescently labeled FAB to ssDNA (blue line) tethered to the
surface of TIRFM flow cell (grey line) brings the MB543 fluorophore within the
evanescent field and its excitation. NA – neutravidin, b – biotin. b) Representative
fluorescence trajectories depicting binding (appearance and disappearance of the signal)
and conformational dynamics (change in fluorescence without FAB dissociation) of the
individual RPA-FAB-AMB543 molecules. Purple lines represent normalized fluorescence,
black lines represent the results of ebFRET fitting of the experimental data to the threestate model (where state 1 is the off state, while states 2 and 3 are the two bound states
with different fluorescent intensities). The levels for the respective states are indicated by
dashed lines. (Top) Representative trajectory of the most commonly observed short
binding events and rare transitions between fluorescence states. (Bottom) At each RPAFAB-AMB543 concentration, several trajectories displaying long binding events can be
observed.
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3.3.5

Rad52 selectively modulates DBD-D dynamics

To determine the mechanism by which the recombination mediator Rad52
remodels the RPA-ssDNA complex, RPA-DBD-AMB543 or RPA-DBD-DMB543 bound to
the surface-tethered ssDNA in the smTIRFM experiments were challenged with Rad52
(Fig. 3-18 a-d). The last 90 second portions of the resulting trajectories were normalized
and globally analyzed using ebFRET. Dwell times for each state were binned and fit to an
exponential decay (Fig. 3-15 a, b, 3-16 a, b). RPA-DBD-AMB543 trajectories after buffer
wash or after Rad52 addition fit best to a 4-state model with the same distribution of
states and the same dwell times (Fig. 3-15 a-d). The trajectories collected for RPA-DBDDMB543 after Rad52 addition instead best fit a 3-state model (Fig. 3-16, a-d). Attempts to
fit these trajectories with a 4-state model resulted in overfitting and overlapping states.
Intensities of the 3-states of RPA-DBD-DMB543 after Rad52 addition correspond to the 3
lowest states seen after the buffer wash with the highest state absent when Rad52 was
present (Fig. 3-18 d, blue shaded area). With RPA-DBD-DMB543 occupancy at state 4 lost
after Rad52 addition, state 3 occupancy decreases, whereas state 1 and 2 occupancy
increases (Fig. 3-16 c). This suggests that Rad52 selectively modulates conformational
dynamics of the RPA-ssDNA complex: reducing the engagement of DBD-D from
ssDNA, providing access to the 3′ end of the occluded ssDNA.
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a)

c)

b)

d)

Data collected by Colleen Caldwell and Maria Spies, University of Iowa
Figure 3-18: Rad52 selectively modulates the conformation of DBD-D on DNA.
Experimental scheme for visualizing the effect of Rad52 on the conformational
dynamics of a) DBD-A and b) DBD-D. Representative fluorescence trajectories
depicting conformational dynamics of the individual c) RPA-DBD-AMB543and d) RPADBD-DMB543 molecules upon addition of Rad52. All the details pertaining to schematic
representation in a) and b), except for addition of Rad52 is the same as figure 3-13.
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a)

b)

Figure 3-19: Dynamics of RPA DBDs and modulation by Rad52. a) Sequential and
directional arrangement of the DBDs allows RPA to occlude 20–30 nt of ssDNA (∼20 nt
under our experimental conditions; Fig. 3-4 b). When RPA is in a stoichiometric complex
with ssDNA, or when the ssDNA is in excess, the individual DBDs of RPA exist in a
variety of distinct dynamic conformational DNA bound states. Such conformational
flexibility allows access to either the 5′ or the 3′ segment of the DNA to other proteins
that function in downstream processes. The circular arrows represent the transitions
between multiple fluorescence states we observe in the single molecule experiments and
which are implied by the bulk stopped flow experiments. Note that while we illustrate the
changes in the conformation of the RPA-ssDNA complex as movement of the DBDs, the
same microscopically bound states may arise from ssDNA dissociating and moving away
from the respective DBDs. b) The DBDs are also selectively modulated by RPAinteracting proteins (RIPs) such as Rad52. In this case, only the DNA binding dynamics
of DBD-D, and possibly the trimerization core, is influenced by Rad52. In the ternary
RPA-ssDNA-Rad52 complex, the ssDNA is shared by RPA and Rad52, which also
interact with one another. The ability of the DBD-D and other RPA elements contacting
the ssDNA near the 3′ end of the occluded sequence is constrained. Such selective DBD
modulation may promote loading of Rad51 onto the 3′ end of the ssDNA during
homologous recombination.
3.4 Discussion

Prior RPA binding models have been based on analysis of subcomplexes or
mutations. In contrast, we have analyzed the dynamics of individual domains in the
context of the full RPA-ssDNA complex. This analysis demonstrates that rather than
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being composed of “high” and “low” affinity domains, all DNA binding domains
transiently engage ssDNA with high affinity, but with differential dynamics. We also
observe interplay between the flexible half of RPA (DBDs-F, A and B) and the
trimerization core. Thus, the RPA-ssDNA complex consists of an ensemble of domains
that dynamically interact with ssDNA. This suggests that integration of these interactions
results in overall high affinity to ssDNA while facilitating diverse functions of RPA. Our
data also suggest that assembly of DBDs on ssDNA is not sequential but rather the result
of dynamic, independent interactions between connected DBDs and DNA.
RPA forms a complex with the recombination mediator Rad52 (M. S. Park,
Ludwig, Stigger, & Lee, 1996). RPA is in dynamic equilibrium on ssDNA and Rad52 has
been shown to increase the residence time of RPA on ssDNA (Gibb, Ye, Kwon, et. al.,
2014a). Formation of “early Rad52-bound” RPA and “late Rad52-bound” RPA are
proposed to play distinct roles during Rad51 filament formation and second-strand
capture during HR (Gibb, Ye, Kwon, et. al., 2014a). The ability to observe the individual
RPA DBDs binding to, and dissociating from, the ssDNA in real time permits a
mechanistic description of RPA-ssDNA-Rad52 interactions. The RPA heterotrimer and
the heptameric Rad52 ring have similar ssDNA binding sites. Each Rad52 monomer
contains an RPA binding site and RPA has two Rad52 binding sites per heterotrimer.
Rad52 is believed to interact with the ssDNA backbone, while the DBDs of RPA,
especially within the trimerization core, engage the bases. Stabilization of RPA by Rad52
is a result of both their physical interactions and their individual interactions with DNA
(Nilisha Pokhrel et. al., 2019). We therefore envision a ternary complex where Rad52 and
RPA interact with one another while both proteins are simultaneously bound to ssDNA.
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Selective modulation of DBD-D ssDNA engagement by Rad52 provides space for Rad52
to interact with ssDNA and stabilize the ternary complex, which then makes more
extensive contacts with the ssDNA than RPA does on its own. By redistributing the
ssDNA between RPA and Rad52, and by reducing the contacts between RPA and
ssDNA, such selective change in binding states of a particular DBD by Rad52 may
provide Rad51 recombinase access to the 3′ end of RPA-occluded ssDNA, while
maintaining its interaction with RPA (Fig. 3-19). Each Rad51 monomer binds to one
monomer of Rad52 and to three nucleotides of ssDNA. Six Rad51 monomers are
required to achieve a stable nucleation cluster (Qiu et. al., 2013), which amounts to 18
nucleotides of open ssDNA. This cannot be achieved without the help of a recombination
mediator. When Rad52 binds to ssDNA-bound RPA, it modifies the dynamics of the
DBD-D engagement. This provides a stretch of ssDNA with sufficient length to initiate
Rad51 filament nucleation. We predict that recombination mediators in other species,
including human BRCA2 may operate by a similar mechanism. The details of this
mechanism, however, will depend on the intrinsic differences in nucleoprotein filament
formation by human RAD51, which nucleates on ssDNA through dynamic association of
RAD51 dimers (Subramanyam et. al., 2016) and grows from heterogeneous nuclei
ranging in size from dimers to oligomers (Candelli et. al., 2014).
The myriad roles of RPA in DNA replication, repair, and recombination is also a
paradigm for reactions where multiple DNA binding enzymes function together on a
single DNA template. Knowledge of where, how, and when each enzyme gains access to
DNA in this multi-enzyme milieu is fundamental to deciphering when and how specific
DNA repair and recombination processes are established and used. RPA-ssDNA
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complexes serve as binding targets for recruitment of appropriate enzymes during various
DNA metabolic processes, and physical interactions between RPA and more than two
dozen enzymes have been identified. Upon recruitment, the bound ssDNA must be
handed over from RPA or remodeled in such a way that the DNA is accessible to the
incoming enzyme while RPA remains at the site. Microscopic binding and dissociation of
the RPA DBDs is likely to enable the persistent residence of RPA at the site of repair as
well as its ability to coordinate access to the DNA by helicases and nucleases. Such a
mechanism might also be applicable to RPA-like proteins that also carry a multi-OB fold
architecture, such as the CST complex associated with telomerase (Chan, Wang, &
Feigon, 2017).
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CHAPTER 4: DNA CONTEXT DEPENDENT RPA- DNA BINDING AND ITS
MODULATION BY RPA CHAPERONE RTT105

4.1 Introduction

The double- helical structure of DNA can adopt a variety of contours and shapes
while maintaining Watson- Crick base pairing. The myriad of ongoing cellular processes
can further change the local structure of DNA and generate unusual structural
intermediates in DNA. For example, the process of DNA replication generates fork like
structures or flaps, transcription generates bubbles and recombination generates
overhangs or joint-molecule structures (Fig 4-1). In several cases, DNA interacting
proteins recognize the particular structural perturbance and act on the DNA substrate to
reinstate the double helical conformation (Cooper, 2000; Wittschieben, Iwai, & Wood,
2005). Replication Protein A (RPA) is a ubiquitous single-stranded DNA (ssDNA)
binding protein present in all eukaryotes and plays a vital role in coordinating crucial
DNA processes. It stabilizes the replication fork upon replication stalling and initiates
replication checkpoint to restore replication fork integrity (Liao, Ji, Helleday, & Ying,
2018). It acts as a sensor for R-loops during transcription and stimulates the activity of
RNAse H1 enzyme to degrade the RNA present in R-loops (H. D. Nguyen et. al., 2017).
It melts the G-quadruplex structures which are abundant at telomeres (Salas et. al., 2006),
and it coats the 3ʹ overhang ssDNA generated during homologous recombination to allow
nucleation of Rad51 recombinase (Hass et. al., 2012). In each of these DNA-related
events, the context in which ssDNA is presented to RPA is different. Therefore,
depending on the ongoing cellular event, the ssDNA substrate encountered by RPA could
distinctly affect the arrangement of RPA-DBDs on ssDNA (Fig 4-2). Since RPA also
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plays a key role in coordinating simultaneous DNA-protein and protein-protein
interactions, the type of DNA encounterd by RPA could directly affect RIP recruitment
and access to ssDNA.
RPA-DNA binding is coordinated by the flexible half, i.e. DBDs A, B and the
less-flexible half, i.e DBDs C. D and RPA14. RPA-DNA binding is dynamic in nature
and several factors could be contributing to this dynamicity. First, RPA-DBDs bind
sequentially onto ssDNA with a polarity of 5ʹ -3ʹ, with DBD-A situated closer to 5ʹ and
DBD-D towards 3ʹ (W. L. de Laat et. al., 1998; Nilisha Pokhrel et. al., 2019). Second,
RPA is able to ‘sense’ the ssDNA substate which is documented by the finding that RPA
prefers to bind to an undamaged DNA, over DNA with adducts (Krasikova, Rechkunova,
Maltseva, & Lavrik, 2018). Third, it has a preferential binding to ssDNA than ssDNA
with a nearby dsDNA structure (R. Chen et. al., 2016b). To elaborate, using EMSA
experiments, studies have shown that RPA has comparatively higher binding affinity to
ssDNA alone, than when ssDNA is presented in form of a bubble substrate, or in DNA
with gaps (R. Chen et. al., 2016b). Fourth, RPA is able to diffuse on ssDNA (B. Nguyen
et. al., 2014b), and finally, RPA-DNA interactions can be manipulated by changing the
force applied on a particular DNA substrate (Kemmerich et. al., 2016). The presence of
multiple ssDNA interacting domains that are connected by flexible linkers allows RPA to
adopt a plethora of conformations, alone and on ssDNA (Elena Bochkareva et. al., 2002a;
Fan & Pavletich, 2012a; Fanning et. al., 2006). This is highlighted by the number of
nucleotides an RPA molecule can associate with. The first two DBDs of RPA have been
shown to associate with 8-nucleotide long ssDNA, whereas all the DBDs require 22-30
nucleotides to stably engage on ssDNA (A Bochkarev, Bochkareva, Frappier, &
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Edwards, 1999; Elena Bochkareva et. al., 2002a; Fanning et. al., 2006). This ssDNA
footprint further changes with increasing salt concentrations, where and RPA has been
shown to occupy around 18-20 nucleotides in low salt concentrations (~100mM),
compared with up to 26-28 nucleotides at high salt concentrations (1.5M NaCl)
(Kumaran et. al., 2006; B. Nguyen et. al., 2014b). In addition to these attributes, which
are derived primarily by monitoring the interaction of a complete RPA-heterotrimer with
a particular DNA substrate under controlled conditions, there are dynamic motions in
play within the DNA binding domains. These dynamic motions have been termed ‘microarrangements’ of RPA where, while an entire RPA is bound to ssDNA, individual DBDs
are in a constant state of association, dissociation, and rearrangement (Arunkumar et. al.,
2003a; Brosey et. al., 2015a; R. Chen et. al., 2016b; Fanning et. al., 2006). Molecular
dynamics simulations of these micro-arrangements depicted that DBDs of RPA could
adopt distinct conformations based on the type of DNA substrates they encounter (R.
Chen et. al., 2016b). These subtleties inherent to RPA-DNA engagement can play a
significant role in how RPA-DBDs assemble on ssDNA with nearby dsDNA-ssDNA

125
junctions, or ssDNA with more complex structures, such as G-quadruplexes and RNADNA hybrids.

a)

c)

e)

b)

d)

f)

Figure 4-1: Modified structures of DNA-double helix during canonical cellular
processes. a) 5ʹ overhang b) 3ʹ overhang DNA substrates are generated as a consequence
of exonuclease and endonuclease enzymatic activity. c) Representation of the double
Holliday junction structure generated during homologous recombination d) Schematics
of the replication fork with 3ʹ overhang or e) 5ʹ flaps and f) 5ʹ overhangs that are
generated during replication, or replication break induced replication repair (BIR).
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a)

b)

c)

Figure 4-2: ssDNA encountered by RPA in different DNA contexts. a) Pictorial
representation of initiation of DNA repair. Multiple DNA damaging agents can cause
ssDNA breaks, whose accumulation lead to dsDNA break. In HR pathway, the broken
ends are degraded by Exonucleases (ExoI) to generated 3ʹ overhangs. These overhangs
are coated by RPA to allow progression of DNA repair. ssDNA is presented to RPA
either as b) 3ʹ ssDNA substrate during recombination or c) 5ʹ ssDNA substrate during
BIR. Both processes distinctly affect the arrangement of DBDs on the ssDNA substrate.
The majority of findings regarding how RPA behaves in a particular DNA context
have been made either using full-length RPA or through computer simulations and
modeling, with limited resolution at the DBD-level. These studies provide critical
insights regarding properties of RPA-engagement in different DNA structure situations
(such as, bubbles, overhangs and replication forks), yet, most of the models derived from
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these studies have a major caveat. Until recently, studies conducted with RPA and
different DNA structures have regarded DBD-A and DBD-B as high-affinity domains
and the trimerization core as the low affinity domains (Bhat, Bétous, & Cortez, 2015;
Iwona M. Wyka, Kajari Dhar, Sara K. Binz, & Wold, 2003). In chapter 3, I
demonstrated that the so called ‘high-affinity domains’ are in fact more flexible, prone to
dissociation and easily remodeled by the trimerization core. The ‘low-affinity domains’
are the stable binders on DNA. Therefore, DBD-A, DBD-B along with OB-F bind to
ssDNA first, followed by the engagement of the trimerization core that stabilizes RPADNA binding (Nilisha Pokhrel et. al., 2019; Yates et. al., 2018). This has shifted the
paradigm of how we envision the processes of RPA binding on DNA and demands a reassessment of several RPA-DNA structural interaction models that were based on the
notion of DBD-A and DBD-B being the high affinity domains. This, in turn, requires a
comprehensive investigation of the ongoing mechanisms at the molecular level of DBDs.
Our findings regarding how RPA interacting proteins can selectively modulate the
binding dynamics of particular DBDs has been key in further exploring the “Domainspecific sequential displacement” hypothesis. According to this hypothesis, a protein with
comparatively lower binding affinity to ssDNA, modulates the binding dynamics of one
or more selective DBDs. This causes a ripple effect, weakening the overall RPA binding
to ssDNA and resulting in RPA displacement. While this hypothesis is being rigorously
tested, the recent discovery of RPA-stabilizing protein or RPA-chaperone, i.e, Rtt105 has
been of key interest, particularly because it is the first known RPA chaperone that
‘stabilizes’ RPA-DNA binding (S. Li et. al., 2018). Similar to DBD-specific modulation
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and subsequent displacement of RPA, a DBD-specific mechanism for stabilizing RPA on
DNA could one of several ways by which Rtt105 stabilizes RPA engagement on DNA.
Regulators of Ty1 transposition genes (RTT genes) were discovered during a
genetic screen to identify genes that would otherwise inhibit or downregulate
incorporation of Ty1 elements into the host genome. Rtt105 was one of the 8 genes with
previously unknown characteristics, and recently has been shown to interact directly with
RPA both in vitro and in vivo (Mularoni et. al., 2012; Scholes, Banerjee, Bowen, &
Curcio, 2001). Using a combination of genetic and biochemical approaches Li et. al.,
2018, demonstrated Rtt105 to function as a stabilizer of RPA-DNA interactions, and an
essential factor required to maintain RPA levels in cells with hydroxyurea (HU) induced
DNA replication stress (S. Li et. al., 2018). While Rtt105 itself did not bind to DNA and
was not present in a ‘post-formed’ RPA-DNA complex, it functioned as a chaperone to
stabilize the RPA-DNA interactions that were in the process of being formed. Finally,
using single-molecule DNA curtain assays, Li et. al., 2018, showed increased DNA
stretching by RPA in the presence of Rtt105, suggesting that Rtt105 affected the binding
mode of RPA (S. Li et. al., 2018). These results clearly demonstrate that Rtt105
influences RPA-DNA interactions, yet the mechanisms underlying it are not fully
dissected. A number of questions remain to be investigated: does Rtt105 interact with all
DBDs of RPA? Does it selectively influence binding dynamics of a particular DBD? Is
DNA required for interaction between Rtt105 and RPA-DBD? Is the ‘chaperoning’
activity of Rtt105 during RPA-DNA interactions different in various DNA structures?.
RPA binds to DNA with sub-nanomolar affinity. In this chapter, we sought to understand

129
Rtt105-RPA interactions at the DBD-level, both in presence and absence of these of
DNA substrates.
RPA is of the central proteins involved in majority of the DNA- related processes
that involves transiently arising ssDNA intermediates. Delineating how RPA coordinates
its DBD binding in different DNA structures could provide be instrumental in dissecting
approaches underlying RIP recruitment, positioning and DNA hand-over by RPA. In this
chapter, we have investigated how the DNA binding dynamics, in particular the
association and remodeling of RPA-DBDs, can be affected when ssDNA has an adjacent
dsDNAstructure (Fig 4-3). Using RPA-Af and RPA-Df as molecular probes for detecting
DBD-specific response on these DNA substrates, and accounting for the fact that DBDs
A, B are the flexible half of RPA, we investigated behavior of these DBDs on dsDNA
with a 5ʹ ssDNA overhang (5ʹ overhang), 3ʹ ssDNA overhang (3ʹ overhang) or ssDNA
flanked by a duplex end (blocked ends DNA) on either side (Fig 4-3).
Our results show that remodeling of DBD-A requires a free 5ʹ open end of DNA
and this remodeling is not observed for DNA substrates with 3ʹ overhang or blocked end
DNA substrates. Stopped-flow reactions monitoring DBD-D association show a linear
increase in the rate of association with increasing lengths of overhangs or length of gaps
in the blocked end DNA substrate. This is different from binding of DBD-D with
increasing lengths of ssDNA in absence of nearby dsDNA structure. Finally, using a
combination of bulk FRET stopped-flow experiments, followed by kinetic fitting of the
observed change in fluorescence, we show that Rtt105 specifically interacts with DBD-D.
Rtt105-RPA-DBD-D interaction doesnot require ssDNA. Finally, Rtt105 affects RPADBD-D DNA binding dynamics on a 5ʹ or 3ʹ overhang DNA substrates.
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a)

b)

c)

Figure 4-3: DNA substrates to delineate context dependent RPA-DBD engagement
on ssDNA used in this study. Individual ssDNA substrates that have an adjacent DNA
duplex region. ssDNA is presented as a) 5ʹ overhang, b) 3ʹ overhang and c) blocked end
DNA to understand effects on RPA-DBD dynamics. The two overhangs and the ssDNA
gap in the blocked end DNA consist of varying numbers of polythymidine residues (dT)n.
Since RPA binds with a polarity of 5ʹ -3ʹ, with DBD-A close to 5ʹ, each of the DNA
substrate used in this study will allow to understand the effects of nearby duplex region
on particular DBD-ssDNA engagement dynamics.
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4.2 Materials and Methods

4.2.1 Purification of Rtt105

Rtt105-his plasmid with (6x-histidine amino acid at C-terminus of the protein)
was a kind gift from Dr. Xiaolan Zhao (Memorial Sloan Kettering Cancer Center, Sloan
Kettering Institute, New York). Approximately 300ng plasmid was transformed into
standard Rosstta-2 PlysS protein expression cell line, plated in ampicillin resistant agar
plates and incubated overnight at 37oC. Next day, colonies on the agar plates were
suspended in total 10ml of Lb, from which 3ml was inoculated in individual 2.8l baffle
flask containing 1l autoclaved Lb, supplemented with 100 g/ml ampicillin. The total
growth volume was 2l. The flask was agitated at 250 rpm at 37oC until the growth
reached an OD600 of 0.6-0.8. At an OD600 0.6-0.8, for each 1l growth, the culture was
induced by adding 1ml of 1M IPTG (1mM final concentration), shifted to 18oC and
allowed to grow overnight with 150rpm agitation. Note: All the steps from here on were
performed at 4oC or on ice.
Cells were pelleted by centrifugation at 5000rpm for 30 mins and resuspended in
100ml cell lysis buffer (30mM Hepes, pH 7.8; 300mM KCl; 1mM TECEP-HCL; 0.02%
Tween-20;, 10% glycerol; 2XPIC). Cells were first lysed with 0.02g lysozyme with
stirring at 4oC for 1 hour. Further lysis was performed by sonication using the following
settings: 1minute pulse followed by 1 minute off, pause for additional one-minute. This
was repeated twice. The culture was stirred during the 1-minute pause to ensure proper
mixing. Amplitude of sonication was set to 50%. Cell lysate was collected by
centrifugation at 17000 rpm for 1 hour. This was then applied to 10ml Ni2+-NTA (Gold
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Bio) equilibrated with 200ml of cell lysis buffer. The lysate was allowed to incubate with
Ni2+-NTA column for a minimum of 3 hours.
Note: Due to elevated levels of expression and subsequent Rtt105 in the cell
lysate, the cell lysate tends to clump the Ni2+-NTA resins and turn them brownish in
color. This may slow the flow-rate of the column, particularly if it is driven by gravity.
After 3 hours, flow-through was collected and the unbound Rtt105 was
sequentially washed with 100mls of cell lysis buffer + 10mM Imidazole, 100ml of cell
lysis buffer + 10mM Imidazole +2M KCl (instead of 300mM KCl) and finally with
100ml of cell lysis buffer + 10mM Imidazole + 100mM KCl. The 2M KCl containing
buffer helps to remove possible DNA contamination that could arise during purification.
Bound protein was batch eluted with Ni2+-NTA elution buffer (cell lysis buffer+100mM
KCl+400mM Imidazole). For batch elution, Ni2+-NTA resins were incubated with 20 ml
of Ni2+-NTA elution buffer for 10 minutes to ensure all the resins contacted the elution
buffer. The was repeated 6 times to collect a total 120ml elution. Ni2+-NTA eluates were
analyzed by 10% SDS-PAGE and Rtt105 containing eluates were pooled and applied to
10ml Q-sepharose col equilibrated with buffer H100, where, buffer H0 is: 30mM Hepes,
pH 7.8; 0.2 mM EDTA, pH 8.0; 0.02% Tween-20; 1mM ECEP-HCl; 10% glycerol
(v/v), 2X PIC. The superscript in H100 denotes concentration of KCl in mM. Unbound
Rtt105 was washed with 100ml of H100 and bound protein was eluted with a 100ml
gradient elution of H100-H1500, and collected as 1.5ml fractions. Fractions were analyzed
on 10% SDS-PAGE, following which fractions containing Rtt105 were pooled and
diluted with buffer H0 to match the conductivity of H100 and applied to 10ml heparin
column equilibrated with H100. The heparin column was washed with 100ml H100 and a
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total of 100ml gradient elution (H100-H1500), with individual 1.5ml volume fractions was
collected. Surprisingly, Rtt105 does not bind to heparin column and almost 80% of the
protein was present in flow-through and wash of heparin column. Hence, we recommend
proceeding to size-exclusion column after Q-column.
In our case, to rescue Rtt105 purification, the flow-though, wash and all the
fractions with Rtt105 from heparin column were pooled, diluted to a conductivity of celllysis buffer, and re-applied to 10ml Ni2+-NTA column equilibrated with cell lysis buffer.
Ni2+-NTA column was processed as mentioned above. These eluates from Ni2+-NTA
column were analyzed on 10% SDS-PAGE and fractions containing Rtt105 were pooled
and concentrated using a 10KDa cut-off spin-concentrator to a volume less than 5ml and
applied on HiLoad 16/600 200 Superdex- 200pg size exclusion column equilibrated with
Rtt105 storage buffer (30mM Hepes, pH 7.8; 200mM KCl; 5mM TECEP-HCl; 0.25mM
EDTA, pH 8.0; 0.01% Tween-20; 10% glycerol). A total of 320ml elution that includes
100ml void volume was collected as 1.7ml fractions. These fractions were analyzed on
10% SDS-PAGE gel, pooled, and concentrated using 10KDa cut of spin-concentrator.
Concentration of Rtt105 was determined by Bradford assay and protein was stored as
100l aliquots at -80oC, after flash-freezing in liquid nitrogen.

4.2.2 Fluorescent Labeling of Rtt105

Rtt105 has two consecutive cysteine residues at position 11 and 12 towards the Nterminus. Such a positioning of cysteine residues could be one reason for higher order
Rtt105 complexes which can be visualized in 10% SDS-PAGE gel. To label Rtt105 with
Cy5 Maleimide (Click chemistry tools), about ~5ml of 172M Rtt105 was thawed and

134
dialyzed extensively in storage buffer that does not contain TECEP-HCl. About 4 buffer
exchanges, with an interval of 12 hours between individual exchange was conducted.
Rtt105 precipitates in the absence of a reducing agent. Therefore, the clear protein was
separated from the precipitate by centrifugation at 2000rpm for 2minutes. Concentration
of Rtt105 in the supernatant was calculated by Bradford assay as 86.8M. To label
Rtt105 with Cy5, 1.5-fold molar excess Cy5 Malemide dye (83.3 l of 6mM Cy5, 10l at
a time) was added to 3.85ml of 86.6M Rtt105 and the dye containing protein was
incubated at 4oC, with gentle rocking for 3 hours. Excess dye was separated from the
protein using a Biogel-P4 column. 1ml fraction each, for a total of 60ml elution was
collected and the fractions were analyzed on 10% SDS-PAGE gel. The concentration of
labeled Rtt105 was determined by Bradford assay and Cy5 present in the protein via
spectroscopic measurements using the equation:
[Cy5] M = [{abs (max @ 640nm)- abs (correction @750nm)}* dilution factor]÷ Cy5, where
=  −cm-1,

Labeling efficiency was ~20%

As a control, we conducted Bradford assays with Cy5 to determine if it affected
absorption at 595nm and found it did not affect absorption reading at 595nm.

4.2.3 Purification of RPA-AMB543 and RPA-DMB543

RPA-AMB543, RPA-DMB543 and RPA-FABMB543 were prepared as mentioned in
methods section of chapter 3.
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4.2.4 Annealing Oligos

All the oligos were purchased from IDT (Coralville, Iowa). For all annealing, in a
1.5ml microfuge tubes, equal molar concentrations (M) of respective DNA substrates
were prepared in a buffer with 20mM Tris-Cl, pH 7.5, 100mM NaCl (annealing buffer).
The microfuge tube was incubated in boiling water for 5 minutes (temperature of 100oC
was confirmed using a thermometer), following which the samples were allowed to
eventually cool down to room temperature. We generally prepared 200l of 10M
annealed substrates for all our reactions.
For 5′ overhang, equal concentrations of 5ʹ (dT)n CTG GGG CTC GAG CCG
ACT CG 3ʹ and 5ʹ CGA GTC GGC TCG AGC CCC AG 3ʹ 20 base mixed sequence were
annealed. (dT)n represents the number of thymidine nucleotides that were varied, and the
underlined region represents 20 base pair mixed sequence that was kept consistent
through all 5ʹ overhang substates and formed a complementary base pair with 5ʹ CGA
GTC GGC TCG AGC CCC AG 3ʹ. For example, to anneal 5ʹ (dT)10 overhang, equal
concentration of 5ʹ TTTTTTTTTTCTG GGG CTC GAG CCG ACT CG 3ʹ and 5ʹ CGA
GTC GGC TCG AGC CCC AG 3ʹ were prepared in annealing buffer, incubated in
boiling water for 5 minutes and allowed to cool down.
To prepare a 3ʹ overhang (dT)n, equal concentrations of 5ʹ ACC GCT GCC GTC
GCT CCG GG (dT)n 3ʹ and 20 base mixed sequence 5ʹ CCC GGA GCG ACG GCA
GCG GT 3ʹ were annealed. (dT)n represents the number of thymidine nucleotides that
were varied, and the underlined region represents 20 base pair mixed sequence that was
kept consistent through all 3ʹ overhang substates and formed a complementary base pair
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with 5ʹ CCC GGA GCG ACG GCA GCG GT 3ʹ. For example, to generate 3ʹ (dT)10
overhang, equal concentration of 5ʹ ACC GCT GCC GTC GCT CCG GG TTTTTTTTTT
3ʹ and 5ʹ CCC GGA GCG ACG GCA GCG GT 3 ʹ were annealed.
To prepare blocked end (dT)n substrates, equal concentrations of 5ʹ ACC GCT
GCC GTC GCT CCG GG 3ʹ; 5ʹ CGA GTC GGC TCG AGC CCC AG 3ʹ and 5ʹ CTG
GGG CTC GAG CCG ACT CG (dT)n CCC GGA GCG ACG GCA GCG GT 3ʹ were
annealed. (dT)n represents the number of thymidine nucleotides that were varied, and the
underlined region represents 20 base pair mixed sequence that was kept consistent
through all blocked ends overhang substates and formed a complementary base pair with
the two distinct 20-mer mixed base sequences. For example, to generate blocked end
(dT)10 overhang, equal concentrations of 5ʹ ACC GCT GCC GTC GCT CCG GG 3ʹ; 5ʹ
CGA GTC GGC TCG AGC CCC AG 3ʹ and 5ʹ CTG GGG CTC GAG CCG ACT
CGTTTTTTTTTTCCC GGA GCG ACG GCA GCG GT 3ʹ were annealed.

4.2.5 Stopped flow measurements

All stopped-flow measurements were carried out with an Applied Photophysics
SX20 instrument (Surrey, UK) at 25oC. Reactions were performed in buffer (30 mM
Hepes, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM β-mercaptoethanol and 6 % v/v
glycerol). All concentrations mentioned are post-mixing concentrations.
For all the DNA context dependent reactions with MB543 labeled RPA (RPAAMB543 and RPA-DMB543), were performed 100nM protein and 100nM individual DNA
substrates. Samples were excited at 535nm and emission monitored at 555nm. Resulting
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stopped flow data for RPA-AMB543 were fit with double-exponential + linear phase model
i.e
ΔF = A1(1 - e-k1t) + A2(1 - e-k2t) + k3t

(Eq. 1)

Where, ΔF is change in fluorescence of AMB543, A1 and k1 are the amplitude and
observed rate of the first exponential phase, A2 and k2 are the amplitude and observed rate
of the second exponential phase, k3 is the steady state rate and t is time.
and the data for RPA-DMB543 were fit with single-exponential + linear phase model i.e
ΔF = A1 (1 - e-k1t) + k2t

(Eq. 2)

Where, ΔF is change in MB543 fluorescence in presence of DNA, A1 and k1 are
the amplitude and observed rate of the exponential phase, k2 is the steady state rate and t
is time.
For all the experiments with RPA-AMB543, RPA-DMB543 and unlabeled Rtt105,
excitation emission parameters as mentioned above (for MB543) were used. RPA-Rtt105
reactions in (dT)30 required rapid mixing of either 100nM RPA-AMB543 or 100nM RPADMB543 with increasing concentrations of Rtt105 (25, 50, 100, 200, 300) in one syringe,
with 100nM (dT)30 in another syringe. Binding reactions with 100nM 5ʹ (dT)30 overhang
and 100nM 3ʹ (dT)30 overhang was performed by rapid mixing with 100nM RPA-AMB543
or 100nM RPA-DMB543 in presence or absence of 200nM Rtt105. Similar rapid-mixing
reactions were performed with 100nM RPA-FABMB543 with increasing concentrations of
Rtt105 (50, 100, 200, 300 nM) in one syringe with100nM (dT)30 in another syringe. All
the data obtained for RPA-AMB543 binding to (dT)30, 5ʹ (dT)30 overhang and 3ʹ (dT)30
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overhang in presence or absence of Rtt105 were fit with equation Eq.1. Similar data for
RPA-DMB543 and RPA-FABMB543 were fit with Eq.2.

4.2.6 FRET analysis to monitor interaction between Rtt105 and RPA-DBDs

For all FRET experiments, samples were excited at 555nm and FRET was
monitored with a 645nm cut-off emission filter. For FRET experiments, RPA-Acy3 or
RPA-DCy3 was the FRET donor and Rtt105Cy5was the FRET acceptor. To monitor DBD
specific interaction, 100nM RPA-ACy3 or 100nM RPA-DCy3 was rapidly mixed with
100nM Rtt105Cy5 and FRET monitored. Resulting FRET between RPA-DCy3 and
Rtt105Cy5 was analyzed using Eq. 1.
FRET in presence of ssDNA was conducted with either 100nM RPA-Acy3/ 100nM
RPA-DCy3 and 100nM (dT)35, and rapidly mixed with 100nM Rtt105cy5. Alternatively,
100nM Rtt105Cy5 and 100nM (dT)35 in one syringe were rapidly mixed with RPA-Acy3/
RPA-DCy3 in another syringe. The resulting FRET between RPA-DCy3 and Rtt105Cy5 in
presence of (dT)35 was analyzed with Eq. 2.
Finally, FRET complex challenging experiments were performed with 100nM
FRET complex (100nM RPA-Acy3 or 100nM RPA-DCy3 and Rtt105cy5) and 100nM (dT)35
in another syringe. The resulting decrease in FRET for RPA-Dcy3 was analyzed using
Eq.2. FRET-DNA complex was formed between 100nM FRET complex and 100nM
(dT)35 and challenged with 1X reaction buffer. No change in FRET for both RPA-ACy3
and RPA-DCy3 was observed.
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4.3 Results

4.3.1 DNA context dependent remodeling of DBD-A

RPA forms a stable complex with DNA, yet, RPA-DNA engagement is plastic at
the microscopic level (Kemmerich et. al., 2016; B. Nguyen et. al., 2014b). In chapter 2,
using fluorescently labeled RPA, we demonstrated the phenomenon of ‘intra-DBD
remodeling’, where DBD-A is remodeled by RPA’s trimerization core under conditions
of low concentration of ssDNA or shorter lengths of ssDNA. To investigate if
trimerization core mediated intra-DBD remodeling could occur in different DNA
structures, similar experiments were performed with 5ʹ (dT)n overhang, 3ʹ (dT)n overhang
or blocked ends (dT)n (where (dT) is flanked by a DNA duplex on both sides; n= number
of thymidine nucleotides, ranging from 6 to 30 nucleotides) (Fig 4-3). The duplex region
in all DNA substrates consists of the same 20 base pairs of complementary sequences.
Stopped flow experiments performed with 100nM RPA-AMB543 and structurally distinct
DNA substrates (5ʹ overhang, 3ʹ overhang and blocked ends) as a functions of increasing
(dT)n produced a robust and quantifiable change in fluorescence which was quantified
using a double exponential followed by a linear state model for all the substrates.
Consistent with previously published results monitoring RPA-AMB543 binding with
increasing lengths of single- stranded DNA (explained in chapter 2), the initial rate of
binding (kobs,1) was directly proportional to increasing lengths of 5ʹ (dT)n and 3ʹ (dT)n
overhangs (Fig 4-4 b, 4-5 c, 4-6 c). However, the kobs,1 measurement for RPA-AMB543
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binding with blocked ends (dT)n did not follow this linear-trend and remained relatively
unchanged (Fig 4-7 c). Surprisingly, trimerization core mediated remodeling of DBD-A
(seen as decrease in signal after initial robust binding) was observed only with 5ʹ (dT)10
(light grey trace) and 5ʹ (dT)12 (navy blue trace) overhang substates (Fig 4-8). This
decrease in signal was not present in 3ʹ (dT)n overhang and blocked ends (dT)n substrates
even when the lengths of overhang were kept same (Compare light grey and navy-blue
traces in Fig 4-8). This is particularly interesting as RPA binds to DNA with a polarity of
5ʹ -3ʹ, such that DBD-A resides close to 5ʹ end of DNA. Blocking the 5ʹ end, as in the
case for 3ʹ overhang and blocked end substrate could pose steric hindrance for DBD-A
movement, thereby, changing the number of conformations it can adopt on DNA. This is
more severe for the blocked end substrates which could be one of the many explanations
for loss of increase in the kobs,1 value as a function of increasing the ssDNA gap
sandwiched between two dsDNA.
All the data sets for RPA-AMB543 engagement can best be described by a two- step
model. Depending on the DNA substrate encountered by DBD-A, there are subtle
changes in the mechanisms of remodeling/ rearrangement in 5′ overhang and 3′ overhang
DNA substrate. This effect is more prfound for blocked ends DNA substrates. This
suggets that the type of DNA structures encountered by DBD-A could influence its
mechanism for engaging with ssDNA. There was a negligible change in the rate of the
linear phase (kobs,3) for all DNA substrates (Fig. 4-4 d, 4-5 e, 4-6 e, 4-7 e) and no
significant conclsuions can be drawn from kobs,2 values given the low signal to noise ratio
(Fig. 4-4 c, 4-5 d, 4-6 d, 4-7 d).
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a)

c)

b)

d)

Figure 4-4: DNA binding dynamics of DBD-A with increasing lengths of ssDNA. a)
Graphic representation of the stopped-flow mixing scheme, where RPA-AMB543 is rapidly
reacted with stoichiometric concentrations of increasing lengths of (dT) oligonucleotides.
Arrow represent conformational arrangement of DBD-A as a function of increasing
lengths of (dT) oligonucleotides. Fitting the raw traces with two-step kinetic model yields
b) plot of observed initial rate of engagement (kobs,1), which follows a linear trend, c) rate
of remodeling/ rearrangement (kobs,2), d) steady-state rate (kobs,3).
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c)

d)

e)

Figure 4-5: DNA binding dynamics of DBD-A with increasing 5ʹ (dT)n overhang
DNA. a) Diagrammatic representation of the stopped-flow reaction where RPA-AMB543 is
rapidly reacted with stoichiometric concentrations of increasing lengths of 5ʹ (dT)n
overhang DNA substrates. b) Stopped-flow traces show robust increase in MB543
fluorescence as RPA-AMB543 binds to increasing lengths of 5ʹ (dT)n overhang DNA
substrates. Remodeling of DBD-A can be observed with shorter overhangs which are
usually less than 15 nucleotides in length. Fitting the raw traces with a two-step binding
followed by steady- state model yields c) plot of observed initial rate of engagement
(kobs,1), which follows a linear trend, d) rate of remodeling/ rearrangement (kobs,2) and e)
steady-state rate (kobs,3).

143

a)

b)

d)

c)

e)

Figure 4-6: DNA binding dynamics of DBD-A with increasing 3ʹ (dT)n overhang
DNA. a) Diagrammatic representation of the stopped-flow reaction where RPA-AMB543 is
rapidly reacted with stoichiometric concentrations of increasing lengths of 3ʹ (dT)n
overhang DNA substrates. b) Plot of raw stopped-flow traces show a robust increase in
MB543 fluorescence as RPA-AMB543 binds to increasing lengths of 3ʹ (dT)n overhang
DNA substrates. Fitting the raw traces with a two-step binding followed by steady-state
model as a function of increasing lengths of 3ʹ (dT)n overhang yields c) plot of observed
initial rate of engagement (kobs,1), which follows a linear trend, d) rate of remodeling/
rearrangement (kobs,2), showing a slightly cooperative behavior e) steady-state rate (kobs,3)
with negligible change in the observed values.
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d)

c)

e)

Figure 4-7: DNA binding dynamics of DBD-A with increasing blocked ends (dT)n
DNA substrate. a) Diagrammatic representation of the stopped-flow reaction where
RPA-AMB543 is rapidly reacted with stoichiometric concentrations of increasing lengths of
blocked ends (dT)n DNA substrates. Blocked end DNA substrate consist of a singlestranded (dT)n region flanked by 20 base-pair (bp)DNA duplex on both ends. The length
of (dT)n region is varied while keeping the 20bp duplex region constant. b) Stopped-flow
traces show a robust increase in MB543 fluorescence as RPA-AMB543 binds to increasing
lengths of blocked end DNA substrates. Fitting the raw traces with a two-step binding
followed by steady-state model as a function of increasing lengths of (dT)n yields c) plot
of observed initial rate of engagement (kobs,1), d) rate of remodeling/ rearrangement
(kobs,2) and e) steady-state rate (kobs,3).
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Figure 4-8: Summary figure showing DNA context dependent DBD-A ssDNA
binding dynamics. Black, red, and blue boxes highlight reactions with 100nM RPAAMB543 vs 5ʹ (dT)n overhang, 3ʹ (dT)n overhang and blocked end DNA substrates,
respectively. Navy blue traces represent reactions with short ssDNA region available for
binding i.e (dT)12 and yellow traces represent comparatively longer DNA substrate i.e
(dT)30 that is enough DNA binding space for all DBDs to stably engage on ssDNA.
Dashed lines in the center of each traces represents curve fitting with two-step + linear
phase binding model equation. Following excitation of MB543 fluorophore, for both
lengths of ssDNA available i.e (dT)12 and (dT)30, robust increase in fluorescence can be
observed upon monitoring emission at 555nm. However, the remodeling-phase of DBDA, which is characterized by decrease in signal, can be seen only for 5ʹ (dT)12 DNA,
suggesting DNA context affects the trimerization core mediated remodeling of DBD-A.
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4.3.2 DNA context dependent remodeling of DBD-D

We next wanted to understand if there were any effects on DBD-D ssDNA
engagement when the ssDNA DNA was presented in the form of 5ʹ (dT)n, 3ʹ (dT)n or
blocked end (dT)n substrates. DNA substrates that were used to monitor DNA-context
dependent remodeling of DBD-A were also used to monitor DBD-D dynamics in these
different DNA structure scenarios. RPA-DMB543 was rapidly mixed with either 5ʹ (dT)n 3ʹ
(dT)n and blocked end (dT)n DNA substrates and change in MB543 fluorescence was
recorded (Fig 4-10 a, 4-11 a, 4-12 a). All the data sets obtained were fit with single
exponential followed by a linear phase model. For all three contextual DNA substrates,
no RPA-DMB543 engagement was observed when the available ssDNA was (dT)6 and
(dT)8 (Fig 4-10 b, c; 4-11 b, c). This was more severe for blocked ends DNA substrates,
where no binding event could be observed until a length of (dT)10, including (dT)6 and
(dT)8 (Fig 4-12 b, c). This is different from RPA-DMB543 engagement on ssDNA that
lacks any other structural complexity, where, binding events could be monitored at (dT)8
(Fig 4-9 b). In addition, there are kinetic differences in DBD-D engagement as a function
of increasing lengths of single- stranded DNA when presented with an adjacent dsDNA
region. RPA-DMB543 showed an increase in rate of binding (kobs,1) with increasing lengths
of (dT)n region in 5ʹ overhang, 3ʹ overhang and blocked ends DNA substates (Fig 4-10 c,
4-11 c, 4-12 c). This is distinct from binding observed with only ssDNA that lacks
adjacent dsDNA region, where, the rate of binding increased with increasing lengths of
ssDNA until (dT)20, following which it saturated (Fig 4-9 b). Under our experimental
conditions, one RPA has a binding site of 20 ±2 nucleotides and saturation of kobs,1 value
at (dT)20 suggested formation of stable trimerization core-DNA complex. However, the
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linear increase in kobs,1 value when ssDNA is presented with a dsDNA region suggests
DBD-D can sense the dsDNA region and perhaps destabilize the helix to open up new
binding sites (Lao et. al., 1999).

a)

b)

c)

Figure 4-9: DNA binding dynamics of DBD-D with increasing lengths of ssDNA. a)
Graphic representation of the stopped-flow mixing scheme, where RPA-DMB543 is rapidly
reacted with stoichiometric concentrations of increasing lengths of (dT) oligonucleotides.
A stable RPA-DBD-D complex is formed. Fitting the raw traces with a single-step
followed by linear phase kinetic model yields b) plot of observed initial rate of
engagement (kobs,1), which increases linearly until (dT)20 following which it saturates, c)
steady-state rate (kobs,2) with increasing lengths of ssDNA (dT)n plotted on X-axis.
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a)

c)

b)

d)

Figure 4-10: DNA binding dynamics of DBD-D with increasing 5ʹ (dT)n overhang
DNA. a) Diagrammatic representation of the stopped-flow reaction where RPA-DMB543 is
rapidly reacted with stoichiometric concentrations of increasing lengths of 5ʹ (dT)n
overhang DNA. MB543 labeled DBD-D produces a robust change in fluorescence upon
binding to overhangs longer than 8 thymidine nucleotides in length. b) Representative
traces from stopped-flow reaction when fit with one-step binding followed by linear
phase model yields c) plot of observed initial rate of engagement (kobs,1), which follows a
linear trend, d) and plot of steady-state rate (kobs,2).
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a)

c)

b)

d)

Figure 4-11: DNA binding dynamics of DBD-D with increasing 3ʹ (dT)n overhang
DNA. a) Pictorial representation of the stopped-flow reaction where RPA-DMB543 is
rapidly reacted with stoichiometric concentrations of increasing lengths of 3ʹ (dT)n
overhang DNA. MB543 labeled DBD-D produces a robust change in fluorescence upon
binding to overhangs longer than 8 thymidine nucleotides in length. b) Representative
traces from stopped-flow reaction when fit with one-step binding followed by linear
phase model yields c) plot of observed initial rate of engagement (kobs,1), which follows a
linear trend, d) and plot of steady-state rate (kobs,2).
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a)

c)

b)

d)

Figure 4-12: DNA binding dynamics of DBD-D with increasing blocked end (dT)n
DNA substrates. a) Illustrative representation of the stopped-flow reaction where RPADMB543 is rapidly reacted with stoichiometric concentrations of increasing lengths of
blocked ends DNA. MB543 labeled DBD-D produces a robust change in fluorescence
upon binding to overhangs longer than 10 thymidine nucleotides in length. b)
Representative traces from stopped-flow reaction when fit with one-step binding model
followed by linear phase yields c) plot of observed initial rate of engagement (kobs,1),
which follows a linear trend, d) and plot of steady-state rate (kobs,2).
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Figure 4-13: Summary figure showing DNA context dependent DBD-D ssDNA
binding dynamics. Black, red, and blue boxes highlight reactions with 100nM RPADMB543 vs 5ʹ (dT)n overhang, 3ʹ (dT)n overhang and blocked end DNA substrates,
respectively. Navy blue traces represent reactions with short ssDNA regions available for
binding i.e (dT)12 and yellow traces represent comparatively longer ssDNA substrate i.e
(dT)30 that is enough DNA binding space for all DBDs to stably engage on ssDNA.
Dashed lines in the center of each traces represents curve fitting with one-step+ linear
phase binding model equation. Following excitation of MB543 fluorophore, for both
lengths of ssDNA available i.e (dT)12 and (dT)30, robust increase in fluorescence can be
observed upon monitoring emission at 555nm. Although there are DNA context
dependent differences in DBD-D interaction with DNA, DBD-D still forms a stable
complex with DNA, as there are no decease in signal suggesting no dsDNA-ssDNA
junction mediated remodeling of DBD-D.
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Figure 4-14: Model- DNA context depending effects on RPA-DBD engagement on
ssDNA. Upon encountering a ssDNA, the flexible half of RPA is remodeled by its
trimerization core (stable half), under conditions of sub-stoichiometric concentrations of
ssDNA or shorter lengths of ssDNA. This remodeling requires a free 5ʹ end in the DNA,
possibly to allow the conformational freedom for DBD-A to undergo several associationdissociation steps on ssDNA and OB-F to interact with appropriate RIPs. No DBD-A
remodeling is observed for 3ʹ overhang or blocked end DNA substrate (represented by
dotted red lines). Since DBD-A is situated close to these junctions in 3′ overhang and
blocked end DNA substrates, it is possible that the nearby dsDNA-ssDNA junction poses
a steric hindrance when the trimerization core is remodeling DBD-A. In addition, it is
also possible that these junctions affect the association- dissociation events
(microdissociation evets) of DBD-A. In conditions where DBD-D is close to duplex and
there is no free 5ʹ end to remodel DBD-A, binding of DBD-D and possibly the
trimerization core is affected, perhaps due to altered conformation of either DBD-C or
DBD-D on DNA. The effect is most profound on blocked-end DNA with highest
potential to conformationally constrain both DBD-A and DBD-D.
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4.3.3 Rtt105 selectively interacts with DBD-D

RPA-DNA interaction is required to stabilize and protect ssDNA intermediates,
yet, RPA has to be displaced by an incoming DNA binding protein. Mechanistically, how
RPA hands over ssDNA space to an incoming protein is still poorly understood. This
situation is further complicated by the dynamic binding of individual DBDs, while the
RPA heterotrimeric complex simultaneously maintains a high-affinity DNA binding.
There is a plethora of DNA binding enzymes that can displace RPA from ssDNA,
however, due to the sub-nanomolar binding affinity characteristics of RPA-ssDNA
engagement, there are no reported instances of factors that stabilize RPA-DNA binding
itself. Recently, Rtt105 has been shown to stabilize RPA-DNA interactions in replication
fork and regulate RPA localization in the replicating genome (S. Li et. al., 2018). We
wanted to systematically understand if this stabilization was a result of protein-protein
interaction, where Rtt105 affected the conformation of RPA during the ongoing binding
event to DNA, or if this was due to Rtt105 induced conformation after RPA-DNA
binding had occurred. To this extent, first, we investigated if Rtt105 could interact with
both DBDs A and D of RPA. Since DBD-A is situated towards 5′ and DBD-D is situated
towards 3ʹ, Rtt105 interaction with both the DBDs would suggest that Rtt105 could be
distributed throughout RPA-DBDs to stabilize RPA-DNA interaction. Thus, we
generated a Cy5 labeled Rtt105 (Rtt105Cy5) and performed stopped-flow bulk FRET
experiments with Cy3 labeled RPA-DBD-A (RPA-ACy3) or RPA-DBD-D (RPA-DCy3) in
presence or absence of single-stranded DNA (dT)30. Bulk-FRET assays showed that
Rtt105 preferentially interacted with DBD-D, and not DBD-A, independent of ssDNA
(Fig 4-15, 4-16, 4-17). In absence of ssDNA, increase in Cy5 fluorescence was observed
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only with RPA-DCy3 as a FRET donor (Fig 4-15 b), suggesting that Rtt105 associated
with DBD-D positioned towards 3ʹ end of DNA. Interaction between Rtt105 and DBD-D
could be explained with a two-step binding model, with an initial rate of interaction
(kobs,1) of 9.2 ± 0.6 s-1. It has been shown that Rtt105 is not present in an RPA-DNA
‘formed’ complex (S. Li et. al., 2018). To further investigate how Rtt105 could affect
DBD-D dynamics during its engagement with ssDNA, we conducted FRET experiments
with RPA-DCy3-ssDNA complex and Rtt105Cy5 and monitored Cy5 emission (Fig 4-16,
a). Alternatively, we performed FRET between Rtt105Cy5 with DNA in one reaction
syringe, and RPA-Dcy3 in another syringe and monitored Cy5 emission (Fig 4-16, a).
FRET occurring (as denoted by the intensity of Cy5 fluorescence after exciting cy3) was
higher when RPA-DCy3 was not bound to ssDNA than RPA-DCy3-(dT)35 complex
(compare navy blue trace and light grey trace). Interestingly, FRET between Rtt105Cy5(dT)35, and RPA-DCy3 could be explained with single-step binding model, where, the rate
of engagement (kobs,1) of 51.2 s-1 is almost equivalent to the sum of rates of interaction
between DBD-D and ssDNA, and DBD-D and Rtt105 i.e (kobs1 for 100nM RPA-DMB543vs
100nM (dT)35 is 36.2±2.3 and kobs,1 for 100nM RPA-Dcy3 vs 100nM Rtt105Cy5 :100nM
(dT)35 complex is 9.2 ± 0.6 s-1). RPA-ACy3 did not produce a FRET signal with Rtt105Cy5
both in presence and absence of ssDNA (Fig. 4-15 a, 4-16. a), suggesting that Rtt105 did
not interact directly with DBD-A. Finally, a slow decrease in Cy5 fluorescence at a rate
of 2.4s-1 was monitored when preformed RPA-Dcy3 and Rtt105Cy5 FRET complex was
mixed rapidly with (dT)35 (Fig 4-17 d) suggesting Rtt105 remodeled DBD-D dynamics as
it engages on ssDNA. No decrease in Cy5 fluorescence was detected upon performing
similar experiments with RPA-ACy3 (Fig 4-17 a, c). Taken together, these results suggest
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that Rtt105 stabilizes engagement of DBD-D as it is binding with DNA and does not
affect DBD-D dynamics once a stable complex with ssDNA has been formed.
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a)

b)

Figure 4-15: Rtt105 selectively interacts with DBD-D independent of ssDNA. For a)
(Top) Graphic illustration of stopped-mixing scheme with FRET donor (RPA-ACy3 ) on
one syringe and FRET acceptor (Rtt105Cy5) in another syringe. The FRET donor was
excited at 555nm and Cy5 emission monitored at 645nm. (Bottom) Green trace shows,
no FRET is observed between RPA-ACy3 and Rtt105Cy5. b) (Top) Similar mixing scheme
but with RPA-Dcy3 as a FRET donor. (Bottom) A robust increase in Cy5 fluorescence
(green trace) is monitored between RPA-Dcy3 and Rtt105Cy5 which can be best described
with a two-step kinetic binding model. For both the experiments, buffer represents
reaction between FRET donor and reaction buffer, with excitation-emission parameter as
mentioned above.
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a)

b)

Figure 4-16: Rtt105 selectively modulates DBD-D binding to ssDNA. a) Top, stoppedflow mixing scheme where, either RPA-ACy3-ssDNA complex is mixed with Rtt105Cy5,
or, Rtt105Cy5 and (dT)35 in one syringe is mixed with RPA-ACy3 in another syringe.
(Bottom) Stopped-flow traces show no FRET occurs between RPA-ACy3 and Rtt105Cy5 in
presence of (dT)35 oligonucleotide. b) (Top) Similar mixing scheme but with RPA-DCy3
as FRET donor. (Bottom) A robust increase in Cy5 fluorescence (navy blue trace) is
observed when Rtt105Cy5:(dT)35 complex in one syringe are mixed with RPA-DCy3 in
another syringe.Similar experiments with preformed RPA-DCy3-(dT)30 complex in one
syringe when mixed with Rtt105Cy5 in another syringe (grey trace) show comparatively
lower amplitude of Cy5 fluorescence.This suggests Rtt105 affects DBD-D dynamics as
DBD-D is engaging on ssDNA and doesn’t affect DBD dynamics when it has completed
forming a complex with DNA.
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a)

c)

b)

d)

Figure 4-17: FRET experiments show Rtt105 selectively affects DBD-D-DNA
interaction. a), b) Complete set of experiments performed between a) RPA-ACy3 b)
RPA-DCy3, and Rtt105Cy5 that were shown as individual data panels in figures 4-15 and 416. Experiments with preformed Cy3 labeled c) RPA-ACy3 or d)RPA-DCy3 and Rtt105Cy5
FRET complex, shows no change in Cy5 fluorescence for DBD-A but a slight decrease in
fluorescence when RPA-DCy3-Rtt105Cy5 FRET complex is reacted with (dT)35. This
decrease in fluorescence (dark grey trace in d)) was fit with a single-exponential+ linear
binding model and shows an initial rate of decrease (kobs,1) of 2.4s-1.
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To confirm this was not a fluorophore induced interaction artifact, we investigated
effects of increasing concentrations of Rtt105 on binding of MB543 labeled RPA-DBDA (RPA-AMB543) and RPA-DBD-D (RPA-DMB543) in presence of (dT)30 oligonucleotide.
Since Rtt105 does not require ssDNA to interact with RPA, stopped-flow measurements
were conducted with preformed 100nM RPA-AMB543 or RPA-DMB543 and Rtt105 complex
and were rapidly mixed with 100nM (dT)30. Samples were excited at 535nm and MB543
emission was monitored at 555nm. Reactions with RPA-DMB543 showed a gradual
moderate decrease in the initial rate of engagement (kobs,1) with increasing concentrations
of Rtt105, until 1:1 molar stoichiometric concentration (Fig 4-18, d), following which it
saturated (Fig 4-18, d). This effect was opposite in case of RPA-AMB543. There was no
change in kobs,1 value until the stoichiometric concentration of Rtt105, following which a
gradual decease was monitored (Fig 4-18, c). Similarly, there was no change in kobs,1
value when similar experiments were performed with RPA-FABMB543 that lacks the
trimerization core (Fig 4-19). It is important to note that DBD-A engagement is
comparatively faster than DBD-D for individual concentrations of Rtt105. Since, all the
FRET experiments were performed with stoichiometric concentration of RPA and Rtt105
(i.e) 100nM, results from MB543 labeled RPA variants confirm that Rtt105 performs
DBD specific interaction and modulation of DBD-D dynamics.
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a)

d)

b)

e)

c)

f)

Figure 4-18: Effects of Rtt105 on MB543 labeled RPA-AMB543 and RPA-DMB543
binding to ssDNA. a) Schematic representation of the stopped-flow reaction showing the
mixing scheme. Either RPA-AMB543 or RPA-DMB543, and Rtt105 in one syringe was
mixed with (dT)30 oligonucleotide in another syringe. Representative raw traces obtained
from stopped flow experiments for b) RPA-AMB543 and d) RPA-DMB543, respectively.
Quantified traces showing the rate of initial engagement (kobs,1) as a function of
increasing concentrations of Rtt105 for c) RPA-AMB543 and e) RPA-DMB543, respectively.
f) kobs,1 value for RPA-AMB543 (pink dots) and RPA-DMB543(green dots) engagement with
(dT)30, as a function of increasing concentrations of Rtt105, when plotted in a single
graph. Red and blue dashed lines represent the stoichiometric concentration (i.e 100nM)
of RPA, Rtt105 and (dT)30, and the point until which kobs,1 value decrease for RPADMB543 but not RPA-AMB543, suggesting a DBD specific modulation of ssDNA binding by
Rtt105.
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a)

b)

c)

Figure 4-19: Effects of Rtt105 on RPA-FABMB543 binding to ssDNA. a) Schematic
representation of the stopped-flow reaction showing the mixing scheme. RPA-FABMB543
with increasing concentrations of Rtt105 in one syringe was mixed with (dT)30
oligonucleotide in another syringe. b) Representative raw traces obtained from stopped
flow experiments. c) Quantified traces showing the rate of initial engagement (kobs,1) of
RPA-FABMB543 in presence of increasing concentrations of Rtt105 with (dT)30.
4.3.4 Effects of Rtt105 on DBD engagement in various structures of DNA.

The replication fork structure consists of dsDNAregions with single-stranded
extension. To understand how Rtt105 could impact DBD dynamics when presented with
DNA that has duplex regions, we performed stopped flow experiments with 5ʹ (dT)30
overhang or 3ʹ (dT)30 overhang harboring a 20 base-pair dsDNA duplex region adjacent
to the ssDNA overhang. Based on our results obtained with ssDNA (dT)30, in our
experiments, we used 200nM Rtt105 complexed with 100nM RPA-AMB543 or RPADMB543 and reacted it against 100nM of 5′ (dT)30 or 3′ (dT)30 DNA (Figure 4-20 a, 4-21
a). Preliminary results with 5ʹ (dT)30 overhang DNA show no kinetic differences in
engagement of DBD-A with 5ʹ (dT)30 and 3ʹ (dT)30 overhang DNA in presence of
Rtt105, although a slight decrease in the net amplitude of MB543 fluorescence is
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observed (Fig 4-20 b, 4-21-b). Similarly, there is slight decrease in the net amplitude of
RPA-DMB543 fluorescence in presence of Rtt105, with negligible effects in the rate of
engagement of DBD-D (Fig 4-20, c). However, similar experiments performed with 3ʹ
(dT)30 overhang showed a significant decrease in the rate of initial engagement of DBDD on DNA (Fig 4-21 c). This suggests interaction between DBD-D and Rtt105 could
potentially affect the conformation of DBD-D as it is engaging on ssDNA with a nearby
dsDNA.
Trimerization core induced remodeling of DBD-A requires a free 5ʹ end of DNA
(Fig 4-5, 4-8 (black box)) and Rtt105 does not interact with DBD-A (Fig 4-15, 4-16, 417). However, Rtt105 significantly decreases the rate of DBD engagement when
presented with a 3ʹ ssDNA overhang with an adjacent dsDNA region. Our results
monitoring the DBD-A and DBD-D dynamics with 3ʹ (dT)n overhang substrates that has
a dsDNA region revealed loss of trimerization core mediated DBD-A dynamics and
significant changes in the nature of binding of DBD-D than bindig with ssDNA lacking
the dsDNA region (Fig 4-8, 4-9, 4-11). Taken together, these results suggest that Rtt105
can selectively affect the DNA binding dynamics DBD-D which is a constituent of the
less-flexible half of RPA.
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b)

a)

or

c)

Figure 4-20: Effects of Rtt105 on RPA-AMB543 and RPA-DMB543 binding to 5ʹ (dT)30
overhang DNA substrate. a) Graphic representation of the stopped-flow reaction
showing the mixing scheme. Either RPA-AMB543 or RPA-DMB543, and Rtt105 in one
syringe was mixed with 5ʹ (dT)30 overhang DNA substrate in another syringe. Traces
obtained from stopped flow experiments for b) RPA-AMB543 and c) RPA-DMB543,
respectively. Obtained data traces were quantified with appropriate kinetic models, as
mentioned in methods, to yield the observed rates of binding (kobs). Trace-fitting is shown
as dashed black lines.
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a)

b)

c)

Figure 4-21: Effects of Rtt105 on RPA-AMB543 and RPA-DMB543 binding to 3ʹ(dT)30
overhang DNA substrate. a) Graphic representation of the stopped-flow reaction
showing the mixing scheme. Either RPA-AMB543 or RPA-DMB543, and Rtt105 in one
syringe was mixed with 3ʹ (dT)30 overhang DNA substrate in another syringe. Traces
obtained from stopped flow experiments for b) RPA-AMB543 and c) RPA-DMB543,
respectively. Red traces represent binding of b) RPA-AMB543 or c) RPA-DMB543 with 3ʹ
(dT)30 alone and grey traces represent binding in presence of 200nM Rtt105. Raw traces
were quantified with appropriate kinetic models, as mentioned in methods, to yield the
observed rates of binding (kobs). Trace-fitting is shown as dashed black lines.
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4.4

Discussion

RPA acts as a center for regulating processes that have a common goal of
maintaining genomic integrity. To perform its functions, RPA binds to transiently
exposed ssDNA with a nanomolar binding affinity, yet, this binding is very dynamic.
Several studies have shown ‘facilitated-exchange’ of RPA, where, if present in excess, an
RPA bound on DNA can be displaced by RPA present in the surrounding (Gibb et. al.,
2014; N. Pokhrel et. al., 2017; Pokhrel et. al., 2019). Micro-dissociation of RPA-DBDs
on DNA has been proposed as one mechanism by which an incoming protein is able to
overcome high affinity RPA-DNA binding to occupy the existing DNA space. In chapter
3, we showed that DBD-A of RPA is more dynamic and its binding can be remodeled by
its own trimerization core under restrictive conditions (intra-DBD remodeling). In
addition, using smFRET microscopy, we showed that DBD-A and DBD-D, each had four
states of binding on ssDNA, and an RPA interacting protein, Rad52, selectively
modulated the binding state of DBD-D.
In this study, first, we investigated the DNA binding dynamics of DBD-A and
DBD-D when ssDNA is presented with a nearby dsDNA (i.e 5ʹ overhang, 3ʹ overhang
and blocked end DNA). We then investigated how DBD dynamics are affected by
Rtt105, a protein known to chaperone RPA-DNA binding and stabilize RPA-DNA
interactions. We show that remodeling of DBD-A requires a free 5ʹ end of DNA and this
is not observed if DBD-A is situated close to a DNA duplex region (Fig 4-14). This
remodeling could arise from trimerization core affecting the binding of DBD-A, as
observed on ssDNA (chapter 3). Additional control experiments monitoring RPA-
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FABMB543 binding with 5′ (dT)n, 3′ (dT)n and blocked-end DNA susbtrates need to be
perfomed to verify this scenario.
Single molecule studies with human RPA have shown that RPA is able to diffuse
freely along single-stranded DNA (B. Nguyen et. al., 2014b), while maintaining its DNA
binding polarity with DBD-A being close to 5ʹ end of DNA (Pokhrel et. al., 2019). This
diffusion of RPA continues on ssDNA, until it reaches an equilibrium, all the while RPA
still forms a high-affinity complex with ssDNA. Since, DBD-A is more dynamic than
DBD-D, presence of duplex region towards the 5ʹ end of DNA can pose as a steric
hindrance and inhibit DBD-A from moving freely even when trimerization core is trying
to remodel DBD-A. Therefore, different DNA contexts can further affect conformations
that can be adopted by DBD-A on DNA (Fig 4-14). This is reflected in teh the kobs,1
values of DBD-A engagement with increasing lengths of blocked ends DNA. This
phenomenon can be particularly important when RPA is bound on DNA that is a
substrate for an incoming DNA modifying enzyme (W. L. de Laat et. al., 1998).
Surprisingly, the DNA binding dynamics for DBD-D in all three DNA contexts
were different than in ssDNA (Fig 4-13, 4-14). DBD-D is one of the constituents of the
trimerization core and forms a stable complex on DNA (Fanning, Klimovich, & Nager,
2006; Pokhrel et. al., 2019; Yates et. al., 2018). RPA has been observed to transiently
destabilize DNA duplexes, particularly at low ionic concentrations (Lao et. al., 1999);
and occupy more nucleotides at high ionic concentrations (Kumaran et. al., 2006). Our
reactions are performed with 100mM KCl and have a binding-site of approximately 20
nucleotides for one RPA. Thus, one explanation for increase in kobs,1 value of DBD-D
with increasing lengths of ssDNA available in all three DNA context could be transient
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destabilization of DNA duplex, further resulting in more ssDNA for DBD-D to bind.
DBD-A interaction with 3′ overhang and blocked ends DNA could have similar effects
and could also explain loss of remodeling phase (Fig 4-14). Indeed, a detailed analysis of
RPA-DBD engagement in these DNA substrates have to be performed at single-molecule
level to understand the core mechanism underlying the observation made by bulk stopped
flow experiments.
Finally, using a combination of bulk FRET and fluorescence enhancement
approaches, our results show that Rtt105 specifically interacts with DBD-D and affects
the ongoing event of DBD-D’s interaction with ssDNA (Fig 4-15 b, 4-16 b, 4-17 b).
Rtt105 does not bind to DNA and has no effect in binding of DBD-A to ssDNA (Fig 4-17
a, 4-20 b, 4-21 b). Rtt105 has been shown to be important for RPA import and
localization in cells under replication stress (S. Li et. al., 2018). To better understand how
Rtt105 affects DBD-D engagement on ssDNA, further studies have to be conducted on a
replication fork and blocked ends DNA. It would be revealing to know if Rtt105-DBD-D
interaction required winged helix domain present in RPA32 to better understand the
importance of change in Rtt105 induced DNA binding behavior of DBD-D. Our studies
provide the first documented event of DNA context specific change in DNA binding
dynamics of DBD-A and DBD-D, and DBD-D specific interaction of Rttt105. Future
implications could include potential role of Rtt105 in stabilizing a particular
conformation/ DNA binding state of DBD-D in a particular DNA related process.
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CHAPTER 5: DOMAIN SPECIFIC REMODELING OF RPA-DBDS IS DRIVEN
BY COOPERATIVITY IN RAD52

5.1 Introduction

In yeast, proteins in the Rad52 epistasis group, which include Rad50, Rad51,
Rad52, Rad54, Rdh54- TID1, Rad55, Rad57, Rad59, MRE11 and XRS2) are critical for
repairing ionization radiation induced DNA damage. Meanwhile several of these proteins
also play a critical role in the DNA replication and DNA damage response pathways
(Game & Mortimer, 1974; Ranatunga et. al., 2001; Sotiriou et. al., 2016; Stein, Kalifa, &
Sia, 2015). Of the proteins in the Rad52 epistasis group, Rad52 is critical for the presynaptic phase of homologous recombination (HR) (Sugiyama & Kowalczykowski,
2002b). During pre-synapsis, the sites of initial double stranded breaks are processed by
5′→ 3′ Exo-1 and Sgs1 nucleases resulting in formation of 3′ ssDNA overhangs which
are immediately bound and protected by RPA (L. S. Symington et. al., 2014). RPAssDNA complexes are stable for prolonged periods both in vitro and in vivo and serve as
a scaffold for recruitment of other HR proteins (Gibb, Ye, Gergoudis, et. al., 2014;
Glover, Marques, Suska, & Horn, 2019). However, for the pre-synapsis phase to proceed
towards synapsis during HR, Rad51 needs to nucleate and form a nucleoprotein filament
on ssDNA. Rad51 filament formation appears to have a 3′ - 5′ polarity. To overcome the
high-affinity binding of RPA on DNA, mediator proteins like Rad52 facilitate Rad51
recruitment and enable effective displacement of RPA from ssDNA (Sugiyama &
Kowalczykowski, 2002b). The Rad51-nucleoprotein filament initiates homology search
and promotes strand invasion once homology region has been established (Qi et. al.,
2015).
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Independent of Rad51 related functions, Rad52 has been shown to perform
single-strand annealing (SSA) and micro-homology mediated DNA repair which serve a
critical role in telomeric maintenance (Bhowmick, Minocherhomji, & Hickson, 2016;
Verma et. al., 2019). It also plays a key role in break induced replication repair to ensure
proper DNA replication and preserve replication fork integrity (Hengel et. al., 2016). The
importance of Rad52 is underscored by its existence throughout eukaryotes and marked
sequence conservation in its DNA binding domain located towards the N-terminal region
of the protein. Several studies have shown structural and functional similarity between
Saccharomyces cerevisiae Rad52 (Sc. Rad52) and human Rad52 (hRad52) with
mutations in Sc. Rad52 severely affecting cell viability and mutations in hRad52 along
with the main mediator protein BRCA2 being synthetically lethal in human cells (Feng
et. al., 2011; Krogh & Symington, 2004). In addition, a key similarity between Rad52
from both the species is that it functions in-concert with RPA.
During HR, the RPA-ssDNA complex serves as a platform for Rad52 recruitment,
and during SSA, RPA bound DNA are annealed by Rad52 (Ceccaldi et. al., 2016;
Hanamshet, Mazina, & Mazin, 2016; Verma & Greenberg, 2016). Similarly, in break
induced replication repair, the attributes of high-affinity ssDNA binding and relative
abundance of RPA results in ssDNA being first occupied by RPA, then processed by
Rad52. Two contrasting models exist for the interplay between RPA and Rad52 on DNA:
The first (older model) suggests the displacement of RPA by Rad52 and concurrent
promotion of Rad51 nucleation through physical interactions between Rad52 and Rad51.
The second (newer model), primarily derived from single molecule DNA curtain
experiments suggest formation of a co-complex between RPA and Rad52, which then
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serves as a handle for Rad51 nucleation and growth. In support of the newer model,
several in vivo studies have shown colocalization of Rad52 with RPA on mitotic and
meiotic double-stranded DNA breaks, and during DNA replication preceding meiosis and
at telomeres (Gasior, Wong, Kora, Shinohara, & Bishop, 1998; Miyazaki, Bressan,
Shinohara, Haber, & Shinohara, 2004; Zhang, Yadav, Ouyang, Lan, & Zou, 2019).
Furthermore, colocalization of RPA-Rad52-Rad51 on ssDNA has been captured by in
vitro single-molecule fluorescence studies (Gibb, Ye, Kwon, et. al., 2014a; Kaniecki et.
al., 2017; Chu Jian Ma et. al., 2017b). Our data on RPA remodeling by Rad52 also shows
a co-complex between the two proteins on ssDNA and selective remodeling of just one
DBD (DBD-D) in RPA (Chapter 3).
RPA physically interacts with Rad52 via multiple interaction sites that lie
primarily in the RPA70 and RPA32 subunits. The smallest subunit, RPA14 also interacts
with Rad52, albeit with weaker affinity (Hays, Firmenich, Massey, Banerjee, & Berg,
1998a; M. S. Park et. al., 1996). In addition to physical interactions, both RPA and Rad52
bind ssDNA (Lao et. al., 1999; A Shinohara, Shinohara, Ohta, Matsuda, & Ogawa, 1998).
Thus, in situations where RPA and Rad52 function together, how RPA and Rad52
coordinate ssDNA occupancy is still not well understood. The model is further
complicated by the oligomeric properties of Rad52. In yeast, Rad52 functions as a
heptamer, and human RAD52 functions either as a decameric (10 subunit) or
undecameric (11 subunit) ring-like complex. Oligomerization creates multiple RPAbinding subunits and DNA engagement points within Rad52. Furthermore, Rad52 can
also bind to dsDNA. Since multiple DNA binding regions in Rad52 have been identified,
investigating the mechanistic details underlying coordination of ssDNA binding between
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RPA and Rad52 is exceedingly challenging (Saotome et. al., 2018; Akira Shinohara &
Ogawa, 1998).
To better establish the interplay between Rad52 and RPA we investigated the
DNA binding properties of Rad52 from Saccharomyces cerevisiae and the assembly of
the Rad52-RPA complex on different DNA structures encountered during DNA
metabolism. Using intrinsic tryptophan quenching and Protein Induced Fluorescence
Enhancement (PIFE), as reproters for ssDNA interaction we demonstrate cooperative
assembly of Rad52 at the 5′ end of DNA, where cooperativity exists between the inner
and outer DNA binding sites (Fig. 5-1 a-c). Mutating key amino acid residues in the inner
or outer binding site perturbs cooperativity but does not have a significant effect on
overall ssDNA binding. Furthermore, we show that cooperativity in Rad52 is required for
modulating RPA-DBD-D dynamics, specifically on a 5′ overhang DNA substrate. Using
FRET, we show that Rad52 is unable to position itself in between multiple RPA
molecules. Our studies provide key insights into RPA-DBD-Rad52 assembly, especially
in situations mimicking recombination or replication, where ssDNA is presented as a
structure flanked by dsDNA.
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a)a)

b)b)

c) c)

Figure 5-1: Crystal structure of hRad521-212. a) Crystal structure of hRad52 (residues
1-212) (PDB: 1KNO) lacking the C-terminal domain. The oligomeric structure shows an
undecamer with 11 protomers. Two subunits are shown in magenta and orange,
respectively to highlight the disordered loop reaching over the the neighboring subunit.
b) Same as in a) but showing the side view. c) Single protomer of hRad52 (1-212)
showing critical amino acids required for DNA binding in the outer site (K133, shown as
red sphere), inner site (K152, shown as purple sphere) and transition site (R55, shown as
navy blue sphere).

173
5.2 Materials and Methods

5.2.1 Generating plasmids for protein purification

Plasmid carrying Rad52-wt with a N-terminal poly-histidine and C-terminal chitin
binding domain (CBD) tags (a gift from Dr. Eric Greene, Columbia University) was used
as a template for cloning. We first removed the poly-histidine tag from the N-terminus
using Q5 site directed mutagenesis and the following primers: forward primer (F)- 5′
ATG AAT GAA ATT ATG GAT ATGG 3′, and reverse primer (R)- 5′ ATG TAT ATC
TCC TTC TTA TAC TTA AC 3′. The annealing temperature of PCR reaction was 63oC.
The Rad52-wt-CBD plasmid was used as template to generate Rad52 mutants by Q5-site
directed mutagenesis. The following primers and PCR conditions were used:
Rad52-R37A
F: 5′ TAT CTC CAA GGC AGT TGG GTT TG 3′

Tm: 56oC

R: 5′ TAC TCA GGT CCT AAT TTC 3′
Rad52-R115A
F: 5′ GGA GAA CGA AGC ACG GAA ACC TG 3′

Tm: 60oC

R: 5′ ACG GTA CCA TAC CCA ATA TC 3′
Rad52-K134A
F: 5′ GGA TGC CTT GGC AAG ATC TTT GAG 3′
R: 5′ GTA ACG GCA GAT TTC TTG 3′

Tm: 58oC
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Plasmid carrying Rad52-R37A-CBD was used as template to generate
Rad52-R37A K134A double mutant using the same primers that were used to
generate Rad52-K134A.
Note: All the constructs have a C-terminal CBD-tag which is cleaved during protein
purification by incubation with DTT to generate untagged Rad52-wt or Rad52 mutants.

5.2.2 Purification of Rad52-wt and Rad52 mutants

Rad52-wt-CBD or Rad52 mutant plasmids were transformed into Rosstta-2 PlysS
cells, plated on agar plates (with 100 g/ml ampicillin) and incubated overnight at 37oC.
Next day, a single colony was inoculated in a 50ml LB starter culture supplemented with
100 g/ml ampicillin and incubated overnight at 250 rpm at 37oC. A larger growth was
started by adding 10 ml of overnight culture to each 2.8 l baffle flask with 1 l autoclaved
LB supplemented with 100 g/ml ampicillin. The flask was agitated at 250 rpm at 37oC
until the growth reached an OD600 of 0.6. At OD600 0.6-0.8, for each 1l growth, the
culture was induced by adding 500μl of 1M IPTG (0.5mM final concentration).
Following induction, the culture was incubated overnight at 150rpm, 18oC. Note: All the
steps from here on were performed at 4oC or on ice. Cells were pelleted by centrifugation
at 5000rpm for 30 mins and resuspended in 200ml cell lysis buffer (50mM Tris-HCl, pH
7.5; 600mM NaCl; 1mM EDTA, pH 8.0; 2X PIC). Cells were lysed by sonication using
the following settings: 2 sec pulse followed by 2 sec off for 60 seconds, pause for
additional one-minute. This was repeated twice. The culture was stirred during the 1minute pause to ensure proper mixing. Amplitude of sonication was set to 50%. Cell
lysate was collected by centrifugation at 17000 rpm for 1 hour. The clarified supernatant
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was then batch-bound for 3 hours on to 20ml chitin resin (NEB, Ipswich, MA)
equilibrated with 200ml of cell lysis buffer. After 3 hours, flow-through was collected
and the resin was sequentially washed with 100mls of cell lysis buffer, 100ml of cell lysis
buffer+1.5M NaCl and again with 100ml of cell lysis buffer. Bound Rad52 protein was
batch eluted with CBD elution buffer (cell lysis buffer+50mM DTT). For batch elution,
CBD column was incubated with 20 mls of CBD elution buffer ensuring all the CBD
resins contact the elution buffer. The batch elution was collected every 6 hours, for a total
of 6 batches, each time using fresh DTT resulting in 120 ml total CBD elution volume.
Chitin column eluates were analyzed by 10% SDS-PAGE and eluates containing Rad52
were pooled, diluted with R0 (50mM Tris-HCl pH 7.5, 1mM EDTA pH 8.0, 2mM ME,
10% glycerol, 2X PIC ) to a final conductivity of R200 and applied on to a10ml heparin
column pre-washed with 2M NaCl and equilibrated with R200 (the subscript denotes
concentration of NaCl in mM). Unbound Rad52 was washed with 100ml of buffer R200
and Rad52 was fractioned using a linear gradient of R200-R1000. The eluted fractions were
analyzed by 10% SDS-PAGE, and fractions containing Rad52 were pooled, concentrated
with a 30kDa cut-off spin concentrator to a volume less than 5ml and applied on to a
HiLoad 16/600 200 Superdex-200pg size exclusion column equilibrated with Rad52
storage buffer (50 mM Tris-HCl, pH 7.5, 200mM NaCl, 2mM me, 0.2 mM EDTA, pH
8.0, 10% glycerol (v/v)). S200 fractions were further analyzed by 10% SDS-PAGE and
those containing Rad52 were pooled, concentrated with a 30kDa cut-off spin concentrator
and stored at -80oC as small aliquots after flash freezing with liquid nitrogen. Before
flash freezing, concentration of Rad52 was determined spectroscopically using abs (280),
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correction at abs (350) and extinction coefficient () 24000M-1cm-1. The equation used
was:
Concentration in Molar = (abs (280)- abs (350))*dilution factor / 
The dilution factor is 1 if no serial dilutions were made.
Rad52-R37A, Rad52-R115A, Rad52-K134A and Rad52-R37A K134A were
purified similar to Rad52-wt-CBD

5.2.3 Purification of fluorescently labeled RPA-DBD-A and RPA-DBD-D

Non-fluorescent RPA-DBD-A or RPA-DBD-D carrying 4-Azidophenylalanine
(4AZP) in DBD-A and DBD-D, respectively was purified and labelled with MB543, Cy3
or Cy5 as described in the Methods section of Chapter 3.

5.2.4 DNA oligonucleotides

Non-fluorescent and fluorescent oligodeoxynucleotides were synthesized by IDT
(Coraville, IA). Poly(dT) was purchased form Midland Certified Reagent Co (Midland,
TX). DNA annealing procedures for obtaining 5′ (dT)30 overhang, 3′ (dT)30 overhang,
and blocked end (dT)30 substrates are described in the Methods section of Chapter 4.
Note: Saccharomyces cerevisiae Rad52 predominantly behaves as a heptamer in
solution. Therefore, in the subsequent sections, we denote the heptametic
concentration of Rad52: i.e., a molar equivalent of Rad52 = 7 molar equivalents of
monomeric Rad52.

177
5.2.5 Fluorescence measurements

5.2.5.1 Excitation-Emission scans

Fluorescence spectra were obtained using a QM40 fluorometer Photon
Technologies Inc (Edison, NJ). For Rad52-wt and Rad52 mutants slit widths were set at
1.25 nm for excitation and 3 nm for emission. 2 ml of 100nM Rad52-wt in reaction buffer
(30 mM Hepes, pH 7.8, 100 mM KCl, 5 mM MgCl2, 2 mM β-mercaptoethanol and 6 %
v/v glycerol) was added to a quartz cuvette, and the excitation spectra (240-330 nm)
recorded at fixed emission of 350nm. To collect emission scans, samples was excited at
290nm and emission spectra recorded at 310-360nm. To this reaction, 100nM of (dT)45
was added with constant stirring for a minute. Samples were excited at 250nm and
emission spectra (310-360 nm) recorded. All reactions were performed at 25oC.

5.2.5.2 Steady-state DNA binding

1.95 ml of Rad52-wt in reaction buffer was taken in a cuvette and titrated with
increasing concentrations of (dT)45. Samples was kept stirring throughout the reaction
period. Samples were incubated for 60 sec after each addition to allow the Rad52-DNA
complex to reach equilibrium. Samples were excited at 290nm and emission spectra
(310-360 nm) monitored. Slit widths were maintained as in 5.2.4.1. The point of
maximum amplitude as seen in the emission spectra was plotted as a function of (dT)45
concentration and fit to a rectangular hyperbola to generate an apparant dissociation
constant.
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5.2.5.3 Site-size determination

The total number of nucleotides occupied by Rad52-wt in reaction buffer (30mM
HEPES, pH 7.8, 5mM MgCl2, 6% glycerol (v/v), 1 mM βME, 100mM KCl) was
determined as previously described using poly(dT) ssDNA (Kumaran et. al., 2006) (see
section 3.2.7 for detailed procedure). Briefly, increasing concentrations of poly(dT) were
added to a 1.95 ml reaction with 100nM Rad52-wt (heptamer concentration, 700nM
monomer concentration). The reaction was incubated for 60 sec after each additition to
reach equilibrium. Changes in intrinsic tryptophan fluorescence were monitored by
exciting the samples at 290nm and emission recorded at emi (max) (Kumaran et al.,
2006)(Kumaran et al., 2006)(Kumaran et al., 2006)(Kumaran et al., 2006)(Kumaran et
al., 2006)(Kumaran et al., 2006)(Kumaran et al., 2006)(Kumaran et al., 2006)(Kumaran
et al., 2006)(Kumaran et al., 2006)(Kumaran et al., 2006)(Kumaran et al.,
2006)(Kumaran et al., 2006)(Kumaran et. al., 2006) Data were phenomenologically
assessed to determine the influxtion points which denote the occluded site-size for
ssDNA binding within Rad52. See section 3.2.7 for more details.
To determine, the effect of [NaCl] on Rad52’s site-size the above mentioned
experiment was repeated in reaction buffer containing 30mM HEPES, pH 7.8, 5mM
MgCl2, 6% glycerol (v/v), 1 mM βME and the concentration of NaCl varied in each
experiment (25mM-1M).
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5.2.6 Stopped flow analysis of Rad52-DNA interactions

Stopped-flow experiments to monitor Rad52-wt binding were performed using an
Applied Photophysics SX20 instrument (Surrey, UK) in reaction buffer (50 mM Tris-Cl,
pH 7.5, 100 mM KCl, 5 mM MgCl2, 2mM β-mercaptoethanol and 6 % v/v glycerol) at 25
°C. All concentrations denoted are ‘pre-mixing’ which are reduced to half upon mixing
the samples to provide final ‘post- mixing’ concentrations.

5.2.6.1 Changes in intrinsic tryptophan fluorescence

100nM Rad52-wt was rapidly mixed with increasing concentrations of (dT)45 or
(dT)97. Samples were excited at 290nm and changes in intrinsic tryptophan fluorescence
was monitored with a 350 nm cut-off filter for a total of 2.25 seconds. 5000 data points
were collected in the first 250 milliseconds and 5000 data points collected over remaining
2 seconds. Resulting traces were analyzed using single-exponential + linear function (also
denoted in the models as a composite single-step binding of Rad52 onto DNA) as shown
below:
F = A (1 - e-k1t) + k2t

(Eq. 2)

Where, F is change in Rad52 tryptophan fluorescence, A and k1 are the
amplitude and observed rate of the exponential phase, k2 is the steady state rate and t is
time.
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5.2.6.2 Fluorescence measurements to determine polarity of Rad52-ssDNA
interactions

To determine the polarity of Rad52-wt or Rad52-mutants (Rad52 variants)
binding to ssDNA, 100nM of fluorescent deoxyoligonucleotide carrying a Cy3
fluorophore at either the 5′ end [5′ Cy3(dT)40 ] or the 3′ end [3′ Cy3 (dT)40] were rapidly
mixed with increasing concentrations of Rad52 (0, 25, 50, 75, 100, 150, 200, 250 nM) in
the stopped-flow instrument. Cy3 fluorophore was excited at 530nm and change in
fluorescence monitored with a 555nm cut-off long pass filter. Binding was monitored for
a total of 2.25 seconds with 5000 data points collected in the first 250 milliseconds and
5000 data points collected over 2 seconds. Raw traces were analyzed using a double
exponential + linear state equation (also denoted as a composite two step model for
Rad52 ssDNA binding):
[F = A1(1 - e-k1t) + A2(1 - e-k2t)+ k3t]

(Eq. 3)

Where, F is change in Cy3 fluorescence, A1 and k1 are the amplitude and
observed rate of the first exponential phase, A2 and k2 are the amplitude and observed rate
of second exponential phase, k3 is the steady state rate and t is time. Resulting kobs values
were plotted as a function of increasing concentration of Rad52 variants to determine
their nature of binding.
As a control, 100nM 5′ 6-FAM (dT)40 or 3′ 6-FAM (dT)40 was rapidly mixed with
increasing concentrations of Rad52-wt (0, 25, 50, 75, 100, 150, 200, 250 nM) in the
stopped-flow instrument. 6-FAM fluorophore was excited at 490nm and change in
fluorescence monitored with a 515nm cut-off long pass filter. Binding was monitored for
a total of 2.25 seconds with 5000 data points collected in the first 250 milliseconds and
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5000 data points collected over 2 seconds. Raw traces were analyzed using Eq. 3 and
plotted as a function of increasing concentration of Rad52-wt.

5.2.6.3 FRET experiments to capture RPA-Rad52 assembly

FRET experiments were performed by rapidly mixing the preformed FRET
complex consisting of 100nM RPA-DBD-ACy3 (donor) and 100nM RPA-DBD-DCy5
(acceptor) in one syringe with 100nM (dT)45 in the second syringe. Samples were excited
at 555nm and emission, i.e., increase in Cy5 fluorescence, was monitored with a 625nm
long-pass cut off filter. To investigate positioning of Rad52 in RPA-DNA complex, a
preformed RPA-DNA complex with 100nM (RPA-Acy3, RPA-DCy5 and 100nM (dT)45)
was rapidly mixed with 100nM Rad52-wt and change in Cy5 fluorescence monitored.

5.2.6.4 RPA-DBD dynamics on varying DNA-contexts

100nM RPA-DBD-AMB543 (RPA-AMB543) and 100nM Rad52 variants, or, 100nM
RPA-DBD-DMB543 (RPA-DMB543) and 100nM Rad52 variants in one syringe were rapidly
mixed with 100nM (dT)25, (dT)30, 5′(dT)30 overhang, 3′ (dT)30 overhang, or blocked end
(dT)30 substrates in a stopped-flow instrument. MB543 fluorescence was measured by
exciting at 535nm and monitoring the emission with a 555nm cut-off long-pass filter.
RPA-AMB543 or RPA-DMB543 engagement with distinct DNA structures in the presence of
Rad52 variants was collected for a total of 60 seconds, where, 5000 data points were
collected in the first 10 seconds and 5000 data points were collected over the remaining
50 seconds. All the raw traces for the reactions RPA-AMB543 were analyzed using Eq. 3
and for the reactions with RPA-DMB543 were analyzed using Eq. 2 and plotted.
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5.3 Results

5.3.1 Occluded site-size of Sc. Rad52

Occluded site-size (or DNA footprint) represents the total number of nucleotides
required to fully saturate the DNA binding site on a protein. Rad52 binds to ssDNA,
dsDNA (A Shinohara et. al., 1998), and to ssDNA-dsDNA junctions. Rad52 functions as
a heptamer and each monomer associates with ~ 4 nucleotides (nt) resulting in each
Rad52 heptamer occupying ~ 28 nucleotides (Grimme et. al., 2010). To precisely
determine the occluded site-size under our reaction conditions, we first tested if Rad52
produced a change in the intrinsic tryptophan fluorescence upon binding to ssDNA. The
N-terminus of Rad52 is required for ssDNA binding and has two tryptophan residues.
Excitation-emission spectra of Rad52 showed a maximum absorption (abs) at ~285nm
and emission (emi) at ~ 325nm, which are characteristic spectroscopic properties for
proteins with tryptophan residues (Fig. 5-2 a). Upon interaction with DNA, a quenching
of the tryptophan signal is observed (Fig. 5-2 b). This finding contradicts a previous study
that reported a lack of such intrinsic tryptophan fluorescence changes in Rad52 upon
binding to ssDNA (Sugiyama & Kowalczykowski, 2002). However, in our hands, and
under our experimental conditions, we observe a robust and quantifiable change in
intrinsic tryptophan fluorescence. By quantitating the change in intrinsic tryptophan
fluorescence as a function of increasing poly-deoxythymidine (poly-dT) ssDNA, we were
able to determine the occluded site-size of Sc. Rad52. The decrease in tryptophan
fluorescence was plotted as a function of number of nucleotides per Rad52 monomer to
determine the occluded site-size as described in methods (Fig. 5-2 c). Under our reaction
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conditions (30mM Hepes, pH 7.8, 100mM KCl, 2mM me, 5mM MgCl2, 6% glycerol
(v/v)), there appears to be two transitions in the data reflecting two clear DNA bound
states. The first DNA-bound state appears with a site size ~ 5.5±1.5 nt/ Rad52 monomer
(Fig 5-2 c), and the second state appears at ~11 nt/Rad52. We interpret this finding to
reflect DNA first wrapping around the Rad52 heptamer once (likely saturating the inner
binding site, explained in detail in section 5.3.3 onwards) and then wrapping it again
(likely saturating the outer binding site, explained in detail in section 5.3.3 onwards).
Since Rad52 has prominent DNA annealing activity, our data agrees with a doublewrapping model for Rad52-ssDNA interactions.
Rad52 is widely assumed to be a heptamer, yet, there have been reports of higher
order structures (Saotome, Saito, Onodera, Kurumizaka, & Kagawa, 2016; Saotome et.
al., 2018). The oligomeric state of a protein can be influenced by ionic environment, until
an equilibrium is established (Alford et. al., 2008). Although we did not investigate if
Rad52 would shift structural states in response to changes in ionic conditions, we tested if
site-size of Rad52 was affected by increasing [NaCl] concentrations. The rationale for
this experiment arises from step-size measurements performed with SSB proteins, where
changes in the monovalent or divalent ion concentrations give rise to unique structural
transitions within protein-DNA complexes (Bujalowski et. al., 1988). We performed
similar experiments with 100nM Rad52 and increasing concentrations of poly (dT) in the
reaction (30mM Hepes, pH7.8, 5mM MgCl2, 2mM me, 6% glycerol (v/v)) supplemented
with increasing concentrations of [NaCl] (25mM -500mM).We did not find change in the
first occluded site-size (site-sze 1) within Rad52-DNA complex as a function of
increasing [NaCl] (Fig. 5-2 d). Additional experiments need to be perfomed to understand
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if the second occluded site-size (site-sze 1) within Rad52-DNA complex is affected as a
function of increasing [NaCl].
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a)

d)

b)

e)

c)

f)

Figure 5-2: Characterization of Rad52 binding to ssDNA. a) Excitation-emission
spectra of Rad52-wt. b) Emission spectra of 100nM Rad52-wt shows a decrease in
intrinsic tryptophan fluorescence upon binding to DNA: 100nM (dT)45. c) Representative
plot of the site-size measurement of Rad52 shows a subsequent decrease in tryptophan
fluorescence with increasing number of nucleotides. Two points of saturation are
observed as shown by the dotted lines. The corresponding site-sizes are denoted. d) The
first DNA bound site-size (site-size 1) does not change as a function of increasing
concentrations of NaCl. e) Raw traces obtained from titrating 100nM Rad52- with
increasing concentration of (dT)45. Samples were excited at 290nm and emission spectra
collected. f) Peak emission obtained for each concentration of (dT)45 is normalized and
plotted against individual (dT)45 concentrations and yields a Kd of 40.2 ± 3.3 nM.
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5.3.2 ssDNA binding properties of Sc. Rad52

We utilized the change in tryptophan fluorescence as a tool to determine the
affinity of Rad52-ssDNA binding. Increasing concentrations of (dT)45 oligonucleotide
were added to 100nM Rad52, and the change in tryptophan fluorescence was measured.
We obtained an apparent dissociation constant (Kd) of 40.2 ± 3.3 nM for Sc. Rad52
ssDNA binding (Fig 5-2 e, f), which agrees with the estimates of human Rad52-ssDNA
interactions, with Kd values raning from sub-nM to 100 nM (Grimme et. al., 2010). Our
study is the first detailed measurement for yeast Rad52 and is in the ballpark of the values
measured for human Rad52.
This tight ssDNA binding is of interest, as it closely resembles to that of RPA.
RPA has slightly higher affinity for binding to ssDNA (Kd of RPA: 29.2 ± 4 nM, Fig. 3-3
f). RPA and Rad52 function on the same ssDNA substrate during HR, and possibly
compete for binding to the same DNA space. Therefore, given similar Kd values of RPA
and Rad52 binding to ssDNA, one can speculate that both the proteins have equal
opportunities to gain access to the available DNA space. To futher characterize Rad52ssDNA binding in detail, we next sought to ascertain if kinetics of Rad52 binding to
ssDNA was similar to RPA-wt. The rationale for this experiment is that if kinetics of
RPA and Rad52 binding to ssDNA are similar, and they have slight difference in Kd
values, it would suggest that the order of DNA occupancy could be driven by the local
concentration of protein available. Whereas, differences in kinetics would suggest that an
inherent biochemical property of the protein would drive DNA occupancy, i.e., the
protein with higher ‘on-rate’ would occupy DNA first and the stability of protein on
DNA would be determined by its off-rate/ on-rate. To this extent, we used stopped-flow
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methodology to rapidly mix 100nM Rad52-wt with increasing concentrations of (dT)45
and monitored changes in intrinsic tryptophan fluorescence (Fig. 5-3 a, d). Data obtained
was quantitated and best described using a single exponential followed by linear phase
equation. For 100nM Rad52 in the reaction, the kobs,1 value i.e., the rate of initial
engagement, showed an initial sigmodial behavior (see kobs,1 value for 50nM and 75nM
(dT)45, Fig. 5-3 b), followed by linear increase until 200nM (dT)45, after which it
saturated (Fig. 5-3 b). Similar experiments with 100nM Rad52 and increasing
concentrations of (dT)97 resulted in saturation at 100nM (dT)97 (Fig. 5-3 e). The initial
sigmodial behavior suggest Rad52 binds cooperatively to ssDNA, and a single Rad52
heptamer is engaging with two molecules of (dT)45 or with one molecule of (dT)97.
Our site-size measurements show that a Rad52 heptamer occupies approximately
35 nucleotides (Fig 5-2 c, d) and the recently solved crystal structure of truncated Rad52DNA complex shows that Rad52 is able to associate with DNA in two distinct ways:
wrapping it around the circumference of the structure or sandwiching it in between two
Rad52 molecules (Saotome et. al., 2018). Therefore, of the two (dT)45, one could be
wrapped around the circumference of Rad52 and the second could be sandwiched
between two Rad52 heptamers (discussed in section 5.3.4). Whereas, in case of (dT)97, a
single (dT)97 could be wrapped around Rad52 heptamer and provide with enough
remaining DNA to be sandwiched between two heptamers. In both these DNA substrates,
a cooperative binding behavior is seen at sub-stoichiometric concentrations of DNA (Fig.
5-3 b, e, until 75nM for (dT)45 and 30nM for (dT)97, respectively) suggesting possible
communications between the inner and outer binding sites dictating overall Rad52-DNA
engagement. Linear fit of the kobs,1 plot until 200nM (dT)45 and 100nM (dT)97, yields the
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bimolecular rate constant (kon) value of 2.2 ± 1.0 x 108 M-1 s-1 which is slightly slower
than RPA-wt (kon 5.2 ± 0.3 x 108 M-1s-1, Fig 3-3 f). In our rate-constant calculations, we
are assuming Rad52 to exist as a heptamer and all the protomers to simultaneously
engage with the available DNA substrate. We recognize that this might not be the case
under cellular conditions or in a multi-protein reaction. Rad52 heptamer dissociated from
(dT)45 with a rate of (koff) 21.6 ± 7.8 s-1 (Fig. 5-3 b) which is slightly higher than the rate
of dissociation of RPA from ssDNA (15.5 ± 0.8 s-1, Fig 3-3 f). Interestingly, Rad52
dissociated from (dT)97 with a koff value of 9.5 ± 0.5 s-1, while maintaining the same kon as
(dT)45. This suggests that Rad52 forms a more stable complex on longer DNA.
Taken together our results suggests that although Rad52 heptamer has DNA
binding affinity similar to RPA, it has slightly slower rate of binding (kon) and a slightly
higher rate of dissociation (for shorter DNA, i.e. (dT)45) than RPA-wt. In our reaction
conditions, RPA has an occluded site-size of 22 nucleotides, and 2 RPAs can stably
engage on a (dT)45 substrate. Therefore, under conditions where RPA is abundant,
exposed ssDNA would be first occupied by RPA followed by Rad52 in the vicinity.
However, in processes like alternative lengthening of telomere (ALT) with limiting RPA
(Zhang et. al., 2019), Rad52 would bind with high affinity to long telomeric DNA repeats
and perform annealing followed by subsequent recombination of telomeric DNA.
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Figure 5-3: ssDNA binding kinetics of Rad52-wt. Representative traces from stoppedflow reaction showing increase in tryptophan quenching when 100nM Rad52-wt is mixed
with increasing concentrations of a) (dT)45 and d) (dT)97, respectively. Fitting of the raw
traces with equation as described in methods yields plot of initial rate of binding (kobs,1)
for b) (dT)45 which shows initial cooperative binding followed by linear increase until
200nM after which it saturates and e) (dT)97 which shows similar binding as (dT)45 until
100nM and then saturates. Plot of kobs,1 for 100nM Rad52-wt binding with c) (dT)45 and
f) (dT)97 respectively.
5.3.3 Differential binding of Sc. Rad52 to ssDNA termini

Fundamentally, protein-DNA interactions are usually driven by availability of the
reacting species, the rate at which the protein binds to DNA, and the affinity with which
it maintains the binding. In most, if not all cases, the efficiency of this interaction can be
further dictated by the directionality or orientation with which the protein associates with
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DNA, also known as the polarity of binding. For example, RPA and Rad51, the two
proteins that physically interact with Rad52 bind to DNA with a specific 5′ to 3′ polarity
(Kolpashchikov et. al., 2001; Qiu et. al., 2013). RPA binds 5′-3′ with DBD-A situated
close to the 5′ end and DBD-D situated close to the 3′ end. Rad51, in the presence of
ATP, forms a nucleoprotein filament with preferential nucleation at the 5′ end followed
by 5′-3′ growth of the filament (Antony et. al., 2009; Pokhrel et. al., 2019). The
orientation of the protein binding to DNA can significantly impact the degree of DNAprotein interactions. Such polarity-specific positioning will also dictate the binding
parameters when forming a higher order complexes on DNA. Since both Rad52 and RPA
can bind with high affinity to ssDNA, we wanted to investigate if Rad52 had a
preferential polarity of binding to ssDNA, and whether polarity of Rad52 binding to
DNA affected RPA-Rad52-DNA binding dynamics.
We used Protein Induced Fluorescent Enhancement (PIFE) which employs
monitoring protein binding by using end-labeled fluorescent oligos (Fischer & Lohman,
2004; Fischer et. al., 2010). When a protein binds to a fluorescently labeled
oligonucleotide, local changes in the fluorophore’s environment results in an overall
change in the fluorescence intensity which can be quantified to determine the kinetic and
thermodynamic parameters of a protein-DNA interaction (Morten et. al., 2015; Song et.
al., 2016). Differences in kinetics of binding between the 5′-end lableled versus 3′-end
labeled DNA can provide information about the polarity of binding.
We performed PIFE using stopped-flow analysis, where, 100nM 5ʹ Cy3 labeled
(dT)40 or 3ʹ Cy3 labeled (dT)40 was rapidly mixed with increasing concentrations of Sc.
Rad52 (Rad52-wt). The reaction was excited at 535nm and the emission monitored at
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555nm, using a long-pass filter. A robust increase in Cy3 fluorescence was observed
upon Rad52 binding to both 5ʹ Cy3 (dT)40 and 3ʹ Cy3 (dT)40 DNA (Fig 5-4 a, e), with an
initial rate of engagement (kobs,1) values of 138.0 ± 10.5 s-1 (Fig. 5-4 b) and 132.5 ± 17.6
s-1 (Fig 5-4 f), respectively. Similar rate of initial engagement for binding to both 5ʹ and 3ʹ
Cy3 (dT)40 DNA suggests that Rad52 does not differentiate between the DNA termini
upon first encountering the DNA. In addition, the high kobs,1 value probably reflects the
sum of total rate of engagement of all seven subunits of Rad52 rather than a single
subunit. Although binding of Rad52 to both 5ʹ Cy3 (dT)40 and 3ʹ (dT)40 DNA could be
explained using a double exponential followed by a liner-phase model, there were subtle
differences in the overall trend of binding between the 5′ and 3′ Cy3 end-labeled DNA.
Rad52 displayed a cooperative binding behavior towards the 5ʹ end of the DNA as seen
by the initial sigmoidal trend of the kobs1 and kobs,2 plots (Fig. 5-4 b, c, see kobs,1 values
from 25nM until 100nM 5′ Cy3 (dT)40). At sub-stoichiometric concentrations of Rad52,
the initial increase in kobs,1 decreased with increasing concentrations of Rad52 (compare
the kobs,1 values at 25nM , 50nM and 75nM Rad52-wt) until it reached a 1:1 molar ratio of
DNA : protein, after which the kobs,1 vaules exhibited a linear trend (Fig 5-4 b). However,
binding towards the 3ʹ end did not exhibit a cooperative behavior and increased linearly
with an increasing concentration of Rad52-wt (Fig. 5-4 f). As a control, to ensure the that
cooperativity observed on a 5′Cy3(dT)40 is not a fluorophore effect, we also performed
similar PIFE experiments with 5′ or 3′ 6-FAM labeled (dT)40. Rad52-wt bound
cooperatively on a 5′ 6-FAM (dT)40 and linearly on a 3′ 6-FAM (dT)40 with ssDNA
binding kinetics similar to 5′Cy3(dT)40 and 3′ Cy3 (dT)40, respectively (Fig. 5-24).
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5.3.4 Mutations in the outer and inner binding site affect the cooperative binding
behavior of Sc. Rad52

There are no crystal structures of apo or DNA-bound Sc. Rad52 that provide
structural insights into Sc. Rad52-DNA engagement. Therefore, we utilized the
extensively studied hRad52 as a guide to decipher the source of cooperativity observed in
Sc. Rad52 binding to 5′ Cy3 labeled (dT)40 DNA. The N-terminal ssDNA binding
domains of Sc. Rad52 and hRad52 share remarkable sequence conservation and could
engage with ssDNA via similar mechanisms. An apo structure of hRad52 fragment
(hRad521-212) solved over a decade ago shows an undecamer with 11 protomers (Kagawa
et. al., 2002; Singleton, Wentzell, Liu, West, & Wigley, 2002) (Fig 5-1 a, b). A positive
groove along the circumference of undecamer, also called the ‘inner binding site’ was
proposed to be well-adapted for accommodating negatively charged ssDNA (Fig 5-1 c, 55 a, b) (Kagawa et. al., 2002; Singleton et. al., 2002). Subsequent studies revealed a
second binding site located outside this groove, also known as the ‘outer binding site’,
which could engage to ssDNA and had implications in DNA annealing as well as D-loop
formation (Fig 5-6 a, b). These findings suggest that there are at least two possible
mechanisms by which Rad52 can engage to ssDNA, one involving the inner binding site
and other involving the outer binding site.
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h)

Figure 5-4: Cooperative binding between Rad52-wt inner and outer site. A robust
increase in Cy3 fluorescence is observed when increasing concentration of Rad52-wt is
reacted with 100nM a) 5′ Cy3 (dT)40 or e) 3′ Cy3 (dT)40 DNA. Fitting the raw traces with
a double exponential followed by steady state model yields plot of b) initial engagement
(kobs,1) c) second phase/ step of binding (kobs,2) and d) linear phase (kobs,3) for Rad52-wt
binding on a 5′Cy3(dT)40 DNA. Similar kinetic fitting of the raw traces obtained for
Rad52-wt binding on a 3′ Cy3 (dT)40 DNA yeilds plot of f) kobs,1 g) kobs,2 and h) kobs,3.
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a

b

Figure 5-5: Crystal structure of hRad521-212 inner binding site-ssDNA complex. a)
(Side-view) crystal structure of DNA of hRad521-212 with ssDNA (black sticks) wrapped
around the undecamer (PDB: 5XRZ), nested in the groove, also known as inner binding
site. Of the 11 subunits, two subunits are shown in magenta and orange color,
respectively. R55 (navy blue sphere) and K152 (purple sphere), two important amino
acids in the transition site and inner site, respectively, make critical electrostatic contacts
(yellow dashed lines) with ssDNA. Each subunit coordinates a K+ metal ion (gray sphere)
that is located in between R55 and K152. Together R55, K152 and K+ makes polar
contacts with ssDNA to “lock” the ssDNA in inner binding site. K133 is mutated to
alanine (light pink sphere) to obtain crystal structure of ssDNA bound to the inner
binding site of hRad521-212. b) Same as in a) but showing only two subunits of the
undecamer.
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a)

b)

Figure 5-6: Crystal structure of hRad521-212-ssDNA complex with ssDNA bound to
the outer binding side. a) (Side-view) hRad521-212 structures showing ssDNA (black
sticks) bound to the edges of hRad521-212 undecamer or “sandwiched” between two
undecamers (PDB: 5SX0). Of the 11 subunits, two subunits are shown in magenta and
orange color, respectively. In each subunit, K133 (red sphere) is required for ssDNA
binding to the outer side. R55 and K152, required for stable binding in the inner binding
site are shown as navy blue spheres and purple spheres, respectively. Critical amino acids
required for coordinating ssDNA between two undecamers are K133 (shown as red
sticks) and K102 (shown as green sticks). Unlike in the crystal structure of inner binding
site (PDB: 5XRZ), coordinating a metal ion is not required for binding to the outer
binding site. b) Same as in a) but showing only two subunits of the undecamer.
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After a decade of solving the apo structure of Rad52, ssDNA bound crystal
structures of hRad521-212 were solved which shed key insights into the mechanism of
hRad52-ssDNA engagement (Fig 5-5, 5-6). However, two lysine residues in the outer
binding site were mutated to alanine (K102A/ K133A) in order to obtain a crystal
structure of ssDNA occupying the inner binding site (Fig 5-5 a, b) (Saotome et. al., 2016,
2018). The hRad521-212 inner binding site-ssDNA complex shows an undecamer with
ssDNA wrapped around nested in the positively charged groove (Fig 5-5 a, b), whereas,
the outer binding site-ssDNA complex shows ssDNA trapped/sandwiched in between two
hRad521-212 undecamers (Fig 5-6 a, b). We recognize that both the apo and DNA-bound
structures of hRad521-212 lack the C-terminal domain which could highly impact the
number of protomers present in the full length hRad52 or protomers that are actively
engaging with ssDNA at a given point.
One key difference is the number of protomers in the oligomeric structure of
ScRad52 and hRad52: 7 in ScRad52 while it is either 7, 10 or 11 in hRad52. Our
interpretations and experimental designs for ScRad52 here are based its the heptameric
nature. Our PIFE experiments with Sc. Rad52 showed two different binding behaviors,
i.e., cooperative towards 5ʹ end and linear binding towards the 3ʹ end, suggesting
existence of at least two different mechanisms for binding across the DNA substrate (Fig
5-4). In addition, the crystal structures of ssDNA-hRad521-212 displayed two distinct ways
of engaging ssDNA (Saotome et. al., 2018). Therefore, we hypothesized that cooperative
binding observed with Sc. Rad52 binding to 5′Cy3 (dT)40 DNA could be due to
coordination of ssDNA between the inner and outer binding sites. Moreover, linear
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binding observed with 3′Cy3 (dT)40 could represent the stable engagement of Rad52ssDNA in the inner binding site carrying the positively charged groove.
To test this hypothesis, we generated Sc. Rad52 inner and/or outer binding site
mutants, where Lys134 in the inner site and/or Arg 115 on the outer site were mutated to
alanine (K134A and R115A), respectively. In addition, we also generated a transition-site
mutant, where Arg 37 (R55 in hRad52) was mutated to alanine (R37A in ScRad52). In
hRad52, Arg 55 has been shown to directly interact with ssDNA and is critical for proper
ssDNA binding (Hengel et. al., 2016; Lloyd, McGrew, & Knight, 2005; Saotome et. al.,
2018). Furthermore, R55 is located between the inner and outer binding sites (Kagawa et.
al., 2002; Saotome et. al., 2018; Singleton et. al., 2002) and therefore, has the ability to
function as a transition site for guiding the DNA binding from inner to outer site, or viceversa (Fig 5-1 c, 5-5 b, 5-6 c). Finally, we generated a double binding site mutant, where
both R37 and K134 are mutated to alanine (R37A K134A). We measured the ssDNA
binding affinities of all these Rad52 mutants and observed varying degrees of net
intrinsic tryptophan fluorescence (Fig. 5-7). Except for Rad52R115A which has mutation in
the outer binding site, Rad52R37A, Rad52K134A and Rad52R37A K134A (transition site- inner
binding site- double binding mutant) had progressively lower affinity, with Rad52R37A
K134A

having the least affinity for binding to ssDNA (Table 5-1). Depending on the

mutation (i.e inner, outer, transition or double), at any given time, individual protomers in
Rad52 heptamer, or the entire Rad52 heptamer could be engaging differently on ssDNA,
resulting in a multiplex of conformational assemblies, reflected as varying degrees of
tryptophan quenching (Fig. 5-7, 5-12). Nonetheless, if 5′-3′ cooperativity is driven by
ssDNA being guided from one binding site to another via the transition site, mutations in
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either the inner, outer or transition site should result in loss of cooperativity observed at 5′
end of DNA. To this extent, we performed PIFE experiments with all three Sc. Rad52
mutants (inner binding site- Rad52K134A, outer binding site- Rad52R115A, and transition
site- Rad52R37A) and compared it with Sc. Rad52-wt.
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Figure 5-7: ssDNA binding affinity of Rad52 mutants. 100nM Rad52-wt or Rad52
mutants was titrated with increasing concentrations of (dT)45. Samples were excited at
290nm and emission spectra (310-360 nm) collected. For each Rad52 variant, peak
emission at ~330nm was plotted for individual (dT)45 concentrations and data were fit
using equation for binding isotherm to obtain the Kd values (Table 5-1). Data points are
an average of at least three independent experiments.
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Stopped flow experiments were performed by rapidly mixing increasing
concentrations Sc. Rad52K134A, Rad52R115A or Rad52R37A with 100nM 5ʹ Cy3 (dT)40 or 3ʹ
Cy3 (dT)40 DNA. Cy3 was excited at 530nm and change in Cy3 fluorescence monitored
using a 555nm long-pass emission filter. For all three Sc. Rad52 mutants, data obtained
was quantitated using a double exponential followed by linear-state kinetic model. As
expected, all three Sc. Rad52 mutants had a loss of cooperativity upon binding to 5′ Cy3
(dT)40 DNA (Fig 5-7- 5-11). However, each binding site mutant showed subtle
differences in binding to either 5′ or 3′ Cy3 (dT)40 DNA, as described below.

5.3.4.1

Rad52 outer binding site mutant exhibits differential binding at DNA ends

PIFE experiments done with the outer site mutant (Rad52115A) showed robust
increase in Cy3 fluorescence with increasing concentrations of Rad52R115A for both DNA
substrates (Fig. 5-8 a, e). Loss of cooperative binding was observed in both 5′ Cy3 (dT)40
and 3′ Cy3 (dT)40 DNA (Fig. 5-8 b, f). However, there were subtle differences in events
of binding between the two DNA substates. For 100nM 5ʹ Cy3 (dT)40 DNA, a decrease in
initial rate of binding (kobs,1) was observed with increasing concentration of Rad52R115A,
until 100nM, following which the kobs,1 values saturated (Fig. 5-8 b). In contrast,
repeating similar binding reactions with 3ʹCy3 (dT)40 DNA produced a typical binding
isotherm with increase in kobs,1 until 100nM Rad52R115A following which it saturated (Fig.
5-8 f). Furthermore, for binding to 5′ Cy3 (dT)40 DNA, the rate of second phase of
binding (kobs,2) and linear phase (kobs,3) remained constant with increasing concentrations
of Rad52R115A, whereas, kobs,2 and kobs,3 for binding to 3ʹCy3 (dT)40 resulted in a
rectangular hyperbola (Fig 5-8 c-d, g-h). Taken together, these results suggest that
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Rad52R115A is not engaging DNA via similar mechanism as Rad52-wt. Opposite trends of
kobs,1 values for binding to 100nM 5′ Cy3 (dT)40 versus 3′ (dT)40 DNA until an equimolar
concentration of Rad52R115A is reached could resemble a repertoire of Rad52R115A-ssDNA
conformational assemblies, where engagement of DNA at one terminal allosterically
affects the engagement of DNA at another end of DNA until substrate is limiting.
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Figure 5-8: Rad52 outer binding site mutant (Rad52R115A) binds differently to 5′ and
3′ end of DNA. Increasing concentrations of Rad52R115A when rapidly reacted with
100nM a) 5′ (dT)40 or e) 3′ (dT)40, shows a robust increase in Cy3 fluorescence.
Quantification of the obtained raw traces with appropriate kinetic models yields plot of
initial engagement (kobs,1) for b) 5′ (dT)40 and f) 3′ (dT)40, respectively. A plot of typical
binding isotherm for all three distinct binding steps i.e. f) kobs,1 g) kobs,2 and h) kobs,3, is
obtained upon Rad52R115A binding to 3′ Cy3 (dT)40 which is not seen with 5′Cy3(dT)40
DNA. Plot of c) kobs,2 and d) kobs,3 upon Rad52R115A binding on a 5′ Cy3 (dT)40 shows no
significant change in the observed rates with increasing concentrations of Rad52R115A.
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5.3.4.2 Mutations in the inner binding site results in loss of polarity and
cooperativity

Similar PIFE experiments performed with the inner site binding mutant
(Rad52K134A) produced robust increase in Cy3 fluorescence (Fig. 5-9 a, e) and upon
quantification with a two- step binding model, revealed an extremely fast binding to both
5′ and 3′ Cy3 (dT)40 DNA, with loss of cooperativity for both DNA substates (Fig. 5-9 b,
f). Rad52K134A bound to both 5′ Cy3 and 3′ Cy3 (dT)40 DNA with an initial rate of
engagement (kobs,1) of ~220 ± 35 s-1, which remained constant irrespective of the
increasing concentrations of Rad52K134A (Fig. 5-9 b, f). This kobs,1 value is equivalent to
maximal rate observed for Rad52-wt binding to 100nM 5ʹ or 3ʹ Cy3 labeled (dT)40, under
conditions with 2.5 fold molar excess of Rad52-wt ( Compare, Fig. 5-9 b, f with Fig. 5-4
b, e, at 200nM Rad52-wt).The kobs,2 values for binding to 5ʹ or 3ʹ Cy3 (dT)40 showed a
marginal increase proportional to the concentration of Rad52K134A (Fig. 5-9 c, g), with no
change in kobs,3 values (Fig. 5-9 d, h). We also performed similar PIFE experiments with
double binding site mutant (Rad52R37A K134A) which did not produce a significant change
in Cy3 fluorescence denoting a severe defect in Rad52-DNA binding (Fig. 5-10 a, b).
Taken together, mutations in the inner-binding sites disrupts the cooperativity that was
observed in Sc. Rad52-wt. Since the inner binding site is comprised of the positively
charged groove that is in a ‘ready’ state to accept and stabilize ssDNA, a single mutation
in the inner binding site (Rad52K134A) probably results in dynamic engagement of DNA
between the outer site and transition site, which is fast and devoid of polarity. However,
mutating the transition site along with critical amino acid residue in the inner site (eg:
Rad52R37AK134A) severely affects Rad52-ssDNA engagement.
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Figure 5-9: Rad52R134A inner site binding mutant shows loss of cooperativity and
polarity. Representative traces from the stopped-flow reactions show increase in Cy3
fluorescence when increasing concentration of Rad52R134A mutant is mixed rapidly with
100nM a) 5′ Cy3 (dT)40, e) 3′ Cy3 (dT)40. All the samples were excited at 530 nm and
emission monitored at 555nm. Fitting the raw traces with double exponential followed by
a linear-phase model yields the plot of b), f) kobs,1 c), g) kobs,2 d), h) kobs,3 for binding to 5′
(dT)40 and 3′ (dT)40, respectively.
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Figure 5-10: Rad52R37A K134A double mutant displays complete loss of binding to
ssDNA in PIFE experiments. Representative traces from the stopped-flow reactions
show no significant change in Cy3 fluorescence when increasing concentration of
Rad52R37A K134A double mutant is rapidly mixed with 100nM a) 5′ Cy3 (dT)40 and b) 3′
Cy3 (dT)40 suggesting Rad52R37A K134A is unable to stably engage with ssDNA. All the
reactions were excited at 530nm and emission monitored with 555nm cut-off long pass
filter.
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5.3.4.3 Transition site is required for cooperative binding in Sc. Rad52-wt

Rad52 inner and outer binding site mutants are able to engage with ssDNA in a
way that is distinct from Rad52-wt, yet, a severe defect in ssDNA binding is observed
when mutation in the inner binding site is coupled with mutation in the transition site
(Rad52R37A K134A) (Fig 5-8- 5-10). In hRad52, R55 (R37 in Sc. Rad52) forms electrostatic
interactions with ssDNA backbone which primarily contributes to secure ssDNA in the
inner binding site (Saotome et. al., 2018). This suggests that transition site plays a key
role in ssDNA binding and could act as a lynchpin in coordinating ssDNA between the
inner binding site and outer binding site. Therefore, we performed similar stopped flow
experiments with Rad52R37A and 5′ Cy3 or 3′ Cy3 (dT)40 DNA. A robust increase in Cy3
fluorescence was observed upon Rad52R37A binding to 100nM 5′ Cy3 (dT)40 or 3′ Cy3
(dT)40 DNA (Fig. 5-11 a, e). Rad52R37A showed a loss of cooperativity for binding to both
fluorescent DNA, yet, subtle differences in binding between the 5′ Cy3 (dT)40 and 3′ Cy3
(dT)40 DNA were observed (Fig. 5-11 b). For reactions with 100nM 5ʹ Cy3 (dT)40 or 3ʹ
Cy3 (dT)40 DNA and 25nM Rad52R37A, the initial rate of binding (kobs,1) was ~30 ± 2s-1
(Fig. 5-11 b, f). Increasing the concentration to 50nM Rad52R37A resulted in dramatic
increase in kobs,1 (~220 ± 40s-1) for binding to 3′ Cy3 (dT)40 DNA, yet, a steady increase
in kobs,1 which saturated at a maximum of ~ 180 ± 10 s-1 was observed for binding to 5′
Cy3 (dT)40 (Fig. 5-11 b, f). Binding to either 5′ Cy3 (dT)40 or 3′ Cy3 (dT)40 showed a
slight increase in kobs,2 reaching with increasing concentration of Rad52R37A until 100nM,
then saturated. No significant changes in kobs,3 was observed. Therefore, R37 is required
for maintaining cooperativity in Rad52-ssDNA binding.

207
The complex structure of Rad52 as a heptamer and its ability to exists as higher
order structure has been a major roadblock in deciphering the precise mechanism
underlying Rad52-ssDNA, for both yeast and human. Here, using PIFE and series of
mutagenesis in full length Sc. Rad52, we showed that Rad52 undergoes cooperative
assembly towards the 5′ end of DNA. Mutating key amino acid residues required in the
inner binding site, outer binding site or transition sites result in loss of cooperativity and
polarity but do not abolish Rad52 binding to ssDNA. Based on literature and our current
findings, we propose a model detailing order of events in Sc. Rad52-ssDNA engagement.
First, the outer binding site samples or engages the ssDNA which is then threaded into
the inner binding site, via the transition site. Ionic interactions between R37 and ssDNA
in the transition site stabilizes the ssDNA, favoring ssDNA binding to the inner binding
site and preventing slipping of ssDNA back to the outer binding site. Finally, ssDNA is
stably wrapped around the inner binding site which consists of a positively charged cleft
well suited to accommodate the negatively charged ssDNA (Fig. 5-12).
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Figure 5-11: Rad52R37A transition site mutant shows loss of cooperativity and
exhibits differential binding in PIFE experiments. Representative traces from the
stopped-flow reactions show robust increase in Cy3 fluorescence when increasing
concentration of Rad52R37A mutant is mixed rapidly with a) 5′ Cy3 (dT)40, e) 3′ Cy3
(dT)40. All the samples were excited at 530 nm and emission monitored at 555nm. Fitting
the raw traces to a two-step binding model with a linear phase yields the plot of b), f)
kobs,1 c), g) kobs,2 d), h) kobs,3 for binding to 5′ (dT)40 and 3′ (dT)40, respectively.
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Figure 5-12: Model for Sc. Rad52-ssDNA engagement. The outer binding site of
Rad52 (red circles) senses and binds to ssDNA (black lines). Two Rad52 complexes can
engage to a single ssDNA and form higher order complexes, here, shown as two
heptamers sharing a single ssDNA. ssDNA then passes through transition site (navy blue
circles), which primes the DNA (dashed grey lines) for binding towards the inner binding
site (purple circles) and could prevent ssDNA moving back to the outer site, locking
ssDNA in place. The positively charged groove in the inner binding site along with R37
in the transition site stabilize ssDNA binding in the inner site to form a stable locked
conformation. Dashed brown arrow shows switching of dimer of Rad52 heptamers with
DNA engaged in the outer site to Rad52 heptamers with ssDNA bound to the inner site.

210
5.3.5 Rad52 does not invade the RPA nucleoprotein filament

Following in-depth investigation of Sc. Rad52 binding to ssDNA, we next wanted
to understand how the DNA binding properties of Rad52 could promote, or in certain
cases, result in displacement of RPA from ssDNA (Gibb, Ye, Kwon, et. al., 2014b;
Sugiyama & Kowalczykowski, 2002a). In chapter 3, we showed that Rad52 selectively
altered the DNA binding dynamics of DBD-D of RPA on a ssDNA, although it interacted
with both DBD-A and DBD-D (Nilisha Pokhrel et. al., 2019). In addition, several studies
have shown that Rad52 localizes with RPA on long stretches of ssDNA (Chu Jian Ma et.
al., 2017b; Plate et. al., 2008). However, we lack a understanding of the positioning of
Rad52 on DNA, especially when multiple RPA molecules are bound on DNA (the RPA
nucleoprotein state).
Experimental bottlenecks have thwarted attempts to obtain a high resolution
quantifiable readout of the Rad52-RPA interactions. For example, several studies
investigating Rad52-RPA-DNA interactions had adopted the technique of tagging RPA,
Rad52, and/or both with bulky GFP or RFP groups which could sterically impact their
assembly on available DNA space. Both RPA and Rad52 have quantifiable tryptophan
fluorescence. Therefore, using intrinsic tryptophan quenching as a readout to monitor
RPA-Rad52 assembly on ssDNA would produce convoluted signal which is hard to
dechipher, as the exact source of the signal cannot be assigned. Finally, PIFE experiments
would not be suitable as both RPA and Rad52 produce a robust change in Cy3
fluorescence upon binding end-labeled fluorescent ssDNA. Therefore to overcome these
roadblocks and investigate how Rad52 would interact on a ssDNA occupied by multiple
RPA molecules, we performed bulk RPA-FRET experiments using Cy3-labeled DBD-A
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(RPA-Acy3), Cy5 labeled-DBD-D, and monitored FRET occurring on a (dT)45 DNA
substrate, in presence and absence of Rad52-wt (Fig 5-13 a, b). Stopped flow reactions
performed by rapidly mixing 100nM each of RPA-Acy3, RPA-Dcy5 and (dT)45, showed a
robust increase in Cy5 fluorescence followed by a slow decrease which denotes the
remodeling phase between the two DBDs (inter-RPA remodeling) (Fig. 5-13 b, orange
trace). The highest amplitude of fluorescence observed in this reaction represent the highFRET state. As a positive control, similar experiments with a preformed RPA-Acy3-Dcy5(dT)45 complex when rapidly mixed with reaction buffer that did not contain Rad52,
showed cy5 fluorescence at the high-FRET state (Fig. 5-13 b, grey trace). Finally, rapid
mixing reaction with preformed RPA-Acy3-Dcy5-(dT)45 in presence of 100nM Rad52-wt
showed no change in cy5 fluorescence i.e. the high FRET state (Fig. 5-13 b, olive green
trace). In our experiments, FRET occurs between two RPA only when the Cy5 labeled
DBD-D of the first RPA is adjacent to Cy3 labeled DBD-A of second RPA in a 5′-3′
direction (Fig. 5-13 a) (Yates et. al., 2018). Thus, no affect in the high-FRET state in
presence of Rad52-wt suggests that Rad52 cannot position itself in between two RPA and
would require access either from the 5′ end or 3′ end of the DNA. Based on our findings
monitoring interaction between one RPA on DNA and Rad52, even for DNA occupied by
multiple RPA, accessibility towards the 3′ end by selectively modulating DBD-D
dynamics would be the most probable route for Rad52 to occupy DNA space.
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Figure 5-13: FRET experiments to monitor positioning of Rad52 between two RPA
on a DNA. a) Model of stopped-flow mixing reaction. b) Representative traces show a
robust increase in FRET followed by slight decrease when RPA-Acy3 and RPA-Dcy5 in
one syringe is rapidly mixed with (dT)45 oligonucleotide in another syringe (orange
trace). High-FRET state is maintained upon mixing of preformed RPA-Acy3-Dcy5-(dT)45
with equimolar Rad52-wt (olive green trace) or in absence of Rad52 (grey trace). No
DNA (black trace) shows the base line FRET (low FRET) when RPA-Acy3 is mixed with
RPA-Dcy3, and FRET monitored.
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5.3.6 Rad52 selectively modifies the DNA binding dynamics of DBD-D on 5′
overhang DNA

In chapter 3, using single-molecule experiments, we showed that Rad52
selectively affected DNA binding events of RPA’s DBD-D but not DBD-A on a (dT)60
single-stranded DNA. This selective alteration in DBD dynamics was not visible when
similar binding reactions were performed on a stopped flow instrument with (dT)25
oligonucleotide (Fig. 5-14 a, b). Although stopped-flow reactions allow monitoring
reaction in a millisecond timescale, the bulk signal output does not have the resolution to
distinguish ongoing microscopic events, especially in situations where length of ssDNA
directly affects the experimental results. Our current findings pertaining RPA-DBD
dynamics in different DNA structures reveal requirement of a free 5′ end (5′ overhang)
for remodeling of DBD-A , further suggesting RPA-DBDs could adopt different binding
conformations when presented with ssDNA flanked by duplexes (chapter 4). While,
Rad52 cannot position itself between two RPAs, it is able to bind to both ssDNA and
dsDNA and could distinctly impact binding/dissociation/remodeling of both RPA-DBDs
in DNA with a 5′ overhang, 3′ overhang, or blocked end DNA. These ssDNA with
adjacent dsDNA are present in distinct cellular events like replication and recombination
and require RPA and Rad52 to function on a common DNA template. Therefore, to
determine if Rad52 distinctly affected RPA-DBD dynamics on ssDNA flanked by duplex
structures, we performed sequential stopped-flow experiments to monitor binding of
RPA-AMB543 or RPA-DMB543 to 5′ (dT)30 overhang or, 3′ (dT)30 overhang, or blocked end
(dT)30. RPA-AMB543 and RPA-DMB543 selectively report the DNA-binding dynamics of
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DBD-A and DBD-D, respectively, in a multi-protein reaction (Pokhrel et. al., 2017;
Pokhrel et. al., 2019).

a)

b)

Figure 5-14: RPA-DBD binding to (dT)25 in presence of Rad52-wt. Stopped-flow
experiments show a robust increase in MB543 fluorescence upon a) RPA-AMB543 or b)
RPA-DMB543 binding to (dT)25. Performing the same binding experiment in presence of
equimolar concentration of Rad52-wt shows quenching of MB543 fluorescence upon
RPA-AMB543 binding (compare pink trace and red trace), but no difference in MB543
fluorescence is observed for RPA-DMB543 binding to (dT)25 ssDNA (compare light green
trace and dark green trace).
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RPA-AMB543 produced a robust change in fluorescence upon binding with all three
DNA substrates and bound with a rate of 24 ±2.3 s-1 to 5ʹ (dT)30, 28.3 ± 2.1 s-1 to 3ʹ
(dT)30 and 22.4 ± 1.9 s-1 to blocked end (dT)30 (Fig. 5-15 a-c) DNA. However, premixing
RPA-AMB543 with Rad52-wt at 1:1 molar ratio and repeating the same binding reaction
reduced the overall amplitude of MB543 fluorescence without changing the rates of
DBD-A binding on all three DNA substrates (27.1 ± 15.0 s-1 for 5ʹ (dT)30, 28.5 ± 9.5 s-1
for 3ʹ (dT)30 and 20.7 ± 5.9 s-1 for blocked end (dT)30 DNA, respectively) (Fig 5-15 a-c).
Data obtained for all the experiments with RPA-AMB543 could be explained by a two-step
binding equation. Similar experiments performed with RPA-DMB543 in presence of
Rad52-wt, produced a robust increase in MB543 fluorescence upon binding to 3′ (dT)30
and blocked end (dT)30 DNA, with no significant changes in fluorescence intensity or
initial rates of binding (Fig. 5-15 e, f) (Table 5-3). However, in presence of Rad52-wt,
upon binding of RPA-DMB543 to a 5′ (dT)30, the initial increase in MB543 fluorescence
representing the initial engagement of DBD-D on 5′(dT)30 was followed by a decrease in
fluorescence. This suggests significant changes in the way DBD-D access/ binds to a
5′(dT)30 in presence of Rad52-wt, since no significant changes in rates of binding were
observed (Fig 5-15, d) (Table 5-3, 5-5). 5′ overhang is not a common substrate during
pre-synapsis phase of HR but occurs frequently under conditions of replication stress (Ait
Saada, Lambert, & Carr, 2018). Rad52 has been shown to facilitate restart of collapsed
replication forks (Sotiriou et. al., 2016; Yeeles, Poli, Marians, & Pasero, 2013) and
promote mitotic DNA synthesis following replication stress conditions (Bhowmick et. al.,
2016). This function of Rad52 is independent of Rad51 recombinase but likely involves
interaction with RPA, as RPA is recruited to these sites (Zou et. al., 2006b). Therefore,
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Rad52 mediated change in DBD-D binding on a 5′ overhang could be a unique
mechanism by which Rad52 interacts with the duplex junction and affects the DNA
binding states as well as conformations of DBD-D.
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a)

d)

b)

e)

c)

f)

Figure 5-15: DNA structure specific remodeling of RPA-DBD-D by Rad52-wt. a), b),
c) (Top) Schematic representation of the stopped-flow mixing reactions. RPA-AMB543 was
incubated with Rad52-wt and rapidly mixed with 5′ (dT)30 overhang, 3′ (dT)30 overhang
and blocked end (dT)30 DNA, respectively. (Bottom) Stopped-flow raw traces show
robust increase in MB543 fluorescence upon binding with DNA substrate alone (olive
green trace) or in presence of Rad52-wt (forest green trace). Reactions are shown for
binding with a) 5′ (dT)30 overhang b) 3′ (dT)30 overhang and c) blocked end (dT)30 DNA.
d), e), f) Similar binding reactions performed with RPA-DMB543 and 5′ (dT)30 overhang, 3′
(dT)30 overhang or blocked end (dT)30 DNA, respectively. Rad52 selectively modulates
binding of DBD-D on a 5′ (dT)30 DNA which is seen as decrease in fluorescence signal
(compare olive green trace in d) with forest green trace).
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5.3.7 Effects of Rad52 inner site and outer site binding mutant on RPA-DBD-DNA
engagement.

Rad52 prefers binding to single-stranded DNA and dramatically affects the
mechanism of DBD-D binding on a 5′ overhang DNA. Our PIFE experiments monitoring
polarity of Rad52 binding suggests cooperative binding between the inner and outer
binding site, where, the outer binding site first engages on the 5′ end of DNA, following
which DNA is threaded to the inner binding site. Therefore, we wanted to investigate if
cooperativity between the inner and outer binding site could be one of the several factors
contributing to selective remodeling of DBD-D particularly on a 5′ overhang DNA.
For the sake of clarity, from here onwards, Rad52 inner binding site mutant,
outer binding site mutant, transition site mutant and double site mutant are collectively
termed as ‘Rad52 variants’.
To this extent, we preformed the following complexes:100nM RPA-AMB543 and
Rad52-wt, 100nM RPA-AMB543 and Rad52 variants, 100nM RPA-DMB543 and Rad52-wt,
or 100nM RPA-DMB543 and Rad52 variants at 1:1 molar ratio. Then, we performed
sequential stopped flow reactions between the preformed complexes and 100nM (dT)30,
5′ (dT)30, 3′ (dT)30 or blocked end (dT)30 DNA, respectively (Fig. 5 -16- 5-21).
These reactions consist of unlabeled Rad52-wt or Rad52 variants precomplexed
with fluorescently labeled RPA-AMB543 or RPA-DMB543, and reacted against unlabeled
DNA substrates. This experimental strategy enables direct and selective monitoring of
DBD-A and DBD-D dynamics in all three DNA contexts, and effects of Rad52 in these
scenarios. For all reactions, RPA-AMB543 or RPA-DMB543 was excited at 535nm and
emission monitored with a 555nm long-pass filter. All the raw data obtained for RPA-
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AMB543 could be fitted with a double-exponential + a linear state model and data obtained
for RPA-DMB543 could be fitted using a single-exponential + a linear state model,
irrespective of the kind of Rad52 variant or the type of DNA substrate used in the
experiment. As a control, binding reactions performed between RPA-AMB543 and (dT)30
showed similar change in MB543 fluorescence both in the presence and absence or
Rad52-wt or Rad52 variants (Fig. 5-16 a). In addition, the rates of DBD-A binding to
(dT)30 i.e. kobs,1 (initial engagement, first step of binding), kobs,2 (second step of binding)
and kobs,3 (linear phase) remained unaffected in the presence of Rad52-wt or Rad52
variants (Fig. 5-16 c, 5-17 a, b) (Table 5-2, 5-4, 5-5). Similar experiments with RPADMB543 showed similar changes in MB543 fluorescence, both in the presence and absence
of Rad52-variants (Fig. 5-16 b). A slight decrease in RPA-DMB543 fluorescence was
observed when RPA-DMB543: Rad52-wt complex was reacted with (dT)30, with no
significant changes in the rates of binding (Fig. 5-16 b, d). Furthermore, the rates of
DBD-D binding to (dT)30 i.e. kobs,1 (initial engagement) and kobs,2 (linear phase) (Fig. 5-16
d, 5-17 c) (Table 5-3, 5-6) remained unaffected in the presence of Rad52 variants.
Interestingly, MB543 fluorescence was slightly quenched upon RPA-AMB543
binding to (dT)25 in presence of Rad52-wt (Fig. 5-14 a). Similar experiment with RPADMB543 showed no quenching of MB543 fluroescne upon binding to a (dT)25 in presence
of Rad52-wt (Fig. 5-14 b). In both these situations, presence of Rad52-wt did not change
the rates of DBD-A or DBD-D binding to (dT)25. Based on our site-size analysis, (dT)30
oligonucleotide offers an additional 8 nucleotides for RPA diffusion which could also be
utilized by Rad52 for initiating engagement on DNA. Therefore, it is possible that
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modulation of DBD-D binding by Rad52 requires both interaction with RPA-DBD-D and
engagement of some of Rad52 subunits, if not the entire heptamer, on DNA.

a)

c)

b)

d)

Figure 5-16: Effects of Rad52 on RPA-AMB543 and RPA-DMB543 binding to (dT)30. a)
RPA-AMB543 or b) RPA-DMB543 was preincubated with Rad52-wt or Rad52 variants and
rapidly mixed with (dT)30 oligonucleotide. In all the reactions, binding of DBD-A as seen
in a), or DBD-D as seen in b) produces a robust change in MB543 fluorescence which
can be quantified with appropriate kinetic equations (mentioned in methods) to obtain
initial rate of engagement (kobs,1) values plotted against individual Rad52 variants for c)
DBD-A and d) DBD-D of RPA.

221

a)

b)

c)

Figure 5-17: Quantification of rates of DBD-A and DBD-D binding to (dT)30 in
presence of Rad52-wt and Rad52 DNA binding mutants. a) Plot of the second
exponential or second step of binding (kobs,2), and b) linear phase (kobs,3) for RPA-DBD-A
binding to (dT)30 when complexed with Rad52-wt or Rad52 variants. c) Similar plot of
linear phase (kobs,2) of RPA-DMB543 binding to (dT)30 DNA.
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a)

c)

b)

d)

Figure 5-18: Cooperativity in Rad52 modulates RPA-DBD-D binding on a 5′ (dT)30
overhang DNA. RPA-DMB543 was preincubated with Rad52-wt or Rad52 variants and
rapidly mixed with 5′ (dT)30 DNA. In all the reactions, a) binding of DBD-A, or b) DBDD produces a robust change in MB543 fluorescence which can be quantified with
appropriate kinetic equations (mentioned in methods) to obtain initial rate of engagement
(kobs,1) values plotted against individual Rad52 variants for c) DBD-A and d) DBD-D of
RPA.
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a)

b)

c)

Figure 5-19: Quantification of rates of DBD-A and DBD-D binding to 5′ (dT)30 in
presence of Rad52-wt and DNA binding mutants. a) Plot of the second exponential or
second step of binding (kobs,2) and b) linear phase (kobs,3) of RPA-DBD-A binding to
5′(dT)30 DNA in presence of Rad52-wt or Rad52 variants. c) Similar plot of linear phase
(kobs,2) of RPA-DBD-D binding to 5′ (dT)30 DNA in presence of Rad52 variants.
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Next, we performed stopped flow experiments to monitor binding of RPA-AMB543
to 5′ (dT)30 DNA in presence or Rad52-wt or Rad52 variants. Raw stopped flow traces
show no differences in the intensity of MB543 fluorescence when RPA-AMB543 is
precomplexed with Rad52-wt or Rad52 variants (Fig. 5-18 a) and mixed with 5′(dT)30
DNA (Fig. 5-18 a). The rates of DBD-A binding to 5′ (dT)30 DNA was similar both in
presence and absence of Rad52-wt and Rad52 variants (Fig. 5-18 c; 5-19 a, b) (Table 5-2,
5-4, 5-5). However, on a 5′ (dT)30 DNA, RPA-DBD-D:Rad52-wt complex showed a
robust increase in MB543 fluorescence followed by a gradual decrease in fluorescence
signal, with no affects on the kobs values, suggesting affects in the DBD-D binding
dynamics (Fig. 5-18 b, compare forest green trace with all other traces). Similar reactions
monitoring RPA-DBD-D binding on a 5′ (dT)30 DNA, when RPA-DMB543 was
precomplexed with Rad52 variants showed no differences in MB543 fluorescence and
similar kobsvalues (Fig. 5-18 b, d, 5-19 c) (Table 5-3, 5-6). Taken together, these results
suggests that cooperativity between the inner and outer binding site in Rad52 selectively
affects RPA-DBD-D dynamics in a 5′ overhang DNA.
We also monitored engagement of both RPA-AMB543 and RPA-DMB543 on a 3′
(dT)30 overhang and blocked end (dT)30 DNA substrates, alone, or in complex with
Rad52-wt and Rad52 variants. Stopped flow reactions performed with RPA-DMB543:
Rad52-wt or RPA-DMB543:Rad52 variants versus 3′ (dT)30 DNA showed a similar degree
of increase in MB543 fluorescence with no significant differences in observed rates of
binding (kobs) values (Fig. 5-20 b, d, 5-21 c) (Table 5-3; 5-6). In the context of 3′
overhang DNA, DBD-A is situated close to the duplex junction which poses a structural
hindrance to dynamic binding of DBD-A. A varying degree of RPA-AMB543 fluorescence
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for each Rad52 variant was observed when rapidly mixed with 3′(dT)30 DNA (Fig 5-20
a). However, quantification of the raw data, as described in methods, revealed no
significant differences in the observed rates of binding (kobs) of DBD-A (Fig 5-20 c, 5-21
a, b) (Table 5-2, 5-4, 5-5). Rad52 physically interacts with OB-F and DBD-A of RPA.
Thus, differences in the degree of fluorescence but not in rates of binding on 3′ (dT)30
DNA could arise due to differences in protein-protein interactions between Rad52-wt and
Rad52 variants. Each Rad52 variant could differentially affect conformations of DBD-A
on DNA without significantly impacting its rate of binding.
Finally, similar experiments performed with blocked end (dT)30 showed no
significant differences in MB543 fluorescence of RPA-AMB543 or RPA-DMB543 in
presence of Rad52-wt or Rad52 variants (Fig 5-22 a, b). Quantification of the raw traces
with appropriate kinetic models showed no differences in the rates of DBD-A or DBD-D
binding (kobs) to blocked end (dT)30 DNA in presence Rad52-wt or Rad52 variants (Fig.
5-22 c, d; 5-23 a-c) (Table 5-2- 5-6). Taken together, our results show that Rad52-wt
selectively affects DBD-D dynamics on a 5′ overhang DNA which is not a primary HR
substrate, but is often found during DNA replication in the form of 5′ flap DNA (Burgers,
2011). Future implications involve selective and unique modifications of RPA-DBD
dynamics by RPA interacting proteins adapted to ongoing cellular event.
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a)

b)

c)

d)

Figure 5-20: Rad52-wt and Rad52 variants do not affect binding of RPA-AMB543 and
RPA-DMB543 to 3′ (dT)30 DNA. 100nM a) RPA-AMB543 or b) RPA-DMB543 was
preincubated with 100nM Rad52-wt or Rad52 variants and rapidly mixed with 100nM 3′
(dT)30 DNA. In all the reactions, binding of a) DBD-A, or b) DBD-D produces a robust
change in MB543 fluorescence which can be quantified with appropriate kinetic
equations (mentioned in methods) to obtain initial rate of engagement (kobs,1) values
plotted against individual Rad52 variants for c) DBD-A and d) DBD-D of RPA.
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a)

b)

c)

Figure 5-21: Quantification of rates of DBD-A and DBD-D binding to 3′ (dT)30 DNA
in presence of Rad52-wt and DNA binding mutants. a) Plot of the second exponential
or second step of binding (kobs,2), and b) linear phase (kobs,3) for RPA-DBD-A binding to
3′(dT)30 in presence of Rad52 variants. c) Similar plot of linear phase (kobs,2) of RPADBD-D binding to 3′ (dT)30 DNA in presence of Rad52 variants.
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a)

c)

b)

d)

Figure 5-22: Binding of RPA-DBD-A and RPA-DBD-D on block (dT)30 DNA in
presence of Rad52-wt and Rad52 variants. Representative traces showing significant
increase in MB543 fluorescence upon a) RPA-AMB543, b) RPA-DMB543 binding to block
end (dT)30 DNA in presence of Rad52-wt or Rad52 variants. Quantification of data as
described in the methods yields kobs,1 plot for c) RPA-AMB543 and d) RPA-DMB543,
respectively.
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a)

b)

c)

Figure 5-23: Quantification of rates of DBD-A and DBD-D binding to blocked end
(dT)30 in presence of Rad52-wt and Rad52 variants. a) Plot of the second exponential
or second step of binding (kobs,2), and b) linear phase (kobs,3) for RPA-DBD-A binding to
blocked end (dT)30 in presence of Rad52 variants. c) Similar plot of linear phase (kobs,2) of
RPA-DBD-D binding to blocked end (dT)30 DNA in presence of Rad52 variants.
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a)

b)

c)

d)

e)

f)

g)

h)

Figure 5-24: PIFE monitoring Rad52-wt binding on a 5′ 6-FAM (dT)40 and 3′ 6FAM (dT)40 DNA. As a control, stopped-flow reactions monitoring binding between a)
100nM 5′ 6-FAM (dT)40 with increasing concentrations of Rad52-wt show a
proportional decrease in 6-FAM fluorescence. Fitting the raw traces with doubleexponential + linear state model yields the plot of b) kobs,1 c) kobs,2 and d) kobs,3 for Rad52wt binding to 5′ 6-FAM (dT)40. e) same as in a) but performed with 3′ 6-FAM (dT)40.
Fitting the raw traces with double-exponential + linear state model yields the plot of f)
kobs,1 g) kobs,2 and h) kobs,3 for Rad52-wt binding to 3′ 6-FAM (dT)40.
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Table 5-1: Binding affinity (Kd) of Rad52-wt, outer site binding mutant
(Rad52R115A), inner binding site mutant (Rad52K134A), double mutant (Rad52R37A
K134A), transition site mutant (Rad52R37A)
Rad52

Kd (nM)

Wt

40.2 ± 3.3

R115A

38.6 ± 1.0

K134A

165.8 ± 13.7

R37A K134A 226.7 ± 41.0
R37A

92.8 ± 11.2
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Table 5-2: Initial rate of engagement (kobs,1) values for RPA-AMB543 binding to
various DNA substrates in presence of Rad52-wt and Rad52 variants.
RPA-AMB543

DNA
substrate
No
Rad52

Rad52 variants
wt

R37A

R115A

K134A

R37AK134A

(dT)30

35.5±0.8

45.1±1.4

34.6±1.5

35.2±1.1

36.7±1.7

38.7±0.3

5′ (dT)30

24.0±2.3

27.1±6.7

21.3±11.4 21.4±9.8

27.4±3.1

21.3±4.5

3′ (dT)30

28.2±2.1

28.5±4.3

25.6±2.4

27.1±2.2

42.0±10.6 26.7±3.5

Blocked
end
(dT)30

22.5±1.9

20.8±3.0

19.8±2.8

19.1±3.1

18.1±3.8

20.1±3.1
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Table 5-3: Initial rate of engagement (kobs,1) values for RPA-DMB543 binding to
various DNA substrates in presence of Rad52-wt and Rad52 variants

RPA-DMB543

DNA
substrate
No
Rad52

Rad52 variants
wt

R37A

R115A

K134A

R37AK134A

(dT)30

29.1±3.5

30.0±6.0

46.1±12.9 50.7±14.0 33.8±3.4

40.6±9.0

5′ (dT)30

24.4±2.1

25.4±3.5

22.1±1.8

23.0±2.0

24.1±4.0

24.8±3.0

3′ (dT)30

24.0±3.6

19.8±3.1

22.1±3.2

28.5±2.2

27.2±5.4

24.1±3.2

Blocked
end
(dT)30

21.2±5.2

20.7±4.1

31.4±3.7

19.0±2.0

22.7±1.0

20.7±1.3
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Table 5-4: Second exponential /second step of binding (kobs,2) values for RPA-AMB543
binding to various DNA substrates in presence of Rad52-wt and Rad52 variants.
RPA-AMB543

DNA
substrate
No
Rad52

Rad52 variants
wt

R37A

R115A

K134A

R37AK134A

(dT)30

3.6±0.8

3.4±1.4

4.2±1.5

3.9±1.1

2.4±1.7

5.5±0.3

5′ (dT)30

3.3±0.5

3.4±0.9

2.8±4.2

3.3±2.4

3.5±0.5

3.2±0.7

3′ (dT)30

4.0±0.2

3.0±0.6

3.2±1.1

3.1±0.9

5.4±2.3

3.4±1.3

Blocked
end
(dT)30

2.8±0.3

2.5±0.4

3.2±0.7

3.0±0.8

2.6±0.7

3.0±0.8
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Table 5-5: Linear phase (kobs,3) values for RPA-AMB543 binding to various DNA
substrates in presence of Rad52-wt and Rad52 binding variants

Note: All the kobs,3 values are in the order of 10-2, i.e. 1.9±1.1 is equal to 0.019±0.01.
RPA-AMB543

DNA
substrate
No
Rad52

Rad52 variants
wt

R37A

R115A

K134A

R37AK134A

(dT)30

1.9±1.1

2.8±2.0

3.0±2.1

3.0±2.0

4.0±3.0

3.0±2.3

5′ (dT)30

3.3±0.5

2.5±0.7

2.0±0.5

20.±0.5

3.0±1.7

2.8±0.7

3′ (dT)30

5.0±1.0

3.6±1.2

3.3±1.7

4.0±2.9

3.4±1.7

2.9±1.7

Blocked
end
(dT)30

2.9±0.5

4.3±1.0

3.1±1.2

3.2±1.2

3.7±1.2

3.3±1.2
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Table 5-6: Linear phase (kobs,2) values for RPA-DMB543 binding to various DNA
substrates in presence of Rad52-wt and Rad52 variants.
RPA-DMB543

DNA
substrate
No
Rad52

Rad52 variants
wt

R37A

R115A

K134A

R37AK134A

(dT)30

3.5±1.4

1.5±0.5

1.9±0.9

0.3±0.1

3.5±1.1

0.9±0.4

5′ (dT)30

1.4±0.4

5.7±2.8

1.2±0.4

3.9±1.6

1.5±0.5

2.1±0.6

3′ (dT)30

6.3±2.2

3.4±2

5.0±2.5

4.0±1.8

4.7±2.2

4.5±2.2

Blocked
end
(dT)30

2.4±1.0

0.8±0.4

2.8±1.1

0.8±0.2

2.0±0.5

1.7±0.9

Note: All the kobs,2 values are in the order of 10-3, i.e. 3.5±1.4 is equal to
0.0035±0.0014
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5.4 Discussion

The order of protein recruitment, positioning and accessibility to DNA
significantly regulates the process of DNA replication, recombination, repair, and
transcription. In this chapter we investigated the DNA binding kinetics of yeast Rad52
and assed its influence on the engagement of RPA-DBDs in-context of different DNA
structures. The myriad of processes required to maintain DNA structure and function
often deal with processing single-stranded DNA intermediates which are usually
protected by ssDNA binding proteins, which in-turn could pose to be steric hindrances
for enzymes attempting to access the same DNA space. How individual proteins
coordinate their turn to access the DNA in order to correctly process the DNA related
functions is still an ongoing mystery awaiting answers. In this study we attempted to
understand the interplay between two DNA interacting proteins, RPA and Rad52, which
often act on the same DNA substrate in multiple DNA pathways. During the process of
homologous recombination, Rad52 prevents facilitated exchange/ self-exchange of RPA
from DNA, meanwhile it also recruits the ATP dependent Rad51 recombinase which inturn displaces RPA from DNA (New et. al., 1998; Sugiyama & Kowalczykowski,
2002a). Studies have also shown that while Rad52 itself does not displace RPA from
DNA, it enhances the ATP hydrolysis activity of Rad51 which leads to faster
displacement of RPA (Sugiyama & Kowalczykowski, 2002a). Apart from its mediator
function with Rad51, Rad52 has been shown to directly anneal homologous ssDNA
strands or RPA-ssDNA complexes which encompasses homology (Brouwer et. al., 2017;
Nimonkar et. al., 2009). Interaction between RPA-Rad52 yields unique outcomes based
on the DNA-context and cellular pathways, yet, fundamentals underlying how similar
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interaction results in unique functions was not well understood. To this extent, first we
investigated the ssDNA binding properties of yeast Rad52 and found that Rad52 bound to
ssDNA with relatively high affinity (Fig. 5-2 f) and this binding was not affected by
increasing salt concentrations (Fig 5-2 c, d). Using tryptophan quenching as signal readout we determined the pre-steady state binding kinetics of Rad52 on ssDNA and showed
that Rad52 bound rapidly to ssDNA (Fig 5-3 a-f).
Rad52 forms a heptameric ring with a central pore, where the ssDNA is wrapped
around the ring structure (Fig. 5-5 a) rather than being threaded through the pore which
usually occurs in other hexameric ATPases (Saotome et. al., 2016, 2018; A Shinohara et.
al., 1998). ssDNA bound crystal structure of truncated hRad52, that does not include the
C-terminus of the protein shows an undecamer with two distinct ways of associating with
single-stranded DNA. First includes a structure a with ssDNA wrapped around the
undecamer when the outer binding site is mutated, and the second includes ssDNA
sandwiched between two undecamer when the inner binding site is mutated (Fig. 5-5, 5-6
a, b, respectively). Based on additional biochemical analysis, a cooperative binding
between the inner and outer-binding site was performed (Saotome et. al., 2018). Our
PIFE analysis monitoring the binding of Sc. Rad52 with 5′Cy3 labeled or 3′ Cy3 labeled
ssDNA shows a cooperative binding mechanism between the inner and outer binding
sites which follows a 5′-3′ directionality (Fig. 5-4 a-c), as mutating key amino acid
residues in either the inner or the outer binding site completely abolishes the observed
cooperativity (Fig. 5-8- 5-10, b, f) . Furthermore, mutations in either inner or outer
binding site rapidly increases the initial rate at which Rad52 binds to ssDNA independent
of Rad52 concentration (Fig. 5-8- 5-10, b, f). Single molecule experiments monitoring
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hRad52-ssDNA binding showed that hRad52 wrapped ssDNA around its structure when
ssDNA was in excess. However, during the conditions of excess hRad52, multiple
hRad52 bound to a single ssDNA (Grimme et. al., 2010). Taken together, these results
suggest communication between the outer and inner binding sites play a critical role in
defining the path and the rate at which DNA threads around a single Rad52, or DNA is
occupied by multiple Rad52, or several DNA is occupied by a Rad52 (Fig. 5-12).
Although Rad52 exists as a heptamer in solution, several studies monitoring Rad52ssDNA binding have reported changes in the number of protomers present in the
heptamer resulting in a ‘horse-shoe shaped’ structure (Deng et. al., 2009). There is a
distinct possibility that Rad52 heptameric ring ‘opens up’ upon interaction with ssDNA
and mutating amino acid residues important for ssDNA interaction alters the way ssDNA
is engaged. These mutations could also induce a different conformational change in
Rad52, which is seen as loss of cooperativity at the 5′ end along with increased rates of
ssDNA binding at sub-stoichiometric Rad52 concentrations in our PIFE experiments.
Since, the C-terminal end of Rad52 has been implicated in mediating DNA annealing and
all our experiments have been performed with full-length yeast Rad52 (Kagawa et. al.,
2014; Yan et. al., 2019), we used end labeled poly(dT)40 to avoid any annealing
situations. Thus, our PIFE observations are relevant to ssDNA binding and not Rad52
mediated DNA annealing.
RPA and Rad52 function together in several different DNA pathways. In chapter
3, we showed that despite its ability to interact with both DBD-A and DBD-D of RPA,
Rad52 selectively altered the DNA binding state of DBD-D but not DBD-A on a ssDNA
(Nilisha Pokhrel et. al., 2019). However, in native conditions RPA and Rad52 undergo
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interactions along long stretches of ssDNA which are presented in the form of overhangs,
or ssDNA with DNA duplexes present in both the ends. Furthermore, in a situation where
ssDNA is occupied by multiple RPAs, whether Rad52 can access DNA between RPAs or
if it requires access at the terminal ends of DNA is important towards understanding the
functioning of these proteins. Therefore, to ascertain positioning of Rad52 when ssDNA
is occupied by multiples RPAs, we performed RPA-FRET assays in presence of Rad52
and showed that Rad52 is unable to position itself in between two RPAs. Therefore,
Rad52 would require access toward the 5′ or 3′ ends of DNA (Fig. 5-13 b). Our data is
consistent with previous finding where access to either DNA termini was required for
Rad52-ssDNA engagement even in the absence of RPA (Parsons, Baumann, Van Dyck,
& West, 2000). Finally, we compared how binding of DBD-A and DBD-D to a 5′
overhang, 3′ overhang and blocked end DNA substrate is affected in presence of Rad52.
Our study is unique in that we provide both RPA and Rad52 with an equal opportunity to
bind to the DNA substrates rather than reacting Rad52 with a pre-formed RPA-DNA
complex. We show that Rad52 selectively modulates the DNA binding dynamics of
DBD-D on a 5′ overhang DNA (Fig. 5-15 d) without affecting the rate at which DBD-D
engages on DNA (Table 5-3, 5-6). Furthermore, cooperativity between the inner and
outer binding sites in Rad52 is required for this modulation of DBD-D dynamics (Fig. 518 b). Our studies provide critical insights into yeast Rad52-ssDNA behavior and unique
modulation of DBD-D dynamics only on a 5′ DNA with future implications pertaining to
RPA-Rad52 functioning in DNA related process other than homologous recombination
mediated DNA repair.
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CHAPTER 6: POST-TRANSLATIONAL MODIFICATION OF RPA
MODULATES RPA-DBD DYNAMICS, ASSEMBLY AND FUNCTIONING

6.1 Introduction

Post translational modifications (PTM) is a common, yet, robust mechanism of
tailoring protein functions and activities in a specific pathway. Replication Protein A
(RPA), the most ubiquitous single-stranded DNA (ssDNA) binding protein in eukaryotes
is extensively modified via phosphorylation, ubiquitination, SUMOylation (small
ubiquitin- related modifier) etc. in a cell-cycle dependent manner or during stress
conditions (Chung & Zhao, 2015; Dou, Huang, Singh, Carpenter, & Yeh, 2010; Dubois
et. al., 2017; Hedglin, Aitha, Pedley, & Benkovic, 2019). In human RPA, the first 40
amino acids (aa) in the N-terminus of RPA32 consists of 9 serines (6 in S. cerevisiae) and
1 threonine (6 in S. cerevisiae) that undergo phosphorylation in accordance with cellcycle checkpoint and during DNA damage. These serines and threonines are
phosphorylated by members of PIKK (phosphatidylinositol-3-kinase-like kinases) family
such as ATM (Ataxia telangiectasia mutated), ATR (Ataxia telangiectasia mutated and
Rad3 related), DNA-PK, and cyclin-dependent kinase (Cdk) family such as Cdk-1/
Cyclin B and Cdk-2/ Cyclin-A; reviewed in (Anantha & Borowiec, 2009; Binz, Sheehan,
& Wold, 2004b; Byrne & Oakley, 2019; Maréchal & Zou, 2015; Oakley & Patrick,
2010). Since these phosphorylation events are tightly coupled with cell-cycle regulation,
deregulation of phosphorylation can have severe outcomes like oncogenesis.
In budding yeast, the Mec1-Ddc2 complex is homologous to the human ATRATRIP complex which initiates cell cycle checkpoint response upon DNA damage or
during replication stalling (Bartrand et. al., 2004; Gangavarapu, Maria, Prakash, &
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Prakash, 2011; Kondo, Wakayama, Naiki, Matsumoto, & Sugimoto, 2001; Pfander &
Diffley, 2011; Tercero & Diffley, 2001). RPA is one of the several Mec1-Ddc2 targets
that gets phosphorylated during DNA damage in order to trigger the DNA damage
response (DDR). DDR then recruits appropriate repair factors at the sites of DNA
damage to repair the damage and ensure cell viability.
Since Mec1 itself cannot interact with RPA, it uses the the coiled-coiled region in
Ddc2 (ccDdc2) as a handle to interact with RPA and phosphorylate specific sites in
RPA70 and RPA32 subunits (Biswas et. al., 2019; Brush et. al., 1996; Deshpande et. al.,
2017; Majka & Burgers, 2007) (Fig. 6-1 a). The crystal structure of ccDdc2 in complex
with the N-terminal protein interaction domain in RPA70 (ccDdc2-PID70N complex)
shows a homodimeric ccDdc2, where each ccDdc2 monomer interacts with one PID70N
(Deshpande et. al., 2017) (Fig. 6-1 a). In humans, similar coiled-coiled region in ATRIP
(homolog of Ddc2) also mediates interaction between RPA and ATR (Ball & Cortez,
2005).
Apart from ccDdc2-PID70N cystal structure showing a dimeric ccDdc2, where,
each ccDdc2 is interacting with PID70N, the stoichiometry of full length RPA-Mec1-Ddc2
complex with or without DNA has not been determined. Recent experiments monitoring
Mec1 kinase activation in presence of RPA and Ddc2 showed an increase in kinase
activity at sub-stoichiometric concentrations of RPA and on longer DNA. However,
excess RPA attenuated the Mec1 kinase activity (Bartrand et. al., 2004; Biswas et. al.,
2019) . This suggests an RPA concentration driven feedback mechanism of Mec1 kinase
activity, where, phosphorylation of RPA by Mec1 kinase is dependent on the recruitment
of Mec1 by Ddc2 and the effects of kinase activity are regulated by extent of RPA
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phosphorylation, concentration of RPA and length of ssDNA available. A prime target of
Mec1 phosphorylation in RPA is serine 178 (S178) which is located near lysine 170
(K170). S178 is phosphorylated by Mec1, while, S170 gets SUMOylated in response to
DNA damage (Bartrand et. al., 2004; Bastos de Oliveira et. al., 2015; Brush et. al., 1996;
Psakhye & Jentsch, 2012) . Mass proteomics studies have found an ATM-ATR mediated
global regulation of SUMOylation levels in member proteins upon replication stress
(Munk et. al., 2017). These findings suggest significant crosstalk between
phosphorylation and SUMOylation in regulating the ATR-ATRIP (or Mec1-Ddc2)
pathway, with RPA being at the center of this crosstalk.
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a)

b)

Figure 6-1: RPA-PID70N-Mec1-Ddc2 interaction. a) Structure of PID70N-ccDdc2ATM-ATR (Sc. Mec1-Ddc2) complex. The crystal structure of PID70N-ccDdcc2 complex
(PDB: 5OMC) showing RPA-PID70N (magenta) and coiled-coiled region of Ddc2 (pale
pink cartoon helices). The ccDdc2 region could be connecting rest of the Ddc2-Mec1
complex via flexible linkers (dashed grey line). The human homolog of Mec1-Ddc2
complex is ATR-ATRIP which is shown as red and pale pink surface diagrams,
respectively (PDB: 5X6O). b) Surface representation of RPA-DNA complex showing
position of Serine 178 (red sphere) located in between PID70N (pale pink) and DBD-A
(hot pink). DBDs A (hot pink), B (orange), C (yellow) are connected by flexible linkers
shown in dashed black lines. DBD-D (green) has an N-terminal phosphorylation domain
(dashed red line) and is connected via flexible linker (black dashed line) to C-terminus
protein interaction domain (PID32C). A representative structure of ssDNA flanked by
duplex DNA is shown in light orange.
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In this chapter, we utilized mutagenesis, fluorescent enhancement using noncanonical amino acids (FencAA), and ensemble FRET to investigate how
phosphorylation of S178 affected RPA-DBD dynamics and assembly. To investigate the
effects of phsophorylation, we generated a phosphomimic RPA, where, serine at position
178 was mutated to aspartate (RPA-S178D) (Fig 6-1 b).
Our results show unique conformational changes in RPA-S178D-DNA
engagement with assembly of multiple RPA-S178D on longer DNA exhibiting
cooperative binding. The RPA-S178D nucleoprotein filament is comparatively resistant
to displacement by Srs2 helicase but is sensitive to the activity of S1 endonuclease.

6.2 Materials and Methods

6.2.1 Plasmids for protein purification

6.2.1.1 4AZP incorporating plasmids

His- tag carrying RPA-A4AZP and RPA-D4AZP (chapter 3, section 3.2.3) were used
as templates to generate the RPA-phosphomimic constructs: RPA-S178D- DBD-A4AZP
(RPA-S178D-A4AZP) and RPA-S178D-DBD-D 4AZP(RPA-S178D-D4AZP)

6.2.1.2 Non 4AZP incorporating plasmids

Sc. RPA70-RPA32-his-RPA14 was used as a template to generate Sc. RPAS178D. For all the experiments, purified Sc. RPA70-RPA32-his-RPA14 was used as
RPA-wt control.
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6.2.2 Purification of 4AZP carrying RPA variants

The RPA-S178D-A4AZP or RPA-S178D-D4AZP were co-transformed with pDule2pCNF plasmid in Rossetta-2 PlysS cells and were purified as described in section 3.2.4 of
chapter 3.

6.2.3 Labeling proteins with fluorophores

RPA DBD-A or DBD-D variants carrying 4AZP were labeled with MB543, Cy3
or Cy5 as described. Approximately, 3 ml of (10 μM) RPA4AZP was incubated on a rocker
with 1.5-fold molar excess (15 μM) of either DBCO-MB543, DBCO-Cy3 or DBCO-Cy5
for 2 hours at 4 oC. Labeled RPA variants were separated from excess dye using a BiogelP4 gel filtration column (65 ml bed volume) using storage buffer (30 mM HEPES, pH 7.8,
100 mM KCl, 0.1mM EDTA, pH 8.0 and 10% (v/v) glycerol). Fractions containing labeled
RPA were pooled, concentrated using a 30 kDa cut-off spin concentrator and flash frozen
using liquid nitrogen. Fluorescent RPA were stored at -80 oC. Labeling efficiency was
calculated using absorption values measured at 280 nm and ε280= 98500 M-1cm-1for RPA,
at 543 nm with ε543= 105,000 M-1cm-1 for DBCO-MB543, ε555= 150,000 M-1cm-1 for
DBCO-Cy3 and at 650 nm with ε650= 250,000 M-1cm-1 for DBCO-Cy5 fluorophores. A
correction factor was applied to the final concentration protein as described in the methods
section of chapter 2.
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6.2.4 Purification of non-4AZP carrying variants

Individual plasmids (Sc. RPA70-RPA32-his-RPA14 or Sc. RPA-S178D were
transformed in Rossetta-2 PlysS cells, plated in LB agarampicillin R plates and incubated
overnight at 37oC. At around 6 pm, individual 2.8l baffle flask (4 flasks in total), each
containing autoclaved 1l LB medium supplemented with 100g/ml ampicillin, was
inoculated with a single transformed colony and incubated overnight at 37oC, without
agitation. Next morning, measurements for OD600 were collected, and the flasks were
shaken at 250 rpm, at 37oC. At OD600: 0.5-0.8, cells were induced with 0.4mM IPTG and
grown for an additional 3 hours at 37oC, 250rpm. Cells were harvested, and purification
was done following the same steps as for 4AZP carrying variants mentioned in section
3.2.4 of chapter 3, with the following modifications. All the buffers (cell resuspension
buffer, H0, H50, H100, H1000, H1500) were supplemented with 1mM tecep-HCl and RPA
storage buffer was supplemented with 2mM tecep-HCl.
Sc. Srs2 was purified as described previously (Antony et. al., 2009a).

6.2.5 Fluorimeter measurements

Tryptophan quenching experiments were performed using a PTI QM40
instrument (Horiba Scientific, Edison, NJ). To determine the emission maxima, a 2ml
reaction with 50nM RPA-wt or RPA-S178D in reaction buffer (30 mM Hepes, pH 7.8, 100
mM KCl, 5 mM MgCl2, 1 mM β-mercaptoethanol and 6 % v/v glycerol) was excited at
290 nm and emission spectra (310nm-350nm) recorded. Following determination of
emission maximum, increasing concentration of (dT)35 oligonucleotide was added to the
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2ml reaction, excited at 290nm and emission recorded for 10 seconds at emi (max).
Fluorescence measurements were normalized, plotted against [(dT)35] and fit using
single- step binding isotherm to determine the Kd values. All experiments were
performed at 25 °C.

6.2.6 Stopped-flow analysis

All stopped-flow measurements were carried out with an Applied Photophysics
SX20 instrument (Surrey, UK) at 25oC. Reactions were performed in buffer (30 mM
Hepes, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM β-mercaptoethanol and 6 % v/v
glycerol). It is important to note that the concentrations of reactants are reduced to half
upon mixing in the stopped-flow instrument. Thus, all the concentrations mentioned
below are post-mixing concentrations.

6.2.6.1 Tryptophan quenching experiments

To determine the rate of association of S178D, 100nM RPA variants (Sc.
RPA70-RPA32-his-RPA14 or Sc. RPA-S178D-D4AZP) in one syringe were rapidly mixed
with increasing concentrations (25, 50, 75, 100, 150, 200nM) of (dT)35 in another
syringe. Optical parameters of exci: 290nm and long pass cut-off emission filter with
emi: 350nm were used to monitor change in tryptophan fluorescence. In total 10000 data
points were collected over a period of 2.25 seconds (5000 data points for first 250
milliseconds+ 5000 data points for rest 2 seconds). Raw traces obtained were fit in
KaleidaGraph using the equation:

250
ΔF = A1 (1 - e-k1t) + k2t

(Eq. 1)

Where, ΔF is change in tryptophan fluorescence, A1 and k1 are the amplitude and
observed rate of the exponential phase, k2 is the steady state rate and t is time.
The values for kobs,1 and kobs,2 were plotted against the concentration of (dT)35. A linear fit
equation:
y = mx + c

(Eq.3)

Where ‘m’, the slope represents the observed association constant (Ka) and ‘c’, the
constant represents the rate of dissociation (koff) was used to determine RPA-DBD-DNA
binding characteristics. Observed dissociation constant (Kd) values were calculated using
reciprocal of Ka i.e. Kd= 1÷ Ka.

6.2.6.2 ssDNA binding kinetics of RPA-S178D-DBDs

The rate of association of DBD-A and DBD were measured using RPA- S178DAMB543 and RPA-S178D-DMB543, respectively. 50nM RPA-S178D-AMB543 or RPAS178D-DMB543 was rapidly mixed with increasing concentrations (10, 20, 50, 75, 100nM)
of (dT)35 oligonucleotide and increase in fluorescence signal monitored by exciting the
sample at exci: 535nm and measuring emission using a long pass cut-off filter at emi:
555nm. In total 10000 data points were collected over a period of 2.25 seconds (5000
data points for first 250 milliseconds+ 5000 data points for rest 2 seconds). Raw traces
obtained for DBD-A binding were fit using equation:
ΔF = A1(1 - e-k1t) + A2(1 - e-k2t) + k3t

(Eq. 2)
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Where, ΔF is change in fluorescence of AMB543, A1 and k1 are the amplitude and
observed rate of the first exponential phase, A2 and k2 are the amplitude and observed rate
of the second exponential phase, k3 is the steady state rate and t is time.
The raw data traces obtained for DBD-D binding were fit using Eq.1. The rates
obtained for first exponential phase (kobs,1), second exponential phase (kobs,2) and steady
state were plotted against (dT)35 concentrations. Note: For DBD-D, kobs,2 values represent
steady state as there is no second exponential phase.

6.2.6.3 FRET analysis to monitor the binding of two RPA molecules

All samples were excited at 555nm and FRET was monitored with a 645nm cutoff emission filter. For FRET experiments with increasing lengths of oligonucleotides
(dT)n, where (n= 20, 35, 45, 60, 70, 79, 97, 140), 40nM RPA-Acy3or RPA-S178D-Acy3
paired with 40nM RPA-Dcy5 or RPA-S178D-Dcy5 was rapidly mixed with 40nM (dT)n
and FRET monitored. Resulting FRET was analyzed using Eq. 2 for all the
oligonucleotides, except (dT)140, which was analyzed using Eq.1 to obtain the observed
rates.

6.2.6.4 Facilitated Exchange

Facilitated exchange experiments were performed with 150nM RPA-S178DDMB543 bound to 50nM (dT)60 or 100nM RPA-S178D-AMB543/ RPA-S178D-DMB543 bound
to 30nM (dT)97 and challenged with increasing concentrations of RPA-wt. Samples were
excited at exci: 535nm and change in signal monitored with a emi:555nm cut-off
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emission filter. In total 10000 data points were collected over a period of 2.25 seconds
(5000 data points for first 250 milliseconds+ 5000 data points for rest 2 seconds). Data
obtained for RPA-S178D-DMB543 facilitated exchange was analyzed using Eq.1 and for
RPA-S178D-AMB543 was analyzed using Eq.2. The kobs values obtained were plotted
against RPA-wt concentrations and fit using Eq.3.

6.2.7 Limited proteolysis

5g of RPA-wt or RPA-S178D were treated with 50ng of trypsin or chymotrypsin
(1:100 dilution) in 20l reaction mixture containing 30mM Hepes, pH 7.8, 1mM EDTA,
pH 8.0, 8mM Tecep-HCl; 60mM MgCl2 with or without equal concentrations of (dT)35
oligonucleotide. All the reactions were carried out at 30oC. Unless specified, after 1 hour
of incubation, the reactions were terminated by adding equal volume of 2X SDS-loading
dye and boiling for 15 minutes. 35l of the total sample (reaction mixture+ dye) was
loaded on a 12% SDS-PAGE gel and the proteolyzed products separated by
electrophoresis. The gel was stained with Coomassie brilliant blue followed by de-stain
treatment to remove excess Coomassie blue stain. The resulting bands were compared
with protein ladder as a reference.

6.2.8 Single-molecule TIRFM experiments

Single molecule TIRFM experiments to monitor DBD dynamics of RPA-S178DDBD-AMB543 and RPA-S178D-DBD-DMB543 was performed as described in section 3.2.16
of chapter 3 and (Nilisha Pokhrel et. al., 2019). Single-molecule TIRFM experiments
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were performed by Colleen Caldwell in the lab of Dr. Maria Spies, University of Iowa,
IA.

6.3 Results

6.3.1 Mutations in the linker region connecting PID70N and zinc finger alters the
DNA bound conformation of RPA

Steady-state state tryptophan quenching experiments have been used to determine
the affinity of protein-substrate interactions (Beattie & Merrill, 1999; Kozlov, Galletto, &
Lohman, 2012; “Protein Fluorescence,” 2006; Tworzydło, Polit, Mikołajczak, &
Wasylewski, 2005). Each DBD of RPA consists of at least one tryptophan whose
fluorescence is quenched upon engagement with DNA. Since the change in tryptophan
fluorescence is intrinsic to RPA, it provides with a robust platform to monitor DBDssDNA engagement and determine binding affinity for RPA-DNA interactions (Kumaran
et. al., 2006). In addition to providing kinetic information, tryptophan quenching can be
used as an initial method of monitoring summation of global conformations that could be
present during RPA-DBD-DNA engagement. Therefore, we performed steady-state
tryptophan quenching experiments with fixed concentrations of RPA-S178D and titrated
increasing concentrations of either (dT)35 or (dT)97 oligonucleotides. A robust increase in
tryptophan quenching was observed with increasing concentrations of oligonucleotides of
both lengths, until saturation. Surprisingly, net amplitude of tryptophan quenching upon
DNA engagement for RPA-S178D was half of RPA-wt, although, binding stoichiometry
of RPA: DNA was maintained at 1:1 (Fig 6-2 a, b). 50nM RPA-S178D or RPA-wt
displayed 1:1 binding at 50nM (dT)35 (Fig 6-2 a) and 100nM RPA-S178D or RPA-wt
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binding was saturated at 18nM (dT)97 (Fig 6-2 b). Under our experimental conditions,
RPA requires 22-nt to stably engage all the DBDs, such that (dT)35 would enable stable
binding of one RPA and (dT)97 would provide binding site for at least four RPA. Taken
together, similar DNA binding stoichiometry of RPA-wt and RPA-S178D in both lengths
of DNA suggests that bind to DNA with similar affinity. However, the ‘half tryptophan
quenching’ in RPA-S178D DNA engagement would suggest that the conformations
adopted by DBDs in mutational background is different than RPA-wt. Perhaps, the DBDs
are more restricted in their conformational freedom which would inhibit exposure of
tryptophan to polar environment as the DBDs engage with DNA resulting in less
quenching of tryptophan signal. Another possibility is that only half of the total number
of DBDs engage the ssDNA for RPA-S178D.
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a

b

Figure 6-2: Steady-state tryptophan quenching experiments to determine binding
affinity. Comparative tryptophan quenching experiments performed with a) 50nM RPAwt or RPA-S178D in presence of (dT)35 or b) 100nM RPA-wt or RPA-S178D in presence
of (dT)97 show both the variants have 1:1 binding to oligonucleotides, yet, the net
amplitude of tryptophan quenching for RPA-S178D is half that of RPA-wt.
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To better understand the 50% loss in fluorescence we performed stopped-flow
measurements by rapidly mixing 100nM RPA-S178D with increasing concentrations of
(dT)35 and compared the observed rates (kobs) with RPA-wt. Our results show that at
25nM (dT)35 both RPA-S178D and RPA-wt bind to ssDNA with similar rate (kobs1= 36.8
± 20.5 s-1 for RPA-S178D and kobs,1= 37 ± 2 for RPA-wt) (Fig. 6-3 a, c). Furthermore,
both the variants had similar overall kon and koff for binding to ssDNA (RPA-S178D: kon=
4.7± 0.2 M-1s-1, koff = 23±7s-1; RPA-wt: kon= 5.2± 0.3 x M-1s-1, koff = 23 ± 7s-1 ) generating
similar Kd values (Kd for RPA-wt: 17.3 ± 4 nM; Kd for RPA-S178D: 38.5 ± 12.8 nM)
(Fig. 6-3 c). Yet, the ‘half-tryptophan quenching’ was observed for RPA-S178D even
during pre-steady state experiments (Fig. 6-3 a, b).
Finally, we performed limited proteolysis of RPA-S178D in presence and absence
of equimolar concentrations of (dT)35 to validate the difference in conformational
arrangement between RPA-wt and RPA-S178D. If both the variants have similar domain
arrangement on DNA, the patterning and size of the bands upon SDS-PAGE analysis
would be similar. As excepted, RPA-wt was more resistant to proteolytic cleavage by
both trypsin and chymotrypsin in the presence of ssDNA (Fig. 6-4 a, c). Although, in
absence of DNA, peptide fragments generated by chymotrypsin digestion of RPA-S178D
were similar to RPA-wt (Fig. 6-4 c, d, -DNA lanes), they both showed different peptide
fragments in presence of DNA (Fig. 6-4, c, d, +DNA lane). Furthermore, peptides
fragments generated by trypsin treatment of RPA-wt and RPA-S178D were distinct from
each other both in presence and absence of DNA (Fig 6-4 a, b). Taken together, these
experiments confirm that RPA-S178D maintains the same rate and affinity for binding to
DNA as RPA-wt and the ‘half- tryptophan quenching’ observed in RPA-S178D stems
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from change in conformational arrangement of one or several DBDs within a single RPA
or between multiple RPAs on DNA and is not due to change in ability of RPA-S178D to
engage on ssDNA.
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a)

c)

b)

d)

Figure 6-3: Pre-steady state binding kinetics of RPA-S178D. Stopped-flow instrument
was used to rapidly mix increasing concentrations of (dT)35 with 100nM RPA-S178D. a)
Representative raw traces of the tryptophan quenching experiments. b) Plot of net
amplitude of tryptophan quenching for RPA-wt and RPA-S178D plotted against (dT)35
concentrations. Fitting of raw traces in a) as described in the methods result in c) plot of
kobs,1 d) kobs,2 as a function of increasing concentrations of (dT)35 where the kobs,1 and kobs2
values are fit using a linear equation to obtain kon and koff parameters.
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a)

b)

c)

d)

Figure 6-4: Time based limited- proteolysis analysis of RPA-wt and RPA-S178D.
RPA-wt or RPA-S178D were digested with trypsin and chymotrypsin in presence or
absence of DNA for specified time-periods and resulting peptides analyzed on 12% SDSPAGE gel. Time-based tryptic digestion of a) RPA- wt b) RPA-S178D. Presence of more
peptide bands for RPA-S178D both in presence and absence of DNA suggests that it is
more sensitive to tryptic digestion than RPA-wt, probably due to difference site
accessibility. Similar experiment with chymotrypsin digestion of c) RPA-wt d) RPAS178D show slightly higher degree of degradation for RPA-S178D both in presence and
absence of DNA.
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6.3.2 RPA-S178D has altered DBD dynamics

The four DBDs in RPA bind in tandem to enable high affinity RPA-DNA
association. Since RPA-S178D had ‘half- tryptophan’ quenching which suggested
engagement of some but not all DBDs, next we wanted to investigate the binding
dynamics of DBD-A and DBD-D in RPA-S178D. Our studies with RPA-wt DBD-A and
DBD-D have shown that DBD-A binds rapidly to ssDNA but can be remodeled by its
own trimerization core under sub-stoichiometric concentrations of ssDNA or shorter
lengths of ssDNA (Pokhrel et. al., 2019). Using same strategy of incorporating ncAAs
followed by click- chemistry based fluorescent labeling, we generated fluorescently
labeled phosphomimic RPA-S178D-AMB543 and RPA-S178D-DMB543 with fluorophores
incorporated at DBD-A and DBD-D respectively. Stopped-flow experiments performed
with increasing concentrations of (dT)35 and RPA-S178D-AMB543 showed a robust
increase in fluorescence signal upon binding to ssDNA (Fig. 6-5 a). For RPA-S178D,
DBD-A had DNA binding dynamics similar to RPA-wt with rapid initial engagement
followed by remodeling phase. Data obtained for DBD-A engagement followed the twostep binding model, where the rates for first- step (kobs,1, engagement phase) increased
linearly with increase in (dT)35 oligonucleotide concentrations (Fig. 6-5 b) and the rates
for second-step (kobs,2, rearrangement phase) showed a subsequent decrease under substoichiometric concentrations of (dT)35, followed by increase after 50nM (dT)35 (Fig. 6-5
c). The kon values obtained from linear fit of kobs,1 was 1.4 x 108 M-1s-1 for RPA-S178DAMB543 which is similar to RPA-AMB543 with kon of 1.1 ± 0.6 x 108 M-1s-1 .
Interestingly, similar experiments performed with RPA-S178D-DMB543 showed
differential binding dynamics for DBD-D (Fig 6-6 a, b). Consistent with RPA-DMB543,
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RPA-S178D-DBD-D engagement to ssDNA could be best described with a one-step
binding model, where, kobs,1 increased linearly with increasing concentrations of (dT)35
(Fig 6-6 b) with a kon of 1.15 x 108 M-1s-1 .However, at higher concentrations of (dT)35
RPA-S178D-DBD-D showed a decrease in fluorescence signal immediately after the
initial increase, suggesting a remodeling step (Fig. 6-6 a, blue and red traces). This
remodeling of DBD-D is not observed with RPA-wt-DBD-D and depicts a novel
phosphorylation induced change in DBD-dynamics of RPA.

262

a)

c)

b)

d)

Figue 6-5: Monitoring DBD-A binding dynamics of RPA-S178D. Stopped-flow
experiments were performed by rapidly mixing 50nM RPA-S178D-AMB543 with
increasing concentrations of (dT)35 with excitation at 535nm and robust change in MB543
fluorescence monitored using a 555nm long pass emission filter. a) Representative traces
showing change in RPA-S178D-AMB543 with increasing concentrations of (dT)35.
Individual traces were fit with double exponential + linear phase equation to obtain b)
plot of kobs,1 (initial binding) c) kobs,2 (rearrangement) d) kobs,3 linear phase along
increasing concentrations of (dT)35 plotted along X-axis.
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a)

b)

c)

Figure 6-6: Monitoring DBD-D binding dynamics of RPA-S178D. Stopped-flow
experiments were performed by rapidly mixing 50nM RPA-S178D-DMB543 with
increasing concentrations of (dT)35. Samples were excited at 535nm and robust change
in MB543 fluorescence was monitored using a 555nm long pass emission filter. a)
Representative traces showing change in RPA-S178D-DMB543 with increasing
concentrations of (dT)35. Individual traces were fit with single exponential + linear phase
equation to b) plot of kobs,1 values and c) kobs,2 plotted on Y-axis along increasing
concentrations of (dT)35 plotted along X-axis.
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6.3.3 S178D selectively alters the DNA binding states of DBD-A

Our studies investigating the micro-dissociation states RPA revealed four distinct
states of binding for DBD-A and DBD-D on DNA. These four states could be four
distinct DBD driven conformations, as FAB, which has two DBDs showed two distinct
states of binding on DNA (Pokhrel et. al., 2019). To probe if S178D had effects on the
DNA binding states of RPA, we performed single- molecule TIRF analysis with RPAS178D with fluorophore at DBD-A or DBD-D. Following fitting the traces from
smTIRF- microscopy with appropriate FRET equations, data analysis showed loss of
distinct states of binding for DBD-A whereas the DNA binding states of DBD-D remain
unchanged (Fig. 6-7, 6-8). This is particularly interesting as the stopped-flow bulk
fluorescence showed remodeling for DBD-D but not for DBD-A (Fig. 6-5 a, 6-6 a,
compare red traces) which is in contradiction to smFRET results. It is possible that during
S178D mutation, DBD-A is able to bind to DNA and maintain a slightly higher stable
interaction than RPA-wt. As a result, DBD-A in RPA-S178D is unable to transition back
and forth between the binding and unbinding state, or there is change in rotational
freedom of DBD-A (microdomain dynamics) which is visible only at the single-molecule
resolution. Using stopped flow to monitor the composite signal of all the binding events
at a timescale of 3.25 seconds shows rate of DBD-A and DBD-D binding is unaffected,
but there are changes in DBD-D binding to DNA in S178D mutation. However, smTIRF
provides information once DBD-A and DBD-D are engaged on DNA and the data
obtained is over a period of 60 seconds (steady- state). At this time period, the stoppedflow reactions would have already reached the steady-state. Further investigations have to
be conducted to understand the mechanism underlying change in pre-steady state of
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DBD-D dynamics in RPA-S178D yet changes in the steady state of DBD-A dynamics
under conditions of excess ssDNA or binding sites.
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a)

b)

Data for figures 6-7 and 6-8 collected and analyzed by Colleen Caldwell and Maria
Spies, University of Iowa, IA.
Figure 6-7: Single-molecule analysis to quantify the conformational dynamics of
RPA-S178D-DBD-A. a) Experimental scheme for visualizing conformational dynamics
of DBD-A. Binding of 100 pM RPA-S178D-AMB543 to ssDNA (blue line) tethered to the
surface of the TIRFM flow cell (grey line) brings the MB543 fluorophore within the
evanescent field and its excitation. NA – neutravidin, b – biotin. b) Representative
fluorescence trajectory depicting conformational dynamics of individual RPA-S178D
molecules labeled within DBD-A. Purple lines represent normalized fluorescence. Unlike
RPA-wt-AMB543, the four states for DBD-A engagement is not observable. The shaded
area on graph represents the time where free RPA was present in the flow cell.
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a)

b)

Figure 6-8: Quantification of ebFRET trajectories for RPA-S178D-DMB543 ssDNA
binding. The trajectories from 120 -210 sec were taken for fitting. Comparison of the a)
fractional visitation to each state available to RPA-DBD-DMB543 (grey) and RPA-S178DDMB543(blue). b) the stability of each state available to RPA-DBD-DMB543 (grey) and
RPA-S178D-DMB543(blue). The numbers on Y axis represent the four- states of binding of
DBD-D.

268
6.3.4 S178D increases the cooperative assembly of RPA on ssDNA

Experiments performed with fluorescently labeled 100nM RPA-S178D with
increasing concentrations of (dT)35 enable monitoring binding of one RPA to an available
DNA substrate and deduce the kinetics and dynamics of DBD-A and DBD-D binding.
Under our experimental conditions, ssDNA of at least 20 ± 2nt is required to engage all
the DBDs and experiments performed with a fixed concentration of fluorescent protein
and increasing concentrations of (dT)35 do not provide information concerning how
multiple RPAs can assemble on ssDNA. To understand if S178D mutation affected the
assembly of multiple RPA on DNA, we performed RPA-S178D-FRET with increasing
lengths of ssDNA (dT)n (where n= 20 to 140 nucleotides) and compared it RPA-wtFRET (Fig 6-9 a-d, 6-10 a-d). FRET experiments were performed with DBD-Acy3 as
donor and DBD-Dcy5 as acceptor. RPA binds with a polarity of 5′-3′ with DBD-A
residing close to 5′ and DBD-D residing close to 3′ end of DNA. Stopped-flow
experiments performed with RPA-Acy3 and RPA-Dcy5 produces FRET only when DBD-A
is adjacent to DBD-D. Bulk FRET analysis performed with fixed concentration (40nM)
of wt or S178D Acy3 and Dcy5 and 40nM ssDNA of increasing lengths showed observable
FRET for (dT)n ≥45-nt which is enough ssDNA space for two RPAs to stably bind (Fig.
6-9 a, 6-10 a). There was no observable FRET for (dT)20 and (dT)35 which allows stable
engagement of only one RPA (Fig. 6-9 a, 6-10 a). Raw traces for increase in Cy5
fluorescence was fit using a two-step kinetic model where, the first step (kobs,1) reflects a
rate of association between RPA ssDNA and/or RPA heterotrimers and the second step
(kobs,2) reflects the arrangements/ movement of DBDs on ssDNA as both the RPAs
attempt to undergo stable DNA interactions. The resulting kobs,1 and kobs,2 values for

269
S178D increased with increasing the length of ssDNA following a cooperative binding
behavior as seen by the sigmoidal shape of the graph (Fig. 6-10 a, b), whereas, the kobs,1
and kobs,2 values for RPA-wt remained unchanged independent of the length of
oligonucleotide (Fig. 6-9 a, b). This result suggests that formation of RPA-RPA
complexes is promoted for RPAS178D. MST analysis to measure binding affinity
between isolated DBD-A and RPA14 (OB-E) showed both the domains interacted with
an affinity of ~100M for RPA-wt which was increased to three-fold for S178D
(~30M) (Yates et. al., 2018). Similar binding experiments performed with full length
protein and (dT)100 showed S178D bound to (dT)100 with one-fourth of the affinity of
RPA-wt (~20nM for RPA-wt and ~80nM for RPA-S178D), yet, with increased
cooperativity i.e Hill coefficient of ~1 for RPa-wt and ~2 for RPA-S178D (Yates et. al.,
2018).
The FRET intensity signatures enable deeper understating regarding the
positioning of the DBDs on ssDNA. Under excess condition of RPA-wt and shorter
oligonucleotides like (dT)45 there is not enough binding sites for all DBDs of two RPAs,
leading to rapid increase in signal followed by a decrease to a lower FRET state,
suggesting remodeling (Low FRET) (Fig. 6-9 a, light blue and light green trace; 6-11
light blue trace). However, similar experiments with RPA-S178D show a monophasic
increase in FRET signal that is stable with loss of the remodeling phase, potentially due
to enhanced interaction with RPA14 (Fig. 6-10 a, light blue trace). Increasing the length
of ssDNA to (dT)79 still displayed the engagement step with increase in FRET amplitude
for both wt and S178D (Medium FRET) with slight remodeling step for RPA-wt only
(Fig. 6-9 a and 6-10 a, orange trace, 6-11 yellow trace). Finally, additional experiments
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with (dT)140 showed a single-step binding with maximum FRET amplitude for RPA-wt
but FRET amplitude still stayed at medium for S178D (Fig. 6-11, compare orange trace
and navy-blue trace). Although there is enough binding space for all the DBDs to bind,
diffuse and still maintain stable engagement, the medium FRET signal observed for
S178D is potentially due to its inflexibility or inability to diffuse along ssDNA.
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a)

c)

b)

d)

Figure 6-9: FRET experiment to monitor assembly of multiple RPA with increasing
lengths of ssDNA. a) Representative traces of stopped-flow FRET experiments
performed with RPA-wt-Acy3 and RPA-wt-Dcy5to monitor assembly of multiple RPA.
The data was fit using a two- step model to obtain b) rate of association (kobs,1) c)
rearrangement step (kobs,2) and d) steady state (kobs,3) and are plotted along increasing
lengths of ssDNA. kobs,1, kobs,2 and kobs,3 values remain constant albeit the increase in the
length of ssDNA. Data points are an average of three experiments and are shown with
standard error.
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a)

c)

b)

d)

Figure 6-10: FRET experiment to monitor assembly of multiple RPA-S178D with
increasing lengths of ssDNA. a) Representative traces of stopped-flow FRET
experiments performed with RPA-S178D-Acy3 and RPA-S178D-Dcy5 to monitor
assembly of multiple RPA-S178D. The data was fit using a two- step model to obtain b)
rate of association (kobs,1) c) rearrangement step (kobs,2) and d) steady state (kobs,3) and are
plotted along increasing lengths of ssDNA. kobs,1, kobs,2 show cooperative binding
behavior along with increase in the length of ssDNA, whereas kobs,3 remains unchanged.
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Figure 6-11: Assembly of multiple RPA-wt or RPAzm with increasing lengths of
ssDNA. For RPA-wt or RPA-S178D, 40nM (Acy3-Dcy5) complex was rapidly mixed with
equimolar concentration of either (dT)97 or (dT)140 and the resulting increase in Cy5
fluorescence i.e FRET was monitored. FRET intensity was ascribed as Low FRET (blue)
trace, medium FRET (orange and yellow trace) and high FRET (navy blue trace) based
on the amplitude of Cy5 fluorescence observed.

274
6.3.5 RPA-S178D-DNA complex is resistant to clearing by Srs2 but sensitive to
nuclease activity

The cryo-EM structure of two RPA-S178D revealed defined electron density for
trimerization core of one RPA but a diffused density for trimerization core of the other
RPA(Yates et. al., 2018). Subsequent MST analysis showed increase in interaction
affinity between isolated DBD-A and RPA14, yet, weaker affinity for binding to (dT)100.
Finally, FRET analysis showed cooperative assembly of RPA-S178D, yet, loss of
remodeling during assembly (Yates et. al., 2018). Taken together, these results suggest
change in assembly of RPA during S178D. To understand how RPA-S178D assembly
differed from RPA-wt, we treated RPA-S178D-ssDNA and RPA-wt -ssDNA complex
with Srs2 helicase and S1 endonuclease (Yates et. al., 2018). Srs2 requires a 3′ open end
to access the ssDNA and several studies including ours have shown that it can remove
major players involved in homologous recombination pre-synaptic complex formation
including RPA, Rad51 and Rad52.
47.5nM RPA-FRET-(dT)97 complex was challenged with increasing
concentrations of Srs2 (100- 400nM) in presence of 2.5mM ATP and decrease in FRET
monitored. For both RPA-wt and RPA-S178D, decrease in FRET due to Srs2 clearing of
RPA bound on ssDNA was explained with a single- step model. RPA-S178D-(dT)97
complex was twice as resistant to clearing by Srs2 than RPA-wt (RPA-wt, Kremoval: 2.01±
0.66 x106 M-1s-1 and RPA-S178D, Kremoval: 0.9 ± 0.23 x106 M-1s-1) (Fig. 6-12 a, b). Cy5
labeled (dT)100 was used to preform RPA-DNA complex for both wt and S178D. This
complex was treated with increasing amounts of S1 nuclease and the resulting fragments
analyzed using EMSA. Relative band intensities plotted to determine the effect of S1
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nuclease treatment showed a mild increase in sensitivity to S1 nuclease for RPA-S178DDNA complex compared to RPA-wt (Yates et. al., 2018). Compared to RPA-wt,
resistance to removal by Srs2 helicase but increased sensitivity to S1 nuclease would
suggest a model where multiple RPA-S178Ds assembly would expose segments of DNA
within or between multiple RPAs which are easily accessible by nuclease. Meanwhile,
the conformations adopted by RPA-S178D due to enhanced interaction between DBD-A
and RPA14 and cooperative binding would result in slower removal of multiple RPAS178D by Srs2.
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a)

b)

Figure 6-12: RPA-S178D-DNA complex is resistant to Srs2 helicase clearing. a)
Representative traces showing decrease in FRET for RPA-wt-DNA (blue) or RPAS178D-DNA (red) when rapidly mixed with Srs2. b) Quantitation of traces in a) using
single exponential+ linear phase provides the rate of FRET decrease (kobs,1) plotted along
increasing concentrations of Srs2. The rate of loss of FRET i.e RPA displacement is
directly proportional to concentration of Srs2, with RPA-S178D showing more resistance
to clearing.
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a)

b)

Figure 6-13: Proposed model of post-translational modifications affecting RPA-DBD
arrangement and assembly. a) Schematics of RPA-wt assembly and DBD dynamics in
three different lengths of ssDNA (shown as blue line). All the DBDs and PIDs follow the
color scheme as shown in Fig. 6-1 b, except for OB-F (also known as PID70N), which is
shown in purple. In shorter DNA, such as (dT)60 with enough space for two RPA
molecules to assemble, rapid binding of two RPAs is followed by extensive remodeling
of DBD-A, here shown as DBD-A of second RPA being pushed out of ssDNA. As a part
of the flexible half of RPA, conformations that can be adopted by DBD-A in various
lengths of DNA is shown as multiple pink rectangles extending from DBD-A and
microdissociation states are indicated by brown arrows. In longer DNA, such as (dT)140
or (dT) >100 with sub-stoichiometric concentration of RPA, trimerization core mediated
remodeling of DBD-A is not observed. There is ample DNA space for rapid binding of
RPA-DBDs, diffusion of RPA, and less impact of trimerization core mediated
remodeling of DBD-A. (Bottom) Under this condition, an RPA nucleoprotein filament is
comparatively resistant to both S1 nuclease and Srs2 helicase mediated displacement. b)
Similar schematic representation showing the binding and remodeling of RPA-S178DDBD dynamics. S178D mutation (shown as red circle) increases the affinity for
interaction between DBD-A and RPA14 and changes conformations adopted by DBD-A
This alters the arrangement of RPA domains as multiple RPA-S178D assemble on DNA
resulting in exposure of more naked ssDNA between two RPA-S178D. Cooperativity
between DBD-A and RPA14 makes RPA-S178D nucleoprotein filament resistant to Srs2
helicase activity but exposed DNA between RPA-S178D makes it sensitive to S1
nuclease.
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6.4 Discussion

In general, nucleic acids interacting proteins undergo transient PTM which instills
complexity in their functioning and behavior. Recently, several research publications
investigating DNA damage response have elucidated towards a potential interrelationship
between Mec1 kinase driven phosphorylation events and SUMOylation events, with RPA
being at the junction of these two events (Cremona et. al., 2012; Psakhye & Jentsch,
2012; C.-S. Wu et. al., 2014). In vivo, how these distinct events simultaneously regulate
RPA’s ability to propagate phosphorylation and SUMOylation driven damage response is
fascinating, but poorly understood. In this chapter we used in vitro biochemical and
biophysical assays to understand how a single phosphorylation event could potentially
regulate RPA-DNA engagement, and how this might translate to customizing RPA’s
functions towards distinct DNA pathways.
Using RPA-S178D, we show a loss of the intra-DBD remodeling (i.e.
trimerization core mediated remodeling of DBD-A) when one RPA-S178D binds to
DNA. Furthermore, we show a change in the assembly of multiple RPA-S178D
molecules on DNA. In addition, steady state tryptophan quenching experiments with
RPA-S178D showed ‘half-tryptophan quenching’, while, maintaining the DNA binding
stoichiometry suggesting a different conformation being adopted than RPA-wt (Fig. 6-2,
6-3). The conformational difference was qualitatively validated by comparative protease
digest in both presence and absence of DNA (Fig. 6-4). Since tryptophan quenching
provides a global measure of engagement of all DBD on DNA, the half quenching would
imply either not all DBDs are engaging the ssDNA, or, if they are, they do not have the
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same conformational freedom. Yet, the stoichiometry points that one RPA-S178D is still
binding to one (dT)35 and the rates of binding to DNA remain unchanged.
These subtle differences in conformational translate into specific outcomes in
complex processes such as HR that requires collective and orderly functioning of a range
of DNA modifying factors. In this chapter, we show several lines of evidence where a
specific PTM in RPA has the potential to yeild distinct outcome in the context of HR.
First, using bulk fluorescence experiments we show an alteration in DBD-A and DBD-D
dynamics in RPA-S178D compared to RPA-wt (Fig. 6-5, 6-6). Furthermore, in-depth
single molecule analysis revealed S178D mutation to completely alter the microscopic
binding states of DBD-A (Fig. 6-7). DBD-A could barely engage with DNA but the
microscoping binding states of DBD-D remained unaffected (Fig. 6-7, 6-8). This is
perhaps the first documentation where a phosphomimic mutation in a non-DNA binding
region has the capability to alter conformation of the DNA binding domain in RPA.
Although not yet documented, it is possible that PID70N occasionally interacts with DBDA and the linker connecting these two regions regulates this interaction. Therefore,
modification in the linker region could translate to affect behavior of both PID70N and
DBD-A, as well as regions of RPA that DBD-A comes into contact with. In a recent
publication portraying cryo-EM structure of RPA-DNA complex, Yates et. al., showed
that ssDNA occupied by two RPA-S178D had an overall poor electron density for the
second RPA-S178D, while, the trimerization core of the first RPA-S178D was better
resolved, further suggesting that S178D mutation altered conformation of RPA
assembled on DNA (Yates et. al., 2018). Our ensemble FRET experiments monitoring
binding of multiple RPAs provide with molecular details underlying this observation.
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Although, RPA-wt assembly is a non-cooperative binding event, RPA-S178D assembles
in a cooperative manner on longer ssDNAs (Fig. 6-9, 6-10, 6-11). Furthermore, this
assembly does not involve DBD-A remodeling by its trimerization core and possibly
perturbs RPA diffusion, as RPA-S178D-FRET complexes are unable to achieve the highFRET state even when ssDNA is not limiting (Fig. 6-11). Finally, RPA-S178D-DNA
complex is more resistant to Srs2 mediated clearing (Fig. 6-12, 6-13) but sensitive to S1
nuclease treatment (Yates et. al., 2018).
The process of HR relies on protection of 3′ exposed ssDNA by RPA, timely and
regulated displacement of RPA by Rad51 and associated factors, and control of Rad51
nucleoprotein filament by Srs2 helicase. In addition, Srs2 helicase can also displace RPA
and therefore has the ability to tip the level of HR in either direction. RPA-S178D-DNA
complex which mimics the Mec1 kinase mediated single-site phosphorylation during
DNA damage shows a minimal displacement of RPA-S178D by Srs2 helicase and
possibly Rad51 recombinase but can be easily targeted by endonucleases. This could be a
defense mechanism to prevent passage of damaged DNA or to ensure proper repair
before DNA propagation, disfavoring HR. Our study provides mechanistic insights into
how phosphorylation events could make slight modifications in RPA-DBD dynamics to
yeild distinct global output (Fig. 6-25), and can be extended to processes which involves
similar modification of RPA.
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Chapter 7: CONCLUSIONS

In a multi-domain protein like RPA, the fundamental mechanism underlying
conformational regulation of each domain is affected by plethora of factors. These
include cellular localization, cell- cycle stage, interacting proteins, type of DNA
substrates, post-translational modifications, and overall conformational freedom available
to individual units in the heterotrimeric complex (reviewed in (Maréchal & Zou, 2015; A.
Prakash & Borgstahl, 2012; Zou et. al., 2006a)). Two functional modules that include
DBDs (A, B, C and D) and PIDs (PID70N and PID32C) connected by flexible linkers (Fig.
7-1 a), are charged with the prime responsibilities of protecting single-stranded DNA
(ssDNA), recruiting appropriate DNA binding factors and coordinating the process of
handing over ssDNA to an incoming protein. In the absence of ssDNA, linkers
connecting individual units in these two functional modules provide RPA with high
degree of conformational flexibility. However, upon binding to ssDNA, the random
conformations of RPA are comparatively restricted, albeit there still exists multitude of
conformations that can be adopted by RPA on DNA (Arunkumar, Stauffer, Bochkareva,
Bochkarev, & Chazin, 2003c; Brosey et. al., 2015a). Given the complex architecture of
RPA, several studies aimed at understanding the contribution of each DBD towards
overall binding and displacement of RPA, including simultaneous protein recruitment
and DNA hand over have developed their models based on the use of truncated DBDs. Of
the most common being DBDs A and B assigned as the ‘high affinity’ domains that bind
stably to ssDNA and the trimerization core (DBDs C, D and RPA14) being the ‘low
affinity’ domain that bind weakly to ssDNA. These models while informative are
incomplete, as they often lack all four DBDs whose coordinated action renders RPA with
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nanomolar DNA binding affinity. Furthermore, they do not account for linkers mediated
conformational regulation of RPA-DBDs and its functional implications.
The central aim of this dissertation research was to probe individual RPA-DBDs
in the context of full-length RPA, with an intent of obtaining real-time assessment of the
global conformational regulation and deciphering how individual conformations adopted
by RPA could potentially translate into specific functions.
To this extent, this chapter summarizes the key findings which include but are not
limited to: a) development of RPA as a fluorescent probe to track RPA-DBDs in a
multiprotein reaction, such as during homologous recombination; b) establishment of a
novel concept for RPA as containing a highly-dynamic half (DBDs A and B) and a
stable-half (trimerization core); c) differential dynamics and states for each domain on
ssDNA; d) regulation of RPA-DBDs dynamics and conformations by external factors,
such as, post translational modifications, RPA interacting proteins (RIPs), and DNA
structures.
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a)

d)
b)

c)

Figure 7-1: Model for DBD specific remodeling by RIPs. a) Diagrammatic
representation of RPA DBDs, PIDs and linkers connecting the functional modules. DBDs
A, B and PID70N form the flexible half of RPA, and the trimerization core with DBDs C,
D and RPA14 forms the stable half of RPA. Possible modes of DBD modulation by RIPs
that specifically interact with b) PID70N and DBD-A, c) share composite interaction site
with multiple DBDs and PIDs, or d) interact specifically interact with PID32C, leading to
displacement of RPA from ssDNA.
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7.1 Probing dynamic nature of RPA-DNA binding into quantifiable events

The advent of site-specifically incorporating non-canonical amino acids (ncAAs)
in protein engineering circumvents the limitations of maleimide chemistry that often
requires mutating all the cysteine residues, except one (or most surface exposed Cys
residues), required to form the thioether (C-S-C) linkage. In addition, it provides freedom
of incorporation site-selection, as any amino acid residue located in any region of the
protein can be substituted with an ncAA. As a first step towards achieving the central
aim, I incorporated 4-Azidophenyalanine (4AZP) in individual DBDs and tethered
fluorescent probes using click-chemistry. We termed this methodology FEncAA
(Fluorescence Enhancement using non-canonical amino acids) as the positions we
selected produced a change in fluorescence upon interactions with ssDNA for a specific
DBD. Although 4AZP could be site-specifically incorporated in all four DBDs and
labeled with fluorophores, only RPA with fluorophores incorporated at DBDs-A and -D
retained DNA binding properties similar to RPA-wt (Chapter 2 and 3). Our results with
RPA-DBD-Af and RPA-DBD-Df revealed that DBD-A bound first to ssDNA with
binding events being highly prone to modulation, followed by DBD-D binding which
was stable in nature. Furthermore, this modulation of DBD-A observed under restrictive
conditions, i.e. shorter ssDNA, or lower concentration ssDNA, was caused by its own
trimerization core. A phenomenon that we termed as “intra-DBD remodeling” (chapter
3). Our finding stands in stark contrast to long held principles of the Sequential Binding
Model that describes RPA-DNA binding. According to this model, DBDs A and B bind
to ssDNA first and are the high-affinity binding domains, whereas, trimerization core
follows DBDs A, B binding and is the ‘low affinity’, easy-to-modulate, part of RPA. Our
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finding establishes DBD-A (possibly with DBD-B) binding first with a slightly faster kon
rates; ~50 s-1), but is the flexible half of RPA as it dissociates; whereas DBD-D (and
possibly the trimerization core) binds with a slower kon rates ~40 s--1) but is the stable
half of RPA as it does not dissociate. In fact, we now have further unpublished data
showing proteins such as Rtt105 preferentially working to modulate even more stable
conformations of the trimerization core on ssDNA during formation of the RPA-ssDNA
nucleoprotein filament.
Site-specific incorporation of 4AZP (ncAA) followed by thethering a fluorophore
(performing click-chemistry) can impact the functioning of a protein. Therefore, finding a
suitable position which allows for ncAA incorporation, subsequent chemistry while still
retaining 100% of the protein activity is not a trivial task. In our endeavor of generating
site-specifically labeled RPA-DBDs, I tried incorporating 4AZP followed by clickchemistry to attach the fluorophore at several positions in DBD-A (W212, F215, L280
and T211), DBD-B (positions S334, A336, F385 and G387), DBD-C (positions E462 and
Y586 ) and DBD-D (F143 and W101). Only positins T211 in DBD-A and W101 in
DBD-D retained 100% of the protein activity after 4AZP incorporation and fluorescent
labeling. All the RPA-DBD-Bf and RPA-DBD-Cf variants retained only ~40% of ssDNA
binding ability compared to RPA-wt. Therefore, using RPA-DBD-Af and RPA-DBD-Df,
I was able to capture the dynamics of DBD-A and DBD-D.
Since I was unable to generate a 100% RPA-DBD-Bf and RPA-DBD-Cf variant, I
would like to acknowledge that our assignment of DBDs A, B as ‘flexible half’ and
DBDs C, D, RPA14 as the ‘stable half’ still draws on the assumption based on the crytal
structure of the protein showing extensive interactions within the trimerization core along
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with the extensive disordered linkers that connect DBDs A and B with the trimerization
core. The model also builds on earlier work made with isolated DBDs that show DBDs A
and B to behave as a unit and DBDs C, D and RPA14 to behave as a separate unit
(Arunkumar et. al., 2003c; Elena Bochkareva et. al., 2002b).
A possible explanation for our inability to generate RPA-DBD-Bf and RPADBD-Cf with ssDNA binding properties similar to RPA-wt could be attributed to the sites
at which ncAAs were incorporated and then labeled with fluorophore. To elaborate, our
strategy for choosing 4AZP incorporation site with aim of monitoring dynamics of
individual DBDs required fulfilment of three specific criteria: a) the site of incorporation
be located away from the secondary structures such as -helix and -sheets in order to
maintain the structure of OB folds. This would often result in substitution of amino acid
residues located in the loops of OB folds with 4AZP; b) following incorporation of 4AZP
and fluorescent labeling, the fluorescently labeled DBD required to be ssDNA
responsive, i.e., produce specific and quantifiable change in fluorescence intensity that
could be used to deduce kinetic parameters. This would narrow the site-selection, as
residues in the vicinity of ssDNA but not too close to impose a significant steric
hindrance were chosen; and finally c) the fluorescently-labeled RPA maintains ssDNA
binding properties similar to RPA-wt.
Using the crystal structure of U. maydis RPA as a guide and comparing the amino
acids residues with Sc. RPA, in case of DBD-B, positions S334 and A336 lie in the
conserverd motif ‘SRAG’ (in Sc. RPA) and ‘SKAS’ in (U. maydis RPA) which also
makes the loop structure. In this loop, S334 forms polar contacts with G337 and R335
forms ionic interactions with the phosphate backbone of the ssDNA. In addition,
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positions F385 and G387 is located in the conserved motif ‘DFGGRAL’ (Sc. RPA) of
the BC-linker which has been shown to play a significant role in communication between
DBD-B and DBD-C, and in the stability of the overall tertiary structure of RPA on DNA.
While F385 could potentially from base stack interactions with DNA, G387 forms polar
contacts with D384 and R388 in the motif ‘DFGGRAL’. Similarly, in case of DBD-C,
E462 lies in the conserved motif ‘EKGDFF’and can make transient ionic contacts with
the solvent during ssDNA binding and Y586 which is located in the conserved motif
‘DTYND’ forms base-stacking interaction with the nitrogen base of the ssDNA.
Therefore, perturbing either S334, A336, F385 or G387 in DBD-B, or, E462, Y586 in
DBD-C via incorporation of 4AZP and fluorescent labeling could significantly impact
the extent of the specific interactions made by the amino acids in this loop. Furthermore,
incorporation of flurophore, which is fairly bulky compared to single amino acid, could
pose a significant steric hindrance, disrupting overall loop structure and affecting
majority of interactions that this loop participates in. Therefore, inability to fulfill these
three criteria to obtain RPA-DBD-Bf and RPA-DBD-Cf, albeit having experimented with
several positions suggests that DBDs B and C are comparatively sterically restricted and
not amenable to structural perturbation. Therefore, inability to fulfill these three criteria
to obtain RPA-DBD-Bf and RPA-DBD-Cf, albeit having experimented with several
positions suggests that DBDs B and C are comparatively sterically restricted and not
amenable to structural perturbation. The crystal structure of U.maydis RPA depicts
individual loops in DBDs B and C that could be considered as candidate sites for
incorporating ncAA to be intimately positioned with respect to ssDNA (Fig. 7-2).
Therefore, along with AB-linker and BC-linker that have been shown to adopt defined
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structures upon binding to ssDNA, the loops present in DBDs B and C could be equally
responsible for coordinating the overall RPA-DNA binding, and also dictate the path of
ssDNA in the RPA complex.
The two DBDs that I was able to fluorescently label are connected to two PIDs
(PID70N is connected to DBD-A via the long N- linker, and PID32C is connected to DBDD via C- linker) (Fig. 7-1 a). Therefore, it is possible that loops in DBDs A and D are
more amenable to structural perturbation, as binding of these two DBDs are often directly
affected by RPA interacting proteins. In the future, additional sites within DBD-B and
DBD-C, including non-tested sites in the loops or position in the surface of the DBD
which would still provide DNA dependent change in fluorescence could be tested in
order to develop RPA-wt like RPA-DBD-Bf and RPA-DBD-Cf. An alternative to this
would be introducing ncAA in the BC linker positioned close to DBD-B and at the Cterminus of RPA70 followed by labeling with fluorophore to generate RPA-DBD-Bf and
RPA-DBD-Cf, respectively.
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Figure 7-2: Crystal structure of U.maydis RPA (PDB: 4GNX) bound to ssDNA
(black sticks) showing DBD-B (orange) and DBD-C (yellow). BC-linker connecting
the two DBDs is shown in purple blue. Part of the BC-linker forms an -helix structure
as the two DBDs arrange themselves on ssDNA. DBD-C has a zinc-finger motif that
binds a Zn2+ metal ion (grey sphere) and is required for stable ssDNA binding. All the
candidate loop structures for incorporating ncAA reside close to ssDNA or in the BClinker that undergo major conformational transitions. Thus, architecture of DBDs B and
C on ssDNA makes it particularly challenging for incorporating ncAA without perturbing
their functions.
In summary, this distinction in dynamics (binding, dissociation, and remodeling)
of DBD-A and DBD-D resulting in ‘flexible-half’ and ‘stable-half’ could be one of the
several ways by which RPA controls and coordinates ssDNA protection with protein
recruitment and DNA handover in distinct DNA metabolic processes. For example, the
DNA damage response protein SMARCALl, which also remodels stalled replications
forks, interacts with PID32C which is a part of RPA32 i.e., stable half of RPA, whereas
proteins involved in checkpoint responses such as ATR, ATRIP, p53 etc. interact with
PID70N present in the flexible half of RPA, and several proteins crucial for HR share
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composite interaction site involving both the halves (Fig. 7-1 a-d) (Elena Bochkareva et.
al., 2005; Feldkamp, Mason, Eichman, & Chazin, 2014; Hays, Firmenich, Massey,
Banerjee, & Berg, 1998b; D. Jackson et. al., 2002; Mer et. al., 2000; Stauffer & Chazin,
2004b; Xu et. al., 2008). Therefore, the type and extent of interaction could selectively
affect conformations attained by individual DBDs or the two distinct halves (Fig. 7-1 ad), ultimately regulating RPA displacement and handing over of ssDNA.

7.2 RPA has defined microdissocaiton states on DNA

Two interesting characteristics which are in contrast to each other but are often
used together to describe RPA-DNA engagement are ‘high-affinity’ and ‘highly
dynamic’ ssDNA binding protein. Several studies have monitored transitions in RPADNA binding in response to changes in ionic environment, external applied force or in
presence of higher concentrations of RPA in the surrounding (Gibb, Ye, Gergoudis, et.
al., 2014; Kemmerich et. al., 2016; Kumaran et. al., 2006). These transitions can be
categorized into two groups: microdissociation and facilitated exchange.
Microdissociation (also called microdissociation states) can be attributed to local
thermal motions (differences in energy levels during conformational sampling to attain
the lowest free energy state) of individual DBDs, PIDs or linkers connecting these
individual units (R. Chen et. al., 2016a; Kemmerich et. al., 2016). Microdissociation of
RPA bound on ssDNA exists independent of free RPA or RIPs in the surrounding.
However, the latter can influence microdissociation. For example, diffusion of RPA on
DNA is a direct result of microdissociation.
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Facilitated exchange is the process in which RPA bound on DNA is exchanged
with excess RPA in the surrounding. In case of facilitated exchange, RPA in the
surrounding allosterically displaces RPA bound on DNA, possibly by affecting/ changing
the microdissociation (Gibb, Ye, Gergoudis, et. al., 2014). I would like to distinguish
facilitated exchange from facilitated dissociation, where, the later involves displacement
of RPA by RIPs. Microdissociation, facilitated exchange and facilitated dissociation of
RPA have been extensively demonstrated using single-molecule FRET, atomic force
microscopy, NMR, and conventional biophysical techniques. However, the spatial and
temporal resolution of occurrence of these events, number of transitions present within
and the functional implications of individual transitions had not been explored.
Using RPA-DBD-Af and RPA-DBD-Df, combined with single molecule
fluorescence microscopy, we demonstrated that RPA has four distinct microdissociation
states on DNA (Chapter 3). The factors that promote microdissociation are
experimentally intractable at the moment. Therotically, the most straight-forward
explanation is that each microdissociation state arises from the thermal motions, i.e.,
sampling of conformational states by individual DBDs in order to attain the lowest free
energy levels of binding on ssDNA. Therefore, the conformations adopted by four DBDs
would account for the four microdissociation states. This is supported by our finding that
truncated RPA with PID70N-DBDs A, B (FAB) had two microdissociation states.
However, this explanation does not account for the action of linkers connecting
individual domains that provide RPA with high degree of mobility, are potentially critical
in coordinating RIP recruitment, and ssDNA handover. RPA has four linkers in total: Nlinker, AB linker, BC linker and C-linker (Fig. 7-1 a). Therefore, an alternative
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explanation could be that individual microdissocaiton states are driven by the concerted
motions of one or more linkers. Therefore, a full-length RPA has four microdissocaiton
states and FAB consisting of N-linker and AB-linker has two microdissociation states. It
is also possible that the local conformations adopted by both linkers and DBDs drive the
microdissociation states of RPA. This explanation is supported by our findings with
RPA-S178D-Af and RPA-S178D-Df which has a single-site mutation incorporated at Nlinker and shows loss of microdissociation state of DBD-A with no effects in states of
DBD-D (Chapter 6).
Each of these possibilities can be additionally experimentally verified. If
microdissociation states are solely based on motion of DBDs on DNA then a truncated
RPA with DBDs C, D and RPA14 (CD14) would constitute two microdissociation states.
In addition, introducing mutations in each DBD to perturb DNA binding of that DBD
would proportionally decrease the number of microdissocaiton states. In case of CD14
that has only C-linker, if these states are linker driven, only one microdissociation state
would be present. Furthermore, changing the length of the linker should affect the
residence time and occurrence of this state. Finally, if microdissocaiton state are a result
of both DBD-DNA binding and linker motions then, in either full-length or truncated
RPA, perturbing ssDNA binding in either DBDs, changing the length of linker, or
combination of both should result in change in number of states, frequency of occurrence
and residence time of each state. We do caution that such mutations could also perturb
important allosteric motions within the protein and might not be a straightforward
interpretation of a loss or gain in microdynamic states.
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7.3 Conformational regulation of RPA-DNA binding

Modern experimental tools have expanded what ‘structure’ could actually mean,
as structures can now be defined as unique conformations in spatial and temporal
dimension, each with a potential of fulfilling specific function. Modular structure and
dynamicity (microdissociation/ facilitated exchange/ facilitated dissociation) in RPA has
often been attributed for its ability to adopt multiple conformations, although only a finite
number of conformations can be attained owing to propensity of rotational freedom of
each molecule coupled with steric clashes. The dynamicity in RPA could be one of the
driving forces which allow RPA to perform multiple functions on DNA but are also the
underlying cause for displacement of RPA from ssDNA. To this extent, we investigated
how RPA’s conformations are affected upon interactions with RIPs, interaction with
different types of DNA substrates and during situations of post-translational
modifications.

7.3.1 Regulation of RPA conformations by RIPs

A common recurring theme in models that depict RPA function posits RPA being
displaced from ssDNA by a RPA-interacting protein and the buried ssDNA being handed
over to the incoming DNA-binding protein. But newer findings looking at multi-protein
reactions using single-molecule DNA curtain experiments show higher order complexes
on ssDNA that build on RPA and not remove it from DNA (Gibb, Ye, Kwon, et. al.,
2014b). These findings agree with our findings, as the stable-half of RPA can remain on
the DNA, and the less-stable, dynamic-half, can be displaced while allowing the vacated
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DNA to be occupied by the RPA-interacting protein. At a minimum, this co-complex or
remodeled RPA and the RIP is a long-lived transition state during the DNA hand-off
process. To directly test how an incoming RIP might influence the dynamics of the two
RPA halves, we looked at RPA dynamics with two distinct RPA-interacting proteins:
Rad52 and Rad51, and one motor protein, Srs2, that does not interact with RPA, but can
remove it from DNA by coupling ATP hydrolysis to physical translocation on the DNA.
All four proteins work together in the pre-synaptic step in homologous recombination.
Of the three, the interplay between Rad52 and RPA has been fraught with most
juxtaposing models. This is further compounded by presence of BRCA2 in humans
which fulfills the role of Rad52, and Rad52 is generally considered as the ancillary
protein in the HR pathway. Therefore, depending on the species being investigated, there
could be slight variants in the proposed models. Both yeast and human Rad52 share a
composite interaction site with RPA. Rad52 binds to both PID32C and DBD-A (Hays et.
al., 1998a; Mer et. al., 2000; Park et. al., 1996). In yeast, Rad52 has been shown to inhibit
the facilitated exchange of RPA but enhance the displacement of RPA from ssDNA in the
presence of Rad51 recombinase (Gibb, Ye, Kwon, et. al., 2014b; Sugiyama &
Kowalczykowski, 2002b). It has been proposed that Rad52 stabilizes the
microdissociation states of RPA (Gibb, Ye, Kwon, et. al., 2014b; Chu Jian Ma et. al.,
2017b). In presence of Rad52, this stabilization of microdissocation states combined with
the stimulatory effect of increasing the rate of ATP hydrolyis by Rad51 could be
speeding up the Rad51-nucleoprotein filament formation (Fig 7-3 a-c) (Sugiyama &
Kowalczykowski, 2002b). Therefore, to dissect the mechanisms involved, we used single
molecule TIRF analysis to monitor microdissociation states of DBD-A and DBD-D of
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DNA bound RPA in presence of Rad52. Our results showed that Rad52 selectively
altered the number of states, including the frequency and residence time for DBD-D but
not DBD-A. Since facilitated exchange is dependent on two distinct parameters,
microdissocaiton states and local concentrations of free RPA, decreasing the number of
states and stabilizing DBD-D binding would explain how Rad52 inhibits facilitated
exchange of RPA, but this stabilization could help other proteins attempting to displace
RPA, as they now have one less conformational barrier to overcome; and also have
access to ssDNA now vacated by DBD-D. We demonstrated that this property of
selective DBD modulation by Rad52 was dependent on Rad52 binding to ssDNA.
Therefore, it seems like Rad52 ‘takes over’ the fourth state of DBD-D ssDNA binding by
engaging itself on DNA. Since we did not perturb RPA-Rad52 interaction in these
experiments, future experiments can target selectively mutating Rad52-DBD-D or
Rad52-DBD-A interaction sites followed by monitoring effects on microdissociation
states. Such a study would decipher if this domain specific modulation is due to Rad52
binding to ssDNA or a combination of Rad52-ssDNA binding with Rad52-DBD
interaction.
Rad51 interacts directly with DBD-A, regions spanning DBD-B (amino acid
residues 169-326 in human RPA) and the middle subunit RPA32 (Golub, Gupta, Haaf,
Wold, & Radding, 1998; Stauffer & Chazin, 2004b). In addition, a physical interaction
between Rad51 and RPA is required for displacement of RPA by Rad51 (facilitated
dissociation) (Stauffer & Chazin, 2004b). Competition between ssDNA and the Nterminus of Rad51 for binding to same site in DBD-A could be responsible for
displacement of DBD-A by Rad51(Stauffer & Chazin, 2004b). To test this model, I here
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show preliminary data collected by challenging RPA-DBD-Af or RPA-DBD-Df complex
with Rad51, and show that Rad51 can displace both DBD-A and DBD-D from DNA,
with faster displacement of DBD-A than DBD-D (Fig. 7-4 a-b, 7-5 a-c). In figure 7-5, the
Rad51 mediated displacement of RPA as a function of increasing lengths of DNA has a
kobs,1 value of ~20 s-1 until (dT)60 followed by decrease in the kobs,1 to ~ 4s-1 for (dT)97.
The kobs,2 values remain relatively constant with increasing lengths of ssDNA. Therefore,
kobs,1 value might be reflecting the rate of initial interaction between Rad51 and DBD-A
and kobs,2 might be reflecting the rate of displacement of DBD-A. It is also likely that we
are observing a two-step mechanism for Rad51 binding, where, the first step involves
nucleation of one- three Rad51 molecules on the RPA-coated ssDNA, and, the second
step involves growth of the Rad51 nucleoprotein. Our RPA-FRET experiments
monitoring the assembly of two RPA molecules with increasing lengths of ssDNA have
shown substantial remodeling of DBD-A until (dT)79 which is not observed for (dT)97
(Chapter 6, Fig. 6-9 a). Since Rad51 directly interacts with both PID70N and DBD-A, both
of which are also the flexible part of RPA and are being remodeled by trimerization core
in a ssDNA length dependent manner, the rate of interaction (kobs,1) between DBD-A
(including possibly PID70N) and Rad51 is fast until (dT)60 (and possibly until (dT)79)
following which it decreases. Preferential binding of Rad51 from 5′ to 3′ (Antony et. al.,
2009) coincides with faster displacement of DBD-A. This would ease Rad51 nucleation
which is shown to be the rate-limiting step in Rad51 nucleofilament formation (Miné et.
al., 2007; Sugiyama & Kowalczykowski, 2002b). However, displacement of DBD-D by
Rad51 likely involves two routes: a) preferential binding of Rad51 in a 5′->3′ direction
requiring displacement of DBDs A-C preceding DBD-D, and b) accessing ssDNA at the
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3′ end of DNA which is the unfavorable direction for Rad51 nucleation and filament
formation. Thus, all these factors could contribute to faster displacement of DBD-A than
DBD-D by Rad51. In presence of Rad52 which selectively modulates the
microdissociation states of DBD-D, the combined effects of Rad51 and Rad52 on DBDA and DBD-D results in faster displacement of RPA, possibly because it stimulates
DBD-D displacement from DNA (Fig. 7-3, 7-4, 7-5). Another likely scenario is that
Rad52-RPA form a complex at the 3′ end of the ssDNA overhang (as found during HR)
and remain on the ssDNA to serve as a capping mechanism to foster the second-strand
capture. Future studies investigating the dynamics of all three proteins will be required to
further tease apart the details of this mechanism.
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a)

b)

c)

Figure 7-3: Rad52 enhances Rad51 mediated displacement of RPA from ssDNA. a)
100nM RPA-DBD-Acy3, RPA-DBD-Dcy5 and (dT)45 (FRET+(dT)45) complex was
challenged with 150nM Rad51 in presence of 2.5mM ATP in RPA reaction buffer
(30mM Hepes, pH 7.8, 100mM KCl, 1mM ME, 5mM MgCl2, 6% glycerol) at 25oC.
Cy3 was excited at 555nm and decrease in Cy5 fluorescence was monitored with a
645nm emission filter. Raw data was fit with single exponential. b) Same as in a) but
FRET+(dT)45 complex in presence of 100nM Rad52-wt is challenged with 150nM
Rad51. Fitting the raw data with double exponential kinetic model shows increase in rate
of displacement of RPA from DNA c) Same as in b) but challenging FRET+(dT)45
complex in presence of 100nM Rad52-wt with 200nM RPA-wt. Fitting the raw traces
with double exponential followed by a linear phase model shows facilitated exchange is
slower than displacement by Rad51-wt in presence of Rad52.
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Srs2 helicase is an anti-recombination mediator enzyme that physically interacts
with Rad51 and disrupts Rad51 nucleoprotein filaments (Antony et. al., 2009b; Krejci et.
al., 2003; Qiu et. al., 2013). Using RPA-DBD-Df, I showed that following Srs2 mediated
displacement of DNA-bound Rad51, RPA present in the surrounding can rebind to the
open ssDNA spaces. Interestingly, Srs2 also displaces RPA and Rad52 from DNA but
does not physically interact with both these proteins (Seong et. al., 2009). RPA also
significantly impedes the DNA unwinding activity of Srs2 (Fig. 6-23 b, e compare red
trace with grey trace; c, f). In all these scenarios, Srs2 translocates in a 3′->5′ direction on
ssDNA (Antony et. al., 2009b) and the template here is a long RPA-coated ssDNA
filament. During DNA unwinding, a dsDNA with the ssDNA overhang will be the
substrate. When multiple RPA molecules are bound, Srs2 needs to gain access to the
DNA. It either has to somehow disengage the trimerization core at the 3′, or, be able to
access the DNA when DBD-A & D dynamically disengage from the DNA. Follow up
work can entail detailed measurements of the DBD dissociation kinetics during DNA
unwinding and translocation by Srs2 on RPA-coated nucleoprotein substrates.

7.3.2 Effects of DNA context on RPA-DBD dynamics

As discussed in section 5.4.2 changes in DNA topology (that includes nucleotide
orientation) can affect protein-DNA interactions. To directly investigate how changing
the topology of DNA encountered by RPA could affect its DBD dynamics (i.e. binding,
dissociation and remodeling), I reacted RPA-DBD-Af or RPA-DBD-Df with either 5′
overhang, 3′ overhang or ssDNA flanked by duplex (blocked-end) DNA, with varying
lengths of overhangs or intervening ssDNA. I show that intra-DBD remodeling (i.e the

300
trimerization core mediated remodeling of DBD-A upon monitoring binding of one RPA
to one ssDNA) requires an open 5′ end at the DNA,whereas DBD-D dynamics changes in
all three DNA contexts (Chapter 4). Interestingly Rad52 mediated remodeling of DBD-D
was more pronounced on a 5′ overhang than the remaining two DNA substrates, and this
remodeling was driven by cooperativity between the inner and outer DNA binding sites
in Rad52 (Chapter 5). In these experiments, I could only monitor dynamics of either
DBD-A or DBD-D, but not both simulteneously. Such a measurement is important
because RPA should not be envisioned as a linear assembly of DBDs, and interactions
between the DBDs should also be quantitated. Such interactions could be inter-RPA
(involving interactions between DBDs of multiple RPAs on DNA) or intra-RPA
(involving ineractions between DBDs of one RPA on DNA). Experimentally, such
experiments would require two site-specific fluorophores (FRET pair) engineered into a
single RPA molecule, e.g., Cy3 at DBD-A and Cy5 at DBD-D , followed by capturing
FRET changes on ssDNA, DNA with overhangs, and blocked end DNA. This will
provide understanding of how dynamics of DBD-A is affected with respect to DBD-D in
each of these DNA contexts. Introduction of RIPs such as Rad52 or Rad51 should then
provide in-depth detail into how RIPs affect the intra-DBD dynamics.
We are now working on a second ncAA incorporation using Tet 3.0 as the
unnatural amino acid. Fluorophores to Tet 3.0 can be tethered using TCO conjugation.
The idea here is that 4AZP and Tet 3.0 can be simultaneously engineered at different
positions within a single RPA trimer. Since the click-chemistry conjucation are different,
we can attach Cy3-DBCO to 4AZP and Cy5-TCO to Tet3.0 (Antony and Mehl;
unpublished work). In case, implementing the dual- incorporation of ncAA affects the
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DNA binding properties of RPA, an alternative approach could be placing either a FRET
donor (or acceptor) in the ssDNA-dsDNA junctions or the open termini of the DNA
substrate and then performing FRET with acceptor (or donor) labeled RPA-DBD-A and
RPA-DBD-D (Fig. 7-6). This method, while logistically easier, would only provide
information with respect to distance of FRET pairs (i.e RPA-DBD and DNA) and would
limit monitoring to just one DBD at a time.
In terms of global regulation of DNA metabolic processes with ssDNA
intermediates, each of these subtle modifications in DBD-dynamics could be unique
scenarios enabling an incoming protein to either interact with RPA, occupy ssDNA space
or both. For example, on 3′ overhang or blocked end substrates where DBD-A is ‘stuck’,
conformations of N-linker and PID70N would be different than if DBD-A were flexible
and easily remodeled. Therefore, it would assist in recruitment of RIPs that would require
DBD-A (and possibly other RPA-DBDs) to remain bound on ssDNA. In addition, it
could affect RIPs requiring synergistic interaction with both PID70N and DBD-A. RIPs
such as Rad52 and Rad51 that have ability to bind to dsDNA and ssDNA-dsDNA
junctions, would be able to modulate DBD dynamics of both the flexible half and stable
half. It would not be too far-fetched to postulate that unique conformations adopted by
each DBD, in a particular DNA context, regulates the level and types of RIPs being

302
recruited to the DNA substrates, ultimately guiding the choice of DNA repair pathway
and regulating continuation of DNA metabolic processes.
a)

b)

Figure 7-4: Rad51 displaces DBD-A faster than DBD-D. a) 100nM RPA-DBD-AMB543
was pre-incubated with 23nM (dT)97 or b) 100nM RPA-DBD-DMB543 was pre-incubated
with 30nM (dT)97, to form a RPA-DNA complex and challenged with a) 750nM b) 1M
Rad51 in in RPA reaction buffer (30mM Hepes, pH 7.8, 100mM KCl, 1mM ME, 5mM
MgCl2 and 6% glycerol (v/v)) supplemented with 2.5mM ATP, at 25oC. Samples were
excited at 535nm and decrease in MB543 fluorescence monitored with 555nm long pass
emission filter. Fitting data for both a) and b) with double exponential (without linear
phase) shows, displacement of DBD-A is faster than DBD-D.
7.3.3 Microscopic and macroscopic regulation of RPA’s conformation by posttranslational modifications

RPA is post-translationally modified by addition of various groups, such as,
phosphate (Pi), small ubiquitin like modifier (SUMO), ubiquitin (ub), acetyl (Ac) etc.
(Maréchal & Zou, 2015). How each of these modifications affect DNA binding properties
of RPA-DBDs, or the assembly of multiple RPA molecules, is poorly understood. Here,
using DBD specific fluorescently labeled RPAs and single molecule, bulk fluorescence as
well as ensemble FRET, I showed that a single phosphomimic site can affect both
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microdissociation and arrangement of multiple RPAs on DNA. RPA-S178D is unable to
move/ diffuse on ssDNA which is a direct consequence of its changed microdissociation
dynamics (Chapter 6). Altered conformation but not DNA binding ability is further
supported as I showed RPA-S178D had DNA binding affinity and kinetics similar to
RPA-wt but showed half quenching of intrinsic tryptophan fluorescence (chapter 6).
Using smTIRF, no quantifiable microscopic binding states of DBD-A could be captured,
whereas, DBD-D retained all four states. Since, serine to aspartate substitution is located
in the N-linker, this selective effect in the states of one DBDs vs other would favor a
model where each microscopic binding state is affected by the short-range
communication of conformations adopted by the DBD and the linkers connecting DBDs
and PIDs. To further test this, similar phosphomimic mutations in the C-linker could be
introduced and DBD-D dynamics monitored. A possible phosphomimic candidate to
experimentally test is S189 located in C-linker close to K199 SUMOylation site that gets
phosphorylated and SUMOylated, respectively, in response to genotoxic stress
(Albuquerque et. al., 2008; Psakhye & Jentsch, 2012).
Subsets of serines/ threonines are phosphorylated by specific kinases in cell-cycle
dependent manner and to elicit a DNA damage response. It would be interesting to
modify (phosphomimic) kinase respective groups of serine/ threonine (for eg: S4, S8, S12
that get phosphorylated by ATM; S23, S29 that gets phosphorylated by CDK etc) and
investigate how this might affect RPA-DBD dynamics and assembly. Alternatively,
generating fluorescent phosphorylated RPA by dual incorporation of ncAAs that involves
incorporation of phosphoserine (an ncAA) and 4AZP would provide precise results
regarding how phosphorylation events affect RPA-DBD-DNA binding and assembly of
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multiple RPAs. Dual incorporation of ncAA can also be used to incorporate two chemical
handles, one for fluorescent labeling, and the other for ligation of functional group (such
as Ub or SUMO). This would enable the unravelling of the exact underlying mechanisms
by which PTMs affect RPA-DBD dynamics on DNA or in presence of RIPs. Adopting
ncAAs based methods to answer mechanistic questions is extremely appealing. However,
compared to the production of wild-type protein, the yield of full-length purified protein
decreases dramatically even with a single ncAA incorporation. The 4AZP carrying RPADBD-A and RPA-DBD-D have the ncAA incorporated at the loop of respective DBDs,
ensuring that the positioning of 4AZP does not affect the overall tertiary structure of
RPA. Hence, upon dual incorporation of ncAAs, extensive biochemical assessments have
to be carried out to ensure that modifications at two different sites do not perturb the local
secondary structure and overall tertiary structure of RPA.

7.4 Post-translational modifications dictate differential DBD dynamics

DBD dynamics and stabilization of specific conformational states of RPA can be
achieved through post-translational modifications. RPA is extensively phosphorylated;
however, the precise functional roles for specific phosphorylations with respect to how
DNA binding is modulated, have not been established. Our work has now shed light on
how phosphorylation at S178 can affect RPA-DNA binding properties and RPA
assembly on DNA in vitro. In vivo S178 is phosphorylated by Mec1 kinase in response to
DNA damage (Bartrand et. al., 2004; Brush & Kelly, 2000).
In chapter 6, I show that RPA harboring a phosphomimetic S178D substitution
has selective changes in microdissociation states, lack of diffusion, and enhanced
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cooperative assembly on ssDNA making it resistant to displacement by Srs2.
Furthermore nucleoprotein filaments made by RPA-S178D make the ssDNA more
susceptible to degradation by S1 nuclease (Yates et. al., 2018). I have also shown that for
RPA-wt, Rad51 can displace DBD-A faster than DBD-D from DNA. Taken together,
extrapolation of these observations would mean that phosphorylation of S178 by Mec1
kinase in response to DNA damage would make it harder to displace phosphorylated
RPA by both Rad51 and Srs2. Rad51 filaments will be formed to a lesser extent and this
would tip the scale of HR occurring in cells. Meanwhile, nucleases in the surrounding can
degrade the accessible DNA and recruit additional factors to repair the damage before
progressing to S-phase. Indeed, for this model to be valid for RPA-S178D, the rate of
displacement of both DBD-A and DBD-D by Rad51 should be comparatively slower than
for RPA-wt. As a control, physical interaction between Rad51 and phosphomimic RPAS178D need to be performed to ensure that phosphorylation does not affect RPA-Rad51
interaction, which has been shown to be critical for RPA displacement.
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a)

b)

c)

Figure 7-5: ssDNA length dependent displacement of DBD-A by Rad51. a) Raw
traces obtained from the stopped-flow experiments when 100nM RPA-DBD-AMB543 was
preincubated with 62.5nM (dT)35, 50nM (dT)45, 37nM (dT)60 or 23nM (dT)97 to form
RPA-DBD-AMB543-DNA complexes. Individual RPA-DNA complex was challenged with
750nM Rad51 in RPA reaction buffer supplemented with 2.5mM ATP. Reactions were
performed under similar conditions as described in figure 7-4 and data obtained was fit
using a double exponential kinetic model to yield plot of b) kobs,1 and c) kobs,2.
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Figure 7-6: Schematics of FRET pairs that can be employed to understand RPADBD dynamics in various DNA-contexts. FRET can be performed with either
fluorescently labeled DNA and Single- fluorescent labeled RPA-DBD (top and middle),
or with dual fluorescently labeled RPA (bottom). Each combination should ideally
provide unique FRET signatures to understand DBD dynamics.
7.5 Proposed model of RPA’s conformation driving specific functions

This dissertation research highlights the mechanistic intricacies of how a
multidomain protein, such as RPA, can achieve functional versatility by the virtue of
conformational arrangements and rearrangements. Several process such as cell-cycle
regulation, DNA replication, recombination, repair, telomere maintenance, transcription
etc., are extensively regulated and are critical for cell survivability. RPA functions in
several of these critical pathways, often acting as a hub protein to control and coordinate
the flux of these pathways. How a single protein regulates/ is regulated to control these
pathways is still far from being understood. Yet, it is conceivable that there has to be a
mechanism in place that allows to fine-tune RPA-DNA binding that would be favorable
for continuing a particular pathway over others.
Our study reveals that RPA-DNA binding is very dynamic in nature and can be
modulated in distinct ways by several factors: concentration of ssDNA, length of ssDNA,
structure of ssDNA encountered, modifications of several key amino acids and in
presence of RIPs. Each of these factors can selectively affect the nature of RPA-DNA
binding which could ultimately drive specific processes. For example, in a scenario
where there are long ssDNAs but not enough RPA to completely saturate the long
ssDNA, binding of RPA to DNA would still leave excess ssDNA space. This particular
structure could be a potential recognition signal for recruitment of a particular RIP that
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requires both RPA-DNA filament and additional free nucleotides to initially gain access
to ssDNA. This RIP could now modulate RPA-DNA binding, to either stabilize or
displace RPA from DNA. In scenarios where ssDNA is flanked by duplex DNA,
conformational freedom of DBDs close to the duplex region can be affected, as RPA
does not bind to dsDNA. Similarly, conformations of DBDs in the vicinity of an RNADNA hybrid would potentially be different than on only ssDNA (with no RNA-DNA
hybrid), as RPA has a weaker binding affinity to RNA. Under these conditions, a protein
that can bind to both dsDNA and ssDNA, or, ssDNA and RNA, respectively, would
potentially affect conformations of DNA bound RPA in distinct ways. Each of these
effects could then dictate the nature and extent of RPA-DNA binding and progression of
specific pathways.
During cell-cycle regulation or DDR, phosphorylation of one or several serine/
threonine could further affect the conformations of individual RPA-DBDs, or, overall
RPA assembly on DNA (as seen in chapter 6 with RPA-S178D). Subsequent changes in
conformations could be recognized by a particular RIP or several RIPs. These RIPs are
then recruited to the RPA nucleoprotein filament to further continue an ongoing process.
In addition, modification of key amino acid residues that are actively participating in
either protein-protein interactions, subunit-subunit interactions, DBD-DBD interactions
or DBD-DNA interactions can further streamline how RPA functions in a particular
pathway. An example of this is shown in appendix II, where, mutating the conserved
NKK motif in DBD-C affected overall conformation of RPA on DNA. It should be noted
that mutating NKK to DRR, or, NKK to NKA, did not affect the DBD-A or DBD-D
dynamics. Therefore, the change in conformation probably arises due to effects in DBD-

310
B and DBD-C interaction, or, change in the way DNA passes from DBD-B to DBD-C.
RPA with mutations in the NKK motif are readily displaced by Srs2 helicase, when
compared to RPA-wt. In vivo, RPA with mutations in the NKK motif rescues the  Srs2
phenotype (Dhingra et. al., unpublished). Therefore, modulating the interactions between
NKK motif and DNA could directly affect HR, as it would result in RPA being easily
outcompeted by other proteins (such as Rad51) attempting to gain access to the DNA.
The dynamicity of RPA is further highlighted by the fact that RPA- DBDs
undergo several association-dissociation events on ssDNA, independent of the external
factors. Each of these association-dissociation events could serve as a potential
opportunity for a RIP to change the pre-existing nature of RPA-DNA binding. This could
either stabilize RPA, completely displace RPA from DNA, or enable a second RIP to
gain access to DNA. The latter is seen in case of Rad52, where, it selectively abolishes
the fourth binding state of DBD-D. In presence of Rad52, loss of this fourth state
combined with stimulation of Rad51’s ATPase activity, could be a synergistic effect in
enhancing RPA displacement by Rad51, potentially because Rad51 has to now overcome
3 binding states of RPA, instead of 4.
In summary, our research highlights the various aspects of RPA’s conformations
playing a key role in driving RPA’s specific functions in various DNA metabolic
pathways. The methodology used throughout this dissertation research and the insights
gained highlighting a multi-domain protein can be implemented to understanding of
similar proteins that participate in DNA related processes like replication, transcription,
recombination, and repair.
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APPENDIX I: ROLE OF THE CONSERVED NKK MOTIF IN REGULATING
RPA-DNA BINDING AND ITS IMPLICATIONS IN HOMOLOGOUS
RECOMBINATION

8.1 Introduction

The DNA binding proteins often contain zinc finger motif as a key component
that regulates their DNA binding activity. The eukaryotic ssDNA binding protein RPA
consists an evolutionary conserved 4-cysteine type zinc finger motif (X(3) CX(2-4)
CX(12-15) CX(2) C, where X represents any amino acid other than C) located in DBD-C
(Brill & Bastin-Shanower, 1998) required for performing redox reactions that regulate
RPA-ssDNA binding (J.-S. Park, Wang, Park, & Lee, 1999; You, Wang, & Lee, 2000).
The zn-finger motif directly interacts with ssDNA and contributes towards the helix
destablilation role of RPA (Lao et al., 1999). Coordination of Zn2+ by four cystenies
stabilizes the L12 loop structure froming a three--strand structure. Direct interactions
between amino acids in the three--strand structure and ssDNA forms a stable Zn domain
(Fan & Pavletich, 2012b). In the crystal structure of U.maydis RPA, N496, K497, K498
(NKK motif) in the Zn domain make specific interactions with the phosphodiester
backbone of ssDNA that could contribute towards DBD-C-ssDNA binding. N496, K497
amide backbone forms hydrogen bonding with the phosphate group of ssDNA, and the
side chains of K497, K498 make ionic interactions with the phosphodiester backbone of
ssDNA (Fan & Pavletich, 2012).
The NKK motif is conserved from yeast to humans. It has been postulated that the
specific interactions made by NKK motif could facilitate initial binding of DBD-C to
DNA and transitioning of ssDNA from a loosely-bound state to a tightly-bound state as it
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passes through DBD-C (Fan & Pavletich, 2012). Indeed, addition of micromolar
concentrations of zinc in RPA-ssDNA binding experiments resulted in a highly stiff,
more compact ssDNA (J. Chen et al., 2015). Surprisingly, in vivo, mutation of NKK
motif rescued Srs2 null phenotype upon dsDNA damage (Dhiungra et. al., unpublished).
Srs2 helicase is an anti-HR meditor that antagonizes Rad51 nucleoprotein filament
formation and plays a key-role balancing the levels of HR in yeast cells. Following
dsDNA damage, suvival of yeast cells in absence of Srs2 when NKK motif is mutated
suggests a gain-of-function, possibly due to effects in the RPA-ssDNA filament that
allows RPA to be easily displaced by other proteins trying to access the ssDNA space.
Therefore, in this chapter, I investigated how mutations in the NKK motif affected
RPA-DNA binding characteristics that could contribute towards survivability of yeast in
absence of Srs2. Our results show RPA with mutations in the NKK motif do not result in
change in DBD-A or DBD-D DNA binding dynamics or RPA assembly, but have distinct
conformational arrangement on DNA making them more susceptible to Srs2 clearing.
RPA-NKK mutants, also known as RPAzm had DNA binding properties similar to wildtype RPA, albeit changes in conformations adopted on DNA.

8.2 Materials and Methods

8.2.1 Plasmids for protein purification

8.2.1.1 RPAzm-4AZP incorporating plasmids

His- tag carrying RPA-A4AZP and RPA-D4AZP (chapter 3, section 3.2.3) were used
as templates to generate RPA-NKK mutant (RPAzm) constructs: RPA-K494A-A4AZP,
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RPA-K494A-D4AZP, RPA-K493A K494A-A4AZP (RPA-KK-AA-A4AZP), RPA-K493A
K494A-D4AZP (RPA-KK-AA-D4AZP), RPA-N492D K493R K494R-A4AZP (RPA-NKKDRR-A4AZP), RPA-N492D K493R K494R-D4AZP (RPA-NKK-DRR-D4AZP). All the
constructs were generated with NEB Q5 site- directed mutagenesis kit, using the
plasmids as described in Table 8-1.

Table 8-1: List of primers used to generate RPAzm

Mutation

Forward primer (5′-3′)

Reverse primer (5′-3′)

Annealing
temperature
(oC)

RPA-K494A

TTGTAATAAGGCAGTTC
TGGAACAGC

TTCTCATTAGAAC
AGGCAG

59

RPA-KK-AA

GAATTGTAATGCTGCTG
TTCTGGAACAGCCTG

TCATTAGAACAGG
CAGGATATG

58

RPA-NKKDRR

TCGAGTTCTGGAACAGC
CTGATG

CGATCACAATTCT
CATTAGAACAGGC

61

339
8.2.1.2 Non 4AZP incorporating RPAzm plasmids

Sc. RPA70-RPA32-his-RPA14 (Sc. RPA-wt) was used as a template to generate
Sc. RPA-NKK-DRR; Sc. RPA-KK-AA and Sc. RPA-K494A using Q5 site- directed
mutagenesis and primers described in table 8-1. For all the experiments, purified Sc.
RPA-wt was used as control.

8.2.2 Purification of 4AZP carrying RPAzm variants

The RPAzm4AZP variants (RPA-K494A-A4AZP, RPA-K494A-D4AZP, RPA-KKAA-A4AZP, RPA-KK-AA-D4AZP, RPA-NKK-DRR-A4AZP, RPA-NKK-DRR-D4AZP ) were
co-transformed with pDule2-pCNF plasmid in Rossetta-2 PlysS cells and were purified
as described in section 3.2.4 of chapter 3.

8.2.3 Labeling RPAzm4AZP with fluorophores

RPAzm4AZP variants were labeled with MB543, Cy3 or Cy5 as described.
Approximately, 3 ml of (10 μM) RPAzm4AZP was incubated on a rocker with 1.5-fold molar
excess (15 μM) of either DBCO-MB543, DBCO-Cy3 or DBCO-Cy5 for 2 hours at 4 oC.
Labeled RPAzm variants were separated from excess dye using a Biogel- P4 gel filtration
column (65 ml bed volume) using storage buffer (30 mM HEPES, pH 7.8, 100 mM KCl,
0.1mM EDTA, pH 8.0 and 10% (v/v) glycerol). Fractions containing labeled RPAzm were
pooled, concentrated using a 30 kDa cut-off spin concentrator and flash frozen using liquid
nitrogen. Fluorescent RPAzm were stored at -80 oC. Labeling efficiency was calculated
using absorption values measured at 280 nm and ε280= 98500 M-1cm-1for RPAzm, at 543
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nm with ε543= 105,000 M-1cm-1 for DBCO-MB543, ε555= 150,000 M-1cm-1 for DBCO-Cy3
and at 650 nm with ε650= 250,000 M-1cm-1 for DBCO-Cy5 fluorophores. A correction
factor was applied to the final concentration protein. See appendix II (section 9.1-9.4) for
detailed procedure on calculation of correction factor.

8.2.4 Purification of non-4AZP carrying RPAzm

Individual plasmids (Sc. RPA-wt; Sc. RPA- NKK-DRR; Sc. RPA- KK-AA and
Sc. RPA-K494A) were transformed in Rossetta-2 PlysS cells, plated in LB agarampicillin R
plates and incubated overnight at 37oC. At around 6 pm, individual 2.8l baffle flask (4
flasks in total), each containing autoclaved 1l LB medium supplemented with 100g/ml
ampicillin, was inoculated with a single transformed colony and incubated overnight at
37oC, without agitation. Next morning, measurements for OD600 were collected, and the
flasks were shaken at 250 rpm, at 37oC. At OD600: 0.5-0.8, cells were induced with
0.4mM IPTG and grown for an additional 3 hours at 37oC, 250rpm. Cells were harvested,
and purification was done following the same steps as for 4AZP carrying variants
mentioned in section 3.2.4 of chapter 3, with the following modifications. All the buffers
(cell resuspension buffer, H0, H50, H100, H1000, H1500) were supplemented with 1mM
tecep-HCl and RPA storage buffer was supplemented with 2mM tecep-HCl.
Sc. Srs2 was purified as described previously (Antony et. al., 2009a).
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8.2.5 Fluorescence measurements of RPAzm

Tryptophan quenching experiments was performed using a PTI QM40 instrument
(Horiba Scientific, Edison, NJ). To determine the emission maxima, a 2ml reaction with
50nM RPA-wt or RPAzm in reaction buffer (30 mM Hepes, pH 7.8, 100 mM KCl, 5 mM
MgCl2, 1 mM β-mercaptoethanol and 6 % v/v glycerol) was excited at 290 nm and
emission spectra (310nm-350nm) recorded. Following determination of emission
maximum, increasing concentrations of (dT)35 oligonucleotide was added to the 2ml
reaction, excited at 290nm and emission recorded for 10 seconds at emi (max).
Fluorescence measurements were normalized, plotted against [(dT)35] and fit using
single- step binding isotherm to determine the Kd values. All experiments were
performed at 25 °C.

8.2.6 Stopped-flow analysis of RPAzm DNA binding

All stopped-flow measurements were carried out with an Applied Photophysics
SX20 instrument (Surrey, UK) at 25oC. Reactions were performed in buffer (30 mM
Hepes, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM β-mercaptoethanol and 6 % v/v
glycerol). It is important to note that the concentrations of reactants are reduced to half
upon mixing in the stopped-flow instrument. Thus, all the concentrations mentioned
below are post-mixing concentrations.
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8.2.6.1 Tryptophan quenching experiments

To determine the rate of association of RPAzm, 100nM RPA-wt or RPAzm (Sc.
RPA- NKK-DRR, Sc. RPA- KK-AA or Sc. RPA-K494A) in one syringe were rapidly
mixed with increasing concentrations (25, 50, 75, 100, 150, 200nM) of (dT)35 in another
syringe. Optical parameters of exci: 290nm and long pass cut-off emission filter with
emi: 350nm were used to monitor change in tryptophan fluorescence. In total 10000 data
points were collected over a period of 2.25 seconds (5000 data points for first 250
milliseconds+ 5000 data points for rest 2 seconds). Raw traces obtained were fit in
KaleidaGraph using the equation:
ΔF = A1 (1 - e-k1t) + k2t

(Eq. 1)

Where, ΔF is change in tryptophan fluorescence, A1 and k1 are the amplitude and
observed rate of the exponential phase, k2 is the steady state rate and t is time.
The values for kobs,1 and kobs,2 were plotted against the concentration of (dT)35. A linear fit
equation:
y = mx + c

(Eq.3)

Where ‘m’, the slope represents the observed association constant (Ka) and ‘c’, the
constant represents the rate of dissociation (koff) was used to determine RPA-DBD-DNA
binding characteristics. Observed dissociation constant (Kd) values were calculated using
+reciprocal of Ka i.e. Kd= 1÷ Ka.
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8.2.6.2 ssDNA binding kinetics of RPAzm

The rate of association of DBD-A for RPAzm was measured using Sc. RPANKK-DRR-AMB543, Sc. RPA- KK-AA-AMB543 and Sc. RPA-K494A-AMB543. The rate of
association of DBD-D was measured using Sc. RPA- NKK-DRR-DMB543 and Sc. RPAK494A-DMB543.
For RPAzm, 100nM of fluorescently labeled protein (either DBD-A or DBD-D
labeled) was rapidly mixed with increasing concentrations (25, 50, 75, 100, 150, 200nM)
of (dT)35 oligonucleotide. For RPAS178D. 50nM of fluorescently labeled protein (either
DBD-A or DBD-D labeled) was rapidly mixed with increasing concentrations (10, 20,
50, 75, 100nM) of (dT)35 oligonucleotide. Increase in fluorescence signal was monitored
by exciting the sample at exci: 535nm and measuring emission using a long pass cut-off
filter at emi: 555nm. In total 10000 data points were collected over a period of 2.25
seconds (5000 data points for first 250 milliseconds+ 5000 data points for rest 2 seconds).
Raw traces obtained for DBD-A binding were fit using equation:
ΔF = A1(1 - e-k1t) + A2(1 - e-k2t) + k3t

(Eq. 2)

Where, ΔF is change in fluorescence of AMB543, A1 and k1 are the amplitude and
observed rate of the first exponential phase, A2 and k2 are the amplitude and observed rate
of the second exponential phase, k3 is the steady state rate and t is time.
The raw data traces obtained for DBD-D binding were fit using Eq.1. The rates
obtained for first exponential phase (kobs,1), second exponential phase (kobs,2) and steady
state were plotted against (dT)35 concentrations. Note: For DBD-D, kobs,2 values represent
steady state as there is no second exponential phase. Similar experiments were performed
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with 50nM RPA-S178D-AMB543 and 50nM RPA-S178D-DMB543 with increasing
concentrations (10, 20, 50, 75, 100nM) of (dT)35. Data were analyzed and plotted as
mentioned above.

8.2.6.3 FRET analysis to monitor the binding of two RPAzm

All samples were excited at 555nm and FRET was monitored with a 645nm cutoff emission filter. For FRET experiments with increasing lengths of oligonucleotides
(dT)n, where (n= 20, 35, 45, 60, 70, 79, 97, 140), 40nM RPA-Acy3or RPAzm-Acy3 paired
with 40nM RPA-Dcy5 or RPAzm-Dcy5 was rapidly mixed with 40nM (dT)n and FRET
monitored. Resulting FRET was analyzed using Eq. 2 for all the oligonucleotides, except
(dT)140, which was analyzed using Eq.1 to obtain the observed rates.

8.2.6.4 Srs2 clearing experiments

The following oligos were annealed as described in methods section of chapter 5 to
prepare DNA substrates for Srs2 clearing experiments are:
i)

5′Cy5 20bp-ds_3′ (dT)25 overhang, also known as DNA subs-1: 5′-/5Cy5/
ACC GCT GCC GTC GCT CCG GGT TTT TTT TTT TTT TTT TTT TTT
TTT -3′ and 5′-CCC GGA GCG ACG GCA GCG GT/ 3BHQ_2/-3′

ii) 5′Cy5 20bp-ds_3′ (dT)50 overhang, also known as DNA subs-2: 5′-/5Cy5/ ACC
GCT GCC GTC GCT CCG GGT TTT TTT TTT TTT TTT TTT TTT TTT TTT
TTT TTT TTT TTT TTT TTT TTT T-3′ and 5′-CCC GGA GCG ACG GCA
GCG GT/ 3BHQ_2/-3′
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50nM RPA-wt or RPAzm was prebound with 50nM 5′Cy5 20bp-ds_3′ (dT)25
overhang and mixed rapidly with 100nM Srs2 in reaction buffer supplemented with
2.5mM ATP. Samples were excited at lexci: 625nm and Cy5 fluorescence monitored with
a lemi: 635nm cut- off long pass filter. Similarly, 100nM RPA-wt or RPAzm was
prebound with 50nM 5′Cy5 20bp-ds_3′ (dT)50 overhang and mixed rapidly with 100nM
Srs2 in presence of 2.5mM ATP. In total 10000 data points were collected over a period
of 2minuts (5000 data points for first 30 seconds+ 5000 data points for rest 90 seconds).
All the raw traces obtained were analyzed using Eq.1 and the kobs values obtained were
plotted against RPA-wt or RPAzm variants for comparative analysis.

8.2.7 Limited proteolysis

5g of RPA-wt or RPAzm were treated with 50ng of trypsin or chymotrypsin
(1:100 dilution) in 20l reaction mixture containing 30mM Hepes, pH 7.8, 1mM EDTA,
pH 8.0, 8mM Tecep-HCl; 60mM MgCl2 with or without equal concentrations of (dT)35
oligonucleotide. All the reactions were carried out at 30oC. Unless specified, after 1 hour
of incubation, the reactions were terminated by adding equal volume of 2X SDS-loading
dye and boiling for 15 minutes. 35l of the total sample (reaction mixture+ dye) was
loaded on a 12% SDS-PAGE gel and the proteolyzed products separated by
electrophoresis. The gel was stained with Coomassie brilliant blue followed by de-stain
treatment to remove excess Coomassie blue stain. The resulting bands were compared
with protein ladder as a reference.
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8.3 Results

8.3.1 Mutations in zinc finger alters the DNA bound conformation of RPA

We investigated the DNA binding properties of RPAzm, as residues in the NKK
motif directly interact with ssDNA and are in close proximity to Zn2+ ion (Fig. 8-1). To
this extent, we measured changes in intrinsic tryptophan fluorescence when RPAzm
bound to ssDNA. Titrating increasing concentration of (dT)35 with 50nM RPAzm showed

Figure 8-1: Structure of U. maydis RPA showing NKK motif. The three amino acid
residues in the NKK motif (red sticks) make direct contact with ssDNA backbone (red
dashes). ssDNA is shown as black sticks. Cystines in the L12 loop in DBD-C coordinate
Zn2+ ion (black sphere) resulting in a defined structure.
varying degrees of change in intrinsic tryptophan fluorescence. Compared to RPA-wt,
RPA-KK-AA mutation showed the least change in tryptophan fluorescence followed by
RPA-K494A and RPA-NKK-DRR (Fig.8-2). Quantification of the binding isotherm
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revealed RPA-KK-AA required approximately 5-fold more DNA to saturate 50nM
protein, whereas, RPA-K494A and RPA-NKK-DRR maintained 1:1 (protein: DNA)
binding stoichiometry (Fig. 8-2, Table 8-2). This observation combined with differences
in the degree of tryptophan quenching suggest that specific mutations in the NKK motif
alters the way RPA-DBDs are associating to DNA, an perhaps the overall all
conformations adopted by RPAzm on DNA.

Figure 8-2: Fluorimeter experiments to monitor steady-state tryptophan quenching
of RPA-wt and RPAzm. 50nM RPA-wt or RPAzm mutants were titrated with increasing
concentrations of (dT)35 and change in tryptophan fluorescence was monitored. Data
were fit as described in methods to obtain dissociation constant (Kd) values. RPAzm
mutant have DNA binding affinity similar to RPA-wt but display a reduction in net
amplitude of tryptophan quenching than RPAwt.
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Table 8-2: Binding affinity for RPA-wt and RPAzm determined from the steadystate tryptophan quenching fluorimeter experiments.

RPA variants

Saturation point

RPA-wt

46.5 ± 5.5

RPA-K494A

40.8 ± 1.7

RPA-NKK-DRR

58.6 ± 1.6

RPA-KK-AA

117.3 ± 13.7

The data points for individual RPA variant in Fig. 8-2 was fit using single-site
binding isotherm to determine the saturation point.
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Next, we wanted to investigate if RPAzm bound with similar kinetics as RPA-wt
to ssDNA. 100nM RPAzm mutants were rapidly mixed with increasing concentrations of
(dT)35 and change in tryptophan fluorescence monitored at 350nm with a long-pass
emission filter. Resulting traces (Fig 8-3 a-d) were analyzed using Eq.1 (methods) and
rate of initial engagement (kobs,1) and steady state (kobs,2) plotted as a function of (dT)35
(Fig. 8-4 a, b). All three mutant variants in RPAzm had kon and koff values similar to
RPA-wt resulting in similar Kd (Table 8-3). Taken together, similar kon and koff values
suggests that mutations in the NKK motif do not affect the overall kinetics of binding or
binding affinity (Kd), but it affects the equilibrium state, i.e arrangement of RPAzmDBDs on DNA, as seen by differences in net tryptophan quenching (Fig. 8-2, Table 8-2).
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a)

b)
RPA-K494A

RPA-wt

c)

RPA-NKK-DRR

d)

RPA-KK-AA

Figure 8-3: Pre-steady state binding kinetics of RPA-wt and RPAzm. Stopped-flow
instrument was used to rapidly mix 100nM RPA-wt and RPAzm with increasing
concentrations of (dT)35. Representative raw traces of the tryptophan quenching
experiment for a) RPA-wt b) RPA-K494A c) RPA-NKK-DRR d) RPA-KK-AA
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a)

b)

Figure 8-4: Plot of observed rates (kobs) of binding for RPAwt and RPAzm stoppedflow experiments. Quantitative analysis of raw traces in figure 8-3 yield a) plot of kobs,1
and b) plot of kobs,2 with (dT)35 concentration plotted along the X-axis. Linear fit of the
plots gives binding parameters shown in table 8-3.
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Table 8-3: Kinetics of RPA-wt and RPAzm binding to ssDNA determined from the
tryptophan quenching experiments.

kon (M-1s-1)

koff (s-1)

Kd (nM)

RPA-wt

5.2 ± 0.3

9 ± 0.8

17.3 ± 4

RPA-K494A

5.35 ± 0.4

15.3 ± 5.8

28.6 ± 11

RPA-NKK-DRR

5.48 ± 1

12.6 ± 3.7

23.0 ± 5.2

RPA-KK-AA

6.0 ± 0.27

13.4 ± 3.7

22.0 ± 5.2

Finally, to confirm if differences in the degree of tryptophan quenching at steadystate measurements but similarity in rates of initial binding could indicate differential
arrangement of RPAzm domains after DNA binding is completed, we carried out limited
proteolysis experiments in presence and absence of DNA and compared it with RPA-wt
(Fig. 8-5, 8-6). Chymotrypsin digestion of RPA-wt in absence of DNA showed distinct
peptide fragments which are further degraded in RPAzm (Fig. 8-5, numbers 1-7). Similar
digestion in presence of DNA showed a large peptide fragment of ~60KDa for RPA-wt,
which is further degraded in RPAzm (Fig. 8-5, band labeled ‘a’). Furthermore, several
peptide bands observed for RPA-wt were absent in RPAzm (Fig. 8-5, bands labeled a-f).
We also performed similar limited proteolysis of RPA-wt and RPAzm with trypsin and
observed distinct peptide fragments present in RPA-wt that were absent in RPAzm
independent of DNA (Fig. 8-6, bands labeled as 1’, 2’ for no DNA and a’-d’ for +DNA)
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Asparagine and the two lysine residues present in the loop of DBD-C that holds
the Zn2+ metal ion makes electrostatic interactions with the phosphate backbone of
ssDNA. Mutating any lysine residue in this motif perturbs interaction with ssDNA as
observed with the single or double lysine mutants (K494A or KK-AA). The double lysine
mutant has the most severe perturbation in ssDNA binding ability, possibly due to
increased loop flexibility and loss in positive charge to interact with the negatively
charged ssDNA backbone. NKK-DRR mutation introduces a negative charge (N-D),
meanwhile maintains the positive charge required to interact with the DNA (KK-RR).
Although the negative charge carried by aspartate has the potential to repel the DNA and
length of the positive sidechain of amino acid is increased, the net charge of this motif is
still positive in nature. Thus, this mutation produces the least effect in tryptophan
quenching compared to other RPAzm variants. Perhaps, minimal differences in the
observed rates of engagement (kon) and dissociation (koff) stems from the fact that RPADNA binding is coordinated by engagement of all four DBDs. Since RPAzm has
particular mutations in a defined loop structure, this may particularly affect the path of
DNA as it passes through DBD-C and change the way DBD-C is engaging with DNA. It
could also affect how DNA passes from DBD-C to DBD-D. The effects of all these
possibilities in is highlighted by the limited proteolysis experiments that shows altered
conformation for RPAzm on DNA (Fig. 8-5, 8-6). Taken together, our results suggest
that RPAzm has DNA binding properties similar to RPA-wt but differences in the way
DBDs (in particular DBD-C) may arrange themselves on DNA.
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Figure 8-5: Limited proteolytic digestion of RPA-wt and RPAzm with
chymotrypsin. Qualitative assessment for understanding conformation of RPA-wt and
RPAzm, alone and in presence of ssDNA, shows regions that are protected from protease
digest in RPA-wt but not in RPAzm. For each RPA variant (RPA-wt or RPAzm), the
first lane represents RPA in absence of chymotrypsin and ssDNA, the second lane
represents chymotrypsin treated RPA in absence of ssDNA and the third lane represents
chymotrypsin treated RPA in presence of ssDNA. The numbered bands (1-5) show the
protected fragments that are present only in RPA-wt in absence of ssDNA. Bands with
alphabets (a-f) show fragments that are protected distinctly in RPA-wt in presence of
ssDNA.
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Figure 8-6: Limited proteolytic digestion of RPA-wt and RPAzm with trypsin.
Qualitative assessment for understanding conformation of RPA and lysine mutants alone
and in presence of ssDNA shows regions are protected from tryptic digestion in RPA-wt
but not in RPAzm. For each RPA variant, left lane represents undigested RPA variant
without ssDNA, the middle lane represents trypsin treated RPA in absence of ssDNA and
the right lane represents trypsin treated RPA in presence of ssDNA. The numbered bands
(1’,2’) show the protected fragments that are present only in RPA-wt in absence of
ssDNA. Bands with alphabets (a’-d') show fragments that are protected distinctly in
RPA-wt in presence of ssDNA.
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8.3.2 RPAzm has DBD-A and DBD-D binding dynamics similar to RPA-wt

Tryptophan quenching and limited- proteolysis experiments suggested RPAzmDBDs potentially adopted different conformation on DNA. To understand if this was due
to change in characteristics of DBD-A and DBD-D engagement, we developed RPAzmAMB543 (RPA-K494A-AMB543, RPA-NKK-DRR-AMB543, RPA-KK-AA-AMB543) and
RPAzm-DMB543 (RPA-K494A-DMB543 and RPA-NKK-DRR-DMB543) and investigated its
DNA binding properties in real-time. Both RPAzm-AMB543 and RPAzm-DMB543 produced
a robust increase in MB543 fluorescence upon binding to ssDNA (Fig. 8-7 a-d, 8-9 a-c).
Similar to RPA-AMB543 and RPA-DMB543, data obtained for RPAzm-AMB543 was best
described by double exponential with a linear phase and the data obtained for RPAzmDMB543 was best described by single exponential with linear phase. The first exponential
represents the initial engagement of DBD-A and DBD-D and the second exponential
represents the trimerization core mediated remodeling phase observed for DBD-A.
RPAzm-AMB543 had reduced initial rate of engagement than RPA-wt but overall
bound to the ssDNA with similar affinity (kobs,1 at 25nM (dT)35 for RPA-AMB543 : 47.7±
14.8; K494A-AMB543: 29.7 ± 2.03; NKK-DRR-AMB543: 25.8 ± 2.0; KK-AA-AMB543: 22.8
± 1.05) (Fig. 8-8 a, d). Consistent with RPA-AMB543 binding to (dT)35, RPAzm-AMB543
showed an initial increase in signal upon engagement of DBD-A with ssDNA (250
milliseconds) followed by a decrease in the fluorescence signa. This decrease in signal
has been attributed to trimerization core mediated remodeling of DBD-A (see chapter 3).
For RPAzm, there were subtle differences in the observed rates of the trimerization core
mediated remodeling phase of DBD-A (Fig. 6-12 a-d, 6-13 b, d). For 100nM RPAzmAMB543, instead of decrease in the rate of remodeling until 75nM (dT)35 (i.e. sub-
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stoichiometric concentration ssDNA: protein) as seen for RPA-AMB543, RPAzm showed a
steady increase in the rate of remodeling with increasing concentrations of (dT)35 (Fig 8-8
b). Since RPAzm mutations are located in DBD-C which is a component of the
trimerization core, a possible explanation for increase in the rate of remodeling could be
reduction in the binding affinity of the trimerization core. This could then lead to partial
loss of trimerization core mediated intra-DBD remodeling of DBD-A, perhaps by
changing the dynamics of linker connecting DBDs B, C which is then propagated to
changes in the dynamics of linker connecting DBDs A, B.
To understand if RPAzm affected the binding of trimerization core, we probed the
DNA binding dynamics of DBD-D for RPAzm. Stopped flow experiments performed
with RPAzm-DMB543 and increasing concentrations of (dT)35 showed a robust increase in
fluorescence signal upon binding to ssDNA with subtle differences in the kobs,1 values for
individual RPAzm (Fig. 8-9 a-c, 8-10 a). For 100nM RPA-K494A-DMB543, the rate at
which DBD-D binds to (dT)35 increases linearly until 100nM (dT)35, following which it
saturates, whereas, RPA-NKK-DRR-DMB543 binds comparatively faster until 100nM
(dT)35 following which it binds to (dT)35 similar to RPA-wt (Fig 8-10 a). Since this
project was done in collaboration with Dr. Xiaolan Zhang (MSKCC), we did not perform
RPA-KK-AA- DBD-D engagement with (dT)35 as this mutation caused poor viability of
S. cerevisiae. Taken together these results suggest mutation in the NKK motif causes
subtle change in the intrinsic DBD dynamics with modest effects in DNA binding ability.
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a)

c)

b)

d)

Figure 8-7: Monitoring DBD-A binding dynamics of RPA-wt and RPAzm mutants.
Stopped-flow experiments were conducted by rapidly mixing 100nM a) RPA-AMB543 b)
RPA-K494A-AMB543 and c) RPA-NKK-DRR-AMB543 d) RPA-KK-AA-AMB543 with
increasing concentrations of (dT)35. Samples were excited at 535nm and robust change in
MB543 fluorescence was monitored using a 555nm long pass emission filter. At substoichiometric concentrations of (dT)35 (red and gray traces) initial increase in MB543
fluorescence followed by slight decrease can be observed for all RPA variants. This is
suggestive of remodeling of DBD-A by the trimerization core of RPA.
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a)

c)

b)

d)

Figure 8-8: Quantitative analysis of DBD-A binding dynamics of RPA-wt and
RPAzm. Quantitation of the raw traces obtained in Fig. 8-7 using a two-step binding +
liner fit model provides observed rates for a) initial binding phase (kobs,1) b) remodeling/
rearrangement phase (kobs,2) c) linear phase (kobs,3). Fitting the plot of a) kobs,1 b) kobs,2 c)
kobs,3 to linear equation (except for kobs,2 of RPA-AMB543) yields the d) apparent
association and rearrangements rates for individual steps in DBD-A engagement on
ssDNA. It should be noted that solid black line for kobs,2 values of RPA-AMB543 is not a
true fit but representation of a trend depicting trimerization core mediated remodeling of
DBD-A.
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a)

b)

c)

Figure 8-9: Monitoring DBD-D binding dynamics of RPAwt and RPAzm mutants.
Stopped-flow experiments were conducted by rapidly mixing 100nM a) RPA-DMB543
b) RPA-K494A-AMB543 and c) RPA-NKK-DRR-DMB543 with increasing concentrations of
(dT)35. Samples were excited at 535nm and robust change in MB543 fluorescence was
monitored using a 555nm long pass emission filter. No remodeling phase is obtained for
all the variants of RPA-DMB543 after binding to (dT)35.
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a)

b)

Figure 8-10: Quantitative analysis of DBD-D binding dynamics of RPA-wt and
RPAzm. Quantitation of the raw traces obtained in Fig. 8-9 using a one-step binding +
liner fit model provides observed rates for a) initial binding phase (kobs,1) and b) linear
phase (kobs,2) plotted along increasing concentrations of (dT)35.
8.3.3 Assembly of RPAzm is similar to RPA-wt on ssDNA

Following subtle differences in overall conformations adopted and in DNA
binding dynamics of DBD-A and DBD-D for RPAzm, we wanted to investigate if
multiple RPAzm assembled similar to RPA-wt on ssDNA. Therefore, we generated
RPAzm FRET pairs with RPAzm-Acy3 and RPAzm-Dcy3 and monitored occurrence of
FRET with increasing lengths of oligonucleotides ((dT)n, where n= 20 to 140
nucleotides). Previous FRET experiments performed with Cy3 labeled ssDNA and cy5
labeled RPA-A or RPA-D have shown maximum FRET between 5′ Cy3 ssDNA and
RPA-ACy5 and 3′cy3 ssDNA and RPA-DCy5 bolstering the fact that RPA binds to DNA
with 5′-3′ polarity (Pokhrel et. al., 2019). Therefore, for FRET to occur, DBD-Acy3 from
one RPA has to be in tandem with DBD-Dcy5 form another RPA. Bulk FRET experiments
performed with 40nM RPAzm-Acy3, 40nM RPAzm-Dcy5 and 40nM increasing lengths of
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oligonucleotides show that RPAzm assembly on ssDNA can be explained by two- step
kinetic process for all ssDNA (Fig. 8-11 a-c). The first step (kobs,1) represents the
engagement of two DBDs along with ssDNA and the second step (kobs,2) represents the
rearrangement DBDs between the RPAs on ssDNA. RPAzm had assembly kinetics
similar to RPA-wt (Fig. 8-12 a, b). Similar to RPA-wt, quantifiable FRET intensity for
RPAzm was observed with ssDNA greater than 45 nucleotides and the increase is FRET
intensity was directly proportional to the length of ssDNA (Fig. 8-11 a-c). Robust
rearrangement step can be observed for (dT)60, (dT)70 and (dT)79 that have ample space
for assembly of at least 2 RPAs, but, have additional DNA space to allow transient
interaction/ binding of few DBDs from third RPA (Fig. 8-11 a-c). Thus, the
rearrangement step could be reflecting arrangement of DNA bound DBDs attempting to
attain stability, diffusion of at least two DNA bound RPAs or transient binding of an
incoming DBD-A which exists in association/ dissociation equilibrium.
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a)

b)

c)

Figure 8-11: Monitoring assembly of multiple RPAzm with increasing lengths of
ssDNA. Representative traces of stopped-flow experiments where, RPA-wt or RPAzm,
labeled with cy3 at DBD-A and Cy5 at DBD-D were mixed rapidly with increasing
lengths of ssDNA for a) RPA-Acy3 and RPA-Dcy5 b) RPA-K494A-Acy3 and RPA-K494ADcy5 c) RPA-NKK-DRR-Acy3 and RPA-NKK-DRR-Dcy5. All the experiments were
performed for n=3.

364

a)

b)

Figure 8-12: Quantification of the bulk FRET experiments in Fig. 8-11. All the data
obtained in Fig. 8-11 were analyzed using a two-step binding+ linear state model and
plotted along the increasing lengths of ssDNA. a) Plot showing the rate of engagement
phase (kobs,1) for RPA-wt and RPAzm. b) Plot showing rates for rearrangement phase for
RPA-wt and RPAzm. The rates for both the phases for RPAzm are within error of
RPAwt. All the experiments were performed for n=3.
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8.3.4 RPAzm are sensitive to clearing by Srs2 helicase

A delicate balance between the activity of pro-HR mediators (facilitating HR) and
anti HR- mediators (inhibiting HR) drive the regulated process of HR. In vivo, upon
mitomycin or camptothecin induced DNA damage, RPAzm rescued survivability of S.
cerevisiae in a Srs2 null background (Dhingran et. al., to be published). Furthermore, this
rescue of cell viability was dependent on interaction between Srs2 and Rad51 as, Srs2
 − which is deficient for interaction with Rad51 did not rescure cell survivability
upon DNA damage for both RPA-wt and RPAzm (Dhingran et. al., to be published). In
context of RPA, our ensemble stopped flow experiments showed only subtle distinction
in DBD dynamics with no significant differences in assembly of RPAzm compared to
RPA-wt. During HR, the main function of Srs2 is to disrupt Rad51-nuceloprotein
filaments in an attempt to prevent excess/ unregulated HR from occurring. Therefore, we
wanted to investigate effects of Srs2 helicase activity on a RPAzm-ssDNA complex to
understand how this complex could be contributing in rescuing cell survivability during
loss of Srs2. For this, we used a 20-bp duplex DNA consisting either a 3′ (dT)25 (DNA
subs-1) or a 3′ (dT)50 overhang (DNA subs-2) with Cy5 fluorophore attached at 5′ of the
long strand and Black Hole Quencher 2 (BHQ2) quencher attached at 5′ of the short
strand (Fig. 8-13 a, d). When annealed, BHQ2 quenches Cy5 fluorescence as they are in
close proximity to each other, followed by (dT)25 overhang in DNA subs-1 that has
enough space for only one RPA to bind and (dT)50 overhang in DNA subs-2 that has
enough DNA binding space for two RPAs. We preformed RPA:DNA subs-1 or
RPA:DNA-subs-2 complex with either RPA-wt or RPAzm and challenged it with 100nM
Srs2 helicase in presence of ATP. Each reaction cycle would sequentially involve ATP
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dependent loading of Srs2 towards the 3′ end for both DNA subs-1 and DNA subs-2,
translocation along the DNA, removal of any RPA bound on the DNA and unwinding of
the duplex DNA. Upon unwinding the duplex DNA, Cy5 attached to long strand would
move away from BHQ2 resulting in increase in Cy5 fluorescence. As expected, our
results showed much slower Srs2 mediated unwinding of duplex DNA in presence of
RPA-wt (Fig. 8-13 b, e, red trace) compared to in absence of any protein i.e DNA subs
only (Fig. 8-13 b, e, grey trace). In absence of any protein bound to the DNA substrates,
unwinding of DNA duplex was approximately 3-fold faster for DNA subs-2 (Fig. 8-13 f)
(kobs 0.13 ± 0.02 s-1) than DNA subs-1 (Fig. 8-13 c) (kobs 0.045 ± 0.017 s-1). Displacement
of RPAzm from ssDNA was faster compared to RPA-wt, with RPA-NKK-DRR showing
the least and RPA-K494A displaying intermediate resistance to clearing by Srs2 for both
DNA substrates (Fig. 8-13 c, f).
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Figure 8-13: Unwinding of duplex DNA by Srs2. Stopped flow experiments were
performed to monitor Srs2 mediated unwinding of 50nM DNA sub-1 with 3’(dT)25 or
50nM DNA-subs2 with 3’(dT)50 overhang either in presence or absence of RPAwt and
RPAzm. a), d) Schematic representation of RPA bound or unbound DNA-subs1 and
DNA subs-2, respectively. b) Stopped flow traces obtained when 50nM DNA-subs-1 was
incubated with 50nM RPA-wt or RPAzm and rapidly with 100nM Srs2 in presence of
ATP. Samples were excited at 625nm and increase in Cy5 fluorescence monitored at
645nm. As a control, Srs2 unwinding of DNA susb-1 was performed either in presence
(grey trace) or absence of ATP (olive green trace). Data obtained for DNA subs-1
unwinding experiments were fit with single-exponential+ linear phase, where the linear
phase represents the rate of unwinding (kobs). c) Plot of kobs of 50nM DNA susb-1 either
alone or prebound to 50nM RPA-wt or 50nM RPAzm when challenged with 100nM
Srs2. e) Similar experiments as mentioned in b) performed with 50nM DNA subs-2,
100nM RPA-wt or 100nM RPAzm and challenged with 100nM Srs2 in presence of ATP.
The reaction condition results in displacement of two RPAs bound to DNA subs-2 in
presence of Srs2. f) Plot of kobs (rate of unwinding) of 50nM DNA susb-2 alone or prebound to 100nM RPA-wt or 100nM RPAzm in presence of Srs2.
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8.4 Discussion

A key feature of RPAzm is that all the mutations are located in DBD-C which
also makes maximum contact with ssDNA (Fan & Pavletich, 2012b). The 32deoxythymidine oligonucleotide bound crystal structure of U. maydis RPA (4GNX)
shows ssDNA following a S-shaped path in DBD-C where, the “S” encompasses 10th
deoxythymidine to 20th deoxyhymidine (Thy10-Thy20). Amino acids in the NKK motif
form the bottom of the “S” and make direct contact with Thy10-Thy13 that stabilizes the
smaller DNA binding groove (L12 loop) (Fan & Pavletich, 2012a). In addition, cysteine
preceeding NKK motif is one of the four cysteines coordinating the Zn2+ metal ion.
Therefore, NKK motif is important in stabilizing the binding of DBD-C to DNA.
In this chapter, we showed that mutating key amino acid residues in the conserved
NKK motif in DBD-C could alter DNA bound conformations of RPA with potential
implications in regulation of HR pathway. Each mutation in RPAzm is different i.e.,
NKK→NKA substitution, NKK→DRR substitution and KK→AA substitution, which
could result in variations in the way the mutant protein is interacting with DNA. Using
steady-state tryptophan quenching as a guide to probe conformations adopted by DBDs,
we show that RPAzm-(dT)35 binding exhibits a varying degree of tryptophan quenching,
while maintaining the initial rate of binding to DNA similar to RPA-wt (Fig. 8-2, 8-3, 84, Table 8-2, 8-3). This change in conformation of RPAzm-ssDNA complex was further
verified by proteolytic digest experiments where, RPAzm showed distinct digestion
profile both in absence and presence of ssDNA (Fig. 8-5, 8-6). Using RPAzm-AMB543 and
RPAzm-DMB543, we show that both DBD-A and DBD-D have DNA binding dynamics
similar to RPA-wt, except for subtle changes in the rate of trimerization core mediated
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remodeling of DBD-A (Fig. 8-7, 8-8, 8-9, 8-10). While RPAzm assembly on ssDNA is
similar to RPA-wt (Fig. 8-11, 8-12), RPAzm nucleoprotein filament is more easily
disrupted by Srs2 helicase (Fig. 8-13). Taken together, these data suggests mutation in the
NKK motif affects properties of an RPA-DNA filament, possibly due to changes in
DBD-C-DNA engagement and communication between DBD-C and other DBDs. In
cellular context, ease in displacement of all the RPAzm variants by other HR proteins
(such as Rad51) trying to gain access to ssDNA could be enough for maintaing the
balance of HR. Under these conditions, upon DNA damage, yeast lacking Srs2 would
still survive as RPA can be easily displaced to allow Rad51 nucleoprotein formation and
HR to continue.
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APPENDIX II: SUPPLEMENTARY METHODS

9.1 Measuring concentration of protein using spectrophotometer (Agilent
Technologies, Cary UV-Visible spectrophotomer)

To measure the concentration of protein, stock protein was diluted about three
fold (Note: dilution depends on the expected yeild of protein and the volume of total
growth that was done). Spectophotometer was set to collect an absorbance range of 240350nm. ~400l strorage buffer was taken in a quartz cuvette and absorption spectra (240350nm) collected. This baseline/ reference absorption was either “zeroed” or “blanked”.
Then, ~400ul of diluted protein was taken in a quartz cuvette and absorption spectra
collected. The following reading were noted: Absprotein max, nm (usually 280±4 nm) and Abs350 (also
known as buffer correction reading).

The following equation was used to calculate protein’s

concentration in Molar (M)
Concentration (M)=

Abs280 (protein max 𝑎𝑏𝑠) −Abs350
𝜀𝑝𝑟𝑜𝑡𝑒𝑖𝑛

∗ dilution factor

9.2 Measuring concentration of fluorescent dye using spectrophotometer (Agilent
Technologies, Cary UV-Visible spectrophotomer)

Resuspend the lypholized flurophore according to the manufactor’s instructions.
For example, for Click chemistry tools DBCO-MB543, spin the vial for a minute using
table top centrifuge, following which add 51l of N, N Dimethylformamide (DMF) and
vortex the vial for about a minute at high-speed. To measure the concentration of the
resuspended dye, dilute the dye about 2000 fold (i.e. 1l of dye was diluted in 1.999ml of
protein storage buffer). Note: fold dilution might need to be adjusted depending on the
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signal saturation in fluorometer. Absorption spectra from 400nm-650nm were collected
and values at Absfluorophore max (usually 550nm), Absfluorophore correction,650nm noted.
Usually, absorption spectra consits of wavelength spanning atleast 100nm
upstream and 100nm downstream of the flurophore’s maximum absotption wavelength.
For example, for Cy5 with maximum absorption at 650nm, absorption spectra fromm
550-750nm would be collected.
The following equation was used to calculate the concentration of stock
fluorescent dye:
Concentration of fluorescent dye (M)=
Absflurophore max − (Absfluorophore correction )
∗ dilution factor
𝜀𝑓𝑙𝑢𝑟𝑜𝑝ℎ𝑜𝑟𝑒

9.3 Measuring correction factor

To measure the correction factor, stock fluorescent dye was diluted about 2000fold in protein storage buffer (i.e. 1l of dye was diluted in 1.999ml of protein storage
buffer). Depending on the fluorophore’s maximum absorption wavelength (Absmax),
absorption spectra spanning both the protein and fluorophore absorption range were
collected. For example, for DBCO-MB543 (click chemistry tools), absorption spectra
from 240nm-650nm were collected and values at Abs280nm, Abs350, Absfluorophore max (usually
550nm),

Absfluorophore correction,650nm noted. Usually, proteins have Absmax at 280± 5 nm with

Abs350nm as correction value for spectrophotometer.
Fluorophore’s correction wavelength= Absfluorophore max + 100nm.
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Correction factor was calculated using the following equation:
Correction factor= Abs

Abs280 −𝐴𝑏𝑠350
Absfluorophore max (usually 550nm) −Absfluorophore correction,650nm

9.4 Measuring concentration of fluorescently labeled protein

Concentration fluorescent protein was diluted either 2 or 3-fold in protein storage
buffer, depending on the expected yield of the protein. Absorption spectra spanning both
the protein and fluorophore absorption range were collected. For example, for DBCOMB543 (click chemistry tools), absorption spectra from 240nm-650nm were collected
and values at Abs280nm, Abs350, Absfluorophore max (usually 550nm), Absfluorophore correction,650nm
noted. For DBCO-Cy5(click chemistry tools), absorption spectra from 240nm-750nm
were collected and values at Abs280nm (the maximum absorption by protein), Abs350,
Absfluorophore max (usually 650nm), Absfluorophore correction,750nm noted.
Corrected concentration of protein in M was calculated using the following
equation:
Corrected Concentration of protein (M)=
Abs280 − (Abs280 ∗ correction factor) − Abs350
∗ dilution factor
𝜀𝑝𝑟𝑜𝑡𝑒𝑖𝑛
Concentration of fluorophore1 (M)=

Absflurophore max −(Absfluorophore correction )
𝜀𝑓𝑙𝑢𝑟𝑜𝑝ℎ𝑜𝑟𝑒

Concentration in M = concentration in Molar *10^6
Concentration of flurophore1 (μM)

Percentage labeling= Corrected concentration of protein (μM) ∗ 100%

∗ dilution factor
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